Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23412.Phospholipids in VLDL,AGRP,Agouti-related protein,40058,0.273753272739451,0.00456425173740518,0.264807339334137,0.282699206144765,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCL27,C-C motif chemokine 27,39868,0.255753270401928,0.00554261277932555,0.24488974935445,0.266616791449406,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCN1,CCN family member 1,39758,0.376003846136631,0.00656714776197966,0.363132236523151,0.388875455750111,0
NMR metabolomics,X23412.Phospholipids in VLDL,F7,Coagulation factor VII,39899,0.117495910929648,0.00266926802823986,0.112264145594298,0.122727676264998,0
NMR metabolomics,X23412.Phospholipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.280433927805216,0.00684820388012163,0.267011448200177,0.293856407410254,0
NMR metabolomics,X23412.Phospholipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0849646349201277,0.00193608832382788,0.0811699018054251,0.0887593680348303,0
NMR metabolomics,X23412.Phospholipids in VLDL,LDLR,Low-density lipoprotein receptor,39882,0.424195503856243,0.00366011633407961,0.417021675841447,0.43136933187104,0
NMR metabolomics,X23412.Phospholipids in VLDL,MFGE8,Lactadherin,39858,0.215241148368645,0.0037660922361394,0.207859607585812,0.222622689151478,0
NMR metabolomics,X23412.Phospholipids in VLDL,NPY,Pro-neuropeptide Y,40030,0.346478085674851,0.00563141141361155,0.335440519304173,0.35751565204553,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.169189184372569,0.0025471884448093,0.164196695020743,0.174181673724395,0
NMR metabolomics,X23412.Phospholipids in VLDL,PROC,Vitamin K-dependent protein C,39908,0.101338952448842,0.00229688153801224,0.096837064634338,0.105840840263346,0
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.178640424720213,0.004227309838214,0.170354897437314,0.186925952003113,0
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.126810890133187,0.00292121375525303,0.121085311172891,0.132536469093483,0
NMR metabolomics,X23412.Phospholipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.162221611010183,0.0038049378798475,0.154763932765682,0.169679289254684,0
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.125294611863406,0.00279830422362737,0.119809935585097,0.130779288141716,0
NMR metabolomics,X23412.Phospholipids in VLDL,PTH,Parathyroid hormone,37039,0.280511261413872,0.00714779728978484,0.266501578725894,0.294520944101851,1.11253692930828e-308
NMR metabolomics,X23412.Phospholipids in VLDL,APCS,Serum amyloid P-component,37333,0.120985869855015,0.00312819563994476,0.114854606400723,0.127117133309307,1.12300501764999e-308
NMR metabolomics,X23412.Phospholipids in VLDL,FURIN,Furin,39913,0.115455272268976,0.00306665605386911,0.109444626403392,0.121465918134559,2.4779068237155e-297
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.107727789303176,0.0028968224580612,0.102050017285376,0.113405561320976,1.90312497019115e-290
NMR metabolomics,X23412.Phospholipids in VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.0972185344025282,0.00261436239718884,0.0920943841040381,0.102342684701018,2.3011175223491e-290
NMR metabolomics,X23412.Phospholipids in VLDL,GHR,Growth hormone receptor,37124,0.0963727461260238,0.00259334879055001,0.0912897824965458,0.101455709755502,1.21027505458052e-287
NMR metabolomics,X23412.Phospholipids in VLDL,LPL,Lipoprotein lipase,39868,-0.157639038710911,0.00428494281373125,-0.166037526625825,-0.149240550795998,1.67541507365908e-284
NMR metabolomics,X23412.Phospholipids in VLDL,CES1,Liver carboxylesterase 1,39854,0.2620573772069,0.00723101949302968,0.247884579000562,0.276230175413238,1.8469444541666e-276
NMR metabolomics,X23412.Phospholipids in VLDL,CCL23,C-C motif chemokine 23,39931,0.135109523852887,0.00373508690429886,0.127788753520462,0.142430294185313,1.5861665959278e-275
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0622226412477158,0.00175349655147936,0.0587857880068162,0.0656594944886153,1.57824052568657e-265
NMR metabolomics,X23412.Phospholipids in VLDL,GCG,Pro-glucagon,39477,0.394200410885739,0.0111516156442656,0.372343244222978,0.416057577548499,2.18513434781509e-263
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.259898661132707,0.00752233426543531,0.245154885972454,0.27464243629296,3.93656073157631e-252
NMR metabolomics,X23412.Phospholipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.207174057422431,0.00606545819992714,0.195285759350574,0.219062355494288,7.8574085995484e-247
NMR metabolomics,X23412.Phospholipids in VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0853597647358743,0.00252850474175572,0.0804038954420331,0.0903156340297155,2.13527709599211e-241
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.267299681774435,0.00792381421811592,0.251769005906928,0.282830357641943,5.13882202357522e-241
NMR metabolomics,X23412.Phospholipids in VLDL,NCS1,Neuronal calcium sensor 1,40030,0.086078215656431,0.00256720007670869,0.081046503506082,0.09110992780678,2.36327831812918e-238
NMR metabolomics,X23412.Phospholipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.257217670815025,0.00772206003959914,0.24208243313741,0.272352908492639,3.84091084615252e-235
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.103043090754514,0.00309602803356057,0.0969748758087348,0.109111305700292,5.46349760513109e-235
NMR metabolomics,X23412.Phospholipids in VLDL,TTR,Transthyretin,37309,0.0762611886282166,0.00229177521668928,0.0717693092035056,0.0807530680529276,2.17340981569854e-233
NMR metabolomics,X23412.Phospholipids in VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.121437537818885,0.0036669589306773,0.114250298314757,0.128624777323012,2.39734029360212e-231
NMR metabolomics,X23412.Phospholipids in VLDL,GPR37,Prosaposin receptor GPR37,39585,0.194103885295728,0.00587850180225184,0.182582021763314,0.205625748828141,3.12110451511031e-231
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.434689783220497,0.0132366352930693,0.408745978046081,0.460633588394913,7.8765487289624e-229
NMR metabolomics,X23412.Phospholipids in VLDL,BCHE,Cholinesterase,37208,0.0822597104471943,0.00251231709732449,0.0773355689364383,0.0871838519579503,3.03065068542319e-226
NMR metabolomics,X23412.Phospholipids in VLDL,CFP,Properdin,37453,0.0688753461638791,0.00210963897330369,0.0647404537762039,0.0730102385515543,3.76805019759608e-225
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.174403016495692,0.00540248846549655,-0.184991893888065,-0.163814139103319,1.67230635129424e-221
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF9,Protein turtle homolog A,37437,0.242185440405655,0.00751549553256689,0.227455069161824,0.256915811649486,1.32674026396119e-219
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.15527044807532,0.00483568823215239,0.145792499140301,0.164748397010339,2.77636578168526e-219
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.224542203362883,0.00702717560956424,0.210768939168137,0.238315467557629,2.54551417984671e-217
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0559853015838343,0.00176510969052451,0.0525256865904063,0.0594449165772623,5.59016866179203e-214
NMR metabolomics,X23412.Phospholipids in VLDL,INHBC,Inhibin beta C chain,39858,0.11971017437275,0.00379859024484852,0.112264937492846,0.127155411252653,1.52917969981398e-211
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.306807784125086,0.00976594737316915,0.287666527273675,0.325949040976498,3.0023472255684e-210
NMR metabolomics,X23412.Phospholipids in VLDL,CFH,Complement factor H,36763,0.0674206134174138,0.00214724371736855,0.0632120157313714,0.0716292111034561,1.33232320328306e-208
NMR metabolomics,X23412.Phospholipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.227860081368909,0.00728325212324295,0.213584907207353,0.242135255530465,1.42533632093181e-208
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS15,Enteropeptidase,39788,0.254993207150422,0.00817127418289808,0.238977509751942,0.271008904548902,1.48118103488268e-207
NMR metabolomics,X23412.Phospholipids in VLDL,CPM,Carboxypeptidase M,39955,0.0979391175802747,0.00316087405957574,0.0917438044235062,0.104134430737043,8.50583658995555e-205
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA4,Kallistatin,37241,0.066293824102317,0.00213906424651323,0.062101258179151,0.0704863900254829,1.0012618793806e-203
NMR metabolomics,X23412.Phospholipids in VLDL,CFI,Complement factor I,37453,0.056537227294542,0.00182624208008864,0.0529577928175683,0.0601166617715158,2.08089420474826e-203
NMR metabolomics,X23412.Phospholipids in VLDL,SNCA,Alpha-synuclein,37124,0.326989912909597,0.0106141002117734,0.306186276494521,0.347793549324673,2.38379260021741e-201
NMR metabolomics,X23412.Phospholipids in VLDL,P4HB,Protein disulfide-isomerase,39776,0.109161175638829,0.00357131960734052,0.102161389208441,0.116160962069216,1.91739750767807e-199
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0889294083956623,0.00291331019918076,0.083219320405268,0.0946394963860566,6.45498987773637e-198
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA1,Glutathione S-transferase A1,39841,0.235888281490159,0.0077945158943822,0.22061103033717,0.251165532643148,1.10615062351321e-195
NMR metabolomics,X23412.Phospholipids in VLDL,PROS1,Vitamin K-dependent protein S,37453,0.06797657453883,0.00224374681804599,0.0635788307754599,0.0723743183022001,3.68731982710314e-195
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0837034944095516,0.00277231111310756,0.0782697646278608,0.0891372241912424,8.1979440704598e-195
NMR metabolomics,X23412.Phospholipids in VLDL,PLAT,Tissue-type plasminogen activator,40002,0.137498620576858,0.00455858828219837,0.128563787543749,0.146433453609966,1.75543475849594e-194
NMR metabolomics,X23412.Phospholipids in VLDL,CRIP2,Cysteine-rich protein 2,39749,0.0994427720317302,0.00329830092454681,0.0929781022196185,0.105907441843842,3.06360194403597e-194
NMR metabolomics,X23412.Phospholipids in VLDL,KYNU,Kynureninase,40058,0.125750061965723,0.00417606096590874,0.117564982472542,0.133935141458904,7.11274966979149e-194
NMR metabolomics,X23412.Phospholipids in VLDL,NRP1,Neuropilin-1,39949,-0.07611043959461,0.00254514755795859,-0.0810989288082088,-0.0711219503810112,2.8612580007849e-191
NMR metabolomics,X23412.Phospholipids in VLDL,SERPIND1,Heparin cofactor 2,37424,0.0771902426263864,0.00258214143922857,0.0721292454054984,0.0822512398472744,3.25189472150364e-190
NMR metabolomics,X23412.Phospholipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.310468887851532,0.0104184488549809,0.290048728095769,0.330889047607294,5.89175979531954e-190
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.154624204421008,0.00519774406188122,0.14443662605972,0.164811782782295,1.89550544261487e-188
NMR metabolomics,X23412.Phospholipids in VLDL,DSG2,Desmoglein-2,39858,-0.0723854049496273,0.00245420875381841,-0.0771956541071113,-0.0675751557921432,3.15931242830919e-186
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0675447204267956,0.0023078390757797,0.0630213558382674,0.0720680850153238,1.71225176066382e-183
NMR metabolomics,X23412.Phospholipids in VLDL,RBP5,Retinol-binding protein 5,39788,0.150749895077039,0.00515053583515434,0.140654844840137,0.160844945313942,1.79780122055553e-183
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN3,Contactin-3,39858,0.0878065977017661,0.00300460699282832,0.0819175679958226,0.0936956274077097,5.9560221035356e-183
NMR metabolomics,X23412.Phospholipids in VLDL,SOST,Sclerostin,39846,0.102596738295783,0.00351932824800441,0.0956988549296943,0.109494621661872,4.37947373754316e-182
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA3,Glutathione S-transferase A3,39477,0.204821761550987,0.00703320159004822,0.191036686434492,0.218606836667481,1.29754062585522e-181
NMR metabolomics,X23412.Phospholipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.293398568986961,0.0101340195523943,0.273535890664268,0.313261247309654,1.42180087008615e-179
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0559474206442888,0.00195211827355564,0.0521212688281197,0.0597735724604578,3.03842478670234e-176
NMR metabolomics,X23412.Phospholipids in VLDL,F10,Coagulation factor X,37445,0.0699088818328104,0.0024354120971668,0.0651354741223635,0.0746822895432573,5.5766198446161e-176
NMR metabolomics,X23412.Phospholipids in VLDL,F9,Coagulation factor IX,39908,0.0479308762251011,0.00167395491977743,0.0446499245823373,0.0512118278678648,6.63842130199718e-176
NMR metabolomics,X23412.Phospholipids in VLDL,ACY1,Aminoacylase-1,39868,0.162282200778292,0.00568299067595144,0.151143539053427,0.173420862503156,5.62290994672922e-175
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0761742307550612,0.0026810403855889,0.0709193915993069,0.0814290699108154,2.97591316971111e-173
NMR metabolomics,X23412.Phospholipids in VLDL,AGR3,Anterior gradient protein 3,39464,0.153839992728033,0.00543340130638286,0.143190526167523,0.164489459288544,5.06280584486319e-172
NMR metabolomics,X23412.Phospholipids in VLDL,ATRN,"Attractin, Isoform 2",37453,0.0424518640934127,0.00149786914134417,0.0395160405763782,0.0453876876104473,9.97598713624253e-172
NMR metabolomics,X23412.Phospholipids in VLDL,ADIPOQ,Adiponectin,37453,-0.172042606913334,0.00607853581407069,-0.183956537108912,-0.160128676717755,2.77504395447511e-171
NMR metabolomics,X23412.Phospholipids in VLDL,SYAP1,Synapse-associated protein 1,37124,0.149691990418975,0.00528830721488226,0.139326908277806,0.160057072560144,3.36746891930316e-171
NMR metabolomics,X23412.Phospholipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0661426984043717,0.00235443980416435,0.0615279963882095,0.0707574004205338,1.47699800399046e-169
NMR metabolomics,X23412.Phospholipids in VLDL,ELN,Elastin,37437,0.0869192626776702,0.00308838083813273,0.0808660362349301,0.0929724891204104,1.97707702992947e-169
NMR metabolomics,X23412.Phospholipids in VLDL,GRP,Gastrin-releasing peptide,37043,0.134520095907628,0.00478663986415141,0.125138281773891,0.143901910041365,8.03513193323107e-169
NMR metabolomics,X23412.Phospholipids in VLDL,AFM,Afamin,37453,0.0489588851213366,0.00174607958446166,0.0455365691357918,0.0523812011068815,3.15212610686137e-168
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0347092357672212,0.00124137536481834,0.0322761400521772,0.0371423314822651,3.061745612071e-167
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0939600050670432,0.00337317588239775,0.0873485803375436,0.100571429796543,4.34263684689834e-166
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR2,Cadherin-related family member 2,39788,0.186734705974521,0.00673084637826256,0.173542247073126,0.199927164875915,1.76600303963401e-165
NMR metabolomics,X23412.Phospholipids in VLDL,GUSB,Beta-glucuronidase,39919,0.150135113540727,0.00541338713030732,0.139524874765324,0.160745352316129,2.09170008665866e-165
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0706846431068318,0.00255294036928648,0.0656808799830303,0.0756884062306333,7.12016338642903e-165
NMR metabolomics,X23412.Phospholipids in VLDL,SORT1,Sortilin,39846,0.0951781476899587,0.00343918101099317,0.0884373529084121,0.101918942471505,1.04810404872706e-164
NMR metabolomics,X23412.Phospholipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0767339316508096,0.00277855239322125,0.0712879689600959,0.0821798943415232,5.0237826647547e-164
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.133016507543694,0.00482689559817826,0.123555792171265,0.142477222916124,2.12613085279556e-163
NMR metabolomics,X23412.Phospholipids in VLDL,UPB1,Beta-ureidopropionase,37437,0.233766089141382,0.0084735906383776,0.217157851490162,0.250374326792603,4.70838887799951e-163
NMR metabolomics,X23412.Phospholipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.149650002492084,0.00546131161707961,0.138945831722608,0.160354173261561,1.67781682177302e-161
NMR metabolomics,X23412.Phospholipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0784674494261281,0.00286539780856445,0.0728512697213418,0.0840836291309144,2.0611843276731e-161
NMR metabolomics,X23412.Phospholipids in VLDL,CCL22,C-C motif chemokine 22,39686,0.126821697332919,0.00465044591302144,0.117706823343396,0.135936571322441,4.60026622359422e-160
NMR metabolomics,X23412.Phospholipids in VLDL,AMBP,Protein AMBP,40003,0.048331897868521,0.00178443806747014,0.0448343992562795,0.0518293964807625,4.9054358689686e-158
NMR metabolomics,X23412.Phospholipids in VLDL,KLKB1,Plasma kallikrein,37187,0.0624773098727522,0.00230398401819636,0.0579615011970873,0.0669931185484171,1.13025967312257e-157
NMR metabolomics,X23412.Phospholipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.184974426781335,0.00684387464194257,0.171560432483127,0.198388421079542,2.4657215104858e-157
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.154241162897882,0.00573995829594963,-0.165491481157943,-0.142990844637821,1.22571988948774e-155
NMR metabolomics,X23412.Phospholipids in VLDL,STAB2,Stabilin-2,37437,0.0695118723593464,0.00258457486301515,0.0644461056278367,0.0745776390908561,2.84320363569019e-155
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.0633554309238957,0.00235800120805938,0.0587337485560993,0.0679771132916921,6.34639485361247e-155
NMR metabolomics,X23412.Phospholipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.213312761120984,0.0079422030722381,0.197746043099398,0.228879479142571,9.42118284072933e-155
NMR metabolomics,X23412.Phospholipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.166757782350238,0.00624418083071569,0.154519187922036,0.178996376778441,1.10612753461651e-153
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0531706810248238,0.00199339719338908,0.0492636225257812,0.0570777395238664,2.07270133121996e-153
NMR metabolomics,X23412.Phospholipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.125595135748251,0.00471455143813545,0.116354614929505,0.134835656566996,5.96969865599439e-153
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.170421976769169,0.0063962452226341,0.157885336132806,0.182958617405532,1.76546522947151e-152
NMR metabolomics,X23412.Phospholipids in VLDL,FN1,Fibronectin,37453,0.0652999580822774,0.00245752899512488,0.0604832012518326,0.0701167149127222,1.05318393840289e-151
NMR metabolomics,X23412.Phospholipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.206251141408001,0.00779235836312792,0.19097811901627,0.221524163799732,1.49695408335453e-150
NMR metabolomics,X23412.Phospholipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0526682551486625,0.00199435038598047,0.0487593283921407,0.0565771819051842,7.84926397218372e-150
NMR metabolomics,X23412.Phospholipids in VLDL,ENO3,Beta-enolase,37043,0.146982521011715,0.00556542975171088,0.136074278698362,0.157890763325068,8.03133852556279e-150
NMR metabolomics,X23412.Phospholipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.343302137401984,0.0130105880569285,0.317801384810404,0.368802889993563,1.16890571797642e-149
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0951397812126639,0.0036265723340351,0.0880316994379551,0.102247862987373,1.36063970290297e-148
NMR metabolomics,X23412.Phospholipids in VLDL,HEG1,Protein HEG homolog 1,37124,0.0655147375406158,0.00250188313403453,0.0606110465979081,0.0704184284833235,2.061295110607e-147
NMR metabolomics,X23412.Phospholipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.182536461081819,0.00699686515070361,0.16882260538644,0.196250316777198,2.35501261460484e-146
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.103100195808163,0.00396878367015382,0.095321379814662,0.110879011801665,8.41744263612127e-146
NMR metabolomics,X23412.Phospholipids in VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.298164311594582,0.0115216362853401,0.275581904475315,0.320746718713848,1.11438128512156e-144
NMR metabolomics,X23412.Phospholipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.118853841090677,0.00459948040290512,0.109838859500983,0.127868822680371,2.81591123215454e-144
NMR metabolomics,X23412.Phospholipids in VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.138374924064211,0.00535531042095644,0.127878515639136,0.148871332489285,9.5615730543812e-144
NMR metabolomics,X23412.Phospholipids in VLDL,NUMB,Protein numb homolog,37056,0.202083265222147,0.00781982106819372,0.186756415928487,0.217410114515806,1.0767958987435e-143
NMR metabolomics,X23412.Phospholipids in VLDL,APOM,Apolipoprotein M,39908,0.0634718369264784,0.00246299561227564,0.0586443655264181,0.0682993083265386,1.56677837798728e-143
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.139128910363533,0.00544668958045694,0.128453398785837,0.149804421941228,4.0279185000617e-141
NMR metabolomics,X23412.Phospholipids in VLDL,DTYMK,Thymidylate kinase,37437,0.162221458407056,0.006343377311968,0.149788438875599,0.174654477938514,6.37491907350465e-141
NMR metabolomics,X23412.Phospholipids in VLDL,CPB2,Carboxypeptidase B2,37424,0.0532329477390736,0.0020870405940293,0.0491423481747762,0.057323547303371,3.2883107371527e-140
NMR metabolomics,X23412.Phospholipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.109346926753899,0.00430451228671416,0.100910082671939,0.117783770835859,1.44799358891206e-139
NMR metabolomics,X23412.Phospholipids in VLDL,IL16,Pro-interleukin-16,40058,0.0967616722842328,0.00381166492164099,0.0892908090378165,0.104232535530649,1.90731008793837e-139
NMR metabolomics,X23412.Phospholipids in VLDL,CCL16,C-C motif chemokine 16,40052,0.122431773814132,0.00482816935285919,0.112968561882528,0.131894985745736,3.77728015885747e-139
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0686242687543757,0.00270580169446394,0.0633208974332264,0.073927640075525,1.09673122540205e-138
NMR metabolomics,X23412.Phospholipids in VLDL,MME,Neprilysin,39788,0.184166916241424,0.00728787993946335,0.169882671560076,0.198451160922772,3.52493116402536e-138
NMR metabolomics,X23412.Phospholipids in VLDL,NPPC,C-type natriuretic peptide,39866,0.106840960710801,0.00423003808946282,0.0985500860554539,0.115131835366148,4.65151745552925e-138
NMR metabolomics,X23412.Phospholipids in VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.19903671910345,0.00789564517366755,0.183561254563062,0.214512183643839,1.71352591088481e-137
NMR metabolomics,X23412.Phospholipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0606961583933179,0.00240872781607891,0.0559750518738032,0.0654172649128325,2.04474501308074e-137
NMR metabolomics,X23412.Phospholipids in VLDL,FCN2,Ficolin-2,39810,0.0944774538018954,0.00375178169719196,0.0871239616753991,0.101830945928392,2.98525631746492e-137
NMR metabolomics,X23412.Phospholipids in VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.281851991959424,0.011171086423374,0.259956662569611,0.303747321349237,3.25973299640709e-137
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0916689966320044,0.00364741983234182,0.0845200537606144,0.0988179395033943,9.65550741173237e-137
NMR metabolomics,X23412.Phospholipids in VLDL,CCL17,C-C motif chemokine 17,39836,0.209843095075679,0.00835437031487431,0.193468529258525,0.226217660892832,1.40265367504088e-136
NMR metabolomics,X23412.Phospholipids in VLDL,MLN,Promotilin,39866,0.206868614528186,0.00824704063303004,0.190704414887448,0.223032814168925,3.14046331813103e-136
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0476285703826157,0.00190006982419745,0.0439044335271887,0.0513527072380427,4.90187806652211e-136
NMR metabolomics,X23412.Phospholipids in VLDL,EEF1D,Elongation factor 1-delta,37437,0.211493494048381,0.00843970147075651,0.194951679165699,0.228035308931064,1.61958835098208e-135
NMR metabolomics,X23412.Phospholipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0907363422886999,0.00362730501845987,0.0836268244525185,0.0978458601248812,1.71658988261985e-135
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR5,Cadherin-related family member 5,39868,0.0896103968776519,0.00359252338695673,0.0825690510392167,0.0966517427160871,9.26535933930453e-135
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0599623624408024,0.00240640832249657,0.0552458021287092,0.0646789227528957,1.61030678296173e-134
NMR metabolomics,X23412.Phospholipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.184632889304899,0.00739738698077362,0.170134010822583,0.199131767787215,1.84475224737412e-134
NMR metabolomics,X23412.Phospholipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0599373800190253,0.00240186649495693,0.0552297216889097,0.0646450383491409,2.43935873094418e-134
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.210313045882358,0.00846263992662203,0.193726271626179,0.226899820138538,8.2302097911125e-134
NMR metabolomics,X23412.Phospholipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0666555227894918,0.00268369438773732,0.0613954817895267,0.071915563789457,1.11556519670016e-133
NMR metabolomics,X23412.Phospholipids in VLDL,NT5E,5'-nucleotidase,39913,0.127321293569301,0.00512591416956431,0.117274501796955,0.137368085341647,1.12909682945897e-133
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0781286978641249,0.00314831384265718,-0.0842993929957329,-0.0719580027325168,1.85287823439436e-133
NMR metabolomics,X23412.Phospholipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.143520104340325,0.00578374807082656,0.132183958121505,0.154856250559145,2.36843445304831e-133
NMR metabolomics,X23412.Phospholipids in VLDL,SCLY,Selenocysteine lyase,39984,0.112827623311771,0.00455943263731815,0.103891135342627,0.121764111280914,1.0131315935424e-132
NMR metabolomics,X23412.Phospholipids in VLDL,DPY30,Protein dpy-30 homolog,39979,0.135631721568793,0.005491478135259,0.124868424423685,0.146395018713901,3.14421613259922e-132
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.164688081613668,0.00667763512296315,0.151599916772661,0.177776246454676,8.11513245643108e-132
NMR metabolomics,X23412.Phospholipids in VLDL,APOC1,Apolipoprotein C-I,37424,0.0855835418356904,0.00346644212983243,0.0787893152612188,0.0923777684101619,1.10434090181699e-131
NMR metabolomics,X23412.Phospholipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.12456199876545,0.00506225938870348,0.114639970363591,0.134484027167309,3.26018718159896e-131
NMR metabolomics,X23412.Phospholipids in VLDL,SORD,Sorbitol dehydrogenase,39963,0.156059527641698,0.00635040219363314,0.143612739342177,0.168506315941219,6.0094674594985e-131
NMR metabolomics,X23412.Phospholipids in VLDL,PLTP,Phospholipid transfer protein,39976,-0.0817482610605968,0.00333011812803484,-0.0882752925915451,-0.0752212295296485,1.12407997132877e-130
NMR metabolomics,X23412.Phospholipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.067337997245569,0.0027433051308518,0.0619611191890994,0.0727148753020385,3.28142101773177e-130
NMR metabolomics,X23412.Phospholipids in VLDL,NOMO1,Nodal modulator 1,39858,0.0538289010583424,0.00219969907501813,0.0495174908713069,0.0581403112453779,7.25443732274405e-130
NMR metabolomics,X23412.Phospholipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.15479457213926,0.00634163650479537,0.142364964589861,0.167224179688659,3.19112914096816e-129
NMR metabolomics,X23412.Phospholipids in VLDL,MYH9,Myosin-9,37437,0.251363235648905,0.0103187585143448,0.231138468960789,0.271588002337021,2.53968327016586e-128
NMR metabolomics,X23412.Phospholipids in VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.256301029581314,0.0105768133211665,0.235570475471827,0.2770315836908,2.03490405924193e-127
NMR metabolomics,X23412.Phospholipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.144763960246625,0.00597748375637591,0.133048092084129,0.156479828409122,6.90087556078904e-127
NMR metabolomics,X23412.Phospholipids in VLDL,GLA,Alpha-galactosidase A,37088,0.0847554314289629,0.00350068261613396,0.0778940935013404,0.0916167693565855,9.53350321074431e-127
NMR metabolomics,X23412.Phospholipids in VLDL,DKK1,Dickkopf-related protein 1,40009,0.133497995609785,0.00554047809551606,0.122638658542574,0.144357332676997,4.68702087404939e-126
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0969895985120047,0.00404997756175394,0.089051642490967,0.104927554533042,1.52048984759997e-124
NMR metabolomics,X23412.Phospholipids in VLDL,DCXR,L-xylulose reductase,39913,0.119469924458563,0.0050013539262316,0.10966727076315,0.129272578153977,5.95385368014037e-124
NMR metabolomics,X23412.Phospholipids in VLDL,C9,Complement component C9,37445,-0.11743349157739,0.00491526889199756,-0.127067418605705,-0.107799564549074,1.30608456559739e-123
NMR metabolomics,X23412.Phospholipids in VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0719908022018339,0.00301933631694755,0.0660729030206167,0.0779087013830511,1.58441833771312e-123
NMR metabolomics,X23412.Phospholipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0440377366559737,0.00184774027828036,0.0404161657105442,0.0476593076014032,2.14334537957535e-123
NMR metabolomics,X23412.Phospholipids in VLDL,F11R,Junctional adhesion molecule A,39858,0.124821636929993,0.0052510091129447,0.114529659068621,0.135113614791364,8.88732150018348e-123
NMR metabolomics,X23412.Phospholipids in VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0622712279681181,0.00261761008369381,0.0571407122040783,0.067401743732158,1.36490913990006e-122
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0571107010877177,0.00240470551157823,0.0523974782850244,0.061823923890411,3.46661452282104e-122
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS1,Protein MTSS 1,37382,0.242174910112872,0.0102415689110583,0.222101435047198,0.262248385178546,3.65074406512379e-121
NMR metabolomics,X23412.Phospholipids in VLDL,RTBDN,Retbindin,39788,0.0641730736587554,0.00272264498812359,0.0588366894820331,0.0695094578354776,9.03866823061603e-121
NMR metabolomics,X23412.Phospholipids in VLDL,AGRN,Agrin,39931,0.0713307219665279,0.00302823291629271,0.0653953854505942,0.0772660584824617,1.21820567497394e-120
NMR metabolomics,X23412.Phospholipids in VLDL,KHK,Ketohexokinase,37043,0.141480732975494,0.0059988168755708,0.129723051899375,0.153238414051613,1.69794306759336e-120
NMR metabolomics,X23412.Phospholipids in VLDL,FYB1,FYN-binding protein 1,39836,0.200152713371864,0.00852177219065791,0.183450039878175,0.216855386865554,5.89243978481831e-120
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.267427996438307,0.0114090394321178,-0.289789713725257,-0.245066279151356,1.637210599872e-119
NMR metabolomics,X23412.Phospholipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.113838601581143,0.00485606700867301,0.104320710244144,0.123356492918142,3.71025687952999e-119
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3F,Semaphorin-3F,39868,0.0554120662231547,0.00236944256638091,0.0507679587930481,0.0600561736532613,5.79446592879325e-119
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0892587149467191,0.00382425947649695,0.0817631663727851,0.0967542635206531,3.69684902433783e-118
NMR metabolomics,X23412.Phospholipids in VLDL,CEP20,Centrosomal protein 20,39477,0.159712879475093,0.0068605670819933,0.146266167994386,0.1731595909558,7.15084785287963e-118
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0843312363759027,0.00362809451599587,-0.0914423016272546,-0.0772201711245508,1.43834680958429e-117
NMR metabolomics,X23412.Phospholipids in VLDL,FUOM,Fucose mutarotase,37124,0.137047108584941,0.00589208624236869,0.125498619549898,0.148595597619983,2.5002862951359e-117
NMR metabolomics,X23412.Phospholipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.156031148217442,0.00672860874595257,0.142843075075375,0.169219221359509,4.77730453191645e-117
NMR metabolomics,X23412.Phospholipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.192841877591231,0.00832081947782033,0.176533071414703,0.209150683767759,6.93282157346643e-117
NMR metabolomics,X23412.Phospholipids in VLDL,F13B,Coagulation factor XIII B chain,37380,0.0548957849945563,0.00236700182960694,0.0502564614085267,0.0595351085805859,1.02286293196222e-116
NMR metabolomics,X23412.Phospholipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0485818185617291,0.00209869376401005,0.0444683787842694,0.0526952583391888,1.21892080797702e-116
NMR metabolomics,X23412.Phospholipids in VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.234775440108375,0.0101625189145428,0.214856903035871,0.254693977180879,7.59155856274824e-116
NMR metabolomics,X23412.Phospholipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.064381144789597,0.00279216874050697,-0.0698537955209906,-0.0589084940582033,2.24927766182382e-115
NMR metabolomics,X23412.Phospholipids in VLDL,EHBP1,EH domain-binding protein 1,37437,0.160268579416775,0.00696628613914744,0.146614658584046,0.173922500249504,6.2708398362146e-115
NMR metabolomics,X23412.Phospholipids in VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.106237474040207,0.00463905044656221,0.0971449351649455,0.115330012915469,3.35057620352685e-114
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0919367954028181,0.00403513625374815,0.0840279283454718,0.0998456624601645,4.12771400253129e-113
NMR metabolomics,X23412.Phospholipids in VLDL,NPL,N-acetylneuraminate lyase,37437,0.0930302471235768,0.00408415547016087,0.0850253024020615,0.101035191845092,9.63511994192966e-113
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.17940764198292,0.00787542145426768,0.163971815932556,0.194843468033285,1.05348129342087e-112
NMR metabolomics,X23412.Phospholipids in VLDL,BTD,Biotinidase,37453,0.0434095763661261,0.00190675426004454,0.0396723380164388,0.0471468147158134,1.25052207174747e-112
NMR metabolomics,X23412.Phospholipids in VLDL,LEP,Leptin,39868,0.142234060293381,0.0062977828785596,0.129890405851404,0.154577714735358,3.32099917049124e-111
NMR metabolomics,X23412.Phospholipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0995485250193199,0.00440511454766221,0.090914500505902,0.108182549532738,5.54519582494477e-111
NMR metabolomics,X23412.Phospholipids in VLDL,CD63,CD63 antigen,39720,0.107863255889643,0.00478748557198893,0.0984797841685448,0.117246727610741,1.13696393419713e-110
NMR metabolomics,X23412.Phospholipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.10266483093246,0.00455015023571939,0.0937465364704501,0.11158312539447,1.19601858637351e-110
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN1,Perilipin-1,39489,0.0723911247724683,0.00321730810043783,0.0660852008956102,0.0786970486493265,2.30635243091468e-110
NMR metabolomics,X23412.Phospholipids in VLDL,EZR,Ezrin,40009,0.0501927382369644,0.00223454006483646,0.045813039709885,0.0545724367640439,4.68875893195523e-110
NMR metabolomics,X23412.Phospholipids in VLDL,TJAP1,Tight junction-associated protein 1,39913,0.173019454216469,0.00772511967614904,0.157878219651217,0.188160688781721,1.98719633872466e-109
NMR metabolomics,X23412.Phospholipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.142522635997557,0.00635539970792225,0.130066052570029,0.154979219425084,2.45348870980537e-109
NMR metabolomics,X23412.Phospholipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0578551577697854,0.00258538904662952,0.0527877952383915,0.0629225203011792,3.05457222447127e-109
NMR metabolomics,X23412.Phospholipids in VLDL,SHBG,Sex hormone-binding globulin,37445,-0.107264266896917,0.00478988301757599,-0.116652437611366,-0.0978760961824679,4.20675954711792e-109
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.115549038617828,0.00516944828481875,0.105416919979583,0.125681157256073,5.25140193751798e-109
NMR metabolomics,X23412.Phospholipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.10708456671624,0.00479367377703421,0.0976889661132531,0.116480167319227,7.80298195613929e-109
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.236285279483503,0.0105893623169404,0.2155301293423,0.257040429624706,1.25112813315962e-108
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE4,Ribonuclease 4,37051,0.0537432646141801,0.00241386673922676,0.0490120858052956,0.0584744434230645,7.83707134772776e-108
NMR metabolomics,X23412.Phospholipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.163815231879085,0.00740280298596029,0.149305738026602,0.178324725731567,7.26122880518935e-107
NMR metabolomics,X23412.Phospholipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.068210632962456,0.00308559528829889,0.0621628661973901,0.0742583997275218,1.070715944079e-106
NMR metabolomics,X23412.Phospholipids in VLDL,GH1,Somatotropin,39846,-0.370786938331226,0.0167852507947007,-0.40368602988884,-0.337887846773613,1.53843089467008e-106
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.168565035198245,0.00762417950240405,0.153621643373533,0.183508427022957,1.96816484377707e-106
NMR metabolomics,X23412.Phospholipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.2007225718597,0.00908615122481885,0.182913715459055,0.218531428260345,2.86502823231065e-106
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.135243392461822,0.00613096337193419,0.123226704252831,0.147260080670813,2.93468172796568e-106
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA5,Integrin alpha-5,39858,0.0507420531151315,0.00230705792786413,0.0462202195765178,0.0552638866537452,1.19548821389503e-105
NMR metabolomics,X23412.Phospholipids in VLDL,NUCB2,Nucleobindin-2,39995,0.076669479542804,0.00348817986004086,0.0698326470171239,0.0835063120684841,1.58122681437756e-105
NMR metabolomics,X23412.Phospholipids in VLDL,DAB2,Disabled homolog 2,40030,0.227771068155589,0.0103793279791329,0.207427585316489,0.24811455099469,3.32339751330886e-105
NMR metabolomics,X23412.Phospholipids in VLDL,THOP1,Thimet oligopeptidase,39798,0.0620808183227859,0.00283020994234779,0.0565336068357843,0.0676280298097876,4.29217568838944e-105
NMR metabolomics,X23412.Phospholipids in VLDL,SELP,P-selectin,39931,0.116859668922605,0.00533710900188663,0.106398935278908,0.127320402566303,9.65335699233607e-105
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0460225444497659,0.00210426107430962,0.0418981927441191,0.0501468961554128,1.75208000122162e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CCL5,C-C motif chemokine 5,39931,0.205280027464055,0.00939269390522757,0.186870347409809,0.223689707518301,2.28121861668408e-104
NMR metabolomics,X23412.Phospholipids in VLDL,MVK,Mevalonate kinase,39587,0.160610018704494,0.00736279650591179,0.146178937552907,0.175041099856081,5.94343023740822e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.19548985732679,0.00896509132563848,0.177918278328539,0.213061436325041,6.4391665754376e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.056871010987621,0.00260858455334346,0.0517581852630678,0.0619838367121742,7.26005210269591e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CKB,Creatine kinase B-type,37437,-0.117985875249512,0.00541003662314837,-0.128589547030883,-0.107382203468141,1.14354017813822e-103
NMR metabolomics,X23412.Phospholipids in VLDL,TXLNA,Alpha-taxilin,39749,0.180856470191471,0.00830389408063385,0.164580837793428,0.197132102589513,1.17999804052252e-103
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.166393300239982,0.00766231851130024,0.151375155957833,0.18141144452213,4.32333340561005e-103
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.070130498516512,0.00324297515422188,0.0637742672142371,0.0764867298187868,2.97245627513735e-102
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.227922082087,0.0105331156305154,0.20727717545119,0.248566988722811,4.42718713484187e-102
NMR metabolomics,X23412.Phospholipids in VLDL,CCN2,CCN family member 2,39880,0.117392830298802,0.00544186325378019,0.106726778321393,0.128058882276212,9.1588382192127e-102
NMR metabolomics,X23412.Phospholipids in VLDL,FGF21,Fibroblast growth factor 21,40011,0.238688030475005,0.0110992926776898,0.216933416826733,0.260442644123277,3.66704400188796e-101
NMR metabolomics,X23412.Phospholipids in VLDL,CD6,T-cell differentiation antigen CD6,40040,0.104919644891127,0.00487907854465086,0.0953566509436115,0.114482638838643,3.7083740368112e-101
NMR metabolomics,X23412.Phospholipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.217166450914336,0.0101011063699527,0.197368282429228,0.236964619399443,7.63740535414237e-101
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0466617622163505,0.00218672478487459,0.0423757816379963,0.0509477427947047,1.2118726834354e-99
NMR metabolomics,X23412.Phospholipids in VLDL,TCTN3,Tectonic-3,37437,0.0585785918347842,0.00274390483777876,0.0532005383527379,0.0639566453168306,1.72107693681835e-99
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS2,Protein MTSS 2,37368,0.198004064138662,0.00928189569672378,0.179811548573084,0.216196579704241,2.45892065971338e-99
NMR metabolomics,X23412.Phospholipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.133091486598038,0.00626188045654382,0.120818200903212,0.145364772292864,7.53448063028322e-99
NMR metabolomics,X23412.Phospholipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0727403023100513,0.00342403363319633,0.0660291963889864,0.0794514082311161,8.61838280189181e-99
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.193980986697447,0.00913312297036652,0.176080065675529,0.211881907719366,9.51007640558782e-99
NMR metabolomics,X23412.Phospholipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.164197793233492,0.00773056693201579,0.149045882046741,0.179349704420243,1.01010879772396e-98
NMR metabolomics,X23412.Phospholipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.209936544514939,0.00989660425849629,0.190539200168287,0.229333888861592,1.63859638709799e-98
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0528815479095342,0.00249506352360106,0.0479912234032761,0.0577718724157922,2.43095151071115e-98
NMR metabolomics,X23412.Phospholipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.107630881641582,0.00507902936920014,0.0976759840779498,0.117585779205214,2.80411604876754e-98
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.113000216918364,0.00533653385583001,0.102540610560938,0.123459823275791,6.8936151815982e-98
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNA4,Plexin-A4,39866,0.159785736189187,0.00756015348746933,0.144967835353747,0.174603637024627,8.1544684824237e-98
NMR metabolomics,X23412.Phospholipids in VLDL,ARF6,ADP-ribosylation factor 6,37382,0.209522044386192,0.00990759915799186,0.190103150036528,0.228940938735856,1.09965908302312e-97
NMR metabolomics,X23412.Phospholipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.192072982367434,0.00909710654393746,0.174242653541316,0.209903311193551,1.29165767071033e-97
NMR metabolomics,X23412.Phospholipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.104999248260703,0.00497925957918447,0.0952398994855013,0.114758597035904,2.23585946710678e-97
NMR metabolomics,X23412.Phospholipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.162519969323413,0.00769682256297185,0.147434197099988,0.177605741546838,2.28905060672295e-97
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0639428252934086,0.00303312635082595,0.0579978976457898,0.0698877529410275,2.48845801936341e-97
NMR metabolomics,X23412.Phospholipids in VLDL,AXIN1,Axin-1,39866,0.186945540551738,0.00888618865343408,0.169528610791007,0.204362470312469,6.05291663780176e-97
NMR metabolomics,X23412.Phospholipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.0922216598694208,0.00438421086330578,0.0836286065773415,0.1008147131615,1.10127361658434e-96
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.246933406346954,0.0117665785052053,0.223870912476751,0.269995900217156,1.7279782625512e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.142136252905752,0.00676505591253745,0.128876743317178,0.155395762494325,1.99147680067829e-96
NMR metabolomics,X23412.Phospholipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.210501670020516,0.0100238288568962,0.190854965460999,0.230148374580032,2.21303402097713e-96
NMR metabolomics,X23412.Phospholipids in VLDL,KAZN,Kazrin,37382,0.203448344200267,0.00970438717258487,0.184427745342001,0.222468943058534,4.62955312699865e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0747952385532545,0.00358051645836751,-0.0818130508116548,-0.0677774262948541,1.24039256023845e-95
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.137930128671535,0.00661172468882559,0.124971148281437,0.150889109061633,2.38728110620495e-95
NMR metabolomics,X23412.Phospholipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.157662571518296,0.00758086810706651,0.142804070028445,0.172521073008146,8.27980343579197e-95
NMR metabolomics,X23412.Phospholipids in VLDL,TPD52L2,Tumor protein D54,37124,0.211488838350755,0.0101711508515598,0.191553382681697,0.231424294019812,1.60019967066407e-94
NMR metabolomics,X23412.Phospholipids in VLDL,MINK1,Misshapen-like kinase 1,37388,0.179997720108938,0.00865862270494817,0.163026819607239,0.196968620610636,1.64836838923032e-94
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.115905240017522,0.00558990393997064,0.10494902829518,0.126861451739865,2.84073398044373e-94
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.122241277462347,0.00590187223710862,-0.13380894704708,-0.110673607877614,4.64658857787125e-94
NMR metabolomics,X23412.Phospholipids in VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.166176506404575,0.00801476323027065,0.150467570473245,0.181885442335906,4.95073357135168e-94
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.0707004119589699,0.0034143464472052,-0.0773925309954921,-0.0640082929224477,5.11996683995733e-94
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.163228802105834,0.0078745579355678,0.147794668552121,0.178662935659547,5.45551153589124e-94
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX2,Heme oxygenase 2,39489,0.0911850580683279,0.00440464539776914,0.0825519530887004,0.0998181630479554,6.03013840550579e-94
NMR metabolomics,X23412.Phospholipids in VLDL,BECN1,Beclin-1,37043,0.115799125258482,0.00563585415629765,0.104752851112139,0.126845399404826,2.28275111683556e-92
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.122598957753419,0.00597790586899821,0.110882262250182,0.134315653256655,4.47668978945021e-92
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.073453622601433,0.00358651834903233,0.0664240466373296,0.0804831985655364,4.71280649856028e-92
NMR metabolomics,X23412.Phospholipids in VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.121848904908847,0.0059547006996245,0.110177691537583,0.133520118280111,7.40315099837242e-92
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.208138839733816,0.0101813861930204,0.188183322795496,0.228094356672136,1.67297736954535e-91
NMR metabolomics,X23412.Phospholipids in VLDL,CREG1,Protein CREG1,39660,0.0715554641337088,0.00350845596744276,0.064678890437521,0.0784320378298966,2.75771374274804e-91
NMR metabolomics,X23412.Phospholipids in VLDL,ERBIN,Erbin,39788,0.194995187083631,0.00958327500128303,0.176211968081116,0.213778406086145,6.97460515374793e-91
NMR metabolomics,X23412.Phospholipids in VLDL,PPY,Pancreatic prohormone,39826,0.190008179482006,0.00933840989931139,0.171704896079356,0.208311462884657,6.99999653126329e-91
NMR metabolomics,X23412.Phospholipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.197593859092293,0.00973812422201415,0.178507135617145,0.216680582567441,2.1584010826056e-90
NMR metabolomics,X23412.Phospholipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0917359299597716,0.00452650399125241,0.0828639821369169,0.100607877782626,3.33995924387421e-90
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.161904855807485,0.00798872073514709,0.146246963166596,0.177562748448373,3.38515516828966e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.172302529777119,0.00850437476422499,0.155633955239238,0.188971104315,4.04981876920166e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CMIP,C-Maf-inducing protein,37368,0.156826515359878,0.00773237694243036,0.141671056552714,0.171981974167041,4.06951041832832e-90
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFC,Platelet-derived growth factor C,39477,0.054991265751599,0.00271966209292635,0.0496607280494633,0.0603218034537346,9.19572784941249e-90
NMR metabolomics,X23412.Phospholipids in VLDL,SDC4,Syndecan-4,39868,0.08549392410876,0.00423001372417572,0.0772030972093756,0.0937847510081444,1.0233773528511e-89
NMR metabolomics,X23412.Phospholipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.140309894253331,0.00694477488447526,0.12669813547976,0.153921653026903,2.04043172128314e-89
NMR metabolomics,X23412.Phospholipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0756224659133374,0.00374462746625448,0.0682829960794786,0.0829619357471962,2.24448462715152e-89
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0542323157709213,0.00268893989530545,0.0489619935761226,0.05950263796572,2.30365297251423e-89
NMR metabolomics,X23412.Phospholipids in VLDL,BCR,Breakpoint cluster region protein,39866,0.172604133799984,0.00856901722240879,0.155808860044063,0.189399407555905,3.94932958926983e-89
NMR metabolomics,X23412.Phospholipids in VLDL,STC1,Stanniocalcin-1,40009,0.078715162762245,0.00391036041781444,0.0710508563433287,0.0863794691811613,4.98157491883676e-89
NMR metabolomics,X23412.Phospholipids in VLDL,HJV,Hemojuvelin,37411,0.0833686871845047,0.00413672854411205,0.0752606992380451,0.0914766751309643,5.05085567705037e-89
NMR metabolomics,X23412.Phospholipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.133432653535736,0.00662359249958666,0.120450412236546,0.146414894834926,5.90243452968069e-89
NMR metabolomics,X23412.Phospholipids in VLDL,CCL13,C-C motif chemokine 13,40024,0.128955717579156,0.00641302561987522,0.116386187364201,0.141525247794112,7.58653589871948e-89
NMR metabolomics,X23412.Phospholipids in VLDL,FETUB,Fetuin-B,39908,0.06306420833739,0.00313782244061841,0.0569140763537779,0.0692143403210021,9.46029751561676e-89
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.062495227351434,0.00311379636576194,0.0563921864745406,0.0685982682283274,1.62941682051627e-88
NMR metabolomics,X23412.Phospholipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.11513523308082,0.00573747079652517,0.103889790319631,0.12638067584201,1.8513336035338e-88
NMR metabolomics,X23412.Phospholipids in VLDL,CST3,Cystatin-C,39897,0.0495644398625622,0.00247721981235974,0.0447090890303371,0.0544197906947873,5.53445210996654e-88
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.191797679350863,0.00960262345800473,0.172976537373174,0.210618821328553,1.83312100243399e-87
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN1,Dynactin subunit 1,40030,0.12092087690388,0.00606633770716054,0.109030854997845,0.132810898809914,2.34846787700893e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CTSO,Cathepsin O,40058,0.0556241953197343,0.00279149209873461,0.0501528708062144,0.0610955198332541,2.66855812140595e-87
NMR metabolomics,X23412.Phospholipids in VLDL,HGF,Hepatocyte growth factor,40058,0.0631209731770922,0.00316775610860917,0.0569121712042182,0.0693297751499661,2.68145557326574e-87
NMR metabolomics,X23412.Phospholipids in VLDL,GOLM2,Protein GOLM2,40009,0.0411441971407933,0.00206556072263606,0.0370956981244267,0.04519269615716,3.09213564339918e-87
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0654436812543617,0.00328591552366656,0.0590032868279753,0.0718840756807482,3.31732578638916e-87
NMR metabolomics,X23412.Phospholipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.213045016492985,0.0106863507931818,0.192099768938348,0.233990264047621,3.49531365343304e-87
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0728668281954342,0.00366010025898344,-0.0800406247030418,-0.0656930316878267,3.89632390267657e-87
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.175833187934884,0.0088332388269151,0.15852003983413,0.193146336035637,4.06271375843895e-87
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINH1,Serpin H1,37169,0.238565784670938,0.0119702324928533,0.215104128984945,0.26202744035693,4.15415487821058e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0447047897853455,0.00224773227667194,0.0402992345230685,0.0491103450476225,5.70449704029618e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CD2AP,CD2-associated protein,39868,0.117362311843203,0.00590836908859829,0.10578190842955,0.128942715256856,9.28015343076519e-87
NMR metabolomics,X23412.Phospholipids in VLDL,FABP5,Fatty acid-binding protein 5,39972,0.126352359757791,0.00636362216217749,0.113879660319923,0.138825059195659,1.07446359051132e-86
NMR metabolomics,X23412.Phospholipids in VLDL,AAMDC,Mth938 domain-containing protein,37043,0.0990501417611693,0.00498327292281399,0.0892829268324539,0.108817356689885,1.2011200007472e-86
NMR metabolomics,X23412.Phospholipids in VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0591111201529074,0.00297457936751031,0.0532809445925872,0.0649412957132276,1.36898900136732e-86
NMR metabolomics,X23412.Phospholipids in VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.196362973113242,0.00990952275695013,0.176940308509619,0.215785637716864,2.34190262665508e-86
NMR metabolomics,X23412.Phospholipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.163256769559685,0.00823009784910973,0.14712577777543,0.17938776134394,2.41918491066789e-86
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4R,Reticulon-4 receptor,40030,0.0612390158745626,0.00309198102619792,0.0551787330632146,0.0672992986859105,2.79340297164029e-86
NMR metabolomics,X23412.Phospholipids in VLDL,F2,Prothrombin,37453,0.0271294023119856,0.00137011417575064,0.0244439785275143,0.0298148260964569,4.75866537001937e-86
NMR metabolomics,X23412.Phospholipids in VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.109960792379642,0.00555547067261901,0.0990720698613083,0.120849514897975,5.59863440013577e-86
NMR metabolomics,X23412.Phospholipids in VLDL,THPO,Thrombopoietin,39585,0.0703121026234951,0.0035595152605396,0.0633354527128375,0.0772887525341527,8.23221867369452e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0507662147540476,0.00257501542599091,0.0457191845191055,0.0558132449889898,2.56805053175478e-85
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.0983508803408738,0.00499487751589226,0.088560920409725,0.108140840272023,2.67911498521936e-85
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.159733956417522,0.00811462837420086,0.143829284804089,0.175638628030956,2.96725132220932e-85
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0493364843534975,0.00251005608640257,0.0444167744241485,0.0542561942828465,5.09896697411233e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB3,Plexin-B3,39812,0.0873650257977717,0.00444553540396023,0.0786517764060096,0.0960782751895337,5.57965273759739e-85
NMR metabolomics,X23412.Phospholipids in VLDL,USO1,General vesicular transport factor p115,39788,0.1645368375383,0.00837748954738037,0.148116958025434,0.180956717051165,7.04608758859289e-85
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0823693884444191,0.00419211759179605,-0.0905859389243393,-0.0741528379644988,8.94955886467418e-85
NMR metabolomics,X23412.Phospholipids in VLDL,SLA2,Src-like-adapter 2,37411,0.193178223580985,0.00983284044247902,0.173905856313726,0.212450590848244,9.37182141587538e-85
NMR metabolomics,X23412.Phospholipids in VLDL,DOK2,Docking protein 2,39868,0.224129188150808,0.0114473214144377,0.20169243817851,0.246565938123106,2.25450745708746e-84
NMR metabolomics,X23412.Phospholipids in VLDL,CES2,Cocaine esterase,39788,0.0988731253402796,0.00505405870861817,0.088967170271388,0.108779080409171,3.10198682962582e-84
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R9B,Neurabin-2,40058,0.172751871213871,0.00883526811698226,0.155434745704586,0.190068996723156,3.65977178115995e-84
NMR metabolomics,X23412.Phospholipids in VLDL,PAXX,Protein PAXX,37124,0.0839091859157819,0.00428975164323924,0.0755012726950329,0.0923170991365308,5.11597759712231e-84
NMR metabolomics,X23412.Phospholipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.175713496688252,0.00900183777714997,0.158069894645038,0.193357098731466,1.05470892841293e-83
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.188957300873041,0.00969282811592486,0.169959357765828,0.207955243980254,1.13860946497923e-83
NMR metabolomics,X23412.Phospholipids in VLDL,SRPK2,SRSF protein kinase 2,39866,0.152909925074118,0.00784523268379037,0.137533269013889,0.168286581134347,1.22286865404924e-83
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.127980819779882,0.00657103329866484,0.115101594514499,0.140860045045265,1.66997302434238e-83
NMR metabolomics,X23412.Phospholipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.250240217000715,0.0128519180359395,0.225050457650274,0.275429976351157,1.8023095727548e-83
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS1,Galectin-1,39868,0.060900878465958,0.00312837288815051,0.054769267605183,0.067032489326733,1.91552334262774e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CES3,Carboxylesterase 3,39788,0.125125077479849,0.00642734203561204,0.11252748709005,0.137722667869649,1.92362724528483e-83
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD5,Programmed cell death protein 5,40009,0.105065657135626,0.00541303138100808,0.0944561156288497,0.115675198642401,5.6184939798088e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CDH2,Cadherin-2,39868,0.063522925372226,0.00327475320025697,0.0571044090997224,0.0699414416447297,7.19079086484879e-83
NMR metabolomics,X23412.Phospholipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0892394860536173,0.00460330055796849,0.080217016959999,0.0982619551472355,9.49438878911532e-83
NMR metabolomics,X23412.Phospholipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.111103468952509,0.00573073172589424,0.0998712347697559,0.122335703135261,1.3947285145044e-82
NMR metabolomics,X23412.Phospholipids in VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.121936897112963,0.00628966519201577,0.109609153336612,0.134264640889314,1.40646090057639e-82
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.179955968795956,0.00929588782536031,0.161736028658249,0.198175908933662,1.47347321654147e-82
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINC1,Antithrombin-III,37424,0.0263231378383962,0.00135914888518051,0.0236592060234424,0.02898706965335,1.88218848804192e-82
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.104816889263372,0.0054203275020494,0.0941930473593554,0.115440731167389,2.28250100992644e-82
NMR metabolomics,X23412.Phospholipids in VLDL,S100A4,Protein S100-A4,39913,0.102521125970879,0.00530917304344875,0.0921151468057192,0.112927105136038,3.76251790387837e-82
NMR metabolomics,X23412.Phospholipids in VLDL,MMP10,Stromelysin-2,39857,-0.105726913190656,0.00547836719618553,-0.11646451289518,-0.0949893134861327,4.6852597973244e-82
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.170347562630622,0.00884530822142733,0.153010758516625,0.18768436674462,1.00595085077847e-81
NMR metabolomics,X23412.Phospholipids in VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0505935357110238,0.00262840207300881,-0.0557452037741211,-0.0454418676479266,1.19764301951287e-81
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.134738858587332,0.00699422246794482,0.12103018255016,0.148447534624504,1.41590182053103e-81
NMR metabolomics,X23412.Phospholipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.114920994350521,0.00597091258819918,0.103218005677651,0.126623983023392,1.82031624767279e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SEC31A,Protein transport protein Sec31A,37043,0.138234194647037,0.0071877076352901,0.124146287681869,0.152322101612206,2.58444959209189e-81
NMR metabolomics,X23412.Phospholipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.162508439208602,0.00849304509124175,0.145862070829769,0.179154807587436,1.5127739103554e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.12953088060312,0.00677196150298859,0.116257836057262,0.142803925148978,1.70782857235629e-80
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0499867341883346,0.00261656105617715,0.0448582745182274,0.0551151938584418,1.85498001864633e-80
NMR metabolomics,X23412.Phospholipids in VLDL,GPC5,Glypican-5,39749,0.0997526958523215,0.00522323219930339,0.0895151607416868,0.109990230962956,2.08965239465033e-80
NMR metabolomics,X23412.Phospholipids in VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.229811475601114,0.0120417861814659,0.20620957468544,0.253413376516787,2.59116571264715e-80
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO1,Forkhead box protein O1,39866,0.153074110463787,0.00802549809597694,0.137344134195673,0.168804086731902,3.25086265838575e-80
NMR metabolomics,X23412.Phospholipids in VLDL,LEFTY2,Left-right determination factor 2,40011,0.0949613516990626,0.00498298244190169,0.0851947061129353,0.10472799728519,4.33323662552272e-80
NMR metabolomics,X23412.Phospholipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.201394868437761,0.0105686234331868,0.180680366508714,0.222109370366807,4.51297808834344e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PENK,Proenkephalin-A,37124,0.0518784342592971,0.00272078376976621,0.0465456980705553,0.0572111704480389,5.50991896012418e-80
NMR metabolomics,X23412.Phospholipids in VLDL,KLK10,Kallikrein-10,39856,0.0700284651041102,0.00367985770084476,0.0628159440104545,0.0772409861977659,7.3032139244027e-80
NMR metabolomics,X23412.Phospholipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0781506620415977,0.00411457799516788,0.0700860891710686,0.0862152349121268,1.45741432611577e-79
NMR metabolomics,X23412.Phospholipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0950596216414216,0.00500516637179791,0.0852494955526977,0.104869747730145,2.20781892440277e-79
NMR metabolomics,X23412.Phospholipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0472103917806391,0.00249151096810443,0.0423270302831544,0.0520937532781237,3.33274858908375e-79
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.191363712176091,0.0101163931330628,0.171535581635288,0.211191842716894,8.70260497492378e-79
NMR metabolomics,X23412.Phospholipids in VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.133825111980949,0.00708255259565754,0.11994330889346,0.147706915068438,8.80423602127207e-79
NMR metabolomics,X23412.Phospholipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.160012787038976,0.00846124054195609,0.143428755576742,0.17659681850121,9.44460397608412e-79
NMR metabolomics,X23412.Phospholipids in VLDL,FKBPL,FK506-binding protein-like,37382,0.105175662348065,0.00556461535345283,0.0942690162552972,0.116082308440832,1.15670381273756e-78
NMR metabolomics,X23412.Phospholipids in VLDL,C1S,Complement C1s subcomponent,37453,0.0369606543254448,0.00195571195896643,0.0331274588858706,0.040793849765019,1.18536006051007e-78
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.119321120392712,0.00632115465242781,0.106931657273953,0.13171058351147,1.24279035684717e-78
NMR metabolomics,X23412.Phospholipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.136608750884968,0.00723580063931476,0.122426581631911,0.150790920138025,1.70332149134604e-78
NMR metabolomics,X23412.Phospholipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.14884981759631,0.00789801583628315,0.133369706557195,0.164329928635425,2.23443410588153e-78
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.159601618970918,0.00847706948866565,0.142986562773133,0.176216675168703,4.46577081330167e-78
NMR metabolomics,X23412.Phospholipids in VLDL,DAG1,Dystroglycan,39931,0.0852533036300721,0.00453358825265062,0.0763674706548768,0.0941391366052673,4.74155449871871e-78
NMR metabolomics,X23412.Phospholipids in VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.128725620389794,0.0068523543621872,0.115295005839907,0.142156234939681,7.04521679888119e-78
NMR metabolomics,X23412.Phospholipids in VLDL,BACH1,Transcription regulator protein BACH1,39866,0.129912967689768,0.00692235817514206,0.11634514566649,0.143480789713047,9.56695183718535e-78
NMR metabolomics,X23412.Phospholipids in VLDL,CTSD,Cathepsin D,38721,0.0688783548792557,0.003669027492289,0.0616870609943692,0.0760696487641421,9.95434452206408e-78
NMR metabolomics,X23412.Phospholipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.113577584139325,0.00605641540533315,0.101707009944872,0.125448158333778,1.29479140862868e-77
NMR metabolomics,X23412.Phospholipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.133769470838018,0.00712875748714698,0.11979710616321,0.147741835512826,1.4011657772509e-77
NMR metabolomics,X23412.Phospholipids in VLDL,BID,BH3-interacting domain death agonist,39866,0.115667019449959,0.00617552032154687,0.103562999619727,0.127771039280191,1.89781976217246e-77
NMR metabolomics,X23412.Phospholipids in VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0706212281890656,0.00377513741782567,0.0632219588501273,0.0780204975280039,2.89529697342068e-77
NMR metabolomics,X23412.Phospholipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.169618398872895,0.00906838461886168,0.151844365019927,0.187392432725864,3.13768477368578e-77
NMR metabolomics,X23412.Phospholipids in VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.160854279817397,0.00860408481324811,0.14399027358343,0.177718286051363,3.59691013493838e-77
NMR metabolomics,X23412.Phospholipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0977209258658672,0.00523264734700695,0.0874649370657336,0.107976914666001,5.06546607293968e-77
NMR metabolomics,X23412.Phospholipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0465477625029474,0.00249027021577392,0.0416668328800306,0.0514286921258643,5.3173128391355e-77
NMR metabolomics,X23412.Phospholipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.164983677606424,0.00884131183389335,0.147654706411993,0.182312648800855,6.87095983826639e-77
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.0990476058682602,0.00532297998660668,0.0886145650945111,0.109480646642009,1.76118461805738e-76
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0340635997598824,0.00183177118427146,0.0304733282387103,0.0376538712810545,2.21567312622264e-76
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.148860036787165,0.00799606599455744,0.133187747437832,0.164532326136497,2.24901630269172e-76
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0530214391294072,0.00286401685441686,0.0474079660947501,0.0586349121640642,1.38968716882147e-75
NMR metabolomics,X23412.Phospholipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.122352070158162,0.00661884202745837,0.109379139784343,0.13532500053198,1.70447727654632e-75
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH2,Neutral ceramidase,39749,0.0902193039827112,0.00489670175620591,0.0806217685405476,0.0998168394248748,5.04580649545855e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0895837054054371,0.00486262747233395,0.0800529555596625,0.0991144552512116,5.10387916242433e-75
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.0960415657341898,0.00521023744946262,0.0858295003332431,0.106253631135137,5.88736932785456e-75
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.22278835285547,0.0121095574062346,0.19905362033925,0.246523085371689,8.02594497844013e-75
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS9,Galectin-9,39859,0.0541102690069991,0.00294318108024833,0.0483416340897124,0.0598789039242858,1.01874731462257e-74
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0537716324760072,0.00292168875179284,0.0480451225224933,0.0594981424295212,1.04363121517894e-74
NMR metabolomics,X23412.Phospholipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0368683391629042,0.00200770792814028,0.0329332316237493,0.0408034467020592,1.47257036840405e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ISM1,Isthmin-1,39866,0.0682803935022176,0.0037246801282653,0.0609800204508176,0.0755807665536175,2.65113708451979e-74
NMR metabolomics,X23412.Phospholipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.196284047500121,0.0107006980328086,0.175310679355816,0.217257415644426,2.97997981115018e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ANG,Angiogenin,39843,0.0577176896991066,0.00315677860962012,0.0515304036242511,0.063904975773962,6.31834454006694e-74
NMR metabolomics,X23412.Phospholipids in VLDL,GHRL,Appetite-regulating hormone,39868,0.131004013079388,0.00716980514871832,0.116951194987901,0.145056831170876,7.83119088762383e-74
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0566092619166368,0.00310095649558254,0.050531387185295,0.0626871366479786,1.04769006359901e-73
NMR metabolomics,X23412.Phospholipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.19098323464918,0.0104728617035869,0.17045642571015,0.211510043588211,1.50806017186793e-73
NMR metabolomics,X23412.Phospholipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0867429095138342,0.00475225645545593,0.0774284868611406,0.0960573321665278,1.58391611773458e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NIT2,Omega-amidase NIT2,37377,0.128568473344999,0.00704550460740341,0.114759284314488,0.142377662375509,1.62525122957286e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CEP43,Centrosomal protein 43,39476,0.118911916901238,0.00654275061224379,0.10608812570124,0.131735708101236,4.63985283598926e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.104112983124206,0.00573348147388842,0.0928753594353846,0.115350606813027,6.15414293027336e-73
NMR metabolomics,X23412.Phospholipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.114130022464033,0.00629130941128662,0.101799056017911,0.126460988910155,8.45226023284444e-73
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0708889015719228,0.0039103679152426,0.0632245804580473,0.0785532226857983,1.04410663749398e-72
NMR metabolomics,X23412.Phospholipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.128686029036453,0.0071020604001829,0.114765990652095,0.142606067420812,1.22396555798802e-72
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.150104525196205,0.00827889397985618,0.133877892995687,0.166331157396723,1.3765105944386e-72
NMR metabolomics,X23412.Phospholipids in VLDL,HEXIM1,Protein HEXIM1,39866,0.138048979877359,0.00762830706907086,0.12309749802198,0.153000461732738,1.77690742944364e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.173538969911532,0.00958065680464031,0.154760882574437,0.192317057248627,1.79013584942541e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CD36,Platelet glycoprotein 4,37056,0.0774719033189171,0.00427807875046072,0.069086868968014,0.0858569376698201,2.03144550199238e-72
NMR metabolomics,X23412.Phospholipids in VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.129879930741505,0.00717925836274716,0.115808584350521,0.14395127713249,2.66649506057739e-72
NMR metabolomics,X23412.Phospholipids in VLDL,VNN1,Pantetheinase,37445,0.122531213630991,0.00677421550398744,0.109253751243176,0.135808676018807,2.79259189266719e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.117351759613247,0.00649185047240285,0.104627732687338,0.130075786539157,3.42690257595262e-72
NMR metabolomics,X23412.Phospholipids in VLDL,OGFR,Opioid growth factor receptor,39788,0.0551351352459329,0.0030570338133148,0.0491433489718359,0.0611269215200299,5.33253165626711e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.10652475200984,0.00590664060272327,0.0949477364285023,0.118101767591178,5.36186458620364e-72
NMR metabolomics,X23412.Phospholipids in VLDL,DNMBP,Dynamin-binding protein,39749,0.104478867605814,0.00580040062670279,0.0931100823774762,0.115847652834151,8.0680245237308e-72
NMR metabolomics,X23412.Phospholipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0395559893340466,0.00220245372845426,0.0352391800262762,0.0438727986418169,2.04478306767686e-71
NMR metabolomics,X23412.Phospholipids in VLDL,C4BPB,C4b-binding protein beta chain,39913,0.066513851841292,0.00370923521765654,0.0592437508146852,0.0737839528678988,3.28538464149282e-71
NMR metabolomics,X23412.Phospholipids in VLDL,DLK1,Protein delta homolog 1,40052,0.0934217089838961,0.00521435565280839,0.0832015719043917,0.103641846063401,4.27523839553519e-71
NMR metabolomics,X23412.Phospholipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.20572237110712,0.0114989040647951,0.183184519140121,0.228260223074118,7.18637162571852e-71
NMR metabolomics,X23412.Phospholipids in VLDL,SIAE,Sialate O-acetylesterase,39875,0.0789233650306833,0.00441452513423676,0.0702708957675793,0.0875758342937873,8.51132885387658e-71
NMR metabolomics,X23412.Phospholipids in VLDL,COCH,Cochlin,37437,0.0764933426291679,0.00427484612873698,0.0681146442168435,0.0848720410414924,8.55037090694295e-71
NMR metabolomics,X23412.Phospholipids in VLDL,PGF,Placenta growth factor,40058,0.0429582358509171,0.00240425111095549,0.0382459036734443,0.0476705680283899,1.00566500864093e-70
NMR metabolomics,X23412.Phospholipids in VLDL,CLUL1,Clusterin-like protein 1,39840,-0.075412324532154,0.00422575425199498,-0.0836948028660642,-0.0671298461982439,1.50429657521741e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.081213878878597,0.00455070254062244,0.072294501898977,0.090133255858217,1.52753098660676e-70
NMR metabolomics,X23412.Phospholipids in VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.050015581197366,0.00280283335036834,0.0445220278306441,0.055509134564088,1.57807976976696e-70
NMR metabolomics,X23412.Phospholipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0491926730220559,0.00275786472811133,0.0437872581549577,0.0545980878891541,1.74621503037988e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0632976217269076,0.0035490306283624,0.0563415216953173,0.0702537217584979,1.79907062649426e-70
NMR metabolomics,X23412.Phospholipids in VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.111304220713706,0.00624611104994256,0.0990618430558188,0.123546598371594,2.34035331849383e-70
NMR metabolomics,X23412.Phospholipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.177039196560933,0.00993352704682573,0.157569483549154,0.196508909572711,3.09612470070801e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SNCG,Gamma-synuclein,39749,0.108152518436192,0.00607788965510435,0.0962398547121872,0.120065182160196,3.74042079094166e-70
NMR metabolomics,X23412.Phospholipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0840251858910344,0.00472171479346552,0.074770624895842,0.0932797468862269,3.76724750622183e-70
NMR metabolomics,X23412.Phospholipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.127622822440516,0.00716667081118679,0.11357614765059,0.141669497230442,3.86309783080398e-70
NMR metabolomics,X23412.Phospholipids in VLDL,QDPR,Dihydropteridine reductase,39790,0.0722512773402828,0.00406497785755391,0.0642839207394772,0.0802186339410885,5.31674048458276e-70
NMR metabolomics,X23412.Phospholipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.105996042076844,0.00596400180014715,0.0943065985485555,0.117685485605132,5.62369741587875e-70
NMR metabolomics,X23412.Phospholipids in VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.14067976914351,0.00791990768734037,0.125156750076323,0.156202788210697,6.47717990950034e-70
NMR metabolomics,X23412.Phospholipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0746617922913767,0.00420340239512254,0.0664231235969365,0.0829004609858169,6.54269753635411e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.172780959075707,0.00973323173387055,0.153703824877321,0.191858093274094,7.76367871652561e-70
NMR metabolomics,X23412.Phospholipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.194268544427675,0.0109454526578612,0.172815457218267,0.215721631637082,8.27344551167668e-70
NMR metabolomics,X23412.Phospholipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.127440779811618,0.00718087425082558,0.11336626628,0.141515293343236,8.49876593403776e-70
NMR metabolomics,X23412.Phospholipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.104049489420437,0.00586233238147344,0.092559317952749,0.115539660888125,1.08353659300139e-69
NMR metabolomics,X23412.Phospholipids in VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.119920332525656,0.00675758200391625,0.10667547179798,0.133165193253332,1.12990359471325e-69
NMR metabolomics,X23412.Phospholipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.168126103403715,0.00948578596581206,0.149533962910723,0.186718243896707,1.26559376420995e-69
NMR metabolomics,X23412.Phospholipids in VLDL,EREG,Proepiregulin,39713,0.13235278856269,0.00746925578704521,0.117713047220081,0.146992529905299,1.38482738856861e-69
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D23,TBC1 domain family member 23,39788,0.149157951305146,0.00842419979024266,0.13264651971627,0.165669382894022,1.74826823844734e-69
NMR metabolomics,X23412.Phospholipids in VLDL,VSNL1,Visinin-like protein 1,37388,0.0626329887789687,0.00353457133520369,0.0557052289619695,0.0695607485959679,1.78502394427413e-69
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.108869701546039,0.00615207481618025,0.0968116349063261,0.120927768185753,2.68507296738038e-69
NMR metabolomics,X23412.Phospholipids in VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.131786804975873,0.00745009893517247,0.117184611062935,0.146388998888811,3.18734761479892e-69
NMR metabolomics,X23412.Phospholipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.115669220380041,0.00654393041128696,0.102843116773918,0.128495323986163,4.03224162100519e-69
NMR metabolomics,X23412.Phospholipids in VLDL,PLG,Plasminogen,37162,0.0374107304621484,0.00211685583408079,0.03326169302735,0.0415597678969467,4.18078572857958e-69
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0880547911178343,0.00498461102960338,0.0782849534998117,0.0978246287358569,4.6205415892279e-69
NMR metabolomics,X23412.Phospholipids in VLDL,MYDGF,Myeloid-derived growth factor,37437,0.167090460391178,0.00947370199166537,0.148522004487514,0.185658916294842,7.45354794569658e-69
NMR metabolomics,X23412.Phospholipids in VLDL,METAP2,Methionine aminopeptidase 2,40011,0.0950943388398321,0.00540190344776646,0.0845066080822098,0.105682069597454,1.00807397603084e-68
NMR metabolomics,X23412.Phospholipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0628737138470997,0.00357422001380704,0.0558682426200379,0.0698791850741615,1.2878940819925e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SH2B3,SH2B adapter protein 3,39477,0.162072577052475,0.0092187782890996,0.14400377160584,0.18014138249911,1.58194507908993e-68
NMR metabolomics,X23412.Phospholipids in VLDL,ARSB,Arylsulfatase B,39788,0.0908446650715755,0.0051713407708489,0.0807088371607117,0.100980492982439,1.94886044396759e-68
NMR metabolomics,X23412.Phospholipids in VLDL,EGLN1,Egl nine homolog 1,39866,0.0876063180110515,0.00498790995682113,0.077830014495682,0.0973826215264209,2.04552063000786e-68
NMR metabolomics,X23412.Phospholipids in VLDL,RILPL2,RILP-like protein 2,37437,0.162213271385109,0.00923618678277873,0.144110345290863,0.180316197479355,2.69692305581778e-68
NMR metabolomics,X23412.Phospholipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0326380454123368,0.00185904550798948,0.0289943162166774,0.0362817746079962,3.03222025138734e-68
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.123144556906281,0.00702584312084076,0.109373904389433,0.136915209423129,3.83292167826417e-68
NMR metabolomics,X23412.Phospholipids in VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.124242563576571,0.00708795347878566,0.110350174758151,0.138134952394991,4.86642450747554e-68
NMR metabolomics,X23412.Phospholipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.127841678208575,0.00729398857064085,0.113545460610119,0.142137895807031,5.19868605029794e-68
NMR metabolomics,X23412.Phospholipids in VLDL,C3,Complement C3,36816,0.0754861068742517,0.00431396680214808,0.0670307319420414,0.0839414818064619,8.89955617212309e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0609331386430241,0.00348309294195892,0.0541062764767847,0.0677600008092636,9.16439563473671e-68
NMR metabolomics,X23412.Phospholipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0444739359845873,0.00254485360891901,0.039486022911106,0.0494618490580685,9.6086162115467e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0379704338020525,0.0021741874063436,0.033709026485619,0.0422318411184859,1.12109515455295e-67
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.179706878659202,0.010297337390155,0.159524097374498,0.199889659943906,1.40037636898817e-67
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.135320537233105,0.0077491085234887,0.120132284527067,0.150508789939143,1.56580273921152e-67
NMR metabolomics,X23412.Phospholipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.118604118393868,0.00680219494487084,0.105271816301922,0.131936420485815,1.83442634121598e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0457597963766193,0.00262620555993731,0.0406124334791422,0.0509071592740965,2.25718303532433e-67
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0577671839203501,0.00331574142895189,0.0512683307196043,0.0642660371210958,2.36066672536697e-67
NMR metabolomics,X23412.Phospholipids in VLDL,AMN,Protein amnionless,39587,0.0776821923056602,0.00445906065059212,0.0689424334304996,0.0864219511808208,2.44128098402067e-67
NMR metabolomics,X23412.Phospholipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0560760509243778,0.00322151362299348,0.0497618842233105,0.062390217625445,3.12855430855127e-67
NMR metabolomics,X23412.Phospholipids in VLDL,MITD1,MIT domain-containing protein 1,39749,0.158220731085365,0.00909559256486932,0.140393369658221,0.176048092512509,3.74887780722236e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SNX15,Sorting nexin-15,37124,0.0878067035736363,0.00504445986416311,0.0779195622398767,0.097693844907396,4.09079988458644e-67
NMR metabolomics,X23412.Phospholipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.117520883038447,0.00675438648040943,0.104282285536844,0.130759480540049,4.63904479423293e-67
NMR metabolomics,X23412.Phospholipids in VLDL,TBCC,Tubulin-specific chaperone C,39749,0.132194306186278,0.00760934498597921,0.117279990013759,0.147108622358797,5.5281377329984e-67
NMR metabolomics,X23412.Phospholipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.158774974421116,0.00914766542894918,0.140845550180376,0.176704398661857,9.6251020388001e-67
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS8,Prostasin,39805,0.0650144120031813,0.0037530522946677,0.0576584295056326,0.07237039450073,1.28244292378599e-66
NMR metabolomics,X23412.Phospholipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0932704310397079,0.00538247494648356,0.0827207801446001,0.103820081934816,1.56487100069311e-66
NMR metabolomics,X23412.Phospholipids in VLDL,IST1,IST1 homolog,37287,0.16197042167181,0.00934904503186157,0.143646293409362,0.180294549934259,1.6140012930821e-66
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.144575924646496,0.00834553282884748,0.128218680301955,0.160933168991037,1.62451159903577e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.19396306478591,0.0112065014804148,0.171998321884296,0.215927807687523,2.11278722067537e-66
NMR metabolomics,X23412.Phospholipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.140414020105967,0.00813200268067159,0.124475294851851,0.156352745360083,3.31277018250946e-66
NMR metabolomics,X23412.Phospholipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0903870926652818,0.00523736528645448,0.080121856703831,0.100652328626733,3.80985035877864e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.110619518006589,0.00641391152492544,0.0980482514177353,0.123190784595443,4.61751581120508e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.16641038950282,0.00965088799420735,0.147494649034174,0.185326129971467,4.93841367066942e-66
NMR metabolomics,X23412.Phospholipids in VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0549607467637192,0.00318752868414785,-0.0612083029846489,-0.0487131905427894,5.03592197211478e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PXN,Paxillin,39489,0.0833833272877994,0.00483591710369404,0.0739049297645591,0.0928617248110398,5.1950909090649e-66
NMR metabolomics,X23412.Phospholipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0989741091657678,0.00574355596485457,0.0877167394746528,0.110231478856883,6.00204208065772e-66
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD1,COMM domain-containing protein 1,37043,0.0999777753174347,0.00579959712602144,0.0886105649504327,0.111344985684437,7.15839808725725e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY4,Protein canopy homolog 4,39788,0.121946941784001,0.00708219089320745,0.108065847633314,0.135828035934687,7.56633127335971e-66
NMR metabolomics,X23412.Phospholipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.151684511887334,0.00881731278814952,0.134402578822561,0.168966444952107,1.00616811176587e-65
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA11,Annexin A11,39829,0.107505751877221,0.00625286223545338,0.095250141895732,0.119761361858709,1.16698069674667e-65
NMR metabolomics,X23412.Phospholipids in VLDL,PALM2,Paralemmin-2,37388,0.0609650331699156,0.00354313344050144,0.0540204916265327,0.0679095747132984,1.1837401608088e-65
NMR metabolomics,X23412.Phospholipids in VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0892994578297625,0.00518994931528349,0.0791271571718068,0.0994717584877181,1.18658198953777e-65
NMR metabolomics,X23412.Phospholipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0722733377456715,0.00420165748757797,0.0640380890700187,0.0805085864213243,1.30401309976792e-65
NMR metabolomics,X23412.Phospholipids in VLDL,MUC13,Mucin-13,39489,0.0814336898784222,0.00473808563614067,0.0721470420315865,0.0907203377252579,1.33009086942048e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0469276836852649,0.00273174294478315,0.0415734675134899,0.0522818998570398,1.46676174418669e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.047861612293499,0.00278652527687726,0.0424000227508196,0.0533232018361784,1.57215895296323e-65
NMR metabolomics,X23412.Phospholipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.129151757623351,0.00752272879192613,0.114407209191175,0.143896306055526,2.25420932431117e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.171096153662545,0.00998651950861435,0.151522575425661,0.190669731899429,4.09854502672626e-65
NMR metabolomics,X23412.Phospholipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.148419779477682,0.00867424024020653,-0.165421290348487,-0.131418268606877,4.70055797053368e-65
NMR metabolomics,X23412.Phospholipids in VLDL,STAMBP,STAM-binding protein,39713,0.103032053378543,0.00602909234746722,0.0912150323775073,0.114849074379579,6.81200871634165e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CNST,Consortin,39868,0.172654042084402,0.0101073128617543,0.152843708875363,0.19246437529344,7.57386978257861e-65
NMR metabolomics,X23412.Phospholipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.116148089072823,0.00681351164699008,0.102793606244723,0.129502571900924,1.74402284483406e-64
NMR metabolomics,X23412.Phospholipids in VLDL,FGF19,Fibroblast growth factor 19,39931,0.121711524719827,0.00716159884235677,0.107674790988808,0.135748258450846,3.25178864852569e-64
NMR metabolomics,X23412.Phospholipids in VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.145732204049008,0.00857150992527587,0.128932044595468,0.162532363502549,3.82950075510124e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.135158720917913,0.00796629437603033,0.119544783940893,0.150772657894932,5.4544058315446e-64
NMR metabolomics,X23412.Phospholipids in VLDL,MAX,Protein max,39489,0.167388691565689,0.0098665732406651,0.148050208013986,0.186727175117393,5.54932460578967e-64
NMR metabolomics,X23412.Phospholipids in VLDL,DBNL,Drebrin-like protein,39931,0.147684626464318,0.00870960930335292,0.130613792229747,0.16475546069889,6.19390658391406e-64
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR,GMP reductase 1,40058,0.0787262946112783,0.00464301263034021,0.0696259898558115,0.0878265993667451,6.19987682789643e-64
NMR metabolomics,X23412.Phospholipids in VLDL,FAM13A,Protein FAM13A,37382,0.107742665005217,0.00634891138358708,0.0952987986933861,0.120186531317047,6.24886048640683e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0799499050254749,0.00471638238101267,0.0707057955586901,0.0891940144922597,6.77034609157926e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.100191601124936,0.00591041628095805,0.0886071852142585,0.111776017035614,8.50806232360469e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CD22,B-cell receptor CD22,40058,0.0635050042048721,0.00375315289694318,0.0561488245268634,0.0708611838828807,1.12024532830952e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CRKL,Crk-like protein,39881,0.169509330708076,0.0100190981320598,0.149871898369239,0.189146763046913,1.17075817084531e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0883177530150042,0.00522560169280377,0.0780755736971088,0.0985599323328996,1.57309643955587e-63
NMR metabolomics,X23412.Phospholipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0751438729722925,0.00444282730828135,0.0664359314480611,0.083851814496524,1.60680858549689e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.132643641868245,0.00784819248081994,0.117261184605838,0.148026099130652,1.97595513278103e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GLB2,Endophilin-B2,37388,0.104769924812376,0.00619933135751985,0.0926192353516366,0.116920614273114,2.00376916725719e-63
NMR metabolomics,X23412.Phospholipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.233459667050998,0.0138212730881128,0.206369971798297,0.260549362303699,2.32319571482593e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.123348805521402,0.00731018992786187,0.109020833262793,0.137676777780012,3.11083536255757e-63
NMR metabolomics,X23412.Phospholipids in VLDL,GDF2,Growth/differentiation factor 2,39868,0.0556806958509729,0.00330260206485907,0.0492075958038491,0.0621537958980967,3.12901741250554e-63
NMR metabolomics,X23412.Phospholipids in VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.026992031565086,0.00160009095579185,0.023855853291734,0.030128209838438,3.3357469523235e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CCL11,Eotaxin,40058,0.0601820058518318,0.00357162703364374,0.0531816168658901,0.0671823948377736,3.61844964304477e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0862688299424167,0.00512249092887322,0.0762287477218252,0.0963089121630082,4.25258215010599e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.13131728264547,0.00781014621753777,0.116009396059096,0.146625169231844,6.71159358487624e-63
NMR metabolomics,X23412.Phospholipids in VLDL,MTDH,Protein LYRIC,37056,0.145667493608116,0.00867585465324181,0.128662818487762,0.16267216872847,1.28833497962984e-62
NMR metabolomics,X23412.Phospholipids in VLDL,GTPBP2,GTP-binding protein 2,37039,0.127007870449108,0.00757939961440639,0.112152247204871,0.141863493693344,2.22375834380339e-62
NMR metabolomics,X23412.Phospholipids in VLDL,DDHD2,Phospholipase DDHD2,37411,0.104605804350783,0.00625021907843336,0.0923553749570539,0.116856233744513,3.00066613907907e-62
NMR metabolomics,X23412.Phospholipids in VLDL,BRAP,BRCA1-associated protein,37249,0.172335327500793,0.0103254332533015,0.152097478324322,0.192573176677263,6.49656773148809e-62
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0805491618404784,0.00483204590046553,0.071078351875566,0.0900199718053909,7.22795688933912e-62
NMR metabolomics,X23412.Phospholipids in VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.132883443335205,0.00798342882995263,0.117235922828498,0.148530963841912,1.11850798370246e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0508737959522237,0.00305725033349493,0.0448815852985736,0.0568660066058737,1.17093077210692e-61
NMR metabolomics,X23412.Phospholipids in VLDL,F11,Coagulation factor XI,37249,0.0487687816099934,0.00293057569881897,0.0430248532403082,0.0545127099796785,1.45018797954319e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0491048579696991,0.00295654502912521,0.0433100297126137,0.0548996862267845,1.97485202751441e-61
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.134131984476627,0.00807842466826948,0.118298272126819,0.149965696826435,2.13591046938323e-61
NMR metabolomics,X23412.Phospholipids in VLDL,C19orf12,Protein C19orf12,39489,0.100918917971357,0.00607778649809734,0.0890064564350859,0.112831379507627,2.16762919747337e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4D,Semaphorin-4D,40009,0.0464957127626824,0.00280440976688509,0.0409990696195876,0.0519923559057772,3.14320678733036e-61
NMR metabolomics,X23412.Phospholipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0776096556195613,0.00468063281010469,0.0684356153117561,0.0867836959273665,3.96563967336506e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0366474661264798,0.00221374814350226,0.0323085197652154,0.0409864124877442,4.77262098614724e-61
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS8,Galectin-8,40009,0.0947959558973308,0.00572867976298552,0.0835677435618792,0.106024168232782,5.29373718020777e-61
NMR metabolomics,X23412.Phospholipids in VLDL,OPHN1,Oligophrenin-1,37388,0.167588264218578,0.010119950523792,0.147753161191946,0.18742336724521,5.38040791907337e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CCL7,C-C motif chemokine 7,39866,0.0900112370511973,0.00545557921814454,0.079318301783634,0.100704172318761,1.18273756215343e-60
NMR metabolomics,X23412.Phospholipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0659660007473598,0.0039983869184252,0.0581291623872464,0.0738028391074732,1.18565392057434e-60
NMR metabolomics,X23412.Phospholipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.14425664051252,0.00874512570083171,0.12711619413889,0.16139708688615,1.2730744461859e-60
NMR metabolomics,X23412.Phospholipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.0871858023704241,0.00529527830078286,0.0768070569008897,0.0975645478399585,2.06003592055753e-60
NMR metabolomics,X23412.Phospholipids in VLDL,WASHC3,WASH complex subunit 3,37388,0.116975524512612,0.00710521415202349,0.103049304774646,0.130901744250578,2.59469203400741e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.124281980332236,0.00756055977271771,0.10946328317771,0.139100677486763,3.17352478651867e-60
NMR metabolomics,X23412.Phospholipids in VLDL,IDUA,Alpha-L-iduronidase,40030,0.0705990676139416,0.00429738848605843,0.062176186181267,0.0790219490466161,3.68070793756358e-60
NMR metabolomics,X23412.Phospholipids in VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.121415182220493,0.00738782723989958,0.10693504083029,0.135895323610696,4.27847753581025e-60
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0645949525622168,0.00393862520506702,0.0568752471602854,0.0723146579641481,7.19482104549846e-60
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0608390170180582,0.00372145987422067,0.0535449556645857,0.0681330783715307,1.38946717065433e-59
NMR metabolomics,X23412.Phospholipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0958876636707108,0.00586198986622893,0.0843981635329021,0.10737716380852,1.48558930067552e-59
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.094028801655277,0.00576279405100622,0.0827337253153048,0.105323877995249,2.26917330944196e-59
NMR metabolomics,X23412.Phospholipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.139368994200288,0.00854645780106414,0.122617936910203,0.156120051490374,3.32207691715613e-59
NMR metabolomics,X23412.Phospholipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.13193586609442,0.00809777592295563,0.116064225285427,0.147807506903413,4.16994412685491e-59
NMR metabolomics,X23412.Phospholipids in VLDL,PYY,Peptide YY,37021,0.141113817112215,0.00866445451969964,0.124131486253603,0.158096147970826,4.646125381405e-59
NMR metabolomics,X23412.Phospholipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0423235462497961,0.00259948787825668,0.037228550008413,0.0474185424911792,4.98483378543052e-59
NMR metabolomics,X23412.Phospholipids in VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0569485297487903,0.00350192912918234,0.0500847486555929,0.0638123108419877,5.45060071929516e-59
NMR metabolomics,X23412.Phospholipids in VLDL,CCL4,C-C motif chemokine 4,39882,0.0949623072995597,0.00583986385936766,0.0835161741351991,0.10640844046392,5.53261607201308e-59
NMR metabolomics,X23412.Phospholipids in VLDL,SPART,Spartin,37124,0.119028196859841,0.00731677197888246,0.104687323781231,0.13336906993845,6.20164906982371e-59
NMR metabolomics,X23412.Phospholipids in VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.0988956227595736,0.00608781915819167,0.086963497209518,0.110827748309629,7.11661943103131e-59
NMR metabolomics,X23412.Phospholipids in VLDL,TWF2,Twinfilin-2,37437,0.128772024848837,0.00792480857004564,0.113239400051548,0.144304649646126,8.11032576527304e-59
NMR metabolomics,X23412.Phospholipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.086152335995258,0.00530601947417338,0.0757525378258781,0.0965521341646378,8.19241353925323e-59
NMR metabolomics,X23412.Phospholipids in VLDL,C2,Complement C2,39908,0.0359215215703821,0.00221318228135256,0.0315836842989311,0.0402593588418331,8.98560271131952e-59
NMR metabolomics,X23412.Phospholipids in VLDL,OGA,Protein O-GlcNAcase,37382,0.108346339264428,0.00667560796162231,0.0952621476596481,0.121430530869208,1.10538808156093e-58
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.120923628844899,0.00746375701041481,0.106294665104486,0.135552592585313,1.45115356288059e-58
NMR metabolomics,X23412.Phospholipids in VLDL,CCL18,C-C motif chemokine 18,39715,0.107052546262856,0.0066147016792055,0.0940877309716127,0.120017361554098,1.9213508698009e-58
NMR metabolomics,X23412.Phospholipids in VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.124428542287863,0.00768455914961289,0.109366806354621,0.139490278221104,2.0224060794684e-58
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0770482038658631,0.00476204364755629,0.0677145983166528,0.0863818094150735,2.09441411298888e-58
NMR metabolomics,X23412.Phospholipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.118598424832294,0.00733069523145436,0.104230262178644,0.132966587485945,2.13898747358456e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0905241389806103,0.00559490673009469,0.0795581217896248,0.101490156171596,2.47211597049627e-58
NMR metabolomics,X23412.Phospholipids in VLDL,CASC3,Protein CASC3,37039,0.0636150819179247,0.00393172831315268,0.0559088944241454,0.0713212694117039,2.54584777698077e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.108549516342949,0.00672954068146134,0.095359616607285,0.121739416078613,4.43021914525624e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.102593528806343,0.00635509227911556,0.0901375479392765,0.115049509673409,4.55145091578246e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SELE,E-selectin,40052,0.0752232457397406,0.00466461540079888,0.0660805995541748,0.0843658919253064,4.71767825236807e-58
NMR metabolomics,X23412.Phospholipids in VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0828533374778631,0.0051398128846878,0.072779304223875,0.0929273707318512,6.59880283990195e-58
NMR metabolomics,X23412.Phospholipids in VLDL,TALDO1,Transaldolase,37415,0.067573051942616,0.00419274820481003,0.0593552654611884,0.0757908384240437,6.72229561187194e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PKD2,Polycystin-2,37021,0.0900713694759374,0.00559118454014647,0.0791126477772503,0.101030091174624,7.80604938422458e-58
NMR metabolomics,X23412.Phospholipids in VLDL,YJU2,Splicing factor YJU2,37368,0.0490331491669841,0.00304468559742952,0.0430655653960222,0.055000732937946,8.18584261747247e-58
NMR metabolomics,X23412.Phospholipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.102759414035855,0.00638130064672729,0.0902520647682693,0.11526676330344,8.54573355737332e-58
NMR metabolomics,X23412.Phospholipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.139477751764384,0.00867442306512441,0.12247588255674,0.156479620972027,1.03716634712247e-57
NMR metabolomics,X23412.Phospholipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0690150340577311,0.00429647209385973,0.0605939487537661,0.0774361193616962,1.62288084712725e-57
NMR metabolomics,X23412.Phospholipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.190427381155597,0.0118682282114108,0.167165653861232,0.213689108449962,2.14241147041886e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2,Microtubule-associated protein 2,37388,0.0692001232959955,0.00431782308398762,0.0607371900513797,0.0776630565406112,2.80245666166476e-57
NMR metabolomics,X23412.Phospholipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.10973662965631,0.00685819043721498,0.0962945763993686,0.123178682913251,3.50076575702804e-57
NMR metabolomics,X23412.Phospholipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0509834511730388,0.0031874205817568,0.0447361068327954,0.0572307955132821,3.81394340687205e-57
NMR metabolomics,X23412.Phospholipids in VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0396498059510601,0.00247803728386329,0.0347928528746881,0.0445067590274321,4.21444642688438e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0696775992921496,0.00436257696168334,0.0611269484472502,0.0782282501370489,5.55107040174991e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ICA1,Islet cell autoantigen 1,39587,0.119902665842232,0.00751673264048157,0.105169869866888,0.134635461817576,7.76959238193231e-57
NMR metabolomics,X23412.Phospholipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0756328109368143,0.00473876845159165,0.0663448247716947,0.084920797101934,7.95634361689562e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0600973886350695,0.0037697166643412,0.0527087439729608,0.0674860332971783,8.73538857952893e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0581726024071759,0.00364701228359018,0.0510244583313391,0.0653207464830126,9.47864646477992e-57
NMR metabolomics,X23412.Phospholipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0859150885760215,0.00539102849596289,0.0753486727239342,0.0964815044281087,9.56426674080018e-57
NMR metabolomics,X23412.Phospholipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.114742017317674,0.00720520930842596,0.100619807073159,0.128864227562188,1.18889847647399e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0561796906523299,0.003528012900964,0.0492647853664405,0.0630945959382194,1.20586233282428e-56
NMR metabolomics,X23412.Phospholipids in VLDL,DOK1,Docking protein 1,37388,0.20508353301903,0.0128717339865948,0.179854934405304,0.230312131632756,1.22651976764322e-56
NMR metabolomics,X23412.Phospholipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0851383052126608,0.00534867394673409,0.074654904277062,0.0956217061482596,1.55993389494182e-56
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0436867034759469,0.00274759597466432,0.0383014153656049,0.049071991586289,1.71374429446961e-56
NMR metabolomics,X23412.Phospholipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.101106858667871,0.00635537545933795,0.0886503227675687,0.113563394568173,1.7834415111715e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0815151855080932,0.00512863642725937,0.0714630581106649,0.0915673129055216,1.91400835896906e-56
NMR metabolomics,X23412.Phospholipids in VLDL,MMP7,Matrilysin,39563,0.0736874883301707,0.00463620234490983,0.0646005317341474,0.082774444926194,1.92271731117602e-56
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.117576629485972,0.00739894456656456,0.103074698135506,0.132078560836439,2.02068589294768e-56
NMR metabolomics,X23412.Phospholipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0488816819321825,0.00308507647590082,0.0428349320394169,0.0549284318249481,5.12760065169228e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.073902299283588,0.00466696351530802,0.0647550507935843,0.0830495477735917,5.7650057228906e-56
NMR metabolomics,X23412.Phospholipids in VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.167845826831672,0.0106028652745426,0.147064210893569,0.188627442769776,6.25405747264868e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0671899241387705,0.00424758647835387,0.0588646546411969,0.0755151936363441,6.31517049097344e-56
NMR metabolomics,X23412.Phospholipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.162849375081321,0.0102981568891284,0.142664987578629,0.183033762584012,6.67828592465715e-56
NMR metabolomics,X23412.Phospholipids in VLDL,RBM17,Splicing factor 45,37411,0.113604131584882,0.00718250464968024,0.0995264224715084,0.127681840698255,7.52581408533389e-56
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0853987931707539,0.00541160463413365,0.0747920480878519,0.0960055382536559,1.13762870696544e-55
NMR metabolomics,X23412.Phospholipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0863091731646452,0.00547194774627321,0.0755841555819497,0.0970341907473407,1.52414387762538e-55
NMR metabolomics,X23412.Phospholipids in VLDL,RWDD1,RWD domain-containing protein 1,40009,0.0942363373717789,0.00598325293813584,0.0825091616130327,0.105963513130525,1.77644349960751e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CD69,Early activation antigen CD69,39785,0.129709726387722,0.00823520895416716,0.113568716837554,0.145850735937889,1.78302736509646e-55
NMR metabolomics,X23412.Phospholipids in VLDL,EGF,Pro-epidermal growth factor,39808,0.152876431237257,0.00971550116091621,0.133834048961861,0.171918813512653,2.2599881124968e-55
NMR metabolomics,X23412.Phospholipids in VLDL,SPRY2,Protein sprouty homolog 2,39587,0.136512191483108,0.00868233861300454,0.119494807801619,0.153529575164597,2.77455707741706e-55
NMR metabolomics,X23412.Phospholipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.107594951600446,0.00684312106358158,0.0941824343158259,0.121007468885066,3.2214403461916e-55
NMR metabolomics,X23412.Phospholipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0678515882215534,0.00431888691678999,0.059386569864645,0.0763166065784618,3.93728356588386e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PPBP,Platelet basic protein,37371,0.125197421202502,0.00797471131763235,0.109566987019942,0.140827855385061,4.68436602295101e-55
NMR metabolomics,X23412.Phospholipids in VLDL,BGLAP,Osteocalcin,37437,0.127106937207682,0.00810857614288139,0.111214127967635,0.14299974644773,6.72141660711857e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CETN3,Centrin-3,37382,0.116106637172524,0.0074118643985931,0.101579382951281,0.130633891393766,7.95878334826656e-55
NMR metabolomics,X23412.Phospholipids in VLDL,NUDC,Nuclear migration protein nudC,40058,0.0943728384684322,0.00603039953458495,0.0825532553806457,0.106192421556219,8.43345721136696e-55
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.129981586628142,0.00831948552324347,0.113675395002585,0.146287778253699,1.27571127937924e-54
NMR metabolomics,X23412.Phospholipids in VLDL,SPARC,SPARC,39913,0.103286250294607,0.00661209238421951,0.0903265492215372,0.116245951367678,1.32545155202311e-54
NMR metabolomics,X23412.Phospholipids in VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.113779705740123,0.00728464674491733,0.0995017981200854,0.128057613360161,1.6109383587399e-54
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.153188725329835,0.00981854440064872,0.133944378304564,0.172433072355107,1.77751272565259e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.11500886862367,0.007373353030141,0.100557096684594,0.129460640562747,1.90557581512654e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0398329517780898,0.00255753401231046,0.0348201851139613,0.0448457184422183,2.67675318560512e-54
NMR metabolomics,X23412.Phospholipids in VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.187482888442418,0.0120375810019406,0.163889229678615,0.211076547206222,2.70252005220445e-54
NMR metabolomics,X23412.Phospholipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0897910723761938,0.00576682219159736,0.078488100880663,0.101094043871725,2.88963538488817e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FST,Follistatin,39908,0.0750477295738018,0.00481997987595061,0.0656005690169386,0.084494890130665,2.89726381492936e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CRADD,Death domain-containing protein CRADD,39713,0.111435360620841,0.00715924472450121,0.0974032409608182,0.125467480280863,3.15894469820352e-54
NMR metabolomics,X23412.Phospholipids in VLDL,MSTN,Growth/differentiation factor 8,39585,0.0756621460775353,0.00486370776322068,0.0661292788616227,0.0851950132934478,3.64209182864097e-54
NMR metabolomics,X23412.Phospholipids in VLDL,KLK13,Kallikrein-13,39490,0.061533491293889,0.00395834126766403,0.0537751424092675,0.0692918401785105,4.35101522064457e-54
NMR metabolomics,X23412.Phospholipids in VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.0905261296066603,0.00583166977524192,0.0790960568471861,0.101956202366134,6.10822038784612e-54
NMR metabolomics,X23412.Phospholipids in VLDL,HNMT,Histamine N-methyltransferase,39669,0.0672489246521876,0.00433545515227626,0.0587514325537261,0.075746416750649,7.24532071917807e-54
NMR metabolomics,X23412.Phospholipids in VLDL,ST13,Hsc70-interacting protein,37124,0.0804832099647438,0.00518648849594116,0.0703176925126991,0.0906487274167884,7.80331125761176e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0477295956482678,0.00308108638319043,0.0416906663372146,0.0537685249593211,9.69775184171726e-54
NMR metabolomics,X23412.Phospholipids in VLDL,KIFBP,KIF-binding protein,39788,0.120569034628032,0.0077852976371575,0.105309851259204,0.135828217996861,1.04979824137898e-53
NMR metabolomics,X23412.Phospholipids in VLDL,ATOX1,Copper transport protein ATOX1,39913,0.105687489801247,0.00682668137704947,0.0923071943022297,0.119067785300264,1.12944595724583e-53
NMR metabolomics,X23412.Phospholipids in VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.125302825802021,0.00809663892417326,0.109433413510642,0.141172238093401,1.23963645175768e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0748334588812938,0.00483936584304333,0.0653483018289288,0.0843186159336587,1.49304439221334e-53
NMR metabolomics,X23412.Phospholipids in VLDL,ELOA,Elongin-A,39788,0.0741079263295894,0.00479238369592035,0.0647148542855855,0.0835009983735933,1.49452315652272e-53
NMR metabolomics,X23412.Phospholipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.108454232126645,0.00701658231695343,0.0947017307854164,0.122206733467874,1.66217461465323e-53
NMR metabolomics,X23412.Phospholipids in VLDL,KITLG,Kit ligand,39868,-0.0536375333453683,0.0034732228412524,-0.060445050114223,-0.0468300165765136,2.03653188869428e-53
NMR metabolomics,X23412.Phospholipids in VLDL,MGLL,Monoglyceride lipase,39908,0.126241539964252,0.00818696135109696,0.110195095716102,0.142287984212402,2.90170996557583e-53
NMR metabolomics,X23412.Phospholipids in VLDL,PF4,Platelet factor 4,37385,0.139820023504174,0.00906257851272882,0.122057369619225,0.157582677389122,3.00052260875781e-53
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0665347124586522,0.00431243479513451,0.0580823402601886,0.0749870846571159,3.06834588789833e-53
NMR metabolomics,X23412.Phospholipids in VLDL,LPP,Lipoma-preferred partner,37021,0.0971598483966538,0.00630455765415919,0.0848029153945018,0.109516781398806,4.01253446773841e-53
NMR metabolomics,X23412.Phospholipids in VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0368702698149301,0.00239494896627379,-0.0415643697888268,-0.0321761698410335,4.22724186030684e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.092884704549049,0.00602871141966515,0.0810684301665053,0.104700978931593,4.2287493743548e-53
NMR metabolomics,X23412.Phospholipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.139046761617907,0.0090370752231666,0.121334094180501,0.156759429055314,4.85139285587458e-53
NMR metabolomics,X23412.Phospholipids in VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.061834270008396,0.00401862527878775,0.053957764461972,0.06971077555482,5.78878506316373e-53
NMR metabolomics,X23412.Phospholipids in VLDL,OCLN,Occludin,37411,0.0619387871255943,0.00402633030795251,0.0540471797220073,0.0698303945291812,5.92204293169538e-53
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT1,Angiopoietin-1,39794,0.121166716352624,0.00790699663930627,0.105669002939584,0.136664429765664,1.25454155417982e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0530850561875353,0.00346587087326603,0.0462919492759338,0.0598781630991367,1.40931790375194e-52
NMR metabolomics,X23412.Phospholipids in VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.112231722352944,0.00733776523497008,0.0978497024924026,0.126613742213485,1.93766802271091e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.0855271983283004,0.00559553893898766,0.0745599420078846,0.0964944546487162,2.26885850407736e-52
NMR metabolomics,X23412.Phospholipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0865967532515186,0.00566295330151447,0.0754973647805502,0.097696141722487,2.37115181170589e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.123409224796157,0.00807904034754767,0.107574305714964,0.139244143877351,3.11046966565834e-52
NMR metabolomics,X23412.Phospholipids in VLDL,CD226,CD226 antigen,37056,0.0601289472930489,0.00393678336963879,0.0524128518885568,0.0678450426975409,3.20350247621899e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0532748822042313,0.00349322443391546,0.046428162313757,0.0601216020947056,3.74367689084146e-52
NMR metabolomics,X23412.Phospholipids in VLDL,FUS,RNA-binding protein FUS,39455,0.0561428572664047,0.00368134016184569,0.0489274305491871,0.0633582839836222,3.87490546118474e-52
NMR metabolomics,X23412.Phospholipids in VLDL,F12,Coagulation factor XII,37453,0.0593500719787914,0.00389057407364956,0.0517245467944383,0.0669755971631445,4.12761753517956e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PMVK,Phosphomevalonate kinase,39480,0.158574232550119,0.0104098325304631,0.138170960790411,0.178977504309826,5.04123371126602e-52
NMR metabolomics,X23412.Phospholipids in VLDL,UBXN1,UBX domain-containing protein 1,37124,0.0992765540864791,0.00651481841340489,0.0865075099962055,0.112045598176753,5.401878923597e-52
NMR metabolomics,X23412.Phospholipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.0979183627126189,0.00643640972879391,0.0853029996441829,0.110533725781055,7.96120534102565e-52
NMR metabolomics,X23412.Phospholipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0836483891202739,0.0055021723506602,0.0728641313129799,0.0944326469275679,9.29461703881139e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.123617529566652,0.0081392589803282,0.107664581965208,0.139570477168095,9.99849180275593e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0795577041219782,0.00523855529692411,0.069290135740007,0.0898252725039495,1.00423780966602e-51
NMR metabolomics,X23412.Phospholipids in VLDL,IL7,Interleukin-7,39866,0.0927019739859192,0.00611239762695114,0.0807216746370949,0.104682273334743,1.35146158110287e-51
NMR metabolomics,X23412.Phospholipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0688943077007083,0.00454036410980307,0.0599951940454943,0.0777934213559223,1.40427402488535e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.10347424116048,0.00682149086396759,0.0901041190671034,0.116844363253856,1.5476770408715e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SPON2,Spondin-2,39775,-0.0476440238122057,0.00314341959261546,-0.053805126213732,-0.0414829214106794,1.56522591664361e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.12152747360027,0.00801763650144125,0.105812906057445,0.137242041143095,1.79044512921528e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CETN2,Centrin-2,39489,0.096187427528056,0.0063502980141011,0.0837408434204178,0.108634011635694,1.84139344504099e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.136666713369715,0.00902814437586384,0.118971550393021,0.154361876346408,2.07147643168714e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.139262075165468,0.00920050193927634,0.121229091364486,0.157295058966449,2.45370489208906e-51
NMR metabolomics,X23412.Phospholipids in VLDL,DTNB,Dystrobrevin beta,37348,0.0624374871162938,0.0041260187728816,0.0543504903214459,0.0705244839111418,2.60187602514703e-51
NMR metabolomics,X23412.Phospholipids in VLDL,RRAS,Ras-related protein R-Ras,37039,0.187017296912078,0.0123631790210288,0.162785466030862,0.211249127793295,2.89594098819272e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.100302797953959,0.00665947369064885,0.0872502295202869,0.11335536638763,6.46166169100766e-51
NMR metabolomics,X23412.Phospholipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0799215952572636,0.00530794426069878,0.069518024506294,0.0903251660082332,6.95717882378409e-51
NMR metabolomics,X23412.Phospholipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0874069648949116,0.00580120335128509,0.0760366063263928,0.0987773234634304,7.07163991810654e-51
NMR metabolomics,X23412.Phospholipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0344015176080725,0.00228565691870091,0.0299216300474187,0.0388814051687262,7.57435587955582e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CTSL,Cathepsin L1,39868,0.0336493887595272,0.00223954555702826,0.0292598794677518,0.0380388980513025,1.11415913189843e-50
NMR metabolomics,X23412.Phospholipids in VLDL,STX8,Syntaxin-8,39866,0.0686311042073005,0.00457262482295744,0.0596687595543039,0.0775934488602971,1.41302688749258e-50
NMR metabolomics,X23412.Phospholipids in VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.109526428726224,0.00730165161518424,0.0952151915604629,0.123837665891985,1.61268957033252e-50
NMR metabolomics,X23412.Phospholipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.103383412416908,0.00688747622877334,0.0898839590085126,0.116882865825304,1.62644185923157e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CASP7,Caspase-7,37388,0.118833091186176,0.0079207852424997,0.103308352110877,0.134357830261476,1.79441996735801e-50
NMR metabolomics,X23412.Phospholipids in VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.118424065459966,0.00789900059127991,0.102942024301058,0.133906106618875,1.81478635790788e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CCL8,C-C motif chemokine 8,40003,0.0848085912361338,0.00565952024663705,0.0737159315527252,0.0959012509195425,2.00514119354592e-50
NMR metabolomics,X23412.Phospholipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0768005155723725,0.00513302200681275,0.0667397924390195,0.0868612387057255,2.85295606557498e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0737109943565499,0.00492962787716011,0.0640489237173161,0.0833730649957838,3.26804502707006e-50
NMR metabolomics,X23412.Phospholipids in VLDL,BLMH,Bleomycin hydrolase,40052,0.0448428994384603,0.00300105302625597,0.0389608355069987,0.050724963369922,3.76924370612093e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0892027820835133,0.0059701703075087,0.0775012482807963,0.10090431588623,3.82800786864832e-50
NMR metabolomics,X23412.Phospholipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.129721427321238,0.00868293722200461,0.112702870366109,0.146739984276367,3.95074346834567e-50
NMR metabolomics,X23412.Phospholipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.0907036757463208,0.00607497223388312,0.0787967301679098,0.102610621324732,4.52851452458434e-50
NMR metabolomics,X23412.Phospholipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0613580742129166,0.0041079011298671,0.0533065879983771,0.0694095604274562,4.842557179024e-50
NMR metabolomics,X23412.Phospholipids in VLDL,HPSE,Heparanase,37306,0.131899459017269,0.00883230496608624,0.11458814128374,0.149210776750798,5.00167138153776e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.119355801184333,0.00800208584890383,0.103671712920481,0.135039889448184,5.76147109144561e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TMED8,Protein TMED8,37382,0.14504190177321,0.00972147256841611,0.125987815539114,0.164095988007305,6.11804529595395e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM106A,Transmembrane protein 106A,37368,0.0996512661495074,0.00668789392759385,0.0865429940514234,0.112759538247591,8.16200632982298e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.1195386151389,0.0080236462448664,0.103812268498961,0.135264961778838,8.37644982755078e-50
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0666087401588563,0.00447756338891537,0.0578327159165822,0.0753847644011305,1.16083577768664e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6AP2,Renin receptor,39477,0.0567926108759227,0.00382181726395489,0.0493018490385711,0.0642833727132743,1.30560454097691e-49
NMR metabolomics,X23412.Phospholipids in VLDL,DLG4,Disks large homolog 4,37388,0.0999738038507618,0.00673223899889282,0.0867786154129319,0.113168992288592,1.70597677665662e-49
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3,Galectin-3,39901,0.0410733589327853,0.00276936825395084,0.0356453971550416,0.0465013207105289,1.95390862791909e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0710791156014639,0.00479041631670122,0.0616898996207295,0.0804683315821983,2.04406404732795e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SPOCK1,Testican-1,39749,0.0352888146814396,0.00238168103107086,0.0306207198605407,0.0399569095023385,2.43652299902447e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TP53,Cellular tumor antigen p53,39477,0.0613553054778237,0.00414321144006516,0.053234611055296,0.0694759999003514,2.78150887532504e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.122139322997079,0.00824409305915266,0.105980900601139,0.138297745393018,2.82564112994784e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CTF1,Cardiotrophin-1,39585,0.11790869954473,0.0079640676045017,0.102299127039906,0.133518272049553,2.91487508803479e-49
NMR metabolomics,X23412.Phospholipids in VLDL,NIT1,Deaminated glutathione amidase,37043,0.0654990704604458,0.00442149246098293,0.0568329452369193,0.0741651956839724,2.96854703980213e-49
NMR metabolomics,X23412.Phospholipids in VLDL,IL18,Interleukin-18,39795,0.0632120336823725,0.00427203986116947,0.0548388355544803,0.0715852318102646,3.26426231838287e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE2,Glia-derived nexin,37437,0.0897053689178336,0.00605944147910732,0.0778288636187832,0.101581874216884,3.32636103824265e-49
NMR metabolomics,X23412.Phospholipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.07621578823798,0.00516576323122945,0.0660908923047703,0.0863406841711897,6.9578795689922e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0260465849233986,0.00176603170307717,0.0225851627853674,0.0295080070614299,7.49806357120441e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR2,GMP reductase 2,37124,0.0928327762685114,0.00629455506876203,0.0804954483337378,0.105170104203285,7.70635195129636e-49
NMR metabolomics,X23412.Phospholipids in VLDL,NEXN,Nexilin,37445,0.0951674994319704,0.00646059272796874,0.0825047376851517,0.107830261178789,9.7613244381901e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FOXJ3,Forkhead box protein J3,37056,0.0620845143348235,0.00421614660450905,0.0538208669899857,0.0703481616796612,1.0773247666461e-48
NMR metabolomics,X23412.Phospholipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0480301289529075,0.00326470190732517,0.0416313132145502,0.0544289446912649,1.12313901254333e-48
NMR metabolomics,X23412.Phospholipids in VLDL,DPT,Dermatopontin,40052,0.0369678737560825,0.00251431795195831,0.0320398105702442,0.0418959369419207,1.27022719702705e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0652655748497283,0.00443562245293286,0.0565717548419799,0.0739593948574767,1.27823409185668e-48
NMR metabolomics,X23412.Phospholipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.101497447000708,0.0068997569483596,0.0879739233819227,0.115020970619492,1.34357547133236e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.106361351963714,0.00723573646035115,-0.120543395426002,-0.0921793085014253,1.34515090055269e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB6,Serpin B6,39970,0.0829477595009717,0.00564829250028076,0.0718771062004214,0.094018412801522,1.64466915055096e-48
NMR metabolomics,X23412.Phospholipids in VLDL,NID1,Nidogen-1,39892,0.0515865927739114,0.00352358930587557,0.0446803577343953,0.0584928278134275,3.17921174895158e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0809118369164882,0.00552784204682648,0.0700772665047083,0.0917464073282681,3.3953140489547e-48
NMR metabolomics,X23412.Phospholipids in VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0507500777376355,0.00347003984668438,0.0439487996381341,0.0575513558371369,4.01508092822046e-48
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0741524587418708,0.00507159086789059,0.0642121406408052,0.0840927768429363,4.22756815570236e-48
NMR metabolomics,X23412.Phospholipids in VLDL,TBCB,Tubulin-folding cofactor B,39749,0.13903112728637,0.00951138848312196,0.120388805859451,0.157673448713289,4.46763792652008e-48
NMR metabolomics,X23412.Phospholipids in VLDL,APP,Amyloid-beta precursor protein,39829,0.091213229619385,0.00624494859946037,0.0789731303644427,0.103453328874327,5.25187980235504e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.163881243982146,0.011217411406769,0.141895117624879,0.185867370339413,5.75535326566811e-48
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0853972584129045,0.0058494098709443,0.0739324150658537,0.0968621017599554,6.54428948988333e-48
NMR metabolomics,X23412.Phospholipids in VLDL,CFB,Complement factor B,37220,0.0452093884070542,0.00309780488253365,0.0391376908372882,0.0512810859768201,7.158759484613e-48
NMR metabolomics,X23412.Phospholipids in VLDL,EHD3,EH domain-containing protein 3,37043,0.160946283803432,0.0110320518085755,0.139323462258624,0.18256910534824,7.78548612041335e-48
NMR metabolomics,X23412.Phospholipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.136225470132015,0.00934005149078321,0.11791896921008,0.15453197105395,8.26165087357446e-48
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0976820603232774,0.00670237966432904,0.0845453961811925,0.110818724465362,8.27843606664403e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.133064376447441,0.0091242914926186,0.115180765121909,0.150947987772974,8.42102581917131e-48
NMR metabolomics,X23412.Phospholipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.10617772725139,0.00728669181336538,0.0918958112971939,0.120459643205586,8.63467159405244e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ESYT2,Extended synaptotagmin-2,37388,0.112565892825334,0.0077357911621283,0.0974037421475629,0.127728043503106,1.31100853685345e-47
NMR metabolomics,X23412.Phospholipids in VLDL,F2R,Proteinase-activated receptor 1,39908,0.0795697339204152,0.00547980887788163,0.0688293085197672,0.0903101593210632,1.79606772459063e-47
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.08374970684586,0.00576741315278983,0.0724455770663919,0.0950538366253281,2.01956060399038e-47
NMR metabolomics,X23412.Phospholipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.04884469674123,0.00336547526876007,0.0422483652144602,0.0554410282679997,2.2616689332773e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0835994041703633,0.00577297887468783,0.0722843655759751,0.0949144427647514,3.58001096618786e-47
NMR metabolomics,X23412.Phospholipids in VLDL,EGFR,Epidermal growth factor receptor,40052,0.0217675277958678,0.00150471571865658,0.0188182849873009,0.0247167706044347,3.89782560332062e-47
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0652156720053659,0.00451142110176537,0.0563732866459058,0.074058057364826,5.16323192451048e-47
NMR metabolomics,X23412.Phospholipids in VLDL,COMT,Catechol O-methyltransferase,39403,0.115327611012222,0.00798683903686386,0.0996734064999692,0.130981815524476,5.85995118090218e-47
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB1,Heat shock protein beta-1,39617,0.0942000451612104,0.00653474679662721,0.0813919414398211,0.1070081488826,8.23623020889216e-47
NMR metabolomics,X23412.Phospholipids in VLDL,RFC4,Replication factor C subunit 4,37368,0.0289334725354302,0.00200726960368778,0.0249992241122022,0.0328677209586583,9.34243602567108e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0561313970817408,0.00389805629280281,0.0484912067478473,0.0637715874156343,1.02076836008582e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0574409133499311,0.00398970591862215,0.0496210897494317,0.0652607369504305,1.06151234175404e-46
NMR metabolomics,X23412.Phospholipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0359232355101747,0.00249561426283597,0.0310318315550162,0.0408146394653332,1.09594282384125e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0848180888435269,0.00589212039584848,0.0732695328676639,0.09636664481939,1.22477246139336e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CD164,Sialomucin core protein 24,39858,0.0353669690132311,0.00245965956413308,0.0305460362675303,0.0401879017589319,1.37195685306706e-46
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.119327938371271,0.00829648113706915,0.103066835342615,0.135589041399926,1.46125707334164e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.10384237793478,0.00722022388230871,0.0896907391254554,0.117994016744106,1.50669823693567e-46
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.078788453229634,0.00548119292327706,0.0680453151000109,0.089531591359257,1.65070443822724e-46
NMR metabolomics,X23412.Phospholipids in VLDL,GP5,Platelet glycoprotein V,37124,0.0488318840192194,0.0033987780250982,0.0421702790900269,0.0554934889484118,1.84723846654892e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0629654866001542,0.00438453595846688,0.0543717961215591,0.0715591770787493,1.99419762680061e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CACYBP,Calcyclin-binding protein,37088,0.139925185250849,0.00974873989690562,0.120817655052914,0.159032715448784,2.26914144335673e-46
NMR metabolomics,X23412.Phospholipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0801902293613273,0.00559041568022402,0.0692330146280883,0.0911474440945664,2.27073708958902e-46
NMR metabolomics,X23412.Phospholipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.12002253478543,0.00836483242475417,0.103627463232912,0.136417606337949,2.37639685147247e-46
NMR metabolomics,X23412.Phospholipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.151422437406303,0.0105771681305204,0.130691187870483,0.172153686942123,3.40746564896476e-46
NMR metabolomics,X23412.Phospholipids in VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0660204499154663,0.00460954184189305,0.0569857479053559,0.0750551519255767,3.5125591804626e-46
NMR metabolomics,X23412.Phospholipids in VLDL,GLB1,Beta-galactosidase,39749,0.0566329749211189,0.0039578774455924,0.0488755351277578,0.06439041471448,3.72510401373293e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0894138071477069,0.00625019421600057,0.0771634264843458,0.101664187811068,3.87715381560769e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.132078679101608,0.00923255780214663,0.1139828658094,0.150174492393815,3.94141834750059e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.134987891443976,0.00944851959418757,0.116468793039368,0.153506989848584,5.08356231669578e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MESD,LRP chaperone MESD,39858,0.163717663468765,0.0114597981008405,0.141256459191118,0.186178867746412,5.11486944475129e-46
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS2,Trypsin-2,39931,0.068738659032167,0.00481664178400915,0.0592980411355091,0.0781792769288249,6.32407028411337e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0484178044951447,0.00339402796745606,0.0417655096789308,0.0550700993113586,6.83992329160766e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0553718843978498,0.00387926774620534,0.0477685196152874,0.0629752491804123,6.91026420111601e-46
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.150058761138868,0.01053147668023,0.129417066845617,0.170700455432119,8.69205096813904e-46
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.104651641688216,0.00734448109659271,0.0902564587388942,0.119046824637538,9.7253625135835e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.102515388727984,0.00720188105027411,0.0883997018694467,0.116631075586521,1.06138635398433e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0609701894749137,0.00428757442065704,0.0525665436104259,0.0693738353394014,1.2941554438784e-45
NMR metabolomics,X23412.Phospholipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.126563646961564,0.00889591681710802,0.109127650000032,0.143999643923095,1.32661963676339e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CTSS,Cathepsin S,36543,0.03260450529202,0.00229250803408093,0.0281111895452214,0.0370978210388186,1.49370796113826e-45
NMR metabolomics,X23412.Phospholipids in VLDL,JAM3,Junctional adhesion molecule C,37124,0.0675548731267612,0.00475443765759409,0.0582361753178768,0.0768735709356456,1.74157748170333e-45
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D5,TBC1 domain family member 5,39866,0.103779306400266,0.00731042052980249,0.0894508821618531,0.118107730638679,1.82880246589817e-45
NMR metabolomics,X23412.Phospholipids in VLDL,STX4,Syntaxin-4,39788,0.0789491650096803,0.00556474291823657,0.0680422688899367,0.089856061129424,2.07331464841368e-45
NMR metabolomics,X23412.Phospholipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.0901446618368533,0.00635928806740075,0.0776804572247478,0.102608866448959,2.43296813593677e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.037954205515793,0.00268114328662169,0.0326991646740145,0.0432092463575716,3.59359743999901e-45
NMR metabolomics,X23412.Phospholipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0625757703032071,0.00442126030246099,0.0539101001103836,0.0712414404960306,3.73220218115419e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0560364194137968,0.0039605900060816,0.0482736630018768,0.0637991758257167,4.05991850619768e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CCL24,C-C motif chemokine 24,39908,0.109277174764563,0.00773549880803237,0.0941155971008192,0.124438752428306,4.84036469585502e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CERT,Ceramide transfer protein,39489,0.0816242184184032,0.00578214822831884,0.0702912078908983,0.0929572289459081,5.67099367293727e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0875267007452895,0.00620409238300407,0.0753666796746015,0.0996867218159774,6.38004520227969e-45
NMR metabolomics,X23412.Phospholipids in VLDL,SCG2,Secretogranin-2,39949,0.0411666845421757,0.00292024815333456,0.03544299816164,0.0468903709227115,7.32959624919239e-45
NMR metabolomics,X23412.Phospholipids in VLDL,IMPACT,Protein IMPACT,37388,0.073401251885474,0.00520397604801789,0.063201458831359,0.0836010449395891,7.37003448048527e-45
NMR metabolomics,X23412.Phospholipids in VLDL,AFP,Alpha-fetoprotein,39699,0.0894117305584456,0.0063454858700247,0.0769745782531972,0.101848882863694,8.09100732256938e-45
NMR metabolomics,X23412.Phospholipids in VLDL,SDHB,Succinate dehydrogenase,37382,0.0928646163177928,0.00659493621740051,0.0799385413316878,0.105790691303898,1.02545578533215e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.125376940982147,0.00891403784335286,0.107905426809176,0.142848455155119,1.15136820707427e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DNM3,Dynamin-3,37411,0.0725110156699197,0.00515656672659985,0.062404144885784,0.0826178864540554,1.34031161072289e-44
NMR metabolomics,X23412.Phospholipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0471941495093618,0.00336097458746605,0.0406066393179284,0.0537816597007953,1.59111685222288e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0351765974523533,0.002505880508479,0.0302650716557345,0.0400881232489722,1.67253962221144e-44
NMR metabolomics,X23412.Phospholipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0396784436396416,0.00283220017919679,0.0341273312884159,0.0452295559908673,2.47069069224559e-44
NMR metabolomics,X23412.Phospholipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0620687179966296,0.00443035871485518,0.0533852149155135,0.0707522210777458,2.81735891089657e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC3B,Tetranectin,37138,0.0278578391101786,0.00198854051467057,0.0239602997014243,0.0317553785189329,2.82915359653921e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0561971526458317,0.00401576578395106,0.0483262517092877,0.0640680535823758,3.06431222011177e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL1,Growth-regulated alpha protein,39839,0.124672374704493,0.00891075354386388,0.10720729775852,0.142137451650466,3.21561056622738e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0741828064481506,0.00530355846676437,0.0637878318532924,0.0845777810430088,3.43995576261529e-44
NMR metabolomics,X23412.Phospholipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0805520522484552,0.00575972660280746,0.0692629881069526,0.0918411163899579,3.49355524864717e-44
NMR metabolomics,X23412.Phospholipids in VLDL,YWHAQ,14-3-3 protein theta,37124,0.0976167602094339,0.00697820723704943,0.083939474024817,0.111294046394051,3.75613865220466e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH9,Protocadherin-9,37382,0.0437021117240874,0.00312478276314791,0.0375775375083175,0.0498266859398573,3.87077455898166e-44
NMR metabolomics,X23412.Phospholipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0417055919630841,0.00298387096322328,0.0358572048751665,0.0475539790510017,3.89003477158763e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0418454367523154,0.00299626961010716,0.0359727483165054,0.0477181251881255,4.54639453330034e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SUGT1,Protein SGT1 homolog,39477,0.10612992444368,0.0076116167219954,0.0912111556685692,0.121048693218791,6.34957564390658e-44
NMR metabolomics,X23412.Phospholipids in VLDL,MARCO,Macrophage receptor MARCO,39868,0.0343069722249729,0.00246081306783652,0.0294837786120133,0.0391301658379325,6.41803745269141e-44
NMR metabolomics,X23412.Phospholipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.107212135566703,0.00769293106849921,0.0921339906724446,0.122290280460961,6.86586918481402e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0544030971576381,0.00390161948003073,0.0467559229767778,0.0620502713384983,7.0077539224863e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.134035694743797,0.0096157503539256,0.115188824050103,0.152882565437491,7.49357179323902e-44
NMR metabolomics,X23412.Phospholipids in VLDL,BIN2,Bridging integrator 2,39858,0.117248478988021,0.00842125949269757,0.100742810382334,0.133754147593709,8.28181441336162e-44
NMR metabolomics,X23412.Phospholipids in VLDL,RBKS,Ribokinase,39504,0.0647435837840779,0.00465073305561358,0.0556281469950752,0.0738590205730805,8.5983599589067e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.130085125491037,0.00935369619796404,0.111751880943028,0.148418370039047,1.14040122332212e-43
NMR metabolomics,X23412.Phospholipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0970648080014556,0.00698435026606392,0.0833754814799703,0.110754134522941,1.19320420717893e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO2,Roundabout homolog 2,40009,0.0296258078680871,0.0021345778615475,0.0254420352594539,0.0338095804767202,1.51034288719059e-43
NMR metabolomics,X23412.Phospholipids in VLDL,RP2,Protein XRP2,39788,0.0544288922193816,0.00392188974884309,0.0467419883116491,0.062115796127114,1.53859806212041e-43
NMR metabolomics,X23412.Phospholipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0646599253764738,0.00465876911632856,0.0555287379084698,0.0737911128444778,1.7387442023295e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.0417542618060673,0.00301073021495791,0.0358532305847498,0.0476552930273848,1.98280484741363e-43
NMR metabolomics,X23412.Phospholipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.156859539520404,0.0113255111833492,0.134661537601039,0.179057541439768,2.25469569033006e-43
NMR metabolomics,X23412.Phospholipids in VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0692062784025382,0.00499754372260501,0.0594110927062323,0.079001464098844,2.31276187754691e-43
NMR metabolomics,X23412.Phospholipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0884891102370225,0.00639074656435339,0.0759632469708899,0.101014973503155,2.37654137081109e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.12190538697368,0.00880140090386236,0.10465464120211,0.139156132745251,2.48646888936347e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CDCP1,CUB domain-containing protein 1,39749,0.064807881530637,0.00468520904426157,0.0556248718038844,0.0739908912573897,2.89323855369611e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0302811971252172,0.0021905085717852,0.0259878003245183,0.0345745939259162,3.25238059708171e-43
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1A,Meprin A subunit alpha,37382,0.0930540295364166,0.00672928201550085,0.0798646367860349,0.106243422286798,3.3882283174315e-43
NMR metabolomics,X23412.Phospholipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0871868002069104,0.00630578896745639,0.0748274538306958,0.0995461465831249,3.50816807410429e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.074581208799049,0.00539779085301365,0.0640015387271423,0.0851608788709558,3.57720488583964e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0844369279372058,0.00610802475361972,0.0724651994201112,0.0964086564543005,3.59349526333337e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.06946450132701,0.00502799751136237,0.0596096262047398,0.0793193764492803,4.13779550809417e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CASP10,Caspase-10,39489,0.0925139316133021,0.00670720098005326,0.0793678176923977,0.105660045534207,5.00203183308984e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0843483022537547,0.0061207861599139,0.0723515613803235,0.096345043127186,6.57875613727892e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TADA3,Transcriptional adapter 3,37368,0.0512480618139686,0.00372364258704641,0.0439497223433576,0.0585464012845795,8.28560870221888e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0792368478888658,0.00575783228720373,0.0679514966059464,0.0905221991717851,8.57455317777256e-43
NMR metabolomics,X23412.Phospholipids in VLDL,LAP3,Cytosol aminopeptidase,39587,0.0628039394153002,0.00456710352043141,0.0538524165152546,0.0717554623153457,8.83543113305366e-43
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.129415137718393,0.00940948952184057,0.110972538255586,0.147857737181201,9.38434317050625e-43
NMR metabolomics,X23412.Phospholipids in VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0290486814430787,0.00211225227950456,0.0249086669752498,0.0331886959109077,9.6664752946714e-43
NMR metabolomics,X23412.Phospholipids in VLDL,C1R,Complement C1r subcomponent,37453,0.0249772635202855,0.00181757086861693,0.0214148246177963,0.0285397024227747,1.09530359597003e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CCL26,C-C motif chemokine 26,39866,0.110060646875798,0.00803048101949516,0.0943209040775872,0.125800389674008,1.638697508887e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0364786941945083,0.00266270016471052,0.0312598018716757,0.0416975865173409,1.77181822677906e-42
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0877858620499211,0.00640760815021486,0.0752269500755,0.100344774024342,1.78082111353322e-42
NMR metabolomics,X23412.Phospholipids in VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0611472970367031,0.00446124009927014,0.0524032664421337,0.0698913276312726,1.78269211123693e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0733883887753218,0.00535542210737234,0.062891761444872,0.0838850161057716,1.88797158600815e-42
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0678075520245062,0.00495418698507503,0.0580973455337591,0.0775177585152533,2.13503078662803e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0982367626475398,0.00717827635793589,0.0841673409859854,0.112306184309094,2.18466767108577e-42
NMR metabolomics,X23412.Phospholipids in VLDL,THTPA,Thiamine-triphosphatase,37345,0.113533942652732,0.00830157621909428,0.0972628532633076,0.129805032042157,2.69727383768326e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CIAPIN1,Anamorsin,39913,0.0810221345255043,0.00593082148912815,0.0693977244068131,0.0926465446441955,2.98253036040455e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB1,Beta-crystallin B1,37437,0.0853169613320468,0.00625404422046951,0.0730590346599266,0.0975748880041671,4.27398993207993e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN3,Ataxin-3,37388,0.0785432363364358,0.00576438753937617,0.0672450367592585,0.0898414359136131,5.33905355804043e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CCL3,C-C motif chemokine 3,39866,0.0802420144434134,0.00589257369254246,0.0686925700060302,0.0917914588807967,5.4028194256309e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0352419388675128,0.0025916936357619,0.0301622193414195,0.0403216583936061,7.72842653204682e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.133694079646468,0.00983812421748698,0.114411356180193,0.152976803112742,8.81276919887243e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB2,Lysosome membrane protein 2,39486,0.036655334200823,0.00270194275753344,0.0313595263960575,0.0419511420055886,1.09275578093663e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.139357927420525,0.0102772074884107,0.11921460074324,0.15950125409781,1.33766118378095e-41
NMR metabolomics,X23412.Phospholipids in VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.0884176335680804,0.00652361582367838,0.0756313465536708,0.10120392058249,1.42898805920321e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0962119881218824,0.00711021740013349,0.0822759620176208,0.110148014226144,1.89157129945046e-41
NMR metabolomics,X23412.Phospholipids in VLDL,GMFG,Glia maturation factor gamma,37437,0.0915788503513067,0.00676905700846435,0.0783114986147166,0.104846202087897,1.95534386114768e-41
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0413716914272158,0.00306122641159744,0.0353716876604848,0.0473716951939468,2.16450252257786e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0599187495868366,0.00443463232446862,0.0512268702308781,0.0686106289427951,2.24338477641429e-41
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.113590839125039,0.00840936891143416,0.0971084760586283,0.13007320219145,2.37898396577514e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ASS1,Argininosuccinate synthase,37021,0.101663626220654,0.00752198783806397,0.0869205300580481,0.116406722383259,2.38963902936437e-41
NMR metabolomics,X23412.Phospholipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.137178304964573,0.0101551506657921,0.11727420965962,0.157082400269525,2.59224275916052e-41
NMR metabolomics,X23412.Phospholipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.082498501903194,0.00611025455759898,0.0705224029703,0.094474600836088,2.87792529389096e-41
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.11578609834691,0.00857704498396749,0.098975090178334,0.132597106515487,2.95565778450302e-41
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.120172403549733,0.00891645497284217,0.102696151802963,0.137648655296504,3.56725943513802e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0706773522954665,0.00524308958090618,0.0604008967168903,0.0809538078740426,3.80428778563993e-41
NMR metabolomics,X23412.Phospholipids in VLDL,DDT,D-dopachrome decarboxylase,37437,0.050864122300534,0.00377404331026763,0.0434669974124094,0.0582612471886585,3.90781267993907e-41
NMR metabolomics,X23412.Phospholipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.15477120628071,0.0115046886694214,0.132222016488644,0.177320396072776,4.94768393867877e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CASP2,Caspase-2,39866,0.0862352502952392,0.00641508923870353,0.0736616753873802,0.0988088252030981,5.67944222183689e-41
NMR metabolomics,X23412.Phospholipids in VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.08488693976816,0.006320808787689,0.0724981545442896,0.0972757249920305,7.51684717972914e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.141718207360712,0.0105603039658814,0.121020011587585,0.16241640313384,7.75670882996834e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0329389958023236,0.00245509203787864,0.0281270154080815,0.0377509761965657,8.78357378711138e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CTSZ,Cathepsin Z,39865,0.039037281066461,0.00291214121302001,0.0333294842889418,0.0447450778439802,9.37583295137586e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.085410274125563,0.00637168511681819,0.0729217712965994,0.0978987769545266,1.03155570832052e-40
NMR metabolomics,X23412.Phospholipids in VLDL,APOA2,Apolipoprotein A-II,37445,-0.059978214599827,0.00447586737034283,-0.068750914645699,-0.0512055145539551,1.09072192172179e-40
NMR metabolomics,X23412.Phospholipids in VLDL,OXT,Oxytocin-neurophysin 1,40009,0.17433318236178,0.0130175499676388,0.148818784425208,0.199847580298352,1.10761605655299e-40
NMR metabolomics,X23412.Phospholipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.159977959026119,0.0119499995290543,0.136555959949172,0.183399958103065,1.29972244808879e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.124136484838296,0.00927991013014274,0.105947860983216,0.142325108693375,1.48998389717592e-40
NMR metabolomics,X23412.Phospholipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.110650819474656,0.00829676086466861,0.0943891681799054,0.126912470769406,2.57632396165266e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TMSB10,Thymosin beta-10,39858,0.0966446517187049,0.00725771227791103,0.0824195356539993,0.110869767783411,3.05455711679076e-40
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB9,Serpin B9,39749,0.0418332387376075,0.0031414885467245,0.0356759211860275,0.0479905562891876,3.05498103115015e-40
NMR metabolomics,X23412.Phospholipids in VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0545806998439649,0.00409674657403952,0.0465510765588475,0.0626103231290824,3.09898751916141e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0620840445334247,0.00466649586342411,-0.071230376425736,-0.0529377126411135,3.57582880881571e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CALB2,Calretinin,39489,0.0364352769206297,0.00273905869013055,0.0310667218879738,0.0418038319532856,3.71978208217387e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0499053604165995,0.00375518898888048,0.0425451899983937,0.0572655308348052,4.72456509082372e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0542500418109178,0.00408454140758066,0.0462443406520597,0.0622557429697759,4.86773865597912e-40
NMR metabolomics,X23412.Phospholipids in VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0778379900915672,0.00586347754795865,0.0663455740975682,0.0893304060855661,5.73764916310248e-40
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0502022810266027,0.00378427201256017,0.0427851078819848,0.0576194541712206,5.95209374983282e-40
NMR metabolomics,X23412.Phospholipids in VLDL,GBP1,Guanylate-binding protein 1,37376,0.0792940688265138,0.00597841238549197,0.0675763805509496,0.0910117571020781,6.6997229732322e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0735362832067481,0.00555307799638955,-0.0844203160796716,-0.0626522503338246,8.0439018454702e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.115094074265056,0.00869203997081985,0.0980576759222494,0.132130472607863,9.0868394039129e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CD83,CD83 antigen,39866,0.0407140722824389,0.0030805027690409,0.0346762868551188,0.0467518577097591,1.13419856659165e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0459923088999764,0.00347950459158192,0.0391724799004759,0.052812137899477,1.22886390161111e-39
NMR metabolomics,X23412.Phospholipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0723746151114546,0.00548052946274397,0.0616327773644764,0.0831164528584327,1.32844872257316e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DCTD,Deoxycytidylate deaminase,37124,0.118944432047531,0.0090064024835729,0.101291883179728,0.136596980915334,1.42720858939481e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CASP3,Caspase-3,40052,0.11020533258679,0.00835713211315115,0.0938253536450136,0.126585311528566,1.66665019600495e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0752500194116862,0.00570577926311694,0.064066692055977,0.0864333467673954,1.81307633207768e-39
NMR metabolomics,X23412.Phospholipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0477852493824313,0.00362528604721768,0.0406796887298846,0.0548908100349779,1.97079175269904e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0442155494619427,0.00335669424543594,0.0376364287408883,0.0507946701829971,2.21186793602224e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.103791871418008,0.00787996044456523,0.0883471489466606,0.119236593889356,2.23351922861546e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAL,Integrin alpha-L,37056,0.0529889139841632,0.00402306129187224,0.0451037138520936,0.0608741141162328,2.27409892570892e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DBI,Acyl-CoA-binding protein,39793,0.0988620960857442,0.00751215879976706,0.0841382648382008,0.113585927333288,2.38294978954221e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GP6,Platelet glycoprotein VI,39836,0.109664444628594,0.00833404470292778,0.0933297170108553,0.125999172246332,2.43247650962918e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0712194298593335,0.00541518888153517,0.0606056596515246,0.0818332000671424,2.65787257222712e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0745889693095481,0.00567211945758688,0.0634716151726778,0.0857063234464184,2.74818354312508e-39
NMR metabolomics,X23412.Phospholipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.109271927570531,0.00830703737092446,0.092990134323519,0.125553720817543,2.80696375505763e-39
NMR metabolomics,X23412.Phospholipids in VLDL,APOL1,Apolipoprotein L1,37445,0.0758389392242558,0.00576945545370848,0.0645308065349871,0.0871470719135244,3.15866046007589e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.082516926238773,0.00628074227124981,0.0702066713871234,0.0948271810904226,3.51383811303784e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN9,Septin-9,39788,0.0349404297506427,0.00266181980171713,0.0297232629392771,0.0401575965620083,3.70593118594811e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0350301737152156,0.00267030069453382,0.0297963843539293,0.0402639630765018,4.11429492876555e-39
NMR metabolomics,X23412.Phospholipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0476028246162589,0.00362739703860695,0.0404931264205893,0.0547125228119285,4.25826328867697e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.0984707265097461,0.00751027799652993,0.0837505816365474,0.113190871382945,4.96706875268252e-39
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0913126124571984,0.0069650971809264,0.0776610219825826,0.104964202931814,4.97872380911857e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GZMA,Granzyme A,40058,0.0415741958640605,0.00317455285683739,0.0353520722646592,0.0477963194634617,5.47055334004953e-39
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0449403216923452,0.0034296620524594,0.0382181840695248,0.0516624593151657,5.51746701146944e-39
NMR metabolomics,X23412.Phospholipids in VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0838849645313448,0.00640843892540172,0.0713244242375574,0.0964455048251321,5.97877330801332e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0982637055234219,0.00750276533750591,0.0835582854619103,0.112969125584933,5.99877310694865e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN4,Cerebellin-4,40030,0.0381175910191739,0.00291272006441249,0.0324086596929254,0.0438265223454224,6.19484806226032e-39
NMR metabolomics,X23412.Phospholipids in VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.101504979218335,0.00776031234713731,0.0862947670179455,0.116715191418724,7.35628809937898e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0462792782291058,0.00354422592384886,0.0393325954183621,0.0532259610398496,9.86014919051577e-39
NMR metabolomics,X23412.Phospholipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0661587379256914,0.00507183894076961,0.0562179336017829,0.0760995422495998,1.08063268585853e-38
NMR metabolomics,X23412.Phospholipids in VLDL,LARP1,La-related protein 1,37368,0.0786598444882785,0.00602936857472915,0.0668422820818094,0.0904774068947477,1.14510852344519e-38
NMR metabolomics,X23412.Phospholipids in VLDL,MICALL2,MICAL-like protein 2,37039,0.0834155406808567,0.00639912240371192,0.0708732607695813,0.095957820592132,1.33207160082573e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0706390248249558,0.00542392735320198,0.0600081272126799,0.0812699224372317,1.41570514640179e-38
NMR metabolomics,X23412.Phospholipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0265316735812741,0.00204021111584843,0.0225328597942112,0.0305304873683371,1.81379929186255e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0469819003784797,0.0036147401767026,0.0398970096321426,0.0540667911248168,2.15122876263161e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.0982771374535961,0.0075616506149226,0.0834563022483478,0.113097972658844,2.19469096482339e-38
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0656258619994745,0.00505704277870605,0.0557140581532106,0.0755376658457383,2.79132868747328e-38
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0600081197328488,0.00463045375393875,0.0509324303751288,0.0690838090905687,3.26993472585706e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0292427806484249,0.0022557157037873,0.0248215778690017,0.033663983427848,3.30539428007996e-38
NMR metabolomics,X23412.Phospholipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.120461370045761,0.00930214756992834,0.102229160808701,0.13869357928282,3.65596572697403e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FMNL1,Formin-like protein 1,39489,0.0740989172457803,0.00572387709855526,0.062880118132612,0.0853177163589486,3.90851059363721e-38
NMR metabolomics,X23412.Phospholipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.0480623793413075,0.00371646875100585,0.040778100589336,0.055346658093279,4.60924349092439e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA3,Annexin A3,39985,0.0847026225876135,0.00655934653474479,0.0718463033795137,0.0975589417957133,5.84317395657305e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0552749171340173,0.00427878487582069,0.0468884987774087,0.0636613354906258,5.94393283218764e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0628314533432081,0.00486682997058649,0.0532924666008586,0.0723704400855577,6.6913816487405e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0602407032007039,0.0046694614510886,0.0510885587565703,0.0693928476448376,7.41408933626362e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0792711893216087,0.00616227217531556,0.0671931358579902,0.0913492427852272,1.09960061173836e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SMTN,Smoothelin,37342,0.116664423967142,0.0090669495930039,0.0988932027648541,0.134435645169429,1.14987206694449e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0582613039900668,0.00452963118450803,0.049383226868431,0.0671393811117025,1.21764707704211e-37
NMR metabolomics,X23412.Phospholipids in VLDL,NRGN,Neurogranin,37445,0.110907140288506,0.00862475167143166,0.0940026270124997,0.127811653564512,1.26604974462148e-37
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0306278909738051,0.00238222073323015,0.025958738336674,0.0352970436109362,1.3038786390083e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DBN1,Drebrin,37056,0.0633205728214054,0.0049343033684421,0.0536493382192589,0.0729918074235519,1.80064684706738e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0408849430667865,0.00319068710010206,0.0346311963505864,0.0471386897829865,2.11126218888836e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0449655218462984,0.00351230965553314,0.0380813949214535,0.0518496487711434,2.44614022787775e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MATN2,Matrilin-2,39885,0.0357716169152315,0.00279483955098918,0.0302937313952927,0.0412495024351703,2.52448443488782e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0928565466382958,0.00725384242517242,0.0786390154849579,0.107074077791634,2.69802965975469e-37
NMR metabolomics,X23412.Phospholipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0473873522649115,0.00370464011688954,0.040126257635808,0.054648446894015,2.81938372617223e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CPA1,Carboxypeptidase A1,40052,0.0710711505810394,0.0055572203000433,0.0601789987929545,0.0819633023691243,2.86220550400609e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF6,SLAM family member 6,39477,0.0453583822629185,0.00354723145894219,0.0384058086033918,0.0523109559224452,2.98070223734037e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0417052746144177,0.00326378151728262,-0.0481022863882916,-0.0353082628405438,3.29852291348048e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0830126105920324,0.00650004725661015,0.0702725179690765,0.0957527032149883,3.59393638976179e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO3,Forkhead box protein O3,39477,0.117053344271048,0.00917771283983958,0.0990650271049622,0.135041661437133,4.52862639580257e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.118691213559351,0.00931956508387648,0.100424865994954,0.136957561123749,6.10308701765497e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.10014291389167,0.00786959052837555,0.084718516456054,0.115567311327286,6.45064525214939e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PARK7,Parkinson disease protein 7,39858,0.0627321834368458,0.00493035042855645,0.0530686965968751,0.0723956702768164,6.59414079906943e-37
NMR metabolomics,X23412.Phospholipids in VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0709547850173811,0.00557707009356311,0.0600237276339975,0.0818858424007648,6.66408784103804e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.105415296935975,0.00828864253273549,0.0891695575718131,0.121661036300136,7.06905620566615e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0530992526024114,0.00417649020052748,0.0449133318093775,0.0612851733954453,7.48960509036982e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.144303808567887,0.0113504462631587,0.122056933892096,0.166550683243678,7.50068637203677e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0490245638461966,0.00386078559894695,0.0414574240722605,0.0565917036201326,9.10122506253604e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0780466988577266,0.00614733430684584,0.0659979236163087,0.0900954740991444,9.42393276273542e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CA13,Carbonic anhydrase 13,39657,0.125766790831587,0.00991509031261158,0.106333213818869,0.145200367844306,1.0897818406525e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FADD,FAS-associated death domain protein,39868,0.091418119062754,0.00722424123976927,0.0772586062328062,0.105577631892702,1.58333709678564e-36
NMR metabolomics,X23412.Phospholipids in VLDL,BLNK,B-cell linker protein,37056,0.0466311616482315,0.00368303206054464,0.0394124188095641,0.053849904486899,1.58419224275713e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0634798346560065,0.00501544434538385,0.0536495637390541,0.0733101055729588,1.66619907452104e-36
NMR metabolomics,X23412.Phospholipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0848968883658753,0.00671421122251728,0.0717370343697414,0.0980567423620092,1.92872829018373e-36
NMR metabolomics,X23412.Phospholipids in VLDL,WDR46,WD repeat-containing protein 46,37368,0.0428834989683865,0.00339398485743432,0.0362312886478152,0.0495357092889578,2.17064369574035e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0825857581200538,0.00653974589070059,0.0697678561742807,0.095403660065827,2.39558210399781e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH7,Protocadherin-7,37382,0.0397122297508344,0.0031617011067408,0.0335152955816224,0.0459091639200464,5.53482202414539e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PALM,Paralemmin-1,37299,0.0335893992208118,0.00267690566252475,0.0283426641222633,0.0388361343193603,6.49249707386913e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0831299465853449,0.00662541553022605,0.0701441321461018,0.096115761024588,6.61470097171785e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3C,Protein FAM3C,39846,0.0340958046243004,0.00271974055579918,0.028765113134934,0.0394264961136668,6.95956414202751e-36
NMR metabolomics,X23412.Phospholipids in VLDL,IMMT,MICOS complex subunit MIC60,37368,0.0517673253298795,0.00412903662779554,0.0436744135394003,0.0598602371203588,7.38016645244261e-36
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0324346100673592,0.00259444535030559,0.0273494971807602,0.0375197229539582,1.07895605894311e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ADD1,Alpha-adducin,37124,0.0811934390648956,0.00649261955121249,0.0684679047445191,0.0939189733852721,1.107056080368e-35
NMR metabolomics,X23412.Phospholipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0349859379396665,0.0027997283747984,0.0294984703250616,0.0404734055542713,1.23677524530308e-35
NMR metabolomics,X23412.Phospholipids in VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0736429310075032,0.00590246959986505,0.0620740905917677,0.0852117714232387,1.57164732777989e-35
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.103295674725995,0.0083083798310905,0.0870112502570574,0.119580099194932,2.53021453030116e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0762221832122099,0.00612828515899098,0.0642107443005876,0.0882336221238322,2.54299049734819e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0324374122220318,0.0026126079275322,0.0273167006840687,0.0375581237599949,3.11351161823158e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0364649544133772,0.00293826795829785,0.0307059492151135,0.042223959611641,3.3199376346619e-35
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.0627645104944089,0.00506144238435284,-0.0726849375677405,-0.0528440834210773,3.78505732464746e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA2,Integrin alpha-2,37124,0.039265689686586,0.00316546749483501,0.0330613733967094,0.0454700059764627,3.87433727906721e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0790592449048585,0.00638370696375483,0.066547179255899,0.0915713105538179,4.58248357547048e-35
NMR metabolomics,X23412.Phospholipids in VLDL,VGF,Neurosecretory protein VGF,37411,0.0340394136628651,0.00275121138461185,0.0286470393490259,0.0394317879767044,5.68516295322576e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0668366050981712,0.00540633602515913,0.0562401864888593,0.0774330237074831,6.494614646628e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0528672556053966,0.00427990758363223,0.0444786367414774,0.0612558744693157,6.80548698332491e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA6,Integrin alpha-6,39866,0.0615591077869802,0.00498492079170464,0.0517886630352392,0.0713295525387213,7.10382383587534e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0519832989522221,0.00420995287730128,0.0437317913127116,0.0602348065917326,7.28844013054104e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0389533350579647,0.00315490402010024,0.0327697231785682,0.0451369469373612,7.3137378801103e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.061935108684445,0.00501714626441574,0.0521015020061901,0.0717687153626999,7.56500904117412e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0706100530501015,0.00572097342694426,0.0593969451332908,0.0818231609669123,7.71922697346169e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.076032611408238,0.00617029393965642,0.0639388352865115,0.0881263875299646,9.95407563643014e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GET3,ATPase GET3,37437,0.0647656038454003,0.00526793763337907,0.0544404460839774,0.0750907616068233,1.4838727578192e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0612410205962361,0.00498391958685742,0.0514725382059955,0.0710095029864766,1.51864934820216e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CD40LG,CD40 ligand,40058,0.0898114826506631,0.00730963104223538,0.0754846058078818,0.104138359493444,1.52098677449506e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0464941340810542,0.00378739656130296,0.0390708368209004,0.053917431341208,1.85802067735351e-34
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0876594471404856,0.00714557956715232,0.0736541111888671,0.101664783092104,2.05894374226631e-34
NMR metabolomics,X23412.Phospholipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.028867167002669,0.00235331267019871,0.0242546741690795,0.0334796598362584,2.08167202625727e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CCL25,C-C motif chemokine 25,40058,0.0574113122596521,0.00468336575743887,0.0482319153750719,0.0665907091442322,2.14726044796886e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0821056893961134,0.00669475232980335,0.0689839748296988,0.0952274039625279,2.14914133257287e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MDK,Midkine,39843,0.0583015397818875,0.00475636148805895,0.0489790712652919,0.067624008298483,2.18298607503529e-34
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0322397449125413,0.00263441703766921,0.0270762875187096,0.0374032023063729,2.77105400014585e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0515445995856495,0.00421277487456341,0.0432875608315052,0.0598016383397938,2.86923745466989e-34
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0386426020826895,0.00316087833889666,0.032447280538452,0.0448379236269269,3.23268739861942e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CPB1,Carboxypeptidase B,40052,0.0659516201212217,0.00539876535416037,0.0553700400270674,0.0765332002153761,3.60768298231608e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB6,Heat shock protein beta-6,40030,0.0430333183048434,0.0035235076707313,0.0361272432702101,0.0499393933394768,3.73698594461032e-34
NMR metabolomics,X23412.Phospholipids in VLDL,TBCA,Tubulin-specific chaperone A,37124,0.0994214344656362,0.00813902811814888,0.0834689393540644,0.115373929577208,3.92356307459891e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0258844641572099,0.00211998747374398,0.0217292887086717,0.0300396396057481,4.16742173541851e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0632069801070815,0.0051794037476137,0.0530553487617587,0.0733586114524044,4.25587985643613e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0610169505399245,0.0049977958256197,0.0512212707217098,0.0708126303581391,4.26338858220292e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRD2,Protein ZNRD2,37382,0.07806437004575,0.00639546616571814,0.0655292563609425,0.0905994837305576,4.35237401485869e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0349467543686436,0.00286304008547608,0.0293351958011105,0.0405583129361767,4.3643092601927e-34
NMR metabolomics,X23412.Phospholipids in VLDL,TTF2,Transcription termination factor 2,37039,0.0564810433338939,0.00463162171718272,0.0474030647682158,0.0655590218995721,5.06124537590196e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0265846971408152,0.00218332619375445,0.0223053778010565,0.0308640164805739,5.89785751047923e-34
NMR metabolomics,X23412.Phospholipids in VLDL,BTC,Probetacellulin,39477,0.0846846261856773,0.00695991236609351,0.071043197948134,0.0983260544232205,6.59439758110794e-34
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0628984198602927,0.00517061637707022,0.052764011761235,0.0730328279593503,6.83022308646287e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CTRB1,Chymotrypsinogen B,39858,0.0611134208741678,0.00502420111371564,0.0512659866912852,0.0709608550570505,6.83776925539247e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0563897733870504,0.00464089967229493,0.0472936100293524,0.0654859367447485,8.5334778351357e-34
NMR metabolomics,X23412.Phospholipids in VLDL,AMOT,Angiomotin,37124,0.0472445029765115,0.00388995067046331,0.0396201996624034,0.0548688062906196,9.18248043607402e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.0887600533192933,0.00731717884179127,0.0744183827893824,0.103101723849204,1.02216735065018e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CD46,Membrane cofactor protein,39777,0.0323293007318521,0.00266555676432807,0.0271048094737691,0.0375537919899351,1.05017155823826e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0497159975899488,0.00410024307267125,0.0416795211675131,0.0577524740123844,1.17425048795177e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ABHD14B,Protein ABHD14B,39687,0.0653181368625301,0.00540791135963842,0.0547186305976388,0.0759176431274214,1.93078674460452e-33
NMR metabolomics,X23412.Phospholipids in VLDL,LGMN,Legumain,39931,0.0407550962743017,0.00337587315721821,0.034138384886154,0.0473718076624494,2.0598504971578e-33
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0342233267337738,0.00283650330902378,0.0286637802480871,0.0397828732194604,2.38385195635893e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.055172093451115,0.00458075870633029,0.0461938063867077,0.0641503805155224,3.07539424206531e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS27,Serine protease 27,39818,0.0454182374620405,0.00377675096739355,0.0380158055659492,0.0528206693581319,3.62044414443296e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0869389626339998,0.00722877448674654,0.0727705646399766,0.101107360628023,3.79279460076611e-33
NMR metabolomics,X23412.Phospholipids in VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0677545371754208,0.00564003152985179,0.0567000753769113,0.0788089989739303,4.46218541114143e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ENAH,Protein enabled homolog,39587,0.0541618818522554,0.00451164402137505,0.0453190595703603,0.0630047041341505,4.66995543378082e-33
NMR metabolomics,X23412.Phospholipids in VLDL,FSHB,Follitropin subunit beta,37043,0.0735592984694455,0.0061554650186561,0.0614945870328795,0.0856240099060114,9.55520956286295e-33
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0932919373859288,0.00781595032642309,0.0779726747461396,0.108611200025718,1.05637832643906e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FGA,Fibrinogen alpha chain,37149,0.0346247157996776,0.00290005771142275,0.028940602685289,0.0403088289140662,1.08479797579042e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0263267619461562,0.00220627549314879,0.0220024619795846,0.0306510619127278,1.09933547997404e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0383675287925355,0.00321551665031873,0.0320651161579108,0.0446699414271602,1.11806473138947e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0455075025964513,0.00381244161833777,0.0380351170245092,0.0529798881683933,1.1249351713788e-32
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0495431180931097,0.00415596623692524,0.0413974242687363,0.0576888119174832,1.27493367521477e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ARFIP1,Arfaptin-1,37411,0.0777406094634591,0.00652052303821406,0.0649603843085595,0.0905208346183586,1.31595364949459e-32
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0443773741908457,0.00372402038754956,0.0370782942312486,0.0516764541504429,1.34108055730487e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0980769878511751,0.00824906216489782,0.0819088260079754,0.114245149694375,1.94766932968072e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0967200387141253,0.00813812687392726,0.0807693100412279,0.112670767387023,2.0772451094893e-32
NMR metabolomics,X23412.Phospholipids in VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0727256376288322,0.00613064847352914,0.0607095666207151,0.0847417086369493,2.67543042824223e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0864215025316627,0.00728567066576943,0.0721415880267546,0.100701417036571,2.70046806624996e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ACRBP,Acrosin-binding protein,37368,0.0428552801978119,0.00361496001470388,0.0357699585689923,0.0499406018266315,2.93030521919533e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0824706355337014,0.00696040130578303,0.0688282489743666,0.0961130220930361,3.17899601138535e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0669180181018612,0.00565283925753001,0.0558384531571024,0.0779975830466201,3.61753227000256e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0445911000705499,0.00377033027641284,0.0372012527287807,0.051980947412319,3.8600043471342e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CCL2,C-C motif chemokine 2,39720,0.0574086145653323,0.00486061166111886,0.0478818157095394,0.0669354134211253,4.66687998013545e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FGF2,Fibroblast growth factor 2,39866,0.0739627900021275,0.00626576849210487,0.0616818837576019,0.086243696246653,5.03752384668889e-32
NMR metabolomics,X23412.Phospholipids in VLDL,APOE,Apolipoprotein E,37453,0.0804689029380695,0.00682679800429729,0.0670883788496468,0.0938494270264922,6.49726844836733e-32
NMR metabolomics,X23412.Phospholipids in VLDL,IL12A_IL12B,Interleukin-12,39788,0.0816295946153729,0.00692843979274168,0.0680498526215992,0.0952093366091466,6.57139019397707e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0521786593687857,0.00443468843068532,0.0434866700446424,0.0608706486929289,7.9592522478428e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0746820287776598,0.00634700419979183,0.0622419005460679,0.0871221570092518,8.37800506583767e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0799264442402158,0.00680291973606835,0.0665927215575218,0.0932601669229098,9.71688591393321e-32
NMR metabolomics,X23412.Phospholipids in VLDL,EPPK1,Epiplakin,37043,0.0824293413304301,0.00701954829092738,0.0686710266802124,0.0961876559806477,1.10546715472699e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0461708484250013,0.00393381215729675,0.0384605765966997,0.053881120253303,1.11786066367665e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PPL,Periplakin,37056,0.0354485858476238,0.0030242934670312,0.0295209706522427,0.041376201043005,1.42177174575973e-31
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0508858641588465,0.00434937099458308,0.0423610970094636,0.0594106313082293,1.72051550473335e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0707283833437385,0.00605457848268502,0.0588614095176759,0.0825953571698011,2.1326552157973e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SCRN1,Secernin-1,39866,0.0617014725228283,0.00528811534450827,0.0513367664475921,0.0720661785980645,2.48885220329834e-31
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0549744856395359,0.00471649507673278,0.0457301552891397,0.0642188159899321,2.85861083245909e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CALCA,Calcitonin,39713,0.066823378078177,0.00573425406955148,0.0555842401018561,0.0780625160544979,2.95778755105528e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0265884272512631,0.00228212632606953,0.0221154596521668,0.0310613948503594,3.0428548176968e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TNF,Tumor necrosis factor,39555,0.0415509453666836,0.00357579616083377,0.0345423848914494,0.0485595058419178,4.36899548129536e-31
NMR metabolomics,X23412.Phospholipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0216045382960852,0.00186268046043474,-0.0252553919985373,-0.0179536845936331,5.57743168084016e-31
NMR metabolomics,X23412.Phospholipids in VLDL,NBN,Nibrin,39587,0.0561992071528159,0.00484542031550996,0.0467021833344164,0.0656962309712154,5.61148190338154e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0489279806711042,0.00422207167130835,0.0406527201953399,0.0572032411468686,6.64185732533262e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0494168906166001,0.00426770692924797,0.0410521850352741,0.0577815961979261,7.400131174435e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PTGR1,Prostaglandin reductase 1,37437,0.0865933118818383,0.00749566414664585,0.0719018101544124,0.101284813609264,9.98624773863979e-31
NMR metabolomics,X23412.Phospholipids in VLDL,NGRN,Neugrin,37388,0.0232034772245948,0.00200893689535093,0.019265960909707,0.0271409935394826,1.0269745728631e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DMD,Dystrophin,37043,0.0562707406548827,0.0048750698889196,0.0467156036726002,0.0658258776371651,1.13030573417406e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.0948616740701323,0.00822290249183478,0.0787447851861361,0.110978562954128,1.21494315985215e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0307450457279578,0.00266644485898599,0.0255188138043453,0.0359712776515704,1.29885174572948e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0671268026360632,0.00583183617025229,-0.0785572015297577,-0.0556964037423687,1.61956181244509e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0733751280246754,0.00639052008778081,0.060849708652625,0.0859005473967258,2.27000823425027e-30
NMR metabolomics,X23412.Phospholipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0957253636540249,0.0083451146210784,0.0793689389967112,0.112081788311339,2.4410717232562e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL1,Chordin-like protein 1,39908,0.0330307599431219,0.00288229810446898,0.0273814556583627,0.0386800642278811,2.7522444048759e-30
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1B,Meprin A subunit beta,39868,0.124130330834057,0.0108320500818292,0.102899512673671,0.145361148994442,2.76445287885009e-30
NMR metabolomics,X23412.Phospholipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.129247334453737,0.0112941597361372,0.107110781370908,0.151383887536566,3.31167068191627e-30
NMR metabolomics,X23412.Phospholipids in VLDL,RAB10,Ras-related protein Rab-10,37437,0.0576618123174276,0.00504005130015209,0.0477833117691295,0.0675403128657257,3.59766349968586e-30
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0516971667898425,0.0045204266781855,0.042837130500599,0.0605572030790861,3.81641215241479e-30
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0515795768254743,0.00451203931724063,0.0427359797636827,0.060423173887266,3.99992852509028e-30
NMR metabolomics,X23412.Phospholipids in VLDL,TREH,Trehalase,37437,0.0811201211053622,0.00709688541323434,0.0672102256954229,0.0950300165153015,4.04805335313193e-30
NMR metabolomics,X23412.Phospholipids in VLDL,RGMB,RGM domain family member B,40009,0.0273550822099806,0.00239745539668817,0.0226560696324718,0.0320540947874894,4.8554996094001e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CCL19,C-C motif chemokine 19,40009,0.123928313382593,0.0108807451589761,0.102602052871,0.145254573894186,6.12322495110978e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ATG4A,Cysteine protease ATG4A,39477,0.062982086002055,0.00553773068221428,0.052128133864915,0.0738360381391949,7.44691237624699e-30
NMR metabolomics,X23412.Phospholipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0720472096872022,0.00634195343536362,0.0596169809538895,0.0844774384205149,8.60148639701141e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0715573796656951,0.00629804181198615,0.0592132177142022,0.0839015416171879,8.89087922021788e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.041612533655166,0.00367702568970996,0.0344055633033345,0.0488195040069975,1.40842387534075e-29
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA4,Ephrin-A4,39720,0.0294714651210839,0.00260474725924279,0.024366160492968,0.0345767697491997,1.4436865025768e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.0387040760171838,0.00342110925865594,0.0319987018702182,0.0454094501641494,1.4645813357055e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0766707990617281,0.00677837404451007,0.0633851859344883,0.0899564121889678,1.56857752241284e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PSAP,Prosaposin,37347,0.0297903704959623,0.00263456008859705,0.0246266327223121,0.0349541082696125,1.63515576647296e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0294614041710775,0.00260550908274141,0.0243546063689044,0.0345682019732507,1.65087573036892e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CD84,SLAM family member 5,39866,0.0330903430452442,0.00292912035775789,0.0273492671440388,0.0388314189464497,1.75520069122389e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CORO1A,Coronin-1A,39520,0.0950523338772356,0.00841839633734328,0.0785522770560428,0.111552390698428,1.88880022765428e-29
NMR metabolomics,X23412.Phospholipids in VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0351821555663358,0.0031171709361895,0.0290725005314044,0.0412918106012672,1.9754017191788e-29
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0464740900232334,0.00412083128344064,0.0383972607076898,0.0545509193387771,2.28404931948276e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0717365009361545,0.00636362021574449,0.0592638053132953,0.0842091965590137,2.31820515961007e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ADM,Pro-adrenomedullin,40030,0.0278754685967658,0.0024760458497643,0.0230224187312278,0.0327285184623038,2.71658037811232e-29
NMR metabolomics,X23412.Phospholipids in VLDL,NID2,Nidogen-2,39858,0.0769367001223839,0.00683642364826961,0.0635373097717754,0.0903360904729923,2.85310929613134e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PAEP,Glycodelin,39749,-0.153330143592146,0.0136270960913428,-0.180039251931178,-0.126621035253114,2.92579099306808e-29
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.096701748366957,0.00859589783914175,0.0798537886022392,0.113549708131675,3.12949778820505e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0317358524847347,0.00282438112741332,0.0262000654750046,0.0372716394944647,3.47543003909308e-29
NMR metabolomics,X23412.Phospholipids in VLDL,DNM1,Dynamin-1,37382,0.121419775267917,0.0108031024223528,0.100245694520105,0.142593856015729,3.51981450847787e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CLTA,Clathrin light chain A,39585,0.0492206598031044,0.00438147829537928,0.040632962344161,0.0578083572620478,3.59359462678945e-29
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3B,Protein FAM3B,39788,0.0379018960835733,0.003378566087535,0.0312799065520047,0.0445238856151419,4.26095609248367e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ING1,Inhibitor of growth protein 1,39453,0.0474795903061186,0.00423347812131681,0.0391819731883377,0.0557772074238996,4.43395553861585e-29
NMR metabolomics,X23412.Phospholipids in VLDL,OPLAH,5-oxoprolinase,37043,0.0732180409260074,0.00653008735405885,0.060419069712052,0.0860170121399628,4.79609742365349e-29
NMR metabolomics,X23412.Phospholipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0737832168910245,0.00658341477710216,0.0608797239279043,0.0866867098541448,4.81482127640903e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ENO2,Gamma-enolase,40009,0.0696794060510335,0.00622725432159361,0.05747398758071,0.081884824521357,5.87093239037488e-29
NMR metabolomics,X23412.Phospholipids in VLDL,UNC79,Protein unc-79 homolog,36962,0.059591906191046,0.00533180158992725,0.0491415750747886,0.0700422373073034,7.16256842229942e-29
NMR metabolomics,X23412.Phospholipids in VLDL,MENT,Protein MENT,37124,-0.0233810897901999,0.00209399446455909,-0.0274853189407357,-0.0192768606396641,8.05986740992532e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH1,Acid ceramidase,37340,0.0496770556628093,0.00445354108785016,0.040948115130623,0.0584059961949956,9.09632859289026e-29
NMR metabolomics,X23412.Phospholipids in VLDL,COLEC12,Collectin-12,39862,0.0260340219490308,0.00233572449562269,0.0214560019376103,0.0306120419604512,9.55538709632688e-29
NMR metabolomics,X23412.Phospholipids in VLDL,KLF4,Krueppel-like factor 4,36991,0.0414059274383923,0.0037143619137479,0.0341257780874464,0.0486860767893382,9.90768697669651e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ACYP1,Acylphosphatase-1,37073,0.0689338450667794,0.00618767160409905,0.0568060087227453,0.0810616814108135,1.06914781412104e-28
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2,Brorin,39684,0.0403051466317808,0.00362519308669006,0.0331997681818683,0.0474105250816933,1.30785311808001e-28
NMR metabolomics,X23412.Phospholipids in VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.027804502476938,0.00250828098225265,-0.0327207332021532,-0.0228882717517228,1.88006638699233e-28
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0934998956541709,0.00843950717038797,0.0769584616002105,0.110041329708131,2.11718685777314e-28
NMR metabolomics,X23412.Phospholipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0940901688964988,0.00850231998689014,0.0774256217221941,0.110754716070803,2.43253467206337e-28
NMR metabolomics,X23412.Phospholipids in VLDL,SNX9,Sorting nexin-9,39868,0.072144399540679,0.00652253645593513,0.0593602280870461,0.0849285709943118,2.46206535846222e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0987713992686312,0.00893196365853566,0.0812647504979013,0.116278048039361,2.53892115833287e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0354055537619471,0.00320348264738446,0.0291267277730735,0.0416843797508206,2.71041716036076e-28
NMR metabolomics,X23412.Phospholipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.111002172904175,0.0100501014314724,0.0913039740984888,0.130700371709861,3.06403331765587e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PTN,Pleiotrophin,39585,0.052119579719997,0.00474213908032869,0.0428249871225527,0.0614141723174412,5.35453138430009e-28
NMR metabolomics,X23412.Phospholipids in VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0199293246105419,0.00181299160304186,0.0163758610685798,0.0234827881525039,5.44902556408744e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0634109579966432,0.00577301867733425,0.0520958413890681,0.0747260746042183,5.75064018668993e-28
NMR metabolomics,X23412.Phospholipids in VLDL,KLK6,Kallikrein-6,39889,0.0305564847222367,0.00278383545007719,0.0251001672400854,0.036012802204388,6.24047972722862e-28
NMR metabolomics,X23412.Phospholipids in VLDL,FGF23,Fibroblast growth factor 23,40008,0.0602950000813983,0.00549442183765766,0.0495259332795893,0.0710640668832073,6.40628560814318e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TSNAX,Translin-associated protein X,37021,0.0406092027575181,0.00369923189247909,0.0333587082482591,0.0478596972667771,6.46205172096354e-28
NMR metabolomics,X23412.Phospholipids in VLDL,FXN,"Frataxin, mitochondrial",40030,0.0753513170580098,0.00690716785400556,0.0618132680641589,0.0888893660518607,1.30079173626203e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA4,Annexin A4,39783,0.0743530991567863,0.00681683856694856,0.0609920955655671,0.0877141027480055,1.33228467064681e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ARSA,Arylsulfatase A,39858,0.046147173489431,0.00423186798049716,0.0378527122476565,0.0544416347312054,1.36902383460859e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0415791880652064,0.00381278536899748,0.0341061287419714,0.0490522473884415,1.41769068499793e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CCN4,CCN family member 4,40030,0.0410812697644637,0.00376939025247635,0.03369326486961,0.0484692746593173,1.45868363299223e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.044619473040012,0.00409690068859062,0.0365895476903744,0.0526493983896496,1.66563718837411e-27
NMR metabolomics,X23412.Phospholipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.039242919979927,0.00360526132616712,0.0321766077806395,0.0463092321792146,1.70741887543194e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0456979512884501,0.00420189309804257,0.0374622408162867,0.0539336617606136,1.97029024522678e-27
NMR metabolomics,X23412.Phospholipids in VLDL,TGFA,Protransforming growth factor alpha,39866,0.0468484744154672,0.00431586489996784,0.0383893792115302,0.0553075696194041,2.35280626428803e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0345801149198305,0.00318633616112848,0.0283348960440186,0.0408253337956423,2.40816737975542e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.03606212406449,0.0033223302342061,0.029550356805446,0.0425738913235339,2.46038956294704e-27
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0784170417929289,0.00723669544939977,0.0642331187121054,0.0926009648737525,2.90480319047467e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.104636532604571,0.00965852498514722,0.0857058236336823,0.123567241575459,3.08685150136922e-27
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0424059226592459,0.00391893363466718,0.0347248127352982,0.0500870325831936,3.42148766360857e-27
NMR metabolomics,X23412.Phospholipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0260125264852011,0.00240395441771585,0.0213007758264781,0.0307242771439242,3.5482538113986e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DKK4,Dickkopf-related protein 4,39718,0.0461595839751537,0.00426728371309843,0.0377957078974808,0.0545234600528266,3.55464775682273e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0492789846959345,0.00455676517952339,0.0403477249440687,0.0582102444478004,3.66874336042726e-27
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0645472327093426,0.00597865561081256,0.05282906771215,0.0762653977065352,4.44309067926094e-27
NMR metabolomics,X23412.Phospholipids in VLDL,KIF22,Kinesin-like protein KIF22,37021,0.123506557472196,0.0114379200271115,0.101088234219058,0.145924880725335,4.56792078388091e-27
NMR metabolomics,X23412.Phospholipids in VLDL,THBD,Thrombomodulin,39868,0.0275670590142262,0.00255831944151045,0.0225527529088657,0.0325813651195867,5.56337271130844e-27
NMR metabolomics,X23412.Phospholipids in VLDL,POMC,Pro-opiomelanocortin,37043,0.0718784600152754,0.00668451283360192,0.0587768148614156,0.0849801051691352,7.41447090018671e-27
NMR metabolomics,X23412.Phospholipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0375870186550411,0.0034973808270649,0.0307321522339939,0.0444418850760883,7.5837914719869e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0512204615576801,0.00476693753904766,0.0418772639811467,0.0605636591342135,7.72910571224191e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PER3,Period circadian protein homolog 3,37056,0.118983628960751,0.0110809847717984,0.0972648988080259,0.140702359113476,8.74093810543864e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.059706785725429,0.00557726561289779,0.0487753451241494,0.0706382263267087,1.18809739555448e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0368025706488635,0.00343677322283255,0.0300664951321117,0.0435386461656153,1.19354840728574e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CD302,CD302 antigen,39788,0.0292507869688315,0.0027346197523762,0.0238909322541742,0.0346106416834889,1.30177968652281e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ADA,Adenosine deaminase,40058,0.0349078596757734,0.00327038916986915,0.0284978969028298,0.0413178224487169,1.6514958199925e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0281326761771701,0.00263946089531625,0.0229593328223503,0.03330601953199,2.03918463385486e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0761842915584991,0.0071613490864221,0.0621480473491118,0.0902205357678864,2.52308130225313e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SWAP70,Switch-associated protein 70,37382,0.0359912399309242,0.00338444176399029,0.0293577340735032,0.0426247457883452,2.62104892057017e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1F,Protein phosphatase 1F,37437,0.0533306830048807,0.00501716199064186,0.0434970455032227,0.0631643205065388,2.75185497498266e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0480522870798373,0.00452195766409042,0.0391892500582201,0.0569153241014545,2.8503404109385e-26
NMR metabolomics,X23412.Phospholipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.072318008084547,0.00684234403371899,0.0589070137784578,0.0857290023906362,5.04456449638412e-26
NMR metabolomics,X23412.Phospholipids in VLDL,HRG,Histidine-rich glycoprotein,37380,0.0315293269991091,0.00298301176160761,0.0256826239463582,0.03737603005186,5.20576569478349e-26
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0330446962106871,0.00313372154115774,0.0269026019900179,0.0391867904313563,6.50891576818282e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0665038889306014,0.00630477323418283,0.0541465333916031,0.0788612444695997,6.55359568131047e-26
NMR metabolomics,X23412.Phospholipids in VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0452799144374315,0.00429746648978518,0.0368568801174526,0.0537029487574105,7.11670023532245e-26
NMR metabolomics,X23412.Phospholipids in VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0367776781938225,0.00349678388171882,0.0299239817856536,0.0436313746019914,8.74246337578314e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB6,Integrin beta-6,39587,0.0293462479988045,0.00279156508346097,0.023874780435221,0.034817715562388,9.21377762397509e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0308460924767261,0.00293636274584641,0.0250908214948672,0.0366013634585851,1.03036917770254e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0458768785553841,0.00437799472631596,0.0372960088918049,0.0544577482189634,1.30761978549233e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CCL14,C-C motif chemokine 14,39843,0.038329740465128,0.0036605278056052,0.0311551059661418,0.0455043749641142,1.41899880865931e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0870952326996038,0.0083257577118595,0.0707767475843592,0.103413717814848,1.57825778304884e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0463720809104393,0.00444589698534799,0.0376581228191572,0.0550860390017213,2.17760956432252e-25
NMR metabolomics,X23412.Phospholipids in VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0320605616429847,0.00307576445547528,-0.0380890599757162,-0.0260320633102531,2.33062460454868e-25
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0377173556367268,0.00362537922560718,0.0306116123545368,0.0448230989189169,2.96975239578301e-25
NMR metabolomics,X23412.Phospholipids in VLDL,XCL1,Lymphotactin,40030,0.0534668445764204,0.00516203371957095,0.0433492584860613,0.0635844306667794,4.62452713164358e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.081804025293067,0.00789658937368368,0.066326710120647,0.097281340465487,4.72231617768658e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0396412528749405,0.00382890995755794,0.0321365893581269,0.047145916391754,4.86036765454644e-25
NMR metabolomics,X23412.Phospholipids in VLDL,PVR,Poliovirus receptor,40009,0.0361430692046909,0.0035020291335925,0.0292790921028496,0.0430070463065322,6.79497899392225e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0533079936168497,0.00517091459255007,0.0431730010154515,0.0634429862182478,7.95542068209981e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ANPEP,Aminopeptidase N,39891,0.0270651272009476,0.0026283088840971,0.0219136417881172,0.0322166126137779,8.63539193767613e-25
NMR metabolomics,X23412.Phospholipids in VLDL,C5,Complement C5,37453,0.0147699476814422,0.00143431068405377,0.0119586987406968,0.0175811966221876,8.90937630085323e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ALCAM,CD166 antigen,40052,0.0188028554131525,0.00182679157958787,0.0152223439171603,0.0223833669091447,9.05007109015625e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SLIT2,Slit homolog 2 protein,39489,0.049971960890176,0.0048558867280553,0.0404544229031876,0.0594894988771644,9.28029948972067e-25
NMR metabolomics,X23412.Phospholipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0326041315780728,0.00316881276615552,0.026393258556408,0.0388150045997376,9.43376912042991e-25
NMR metabolomics,X23412.Phospholipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.031014151453544,0.00301548284830855,0.0251038050708592,0.0369244978362288,1.01496943154575e-24
NMR metabolomics,X23412.Phospholipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0683737135818238,0.00665948500856474,0.0553211229650369,0.0814263041986107,1.22697298299057e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CCL20,C-C motif chemokine 20,40058,0.0813269851414074,0.00792542486491741,0.0657931524061693,0.0968608178766455,1.2494287170117e-24
NMR metabolomics,X23412.Phospholipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0539728525134877,0.00526281569870593,0.0436577337440241,0.0642879712829513,1.37993098321658e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NADK,NAD kinase,39868,0.0512813254311469,0.00502426932765528,0.0414337575489425,0.0611288933133512,2.19727206696367e-24
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN6,Dynactin subunit 6,39489,0.0681359448841085,0.00668340489144155,0.0550364712968831,0.081235418471334,2.492723873776e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.052500370097348,0.00515043229037207,0.0424055228082188,0.0625952173864773,2.52910553602041e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0253005858256546,0.00248269854898751,0.0204344966696391,0.0301666749816701,2.59179563870935e-24
NMR metabolomics,X23412.Phospholipids in VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0507225901154553,0.00499754885089218,0.0409273943677067,0.060517785863204,4.06044563204421e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ACAN,Aggrecan core protein,39730,0.0268543087322606,0.00265177578901064,0.0216568281857998,0.0320517892787215,4.96543120121725e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FCN1,Ficolin-1,37430,0.0536820988225673,0.0053033673836904,0.0432874987505341,0.0640766988946005,5.35495437762737e-24
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.103730882564861,0.0102599594607906,-0.12384040310801,-0.0836213620217113,6.12558694585078e-24
NMR metabolomics,X23412.Phospholipids in VLDL,XG,Glycoprotein Xg,39985,0.0285904314398727,0.00283107483634434,0.0230415247606378,0.0341393381191076,6.58762821812627e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0191413951296779,0.00189692480026619,-0.0228593677381996,-0.0154234225211561,7.15038437504678e-24
NMR metabolomics,X23412.Phospholipids in VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0857640629709266,0.00852182148047351,0.0690612928691985,0.102466833072655,9.65125638800393e-24
NMR metabolomics,X23412.Phospholipids in VLDL,MMP12,Macrophage metalloelastase,39900,0.04757875226864,0.00472976553280099,0.03830841182435,0.0568490927129299,9.81656148519217e-24
NMR metabolomics,X23412.Phospholipids in VLDL,TLR3,Toll-like receptor 3,40058,0.057653850665374,0.00573454685158105,0.0464141388362751,0.0688935624944729,1.03767199596939e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CSTB,Cystatin-B,39619,0.0401149848025489,0.00399656611303367,0.0322817152210029,0.0479482543840948,1.22979211545019e-23
NMR metabolomics,X23412.Phospholipids in VLDL,STX16,Syntaxin-16,39477,0.0550106152124766,0.00548717019709253,0.0442557616261752,0.0657654687987779,1.39036982457062e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0692720945821441,0.00691185837449103,0.0557248521681417,0.0828193369961465,1.4310057106201e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TCOF1,Treacle protein,37437,0.0287205798916094,0.00287003787980628,0.0230953056471891,0.0343458541360297,1.7119383321902e-23
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0329066808768113,0.00330111000635509,0.0264365052643553,0.0393768564892673,2.53071788536314e-23
NMR metabolomics,X23412.Phospholipids in VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0454889834005417,0.0045665007029988,0.036538642022664,0.0544393247784193,2.70554433919202e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0375198268004576,0.00377693829740201,0.0301170277375496,0.0449226258633655,3.45884559367857e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0560688716560158,0.00564323529090547,0.0450081304858411,0.0671296128261905,3.51583852596041e-23
NMR metabolomics,X23412.Phospholipids in VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0488927419242845,0.00492517545254714,0.0392393980372921,0.0585460858112768,3.69534450437456e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0438517329793011,0.0044179211239528,0.0351926075763536,0.0525108583822486,3.76213287108744e-23
NMR metabolomics,X23412.Phospholipids in VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0814274924172112,0.00821203422581242,0.0653319053346189,0.0975230794998036,4.15025641566365e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA9,Serpin A9,39715,0.0678766481771773,0.00684611737408846,0.0544582581239639,0.0812950382303906,4.19839147581134e-23
NMR metabolomics,X23412.Phospholipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.028024370644521,0.00282975009668597,-0.0335706808340255,-0.0224780604550165,4.68143961279795e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0575416376925978,0.00581985457532352,0.0461347227249637,0.0689485526602319,5.66048154220986e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA2,Annexin A2,36879,0.0648420748439192,0.00656718554016801,0.0519703911851899,0.0777137585026485,6.51849158947623e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX,Glutaredoxin-1,39771,0.0520691935207047,0.0052782880222926,0.0417237489970112,0.0624146380443982,6.88175272375114e-23
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0393412188877491,0.00399234738310862,0.0315162180168562,0.047166219758642,7.85053565455504e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0341671433507522,0.00346891292111483,0.0273680740253671,0.0409662126761372,8.25796208992942e-23
NMR metabolomics,X23412.Phospholipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.034857702690137,0.00354116135243142,0.0279170264393714,0.0417983789409026,8.48149547297201e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PMM2,Phosphomannomutase 2,37021,0.055925591898994,0.00568063879643287,0.0447915398579856,0.0670596439400024,8.63972511253197e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0448620413155778,0.00456091596654861,0.0359226460211425,0.0538014366100131,9.37363115240104e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL1,Fc receptor-like protein 1,39868,0.040627270406227,0.00413231166771073,0.032527939537514,0.04872660127494,9.54518020229768e-23
NMR metabolomics,X23412.Phospholipids in VLDL,VIT,Vitrin,37437,0.0340480799678387,0.00346645691847695,0.0272538244076239,0.0408423355280535,1.07578983658537e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0435547698224226,0.00443464814173269,0.0348628594646265,0.0522466801802187,1.08342813376484e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0467346667743801,0.00476020125587457,0.037404672312866,0.0560646612358943,1.09780297444348e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CLU,Clusterin,37453,0.0294746398976317,0.00300383568900471,0.0235871219471825,0.0353621578480809,1.1847909655815e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0276706715984832,0.00282129459711543,0.0221409341881369,0.0332004090088294,1.23919624782442e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0537448349474229,0.00549913474183234,0.0429665308534316,0.0645231390414143,1.73897680725342e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0565703637940749,0.0057904161074431,0.0452211482234865,0.0679195793646634,1.8113705257656e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0318679678410519,0.00326303754693017,0.0254724142490688,0.0382635214330351,1.81605636874445e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0484327412317217,0.0049630309236528,0.0387052006213622,0.0581602818420812,2.01646223727882e-22
NMR metabolomics,X23412.Phospholipids in VLDL,KLB,Beta-klotho,39489,-0.0675691763921998,0.00693051243762316,-0.0811529807699412,-0.0539853720144584,2.14681228052026e-22
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0234006731326139,0.00240511978601897,0.0186866383520167,0.0281147079132111,2.60158806754554e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0335129223941219,0.00345191405175293,0.0267471708526862,0.0402786739355577,3.29272160859284e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ELOB,Elongin-B,37021,0.0359822519410461,0.00370656903987153,0.0287173766228979,0.0432471272591943,3.318688178289e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0463468404912662,0.00478062216132495,-0.0557168599274631,-0.0369768210550693,3.74558956982991e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR3,Small proline-rich protein 3,37388,0.0599023585910743,0.00617909563748156,0.0477913311416104,0.0720133860405382,3.7614451901145e-22
NMR metabolomics,X23412.Phospholipids in VLDL,HEPH,Hephaestin,37437,0.0239747470831325,0.00248178157495342,0.0191104551962238,0.0288390389700412,5.23298745950483e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0265765598755605,0.0027544420256289,0.0211778535053279,0.0319752662457932,5.73036835431749e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0270153749726116,0.00280021676774796,0.0215269501078256,0.0325037998373976,5.76657992687822e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CCL15,C-C motif chemokine 15,40052,0.0393534752763957,0.00408228875179576,0.0313521893228761,0.0473547612299154,6.20308603769122e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0349227876768664,0.00363483077096121,0.0277985193657825,0.0420470559879504,8.47359637781471e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0536527061125693,0.0055937694018521,0.0426889180849392,0.0646164941401994,1.01743109948649e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0559013928670029,0.00584329237602295,0.0444485398099979,0.0673542459240079,1.29681373448205e-21
NMR metabolomics,X23412.Phospholipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0286972041169835,0.00301464466165062,0.0227885005801483,0.0346059076538187,1.98437843556364e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO1,Roundabout homolog 1,39885,0.0211455954594497,0.00222191717556816,0.0167906377953361,0.0255005531235633,2.03399908824077e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SCRIB,Protein scribble homolog,37043,0.0809009470419173,0.00850702926317087,0.0642271696861024,0.0975747243977323,2.23480604625498e-21
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0140271855691911,0.00147555729834217,0.0111350932644404,0.0169192778739417,2.24492508545724e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0498672037333239,0.00524788995756522,0.039581339416496,0.0601530680501517,2.40436109697277e-21
NMR metabolomics,X23412.Phospholipids in VLDL,MMP1,Interstitial collagenase,39314,0.0818701195669788,0.0086337914481743,0.0649478883285572,0.0987923508054005,2.83567543894838e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0298952364578127,0.00315634212436792,0.0237088058940515,0.0360816670215738,3.21784460040893e-21
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS1,Nephrin,37056,0.0305750175320339,0.00323334203107004,0.0242376671511366,0.0369123679129312,3.72686689658625e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.024567732751312,0.0025997027133429,0.0194723154331599,0.0296631500694641,3.84026638372059e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CTSE,Cathepsin E,37124,0.047086289303633,0.00498342576647323,0.0373187748013455,0.0568538038059205,4.00201352946781e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0441225478800312,0.00467811112765554,0.0349534500698264,0.0532916456902361,4.57625500837615e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL8,Interleukin-8,39750,0.0586367562185293,0.00622449510389004,0.0464367458149048,0.0708367666221538,5.1019680311876e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LAMB1,Laminin subunit beta-1,37043,0.0270059392857557,0.00286644801386405,0.0213877011785822,0.0326241773929292,5.18249965646602e-21
NMR metabolomics,X23412.Phospholipids in VLDL,BGN,Biglycan,39448,-0.105798619579211,0.0112354768668306,-0.127820154238199,-0.0837770849202226,5.30405808963918e-21
NMR metabolomics,X23412.Phospholipids in VLDL,GRN,Progranulin,39787,0.0218724512346303,0.00232631411091513,0.0173128755772367,0.026432026892024,6.05513263456563e-21
NMR metabolomics,X23412.Phospholipids in VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0656469437674227,0.00698262796552923,0.0519609929549854,0.07933289457986,6.08409622103373e-21
NMR metabolomics,X23412.Phospholipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0586810403927016,0.00624386863785472,0.0464430578625064,0.0709190229228969,6.42724274678973e-21
NMR metabolomics,X23412.Phospholipids in VLDL,BRK1,Protein BRICK1,39489,0.0393650300451505,0.00419132860501072,0.0311500259793295,0.0475800341109715,6.68193712204197e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ASPN,Asporin,37437,0.0238849832882968,0.00254320309067522,0.0189003052305734,0.0288696613460202,6.83150794113102e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DENR,Density-regulated protein,37056,0.0512655107185093,0.00545852933663753,0.0405667932186998,0.0619642282183189,6.8521822643066e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0286816045306637,0.00305421270694908,0.0226953476250435,0.0346678614362839,6.88711098465759e-21
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_E,,39866,0.0241921764413032,0.00257775186823613,0.0191397827795604,0.0292445701030461,7.11901953354131e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN2,Dynactin subunit 2,39788,0.0838543036564772,0.00893562074917213,0.0663404869880998,0.101368120324855,7.17170083524633e-21
NMR metabolomics,X23412.Phospholipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0809701809473386,0.00863237663064698,0.0640507227512705,0.0978896391434067,7.6734687118522e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CBS,Cystathionine beta-synthase,37043,0.045074250911523,0.00480651938976033,0.0356534729075927,0.0544950289154532,7.82625091460432e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0852892588701045,0.00910018838529521,0.0674528896349258,0.103125628105283,8.0372551183461e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CPA2,Carboxypeptidase A2,39933,0.0566990738336435,0.00607074153982104,0.0448004204155943,0.0685977272516927,1.08963350064732e-20
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0368563094256653,0.00395387669223291,0.0291067111088888,0.0446059077424418,1.32177914077435e-20
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA1,BolA-like protein 1,36991,0.0482440582630903,0.00518122128234463,0.0380888645496949,0.0583992519764858,1.4605225774107e-20
NMR metabolomics,X23412.Phospholipids in VLDL,S100A13,Protein S100-A13,37056,0.0304952757289285,0.00328154216939442,0.0240634530769154,0.0369270983809416,1.73266173301114e-20
NMR metabolomics,X23412.Phospholipids in VLDL,KLK7,Kallikrein-7,36818,0.0342279785178604,0.00368376447723004,0.0270078001424895,0.0414481568932312,1.7599927160709e-20
NMR metabolomics,X23412.Phospholipids in VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0200576964081106,0.00216082059742579,-0.0242929047790651,-0.015822488037156,1.86276497837672e-20
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0196214561534831,0.00211711160422089,0.0154719174092101,0.023770994897756,2.13375615411103e-20
NMR metabolomics,X23412.Phospholipids in VLDL,GLO1,Lactoylglutathione lyase,39585,0.0505271789858843,0.00545380347795179,0.0398377241690988,0.0612166338026698,2.2069322274671e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.0421635818673608,0.00456130645274019,0.03322342121999,0.0511037425147315,2.68125124000614e-20
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0437419605127905,0.00473957493312189,0.0344523936438716,0.0530315273817094,3.14019758858248e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN2,Nectin-2,39846,0.0244841982774459,0.00265575180789817,0.0192789247339655,0.0296894718209263,3.3553413975668e-20
NMR metabolomics,X23412.Phospholipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0220092343156822,0.00238908877768259,0.0173266203114243,0.0266918483199401,3.57809827204918e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0468551574721104,0.0050914836605739,0.0368758494973856,0.0568344654468353,3.91035738022516e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0365911181778075,0.00397631224495958,0.0287975461776867,0.0443846901779283,4.01157429318332e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0408128032160215,0.00443739743797702,0.0321155042375866,0.0495101021944565,4.119161203341e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0352872913128716,0.0038397398867064,0.0277614011349271,0.0428131814908162,4.50762420318837e-20
NMR metabolomics,X23412.Phospholipids in VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0596834367914369,0.00649714255708204,0.0469490373795561,0.0724178362033177,4.65688556092715e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0411102931451517,0.00447622193632552,0.0323368981499537,0.0498836881403497,4.65967358377164e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CASP8,Caspase-8,39984,0.0533359288051028,0.00580850131603101,0.041951266225682,0.0647205913845236,4.71799491925109e-20
NMR metabolomics,X23412.Phospholipids in VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0189831487544996,0.00206819970470592,0.014929477333276,0.0230368201757233,4.99275697663185e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0192594446768198,0.0021029016213115,0.0151377574990492,0.0233811318545903,6.00488332486553e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TEK,Angiopoietin-1 receptor,39913,0.0186259591236481,0.00204098599473883,0.0146256265739599,0.0226262916733362,7.93874959640232e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0382477571000255,0.00419929578473082,-0.0464783768380979,-0.0300171373619531,9.34353926385578e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0624165662625184,0.00685597662682851,0.0489788520739345,0.0758542804511023,9.74357843648167e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0946294082257572,0.0104144649499251,-0.11504175952761,-0.074217056923904,1.14273406931387e-19
NMR metabolomics,X23412.Phospholipids in VLDL,UMOD,Uromodulin,40012,-0.0451141495602937,0.00496519047175984,-0.054845922884943,-0.0353823762356444,1.14339427197175e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CAPG,Macrophage-capping protein,39739,0.0496329457986848,0.00547098947582591,0.038909806426066,0.0603560851713036,1.30260834626542e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0558215829222172,0.00615397769560298,0.0437597866388354,0.067883379205599,1.31468209930767e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0517120588082764,0.0057071481042832,-0.0628980690926715,-0.0405260485238813,1.4735855937177e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0564371859849302,0.00623285949167859,0.0442207813812401,0.0686535905886202,1.52753098430403e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0774372860816861,0.00855318328348819,-0.0942015253173229,-0.0606730468460492,1.54398111989068e-19
NMR metabolomics,X23412.Phospholipids in VLDL,BSG,Basigin,40040,0.0165722440207531,0.00183102200662232,0.0129834408877734,0.0201610471537329,1.57747046602884e-19
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0450053965800436,0.00497939853538625,0.0352457754506865,0.0547650177094006,1.77297417195893e-19
NMR metabolomics,X23412.Phospholipids in VLDL,JAM2,Junctional adhesion molecule B,40009,0.0213407761743369,0.00236208811418335,0.0167110834705375,0.0259704688781363,1.82702288161013e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0414915777871326,0.0046000090387131,0.0324755600712549,0.0505075955030103,2.09235684417803e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NFASC,Neurofascin,40058,0.0235127507306165,0.00260774937882524,0.018401561948119,0.0286239395131139,2.15528057777151e-19
NMR metabolomics,X23412.Phospholipids in VLDL,IL17D,Interleukin-17D,39587,0.0287617386213191,0.00319090390046312,0.0225075669764113,0.0350159102662268,2.21817998704001e-19
NMR metabolomics,X23412.Phospholipids in VLDL,C7,Complement component C7,37149,-0.0272825505169108,0.00302681103024382,-0.0332151001361887,-0.0213500008976329,2.26277417807281e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CD59,CD59 glycoprotein,39173,0.0179448755193876,0.00199182898184789,0.0140408907149657,0.0218488603238095,2.31559986786276e-19
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0286423733293156,0.00319171146519954,0.0223866188575245,0.0348981278011066,3.1795947032946e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NPPB,Natriuretic peptides B,39585,-0.107072032651412,0.011934061658241,-0.130462793501565,-0.0836812718012601,3.2357143702407e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TF,Serotransferrin,37453,0.0184061457818498,0.00206036040316901,0.0143678393916386,0.0224444521720611,4.65344360879556e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0222459789418551,0.00249304012177466,0.0173596203031767,0.0271323375805334,5.00933105626881e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.061282810099512,0.00687485130562406,0.0478081015404889,0.0747575186585352,5.44410638281142e-19
NMR metabolomics,X23412.Phospholipids in VLDL,STX7,Syntaxin-7,37056,0.0414858949746134,0.00466268341634646,0.0323470354785744,0.0506247544706525,6.45215724064762e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LEPR,Leptin receptor,39868,-0.0258585458604039,0.00291080393975833,-0.0315637215823303,-0.0201533701384776,7.14669031908613e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.095668537155656,0.0107813226024087,0.0745371448549349,0.116799929456377,7.96544437363715e-19
NMR metabolomics,X23412.Phospholipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0146719517982946,0.0016555701801971,0.0114270342451083,0.017916869351481,8.658693384133e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0562085942094556,0.00634636023228947,0.0437697281541682,0.068647460264743,9.24482098909236e-19
NMR metabolomics,X23412.Phospholipids in VLDL,STX6,Syntaxin-6,39477,0.056901077243398,0.00642670111063994,0.0443047430665437,0.0694974114202523,9.34892752008514e-19
NMR metabolomics,X23412.Phospholipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0323539910979683,0.00365512519102238,-0.0395180364723721,-0.0251899457235644,9.50901654836363e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0464008031240258,0.00525019116934843,0.0361104284321029,0.0566911778159487,1.07379050719198e-18
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0496195572304641,0.00562977120609502,0.0385852056665178,0.0606539087944103,1.3346328644418e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0264368357693437,0.00300542404715297,0.0205462046369239,0.0323274669017636,1.55657046415151e-18
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0435991473694333,0.00495878183633893,0.033879934970209,0.0533183597686576,1.64388179438151e-18
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0343063440155939,0.0039062845594086,0.026650026279153,0.0419626617520347,1.75988793399034e-18
NMR metabolomics,X23412.Phospholipids in VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0419427531783548,0.00477684134171996,0.0325801441485837,0.051305362208126,1.8275467740959e-18
NMR metabolomics,X23412.Phospholipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0327139181928987,0.00372868405742529,0.0254056974403452,0.0400221389454523,1.90303523825163e-18
NMR metabolomics,X23412.Phospholipids in VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0210558013995827,0.00240707510393787,0.0163379341958644,0.0257736686033009,2.43720165752455e-18
NMR metabolomics,X23412.Phospholipids in VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0482213344114639,0.00551574334623626,0.0374104774528409,0.059032191370087,2.55373161237173e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PVALB,Parvalbumin alpha,39971,0.0939503274524806,0.0107548871606787,0.0728707486175503,0.115029906287411,2.65849325011448e-18
NMR metabolomics,X23412.Phospholipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0609428413580003,0.00698280889443456,0.0472565359249086,0.074629146791092,2.90908888119668e-18
NMR metabolomics,X23412.Phospholipids in VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0781333603756956,0.00895526234733595,-0.0956856745764741,-0.0605810461749172,2.92374814954191e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CYTL1,Cytokine-like protein 1,37437,0.0188373717675223,0.00215883112214527,0.0146060627681176,0.023068680766927,2.9496990140603e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0299887877942521,0.00344578455200916,0.0232350500723141,0.0367425255161901,3.6109614062983e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PKD1,Polycystin-1,37437,0.0214926854141058,0.0024711714685916,0.0166491893356663,0.0263361814925454,3.78311707256535e-18
NMR metabolomics,X23412.Phospholipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.052906218914914,0.00609389661124199,0.0409621815568797,0.0648502562729483,4.27370658383822e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0331298206005128,0.00382324980661885,0.0256362509795398,0.0406233902214857,4.93341272077472e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IL32,Interleukin-32,39866,-0.0349235797549302,0.00403260058239086,-0.0428274768964163,-0.0270196826134441,5.1473438020984e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN3,Calsyntenin-3,37388,0.0247164717817506,0.00285443130518801,0.0191217864235821,0.0303111571399191,5.29353459428704e-18
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0536280053288548,0.0061968170577342,0.0414822438956958,0.0657737667620138,5.5390898022131e-18
NMR metabolomics,X23412.Phospholipids in VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0762095021996984,0.00884507115796423,0.0588731627300885,0.0935458416693083,7.56316164846687e-18
NMR metabolomics,X23412.Phospholipids in VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0653541625248033,0.00758876389749286,0.0504801852857173,0.0802281397638893,7.99070332177277e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0622737228714332,0.00723561307902539,0.0480919212365435,0.076455524506323,8.3778458047595e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.052544660243387,0.00610762738722569,0.0405737105644246,0.0645156099223493,8.62666822745895e-18
NMR metabolomics,X23412.Phospholipids in VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0380488051096229,0.00442587281266027,0.0293740943968088,0.0467235158224371,8.93606013927896e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0961933980990552,0.011195597341503,0.0742500273097093,0.118136768888401,9.46897356916045e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0205271483203922,0.00239151567800695,0.0158397775914986,0.0252145190492858,1.02343625287925e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0410038122524196,0.00478289929659488,0.0316293296310936,0.0503782948737455,1.09895157028816e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0291636226428434,0.00340188047833297,0.0224959369053108,0.0358313083803761,1.10121001154814e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0420214487040101,0.00490722573875423,0.0324032862560518,0.0516396111519684,1.19734086075376e-17
NMR metabolomics,X23412.Phospholipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.029086149036328,0.00339962789452505,0.0224228783630589,0.0357494197095971,1.27525280115091e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0512024463131051,0.00599012357945636,0.0394618040973707,0.0629430885288396,1.39139370463805e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0311433953246423,0.00365778840547721,0.023974130049907,0.0383126605993776,1.82461767833433e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0196761705801221,0.00231048764041914,-0.0242047263553436,-0.0151476148049006,1.82759847395581e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FABP6,Gastrotropin,39564,0.043391016735102,0.00509748017448193,0.0333999555931174,0.0533820778770866,1.85841043142194e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0434884926833201,0.00511162909635765,-0.0535072857121811,-0.0334696996544592,1.92838047278516e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0699088857293144,0.00821717255218758,0.0538032275270267,0.086014543931602,1.95977481514678e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0232797771614721,0.00274243041567969,0.0179046135467399,0.0286549407762043,2.30491289682841e-17
NMR metabolomics,X23412.Phospholipids in VLDL,POSTN,Periostin,37437,-0.0296998848608418,0.00350771379351394,-0.0365750038961291,-0.0228247658255545,2.77371118426047e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0440866218999802,0.00521173634000417,0.0338716186735721,0.0543016251263884,2.97121285840582e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CTSF,Cathepsin F,39913,0.0321100223213275,0.00381186944758746,0.0246387582040561,0.0395812864385989,3.95326855072974e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD300E,CMRF35-like molecule 2,39991,0.0304866481018249,0.00362445239239451,0.0233827214127316,0.0375905747909181,4.38754747130222e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0415571359899535,0.00494550710378513,0.0318639420665347,0.0512503299133724,4.78194561885778e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0470816514853425,0.005625803986488,0.0360550756718261,0.058108227298859,6.28752523710903e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0275523102321893,0.00329418031211336,0.0210957168204471,0.0340089036439315,6.57300120490876e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0285650880945968,0.00341787163470565,0.0218660596905738,0.0352641164986199,6.9165541721645e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB8,Serpin B8,40058,0.0431998520927292,0.00518643323522212,0.0330344429516938,0.0533652612337646,8.76903243166904e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0321914930936883,0.00386725710983757,0.0246116691584066,0.0397713170289699,9.18897223058071e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CR1,Complement receptor type 1,37420,0.0280037673230502,0.00336369910153518,0.0214109170840412,0.0345966175620591,9.21191355531103e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0211887387192904,0.00254667914621883,-0.0261802298458793,-0.0161972475927015,9.48458129365508e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TPR,Nucleoprotein TPR,37021,0.0370039650688227,0.00444779300099526,0.028286290786872,0.0457216393507734,9.68715296413745e-17
NMR metabolomics,X23412.Phospholipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0434830284430245,0.00522971298610078,0.033232790990267,0.0537332658957821,1.00782905756925e-16
NMR metabolomics,X23412.Phospholipids in VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0440834844250571,0.0053135022602279,0.0336690199950104,0.0544979488551037,1.15890095736385e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LY75,Lymphocyte antigen 75,39866,0.0301778562762722,0.00364046023631603,0.0230425542130928,0.0373131583394517,1.22591332954202e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CASP9,Caspase-9,37056,0.0496082473948304,0.00598357154583708,0.0378804471649897,0.0613360476246711,1.233625399333e-16
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0248159989983684,0.00299512825523883,0.0189455476181003,0.0306864503786365,1.26877710818515e-16
NMR metabolomics,X23412.Phospholipids in VLDL,INSR,Insulin receptor,37056,0.0130277508430409,0.00157200935225207,0.00994661251262685,0.016108889173455,1.2693953525483e-16
NMR metabolomics,X23412.Phospholipids in VLDL,S100P,Protein S100-P,39585,0.0409776535320901,0.00496733598354739,0.0312416750043372,0.050713632059843,1.71654203766383e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PZP,Pregnancy zone protein,37453,0.04279171787878,0.00519508260725562,0.032609355968559,0.052974079789001,1.92660395267613e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CCN5,CCN family member 5,39858,0.0298302372414616,0.00362631078645002,0.0227226681000196,0.0369378063829036,2.08223821197888e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0198921774219667,0.00242499332178589,0.0151391905112664,0.0246451643326671,2.55427949747109e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0412122917414897,0.00503101920868374,0.0313514940924696,0.0510730893905098,2.8126773373037e-16
NMR metabolomics,X23412.Phospholipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0454924839046315,0.00555911069126718,0.0345966269497478,0.0563883408595152,3.00326336199926e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0266383468877379,0.00326019882248379,0.0202483571956697,0.0330283365798062,3.2920969857509e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0270951058391959,0.00331922817344353,0.0205894186192465,0.0336007930591452,3.51335767803099e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0414226923520261,0.00507425294315431,0.0314771565834436,0.0513682281206085,3.54512368526385e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0319942089831561,0.00391927899829683,0.0243124221464943,0.0396759958198179,3.55268723667132e-16
NMR metabolomics,X23412.Phospholipids in VLDL,TXN,Thioredoxin,37289,0.0331655002205907,0.00407403160881517,0.025180398267313,0.0411506021738684,4.27383499793172e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0438191435222291,0.00538481421467291,0.0332649076614702,0.054373379382988,4.33547079011061e-16
NMR metabolomics,X23412.Phospholipids in VLDL,AGT,Angiotensinogen,37445,0.0172169937870649,0.00211629605069515,0.0130690535277024,0.0213649340464273,4.45870991565327e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI1,Neuroserpin,37088,0.0236324241261567,0.00290822663735632,0.0179322999169383,0.0293325483353751,4.82623223719113e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0234494642697434,0.0029053842036228,-0.0291440173088441,-0.0177549112306428,7.45585980137089e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SCT,Secretin,37039,0.0336412665529993,0.00416947450481121,0.0254690965235693,0.0418134365824292,7.73142989768529e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0251653763721543,0.00312070996003143,-0.0312819678938159,-0.0190487848504927,8.00185761768175e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DHPS,Deoxyhypusine synthase,37368,0.0311749913416684,0.00386825379802115,0.0235932138975469,0.0387567687857898,8.32157095598623e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0498934348342321,0.00621024026006972,0.0377213639244955,0.0620655057439688,1.00823318403045e-15
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0458869509275751,0.00571093342729069,0.0346935214100853,0.0570803804450648,1.01545324086354e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0427372216446145,0.00532069119212931,0.032308666908041,0.0531657763811879,1.03571199405126e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CA9,Carbonic anhydrase 9,40030,-0.0327118891444867,0.00407899289582116,-0.0407067152202961,-0.0247170630686772,1.1330065615091e-15
NMR metabolomics,X23412.Phospholipids in VLDL,FEN1,Flap endonuclease 1,39477,0.047145393669744,0.00587996266658537,0.0356206668432367,0.0586701204962513,1.15069400251293e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB2,Plexin-B2,39984,0.0178456083026591,0.00222617546444757,0.0134823043923419,0.0222089122129764,1.16428635876842e-15
NMR metabolomics,X23412.Phospholipids in VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0471680924740175,0.00590185597694055,0.035600454759214,0.058735730188821,1.41668175790331e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0244756256628301,0.00306235334955672,0.018473413097699,0.0304778382279613,1.4326423858227e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0253786397535542,0.00317856729288373,0.0191486478595021,0.0316086316476063,1.52958369912848e-15
NMR metabolomics,X23412.Phospholipids in VLDL,RPL14,60S ribosomal protein L14,37043,0.0304809810251756,0.00381774651377698,0.0229981978581727,0.0379637641921785,1.53312737957323e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.018076208323566,0.00226522748978155,0.0136363624435942,0.0225160542035378,1.56304204380771e-15
NMR metabolomics,X23412.Phospholipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0314421526566389,0.00394240730331269,0.0237150343421461,0.0391692709711318,1.62407159412183e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SYT1,Synaptotagmin-1,37388,0.0277963165593558,0.00349606444836369,0.020944030240563,0.0346486028781487,2.00019131938623e-15
NMR metabolomics,X23412.Phospholipids in VLDL,THBS4,Thrombospondin-4,39892,0.0334713314301033,0.0042117654870474,0.0252162710754904,0.0417263917847162,2.03541026197416e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CHAD,Chondroadherin,37124,0.0378231000546414,0.00475960644943664,0.0284942714137456,0.0471519286955372,2.06958703218087e-15
NMR metabolomics,X23412.Phospholipids in VLDL,LTA,Lymphotoxin-alpha,39866,0.0294503986572827,0.00372009079508898,0.0221590206989083,0.0367417766156571,2.60040244239501e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0303391830737564,0.00383479972335305,0.0228229756159844,0.0378553905315284,2.73911882809123e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0579904054684098,0.00734329539323077,0.0435975464976774,0.0723832644391421,3.08078960531429e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1,Programmed cell death protein 1,39998,0.0304250580267293,0.00385760542348528,0.0228641513966982,0.0379859646567605,3.29152611117737e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0209931345236879,0.00266191081806835,0.0157757893202739,0.0262104797271018,3.31301883100755e-15
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0317335086835616,0.00402476835081279,0.0238449627159685,0.0396220546511547,3.40376430085912e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0303414146703705,0.00385008415052218,0.022795249735347,0.037887579605394,3.46349307063867e-15
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0287838342447405,0.00365948129172006,0.0216112509129692,0.0359564175765118,3.90922340944705e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.027366338117819,0.00348235500097129,0.0205409223159153,0.0341917539197227,4.13111435729131e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0599248463367607,0.00762990000650915,0.0449702423240028,0.0748794503495186,4.29227273949349e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0454140941995287,0.00578158055761801,0.0340821963065974,0.05674599209246,4.297895826746e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GC,Vitamin D-binding protein,37453,0.0191456211354171,0.00244098046481681,0.0143612994243761,0.023929942846458,4.71021036136954e-15
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0297359254109375,0.0037969811959068,0.0222938422669602,0.0371780085549148,5.19077170223492e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0345865980747606,0.00442594224853581,0.0259117512676304,0.0432614448818908,5.86785082158042e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0519210562022384,0.00665621267606722,0.0388748793571467,0.0649672330473302,6.55323861191227e-15
NMR metabolomics,X23412.Phospholipids in VLDL,IDS,Iduronate 2-sulfatase,40058,0.00661239139665951,0.000848439832657267,0.00494944932465127,0.00827533346866775,6.90668845544075e-15
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0383809727899384,0.00493665419140228,0.02870513057479,0.0480568150050869,8.1223563476089e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CCN3,CCN family member 3,40042,0.0236915495328169,0.0030511932359135,0.0177112107904264,0.0296718882752074,8.67252071017898e-15
NMR metabolomics,X23412.Phospholipids in VLDL,APOD,Apolipoprotein D,36780,-0.0318082731183043,0.00410517055724362,-0.0398544074105018,-0.0237621388261068,1.00032122407705e-14
NMR metabolomics,X23412.Phospholipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0185904372170361,0.00239976730460982,-0.0232939811340713,-0.0138868933000008,1.00917962853471e-14
NMR metabolomics,X23412.Phospholipids in VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0266216602050188,0.00343783436890814,0.0198835048419588,0.0333598155680787,1.03392420535066e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0519815930427781,0.00671661638829379,0.0388170249217222,0.0651461611638339,1.07191100090741e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0361472890270056,0.00468875138372992,0.0269573363148949,0.0453372417391162,1.35539993925117e-14
NMR metabolomics,X23412.Phospholipids in VLDL,C8B,Complement component C8 beta chain,37453,0.0220603401209113,0.00286280763044499,0.0164492371652391,0.0276714430765834,1.38967403543504e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR2,Folate receptor beta,40009,-0.0208997181614866,0.00271708518185924,-0.0262252051179307,-0.0155742312050425,1.5322132806964e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0370742807294391,0.00483066487246615,0.0276061775794054,0.0465423838794727,1.754720751847e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0261931169248303,0.00341686045524214,0.0194960704325557,0.0328901634171049,1.8976894142096e-14
NMR metabolomics,X23412.Phospholipids in VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0204303827250301,0.00267241127312602,0.0151924566297031,0.0256683088203571,2.23202348591395e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI2,Serpin I2,37382,0.0412816647458526,0.00540824494106646,0.0306815046613624,0.0518818248303429,2.44500266060555e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.021212756382345,0.00277966072652693,0.0157646213583522,0.0266608914063378,2.48103400587726e-14
NMR metabolomics,X23412.Phospholipids in VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0347464467519804,0.0045560080821007,0.025816670911063,0.0436762225928978,2.57313651179501e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0744048633648236,0.00976241489891542,0.0552705301629494,0.0935391965666978,2.6727488264692e-14
NMR metabolomics,X23412.Phospholipids in VLDL,S100A12,Protein S100-A12,39615,0.053580722857954,0.00704573032976781,0.0397710914116091,0.0673903543042989,3.01619836702217e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0527530572400505,0.00694724106556921,0.0391364647515348,0.0663696497285661,3.29242324580573e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0407878214330922,0.00537333373967943,0.0302560873033206,0.0513195555628639,3.35773259742547e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0240352604087468,0.00316666530222043,0.0178285964163947,0.0302419244010988,3.4049682885561e-14
NMR metabolomics,X23412.Phospholipids in VLDL,APLP1,Amyloid-like protein 1,39868,-0.036602261019178,0.00482598021839179,-0.0460611822472259,-0.0271433397911301,3.522730688514e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IL1B,Interleukin-1 beta,39478,0.0398476852203716,0.00525750858012171,0.029542968403333,0.0501524020374102,3.67185052479346e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.0212791006190551,0.00280951734494253,0.0157724466229677,0.0267857546151424,3.81755039661115e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SMS,Spermine synthase,36991,0.0458052239885399,0.00605508778888883,0.0339372519223178,0.057673196054762,4.14430794818144e-14
NMR metabolomics,X23412.Phospholipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0171541382375064,0.00226921601539804,0.0127064748473263,0.0216018016276866,4.26654392285662e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0402674888029701,0.00532687687773283,0.0298268101226138,0.0507081674833265,4.3200895533451e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.029946023660322,0.00397938414610206,0.0221464307339619,0.037745616586682,5.59090651520606e-14
NMR metabolomics,X23412.Phospholipids in VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0341216391694989,0.00453767964651955,0.0252277870623206,0.0430154912766773,5.78658872886155e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0268871245847582,0.00357665839742568,0.0198768741258039,0.0338973750437126,5.93859986273706e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS53,Serine protease 53,37388,0.0264647214348566,0.0035223443835893,0.0195609264430215,0.0333685164266916,6.1230275766428e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0485128382268432,0.00646526937319916,0.0358409102553729,0.0611847661983136,6.534732377546e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0206432836737778,0.00275119157989664,0.0152509481771804,0.0260356191703752,6.54718289846632e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CIT,Citron Rho-interacting kinase,37039,0.0320763445495503,0.00427882265326186,0.0236898521491571,0.0404628369499436,6.97077180630027e-14
NMR metabolomics,X23412.Phospholipids in VLDL,INSL3,Insulin-like 3,37388,0.0513072585028057,0.00684582804089353,0.0378894355426544,0.0647250814629571,7.05867034793912e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0176523158211525,0.00235629175790311,0.0130339839756624,0.0222706476666426,7.22742805866709e-14
NMR metabolomics,X23412.Phospholipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0263016787784422,0.00351142191452825,0.0194192918259668,0.0331840657309176,7.30727651015084e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD300A,CMRF35-like molecule 8,37124,0.0204028480537157,0.00273182528167442,0.0150484705016339,0.0257572256057976,8.61277217024227e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ULBP2,UL16-binding protein 2,39749,0.0256877230979425,0.0034439724216297,0.0189375371515483,0.0324379090443367,9.18560094917191e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0330878873620681,0.0044412916663264,0.0243829556960684,0.0417928190280678,9.80113781186166e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GPR15L,Protein GPR15L,37382,0.0431983314631769,0.00579899322835228,0.0318323047356064,0.0545643581907474,9.953479759443e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0252569457905887,0.00339277206235943,0.0186071125483642,0.0319067790328132,1.02472481492511e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH1,Neurexophilin-1,39489,0.0262760705442302,0.00353859766431839,0.0193404191221662,0.0332117219662942,1.18092680354995e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CDA,Cytidine deaminase,37422,0.0323636340826787,0.00437986498552514,0.0237790987110494,0.0409481694543079,1.56365190763807e-13
NMR metabolomics,X23412.Phospholipids in VLDL,APOB,Apolipoprotein B-100,37445,0.0158009287887475,0.00213931722258599,0.011607867032479,0.0199939905450161,1.60162627792713e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GFAP,Glial fibrillary acidic protein,39453,0.0304251494501953,0.00412093555809185,0.0223481157563352,0.0385021831440553,1.62492630550137e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0376231599986765,0.0050984661679436,0.0276301663095071,0.047616153687846,1.68351193378623e-13
NMR metabolomics,X23412.Phospholipids in VLDL,COPB2,Coatomer subunit beta',37021,0.0298069605119807,0.00404179491561733,0.0218850424773708,0.0377288785465907,1.74585793880452e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1A,Protein phosphatase 1A,39477,0.0212068306443034,0.00287942977667827,0.015563148282014,0.0268505130065928,1.860716097075e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CRYGD,Gamma-crystallin D,37388,0.0669440355162868,0.00909796875516385,0.0491120167561656,0.0847760542764079,1.97248600393807e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SNX5,Sorting nexin-5,37043,0.0211471754758521,0.00287523131454119,0.0155117220993513,0.0267826288523528,2.02281021383562e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB2,Lamin-B2,37388,0.0189802265614303,0.00258334564551211,0.0139168690962265,0.024043584026634,2.14072582535326e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL2,Fc receptor-like protein 2,39990,0.03202792625614,0.00436100782413541,0.0234803509208346,0.0405755015914454,2.16946960266707e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0293410479565278,0.00400669482352221,0.0214879261024243,0.0371941698106313,2.53965767773099e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GM2A,Ganglioside GM2 activator,37178,0.0249915338282401,0.00341366526273387,0.0183007499132817,0.0316823177431985,2.60195742870384e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SNX2,Sorting nexin-2,37368,0.055713934500472,0.00761338059279599,0.0407917085385918,0.0706361604623521,2.66101869130083e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH1,Protocadherin-1,40018,0.0143020807123392,0.00195982209806754,0.0104608294001268,0.0181433320245515,3.06461144383792e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0324601631271621,0.00446584682137168,0.0237071033572736,0.0412132228970506,3.80612074521674e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0287856516808758,0.00396105528933305,0.021021983313783,0.0365493200479686,3.871823067412e-13
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0347219412328066,0.00477907558738331,0.0253549530815353,0.0440889293840779,3.92275909189275e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0159212871329653,0.00219604268845224,0.0116170434635989,0.0202255308023317,4.35677732689243e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TSHB,Thyrotropin subunit beta,39868,0.0511735020703232,0.00705839393595267,0.0373390499558559,0.0650079541847904,4.35748354766884e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0188900285314248,0.00260945688124836,0.013775493044178,0.0240045640186716,4.72306189101985e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GRSF1,G-rich sequence factor 1,36874,0.0553524159455193,0.00764931625271349,0.0403597560902009,0.0703450758008378,4.87084198732718e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0226580323004297,0.00313442802921712,-0.0288015112376952,-0.0165145533631641,5.09833715151197e-13
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0422432869449585,0.00584612286536498,0.0307848861288431,0.0537016877610739,5.24589023280782e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LCP1,Plastin-2,37437,0.031937554314648,0.00443191579711048,0.0232509993523115,0.0406241092769845,6.05425444356565e-13
NMR metabolomics,X23412.Phospholipids in VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0248908560963616,0.00345896631914835,0.0181112821108309,0.0316704300818924,6.53445405249325e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DGCR6,Protein DGCR6,36991,0.0294318052328538,0.004091097492929,0.021413254146713,0.0374503563189947,6.62791794698919e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0322967103654644,0.00450450172178188,0.0234678869907719,0.0411255337401569,7.83493171600455e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0289074276377865,0.0040320699842091,0.0210045704687367,0.0368102848068363,7.86341419981625e-13
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1,Integrin beta-1,39862,0.0146745469832657,0.00204842006760068,0.0106596436507683,0.018689450315763,8.18678856267173e-13
NMR metabolomics,X23412.Phospholipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0236589531057156,0.00330563672861671,-0.0301380010938043,-0.0171799051176268,8.6726681035818e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH3,Neurexophilin-3,37056,0.0200862601161558,0.00280861142384775,0.0145813817254142,0.0255911385068974,9.02460338912721e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0387576139770192,0.00543166889129972,0.0281115429500717,0.0494036850039666,1.00599072623778e-12
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0381335615311205,0.00534690882365097,0.0276536202367646,0.0486135028254764,1.03313544422279e-12
NMR metabolomics,X23412.Phospholipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0472396544000783,0.00662522850587789,0.0342542065285576,0.0602251022715989,1.0539401005639e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.01674501048305,0.00235399108262278,0.0121311879611093,0.0213588330049906,1.17945702323539e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0162405525879931,0.00228466597659981,0.0117626072738575,0.0207184979021288,1.23347800440485e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DSG4,Desmoglein-4,39725,0.0329082832503573,0.00463149649076279,0.0238305501284623,0.0419860163722524,1.25146326135609e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0228339494835967,0.00321800098732336,0.0165266675484429,0.0291412314187505,1.35086452524091e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GAST,Gastrin,37388,0.0778137802083621,0.0109713053490623,0.0563100217242,0.0993175386925242,1.382727309475e-12
NMR metabolomics,X23412.Phospholipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0560593577409978,0.00792724480197561,0.0405219579291256,0.0715967575528699,1.59494810146454e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CTSH,Pro-cathepsin H,39546,0.0482062777279487,0.00682152735018343,0.0348360841215892,0.0615764713343082,1.65238300811035e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO3,R-spondin-3,40030,0.0179306271070755,0.00254074578585055,0.0129507653668084,0.0229104888473425,1.76750314322867e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.029250908408257,0.00414529906176462,0.0211261222471983,0.0373756945693156,1.77871499178362e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.055995009552434,0.00794573787973547,0.0404213633081525,0.0715686557967155,1.91430753036068e-12
NMR metabolomics,X23412.Phospholipids in VLDL,NCAN,Neurocan core protein,40009,0.0242834001063182,0.00346152215728916,0.0174988166780314,0.031067983534605,2.3867071095952e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CST5,Cystatin-D,39559,0.0358949193388083,0.00511904492046932,0.0258615912946885,0.0459282473829282,2.44455094837861e-12
NMR metabolomics,X23412.Phospholipids in VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0220984306278769,0.00315768270526106,0.0159093725255652,0.0282874887301886,2.69443074992186e-12
NMR metabolomics,X23412.Phospholipids in VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0226987519147466,0.00325916757304446,0.0163107834715794,0.0290867203579137,3.44557123525845e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PRELP,Prolargin,39862,0.0145555028361125,0.00209058383105403,0.0104579585272466,0.0186530471449784,3.47502139391821e-12
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA1,Ephrin-A1,39826,0.0172979863923784,0.00248504267740779,0.0124273027446591,0.0221686700400977,3.51414984815272e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0351119740435305,0.00505254349475621,0.0252089887938083,0.0450149592932527,3.8375553282569e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0554186418185318,0.00801645013115977,0.0397063995614587,0.0711308840756049,4.95813191721442e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0288925895655338,0.004180884596676,0.0206980557560488,0.0370871233750187,5.04685111052399e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0238816408147283,0.00345642072478496,0.0171070561941498,0.0306562254353068,5.086719607682e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM3,Myomesin-3,37124,-0.0607188719139035,0.00884852943260237,-0.0780619896018042,-0.0433757542260029,7.09035526412173e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0246309272811057,0.00359033541830627,0.0175938698612254,0.031667984700986,7.17330510758344e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0268003687053642,0.00391255743951062,0.0191317561239234,0.034468981286805,7.72160343189417e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.023103597790133,0.00337753163487498,0.016483635785778,0.0297235597944879,8.23780883013744e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0351884291917175,0.00514925204346994,0.0250958951865164,0.0452809631969186,8.57538463534201e-12
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.021138382601816,0.00309387265451682,0.0150743921989631,0.027202373004669,8.7206983492607e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0261354738629551,0.00382780002253047,0.0186329858187954,0.0336379619071148,8.94017503703391e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0626798959543003,0.00918481978057673,0.0446776491843699,0.0806821427242307,9.15349552563487e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.029363556305959,0.0043092848657282,0.0209173579691317,0.0378097546427862,9.90272717620296e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0355185736657573,0.0052144156685981,0.025298318955305,0.0457388283762096,9.99485417000917e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AHCY,Adenosylhomocysteinase,39868,0.0433289422468101,0.0063902090555586,0.0308041324979153,0.0558537519957049,1.23930777895322e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ENSA,Alpha-endosulfine,37368,0.0335666769465262,0.00496346085211205,0.0238382936763865,0.0432950602166658,1.40958257668376e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.020020317108797,0.00296119537105229,0.0142163741815346,0.0258242600360595,1.42915494795983e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CFC1,Cryptic protein,39477,0.0297304158342162,0.00440289637110497,0.0211007389468505,0.0383600927215819,1.50477584199594e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0254214391656674,0.00377691485389755,0.0180186860520282,0.0328241922793066,1.75797380531165e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MDM1,Nuclear protein MDM1,37039,0.0198818893935037,0.00295541930607553,0.0140892675535957,0.0256745112334118,1.80019916892992e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.0111770548625751,0.00166274357583812,0.00791807745393243,0.0144360322712179,1.86325496391222e-11
NMR metabolomics,X23412.Phospholipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0243929899073198,0.00363087033346871,0.0172764840537211,0.0315094957609184,1.91501462370836e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0191593042018161,0.0028563951606688,0.0135607696869053,0.0247578387167269,2.04764486931095e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MMP3,Stromelysin-1,39858,-0.0301308865970904,0.00449554597059107,-0.0389421566994489,-0.0213196164947319,2.11893486428906e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.0185315622239892,0.00276979154907711,0.013102770787798,0.0239603536601803,2.31007835215381e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0117219161090988,0.00175221308247203,0.00828757846745358,0.0151562537507439,2.32255552013579e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0757682669706893,0.011330471513691,0.0535605428038549,0.0979759911375238,2.36787895567007e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL,Podocalyxin,39788,0.00946348543481021,0.00141876454900486,0.00668270691876069,0.0122442639508597,2.63812290724481e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0212696023320315,0.0031948876884507,0.0150076224626682,0.0275315822013949,2.89505751352214e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SDC1,Syndecan-1,39868,0.0249304890355067,0.00374583772811041,0.0175886470884103,0.0322723309826031,2.91471426370422e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0385131984652798,0.0057873388263167,0.027170014365699,0.0498563825648605,2.94794849218701e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0164598814174394,0.00247824886561393,0.0116025136408361,0.0213172491940427,3.19948074458848e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0375766489682876,0.00566958075312143,0.0264642706921696,0.0486890272444056,3.51967956721017e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE3,Eosinophil cationic protein,39791,0.067083690042747,0.010140435134301,0.047208437179517,0.0869589429059769,3.82185884723157e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RNASET2,Ribonuclease T2,39974,0.0158631994297346,0.00240177438657216,0.0111557216320532,0.0205706772274161,4.10555158565786e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.02220579680552,0.00338011490690855,0.0155807715879793,0.0288308220230608,5.20558211305232e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RCOR1,REST corepressor 1,39585,0.0278518254251094,0.00424153953580441,0.0195384079349327,0.036165242915286,5.31465637724908e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0196202767901644,0.00299090730657122,0.0137580984692848,0.025482455111044,5.54793343970954e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.018942883371508,0.00288782644816406,-0.0246030232099095,-0.0132827435331064,5.56494860244105e-11
NMR metabolomics,X23412.Phospholipids in VLDL,BAX,Apoptosis regulator BAX,39456,0.0563985839278448,0.00863163463356625,0.0394805800460549,0.0733165878096346,6.60466362291772e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE6,Ribonuclease K6,37386,0.0169501875462335,0.00260955649251046,0.011835456820913,0.022064918271554,8.56929653086015e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0171606548286287,0.00264228105946318,0.0119817839520809,0.0223395257051766,8.62204602879487e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CPQ,Carboxypeptidase Q,37430,0.0231601009147136,0.00356665360802942,0.0161694598429759,0.0301507419864512,8.67787861998184e-11
NMR metabolomics,X23412.Phospholipids in VLDL,S100A11,Protein S100-A11,39703,0.0278022016482775,0.00428380237266612,0.0194059489978519,0.0361984542987031,8.83407597482786e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0386536381328963,0.0059698443524517,0.026952743202091,0.0503545330637017,9.76961030104907e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.06029840768035,0.00932652278038574,0.0420184230307939,0.078578392329906,1.04693242091673e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.01937013537156,0.0030009544092318,0.0134882647294657,0.0252520060136543,1.12148634042861e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0317315289488161,0.00491691939375823,0.0220943669370499,0.0413686909605822,1.12464627366935e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.0206813216527761,0.00320622701959887,0.0143971166943623,0.0269655266111899,1.14783983331756e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0251103516753686,0.00389759875360793,0.017471058118297,0.0327496452324402,1.21586106967909e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CA2,Carbonic anhydrase 2,39821,0.0412426690301928,0.00640458856639993,0.0286896754400489,0.0537956626203366,1.23251916113547e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LUZP2,Leucine zipper protein 2,37368,0.0265883045989168,0.0041294294108908,0.0184946229535708,0.0346819862442627,1.24547174922451e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0226311371722294,0.00351915228475908,0.0157335986941016,0.0295286756503572,1.30490939474068e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0253687456435421,0.00394745595931441,0.0176317319632859,0.0331057593237983,1.34171765648184e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0366471695319774,0.00570434109608209,0.0254666609836565,0.0478276780802983,1.36910275603973e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0330017692033474,0.00513815913716713,0.0229309772944998,0.043072561112195,1.38313571664435e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.0170516181056292,0.00265545832436818,0.0118469197898676,0.0222563164213909,1.38864054680719e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0152551203248147,0.00237643271885386,0.0105973121958612,0.0199129284537683,1.40681702511448e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GAS2,Growth arrest-specific protein 2,37169,0.03204084369718,0.0050023132063656,0.0222363098127034,0.0418453775816565,1.55217012200561e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PRTG,Protogenin,40030,0.0150155833438754,0.00234790749809149,0.010413684647616,0.0196174820401347,1.64624253702278e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0222165543867503,0.00347795745560375,0.015399757773767,0.0290333509997337,1.72997848214103e-10
NMR metabolomics,X23412.Phospholipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0161528133904457,0.00253440895302361,0.0111853718425194,0.021120254938372,1.89913098105135e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.0152698687044632,0.00239596756049354,0.0105737722858958,0.0199659651230305,1.90204698325706e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MRC1,Macrophage mannose receptor 1,37445,0.0165719310172612,0.00260128331309686,0.0114734157235914,0.0216704463109311,1.94264824477263e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LXN,Latexin,39682,-0.0400900716672287,0.00630659009147701,-0.0524509882465236,-0.0277291550879338,2.115677325085e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.0151345068289135,0.00238991754134109,0.010450268447885,0.0198187452099421,2.47337521023094e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RBP2,Retinol-binding protein 2,39788,-0.0454470480437121,0.00721047148057501,-0.0595795721456391,-0.031314523941785,2.99766158894976e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CTSB,Cathepsin B,39847,-0.0304955218039196,0.00484248942090916,-0.0399868010689015,-0.0210042425389376,3.10406651408314e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0186281905564455,0.00295787495140682,0.0128307556516882,0.0244256254612029,3.11427638989638e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL34,Interleukin-34,39456,0.0212249261287821,0.00337302454339212,0.0146137980237335,0.0278360542338307,3.20628855962946e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CD300C,CMRF35-like molecule 6,40009,0.019699068112147,0.00313701527525446,0.0135505181726483,0.0258476180516457,3.48216568552303e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.03542904611957,0.00565410032665868,0.024347009479319,0.046511082759821,3.81773065808397e-10
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.0138733498521591,0.00221570101483391,-0.0182161238412336,-0.00953057586308464,3.91197650502294e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CDH5,Cadherin-5,40052,-0.0179679833372471,0.00287597960998186,-0.0236049033728116,-0.0123310633016827,4.2720819721216e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.14097824325721,0.0225893840843433,0.0967030504518971,0.185253436062523,4.48022654385392e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA12,Serpin A12,39405,0.0694580583349993,0.0111334290376419,0.0476365374212213,0.0912795792487773,4.52661809413568e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0132906777713495,0.00214026292529166,0.0090957624377778,0.0174855931049211,5.43343358059213e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0191548919326701,0.0031183141888415,0.0130429961225408,0.0252667877427995,8.33892225855799e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MPO,Myeloperoxidase,39858,0.0262453763379994,0.00427498499355256,0.0178664057506363,0.0346243469253624,8.48471265171609e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0219585249930828,0.00358011192390871,0.0149415056222217,0.0289755443639439,8.84432262303677e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0162040390547737,0.00264531447264681,0.0110192226883859,0.0213888554211614,9.24610907569483e-10
NMR metabolomics,X23412.Phospholipids in VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0560119977000431,0.00915998586289751,0.0380584254087639,0.0739655699913222,9.93054941011579e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0206080520052633,0.00338929140022183,0.0139650408608285,0.0272510631496981,1.22620241456132e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0196522067477933,0.00323754015368401,0.0133066280465726,0.025997785449014,1.30676427061141e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0209375682304579,0.00345711321146714,0.0141616263359823,0.0277135101249335,1.42393906996189e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0151776455161247,0.00250626842020411,0.0102653594125246,0.0200899316197247,1.42746355346815e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.019823641870612,0.00328880738680828,0.0133775793924678,0.0262697043487562,1.70013338806438e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0152266322531823,0.00252624930616621,0.0102751836130965,0.0201780808932681,1.70978399234952e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0173757752042387,0.00288375820338439,-0.0230279412828721,-0.0117236091256053,1.73225101408082e-09
NMR metabolomics,X23412.Phospholipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0209812895677979,0.00349615811772242,0.014128819657062,0.0278337594785339,2.0081142057246e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX1,Heme oxygenase 1,39691,-0.0269571962953543,0.00449289173742136,-0.0357632641007002,-0.0181511284900085,2.01659989539977e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.052962952617547,0.00883005869250277,0.0356560375802416,0.0702698676548524,2.04026178027098e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CD276,CD276 antigen,39862,-0.0198841818957579,0.00331803284035452,-0.0263875262628528,-0.0133808375286631,2.10732663298154e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0367985717043261,0.00614688104219082,0.0247506848616321,0.0488464585470201,2.18907279912059e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0324621052752366,0.00543574139402847,0.0218080521429408,0.0431161584075324,2.39358711942627e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0184955155868436,0.00310115028134978,0.012417261035398,0.0245737701382892,2.51190220996342e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0193734406756648,0.00325034071255513,0.0130027728790567,0.0257441084722728,2.56875686366601e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LTB,Lymphotoxin-beta,37368,0.0192157365645927,0.00322855503328813,0.0128877686993479,0.0255437044298374,2.71769638027196e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0157067154096678,0.00264643841529936,-0.0208937347036545,-0.0105196961156811,2.99840703885879e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CA7,Carbonic anhydrase 7,37169,-0.0188773176636386,0.00318107584523936,-0.0251122263203077,-0.0126424090069694,3.0252073099397e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0464019815926591,0.00782850851302994,0.0310581049071204,0.0617458582781978,3.14276082603173e-09
NMR metabolomics,X23412.Phospholipids in VLDL,DSC2,Desmocollin-2,39673,-0.0185791525115241,0.00314125011845941,-0.0247360027437045,-0.0124223022793436,3.39599283830803e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0351823374757744,0.00596353696403478,0.0234938050262662,0.0468708699252825,3.73224183839217e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICOSLG,ICOS ligand,39788,0.0104946724235921,0.00177935772101049,0.00700713129041153,0.0139822135567727,3.75356860474503e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0144559270155981,0.00245487712557935,-0.0192674861817337,-0.0096443678494626,3.98830595978824e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF7,SLAM family member 7,39866,-0.0320379622301996,0.00544150985169259,-0.0427033215395171,-0.0213726029208821,3.99449379622383e-09
NMR metabolomics,X23412.Phospholipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0235829627024283,0.00401502998147202,0.0157135039387431,0.0314524214661135,4.36517103654905e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0203099454223876,0.00345997314212271,0.0135283980638271,0.0270914927809481,4.44384136313487e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0397426720700511,0.00677991259994713,0.0264540433741547,0.0530313007659475,4.68648473992633e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0278960178646098,0.00476720448797204,0.0185522970681846,0.037239738661035,4.98279040750834e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0252414889623322,0.00432545652929572,0.0167635941649125,0.0337193837597518,5.48700639871723e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0380515211948495,0.00652799281598568,0.0252566552755175,0.0508463871141814,5.70411890584007e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0295549616123019,0.00507952469123545,0.0195990932174804,0.0395108300071234,6.05358051185328e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0217431214316118,0.0037374477088882,0.0144177239221909,0.0290685189410326,6.10703759577844e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.017233333781818,0.00296309733397881,0.0114256630072195,0.0230410045564165,6.1673916266312e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0168157212096608,0.00289720802110736,-0.0224942489310312,-0.0111371934882904,6.60926696427377e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0121731042126006,0.00209794513889246,0.00806113174037135,0.0162850766848298,6.66116470857133e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CABP2,Calcium-binding protein 2,37039,0.0359722362088455,0.00621734606165391,0.0237862379280039,0.0481582344896872,7.38143168809893e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0165133925214694,0.0028545670173079,0.0109184411675459,0.0221083438753929,7.38974221276041e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0332143938140043,0.00576197736748744,0.0219209181737289,0.0445078694542797,8.37795616081797e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CLC,Galectin-10,39841,-0.0361828573213278,0.00628144537898888,-0.048494490264146,-0.0238712243785096,8.55210381739157e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.042257747568506,0.00734099239376414,-0.0566460926602837,-0.0278694024767282,8.74959037224583e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.016098171612084,0.00279852976040851,0.0106130532816833,0.0215832899424847,8.96098449987235e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MILR1,Allergin-1,39587,-0.0268409330780366,0.00466948347976072,-0.0359931206983676,-0.0176887454577056,9.18927894446565e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CA12,Carbonic anhydrase 12,39788,-0.0172663664125342,0.00300696872976094,-0.0231600251228657,-0.0113727077022028,9.52042292952061e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0195826124600017,0.0034139379646141,0.0128912940493581,0.0262739308706453,9.90359154801883e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EDN1,Endothelin-1,37043,0.0152106282658642,0.00265281843151885,0.0100111041400872,0.0204101523916411,1.00381525542811e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CLPS,Colipase,39836,0.0373403336905326,0.00653086414465349,0.0245398399670118,0.0501408274140535,1.10022456535763e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0311394543032632,0.00546309055318376,-0.0418471117875034,-0.0204317968190231,1.21930993576101e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MUC2,Mucin-2,37437,0.0484962133818134,0.00852335718746909,0.0317904332943739,0.0652019934692528,1.29813854852635e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MUC16,Mucin-16,39788,0.0998914587082704,0.0175600308619747,0.0654737982188,0.134309119197741,1.30358500025064e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CLMP,CXADR-like membrane protein,40030,0.0109797972246274,0.00193193893287403,0.00719319691619431,0.0147663975330605,1.34394541801942e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0320415647202633,0.00564169210664328,0.0209838481912425,0.0430992812492841,1.37934418967128e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0217629547119276,0.00383455752953318,-0.0292786874698126,-0.0142472219540426,1.40708153630118e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.0152178808896961,0.00268129655391644,0.00996253964401984,0.0204732221353723,1.4112365996112e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0262971719651028,0.00463413403973369,0.0172142692472247,0.0353800746829808,1.41798186093485e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0216928909749775,0.00382628798124106,0.014193366531745,0.02919241541821,1.4580107566669e-08
NMR metabolomics,X23412.Phospholipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0141192806092848,0.00249561533087012,0.00922787456077935,0.0190106866577902,1.56100106457614e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0414225328665529,0.00733006780626333,0.0270555999662768,0.055789465766829,1.62781080220384e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0319366916157589,0.00565347703955814,0.020855876618225,0.0430175066132929,1.64108977225475e-08
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0190617622682195,0.00338301583096387,0.0124310512395303,0.0256924732969087,1.78641636927115e-08
NMR metabolomics,X23412.Phospholipids in VLDL,APOA1,Apolipoprotein A-I,37453,-0.0145414072088086,0.00258172677388596,-0.019601591685625,-0.00948122273199209,1.81206031463588e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EBI3_IL27,Interleukin-27,40011,-0.0163214598569451,0.00290438844438531,-0.0220140612079403,-0.0106288585059499,1.94577302744472e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN8,Septin-8,37357,0.0169311208292444,0.0030134236330598,0.0110248105084472,0.0228374311500416,1.96356306780991e-08
NMR metabolomics,X23412.Phospholipids in VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0162793283991631,0.00290736269395841,-0.0219777592793216,-0.0105808975190046,2.19420725505629e-08
NMR metabolomics,X23412.Phospholipids in VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0222277867316628,0.00396975844046019,0.0144470601883608,0.0300085132749648,2.19541037967735e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0204556633675442,0.00365499573736579,0.0132918717223073,0.0276194550127811,2.22805494817863e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CST1,Cystatin-SN,35640,0.0533694084109197,0.0095386111602485,0.0346737305368327,0.0720650862850068,2.25425582611768e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0147366056839322,0.00264360572836572,0.00955513845633538,0.019918072911529,2.53078617106736e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0185063453902988,0.00332042886155957,0.011998304821642,0.0250143859589555,2.54607596824465e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0268709237983873,0.0048288781803318,0.0174063225649369,0.0363355250318376,2.67033042648687e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0225381021980001,0.00406321409303009,0.0145742025756611,0.0305020018203391,2.95525051346211e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0303351770966931,0.00547134457929612,0.0196113417212727,0.0410590124721134,2.99786467399199e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SPON1,Spondin-1,39885,0.0166137283263156,0.00300386305299987,0.0107261567424358,0.0225012999101954,3.23782750913904e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.0164448085396989,0.00299022168239177,0.010583974042211,0.0223056430371867,3.8664098866579e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN2,Prefoldin subunit 2,39489,0.02892831585736,0.0052646433814805,0.0186096148296582,0.0392470168850617,3.97204299848038e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0306108335620296,0.00557503066806939,-0.0415378936714456,-0.0196837734526136,4.06432482885697e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0247613510878601,0.00451040754863581,0.0159209522925339,0.0336017498831863,4.09784141955569e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RAB37,Ras-related protein Rab-37,39587,0.0429406064276257,0.00786287320752734,0.0275293749408721,0.0583518379143792,4.80141642004738e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0229091425689199,0.00419858464720582,-0.0311383684774433,-0.0146799166603965,4.94683412685172e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GPC1,Glypican-1,40030,0.0149049539989906,0.00273548508545514,0.00954340323149856,0.0202665047664827,5.14688942867684e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GBP4,Guanylate-binding protein 4,39489,0.0250900672171356,0.00461078965932045,0.0160529194848675,0.0341272149494037,5.35994149076186e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0137523735973621,0.00252728748483307,0.00879889012708926,0.0187058570676349,5.37336151788457e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN8,Tetraspanin-8,37382,0.0504012527331634,0.00926466199769394,0.0322425152176833,0.0685599902486435,5.41586039997283e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.027839318769316,0.00513265839899736,-0.0378993292313508,-0.0177793083072811,5.91440176069671e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0137658870849294,0.00253969842410895,-0.018743695996183,-0.00878807817367587,6.05293151097553e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L,Seizure 6-like protein,39913,0.0137499798809178,0.00254124455258313,0.00876914055785486,0.0187308192039807,6.36691029117969e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CALB1,Calbindin,39788,0.0213742574590511,0.00395588181695561,0.0136207290978181,0.0291277858202841,6.64181459706646e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DSG3,Desmoglein-3,39964,0.0169903834187469,0.00314591711951277,0.0108243858645019,0.023156380972992,6.72956261365904e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.01144760753495,0.00212054381420671,-0.0156038734107952,-0.00729134165910487,6.81867708027691e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0224667439583526,0.00416217002824855,0.0143088907029854,0.0306245972137197,6.84069310258797e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0144399503860814,0.00267687827425012,-0.0196866318036116,-0.00919326896855113,6.97617841334732e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0105427329923573,0.00195480705481296,0.00671131116492392,0.0143741548197907,7.01875884250674e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PRUNE2,Protein prune homolog 2,37169,0.0144945880449941,0.00269312487910784,0.00921606328194275,0.0197731128080455,7.48822121553995e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0282613416124799,0.00527159938821802,-0.0385936764133872,-0.0179290068115726,8.38845444305354e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0149050115207669,0.00278661516185659,0.00944324580352802,0.0203667772380058,8.97575491529531e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAM,Integrin alpha-M,39858,-0.0159079312139795,0.00297550755200079,-0.0217399260159011,-0.010075936412058,9.10066961190134e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CX3CL1,Fractalkine,39749,-0.016655040885828,0.00313143439681962,-0.0227926523035944,-0.0105174294680615,1.05948955723358e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0151721329251639,0.00285398514534127,0.00957832204029502,0.0207659438100328,1.07438440591553e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NINJ1,Ninjurin-1,39477,0.0282909941429427,0.00532554120162246,0.0178529333877627,0.0387290548981228,1.09721347401674e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0263736290965998,0.00497239511192005,0.0166277346772366,0.0361195235159631,1.15073884853454e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0179023431489878,0.00338653357583411,0.0112647373403529,0.0245399489576226,1.2678774184867e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0143210548414395,0.00271023987424735,-0.0196331249949643,-0.00900898468791472,1.27992740960761e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NTF4,Neurotrophin-4,39477,0.0198240643825301,0.00375270216262677,0.0124687681437817,0.0271793606212786,1.29065110160061e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GNLY,Granulysin,39858,0.025379486681498,0.00480734788247136,0.0159570848318542,0.0348018885311419,1.31364745580278e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD93,Complement component C1q receptor,39238,-0.0153019305432321,0.00290406864729698,-0.0209939050919342,-0.00960995599453005,1.38917777528365e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA6,Carbonic anhydrase 6,39817,-0.0316032524801346,0.00599795248155217,-0.0433592393439768,-0.0198472656162923,1.38947323117043e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAV,Integrin alpha-V,40030,0.00820164619274245,0.00156034990289769,0.00514336038306297,0.0112599320024219,1.48861498323958e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MSLN,Mesothelin,39766,0.0260066276609063,0.00495537007936174,0.0162941023053573,0.0357191530164554,1.55590153762031e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ECM1,Extracellular matrix protein 1,37106,0.0179686142151909,0.00342476243416706,0.0112560798442234,0.0246811485861583,1.57257621240824e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0441775678386527,0.00845680727589118,0.027602225577906,0.0607529100993994,1.77377936360509e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CPA4,Carboxypeptidase A4,36868,0.0215157582214775,0.00412156537241085,0.0134374900915523,0.0295940263514028,1.81396569017692e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NEFL,Neurofilament light polypeptide,39438,0.0213855772568953,0.00409978248348654,0.0133500035892617,0.0294211509245289,1.84899291596181e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0155432819200527,0.00298157670972312,0.00969939156899539,0.02138717227111,1.88014748572186e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0190956925675532,0.00366682431306305,0.0119087169139496,0.0262826682211567,1.93629245741033e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0218090917141581,0.0041944860210032,0.0135878991129918,0.0300302843153243,2.02778643647718e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0134551307003077,0.00259146643721971,0.00837585648335709,0.0185344049172583,2.10491724795099e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0169358260058994,0.00326767578279343,0.0105311814716242,0.0233404705401745,2.21194597809713e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.0258463936901824,0.00498839744322042,0.0160691347014703,0.0356236526788944,2.23574492211664e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0188388693179458,0.00363758970384294,0.0117091934984136,0.0259685451374779,2.25871718927019e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0416739821386023,0.00805054720443977,0.0258949096179003,0.0574530546593042,2.28778437993119e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY2,Protein canopy homolog 2,39585,0.0294454579449377,0.00568979445152818,0.0182934608199425,0.0405974550699329,2.30547726791319e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.0286170268909956,0.00553136714843241,0.0177755472800681,0.0394585065019231,2.32382384093366e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0254661769767076,0.00494524341895689,-0.0351588540778631,-0.0157734998755521,2.64094728942621e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD55,Complement decay-accelerating factor,39315,0.0122833992558019,0.00239630646555338,0.00758663858331728,0.0169801599282865,2.99578178577979e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0119130471617263,0.0023273974040418,0.00735134824980437,0.0164747460736482,3.11356294316989e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0137624499459672,0.00269990949221192,0.00847062734123179,0.0190542725507025,3.48391565392587e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CAT,Catalase,37252,0.0254459471510548,0.0049925691543207,0.0156605116085862,0.0352313826935234,3.50216921461035e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MTPN,Myotrophin,39585,0.0155211862262175,0.00306319193255874,0.00951733003840241,0.0215250424140327,4.08720569381277e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FCRLB,Fc receptor-like B,39477,0.0276750815553613,0.0054619190203538,0.0169697202754678,0.0383804428352547,4.08928640805329e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EGFLAM,Pikachurin,37382,0.0146736686695296,0.0028980659307473,0.00899345944526491,0.0203538778937943,4.17563253123318e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0274990154729847,0.00545650358284406,0.0168042684506103,0.0381937624953591,4.71530610324191e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NEO1,Neogenin,37411,0.0102643184979348,0.00204198900930608,0.00626202003969493,0.0142666169561747,5.05550531293209e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0402133290150487,0.00800343195911057,0.024526602375192,0.0559000556549054,5.10289583921336e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0128919500013438,0.00257178110863487,0.00785125902841949,0.0179326409742682,5.42167542388072e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0185355732425977,0.00370204681426046,0.0112795614866472,0.0257915849985482,5.60446626260717e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0143336610203697,0.00286437044776866,0.00871949494274312,0.0199478270979963,5.68220187522793e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0227749693576028,0.00455427038168902,0.0138485994094923,0.0317013393057133,5.77096454443971e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CRH,Corticoliberin,39455,0.0410109501563397,0.0082081369165192,0.0249230017999621,0.0570988985127173,5.90496614724222e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0556184569777123,0.0111323866686646,0.0337989791071297,0.0774379348482948,5.91274214202032e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA4,Carbonic anhydrase 4,40052,-0.0110226631591988,0.00220992227127433,-0.0153541108108965,-0.00669121550750116,6.17013032339791e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT2,Angiopoietin-2,40030,-0.0179164969022913,0.0035946189395135,-0.0249619500237377,-0.0108710437808448,6.28442776252082e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0244689035184849,0.00491248431338388,-0.0340973727727173,-0.0148404342642525,6.39282163240256e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0194775357148571,0.00391192967938599,0.0118101535432605,0.0271449178864536,6.46990175786373e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0226307465410635,0.00456449762386739,0.0136843311982834,0.0315771618838436,7.21114119984904e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.013156138887708,0.00265674592489481,0.00794891687491417,0.0183633609005018,7.42124723886311e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NTF3,Neurotrophin-3,39866,0.0156716209874246,0.00317531502063366,0.0094480035469826,0.0218952384278665,8.07687640763888e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AREG,Amphiregulin,39788,-0.021787242827873,0.00441475573769977,-0.0304401640737646,-0.0131343215819815,8.09208150653026e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM2,Myomesin-2,37021,-0.0239932236388224,0.00487487691645905,-0.0335479823950822,-0.0144384648825627,8.67854253832727e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0139296215443604,0.00283173899634196,0.00837941311153014,0.0194798299771906,8.78256151999299e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.011811551883661,0.0024094938548633,0.00708894392812889,0.016534159839193,9.57493566017958e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GZMB,Granzyme B,39866,0.0296203448806898,0.00604447385965918,0.0177731761157578,0.0414675136456218,9.65770240267926e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.026029854034124,0.00531348422399729,0.0156154249550893,0.0364442831131587,9.75558461306478e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0152091093555816,0.00310562573930754,-0.0212961358046244,-0.00912208290653885,9.829264351723e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CDH1,Cadherin-1,39315,0.0186232326418983,0.00380805980982638,0.0111594354146386,0.0260870298691581,1.01602822116468e-06
NMR metabolomics,X23412.Phospholipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0157808313290631,0.00324738678318005,0.00941595323403024,0.022145709424096,1.18774068287152e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0321438946380929,0.00661700400749632,0.0191745667834001,0.0451132224927857,1.19845365073331e-06
NMR metabolomics,X23412.Phospholipids in VLDL,B2M,Beta-2-microglobulin,37453,0.014065700320036,0.00291101686161652,0.00836010727126764,0.0197712933688044,1.36722516287487e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CENPF,Centromere protein F,37169,0.0246359038648978,0.00509980576707205,0.0146402845614365,0.034631523168359,1.37532801440699e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RALY,RNA-binding protein Raly,37368,0.0222084642403293,0.00460237492015549,0.0131878093968246,0.0312291190838341,1.41224384312263e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CA1,Carbonic anhydrase 1,39531,0.0269670947773821,0.00559800695830841,0.0159950011390976,0.0379391884156666,1.46899184892514e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0279095642362451,0.0057955509997175,0.0165502842767989,0.0392688441956914,1.48059455922731e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.017965577402235,0.00373149782844379,0.0106518416584852,0.0252793131459848,1.49102450694529e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN1,Calsyntenin-1,39489,0.0228583358043782,0.00475029063886587,0.0135477661522011,0.0321689054565553,1.50832933968051e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FGF16,Fibroblast growth factor 16,37056,0.0218312381003849,0.00456963608880596,0.0128747513663253,0.0307877248344446,1.79437515657546e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0451323137060755,0.00945550237411225,0.0265995290528155,0.0636650983593355,1.83042518304452e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4C,Semaphorin-4C,39788,0.0127484539381686,0.00267473838114604,0.00750596671112236,0.0179909411652148,1.89350299084144e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0148472167279672,0.00312182964200068,0.00872843062964586,0.0209660028262885,1.9923481500194e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.0134923734915547,0.00284054858777945,0.00792489825950703,0.0190598487236025,2.05243609658088e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00904288349261168,0.00190488037105381,0.00530931796534622,0.0127764490198771,2.08010621196298e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0120077215372746,0.00253139961584125,0.00704617829022579,0.0169692647843235,2.11857813613737e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0126741721366962,0.00268315867992022,0.00741518112405257,0.0179331631493398,2.34091966065047e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK2,Protein AHNAK2,37043,0.0130931355167628,0.00277252864453132,0.0076589793734814,0.0185272916600442,2.35418527006083e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0217483014046074,0.00461401219060499,0.0127048375110216,0.0307917652981932,2.45885548175922e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0142300904275571,0.00302193820186875,0.00830709155189432,0.0201530893032198,2.5155808688542e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ARTN,Artemin,39587,0.0198959955444237,0.00422817604217338,0.0116087705017639,0.0281832205870836,2.55307987153984e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0170746027729137,0.00362899195120502,0.0099617785485519,0.0241874269972756,2.55972468044358e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0445591810945234,0.00948406102222884,0.0259704214909549,0.0631479406980919,2.64957549720918e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN2,Contactin-2,40030,0.0196386364800497,0.00418148370512706,0.0114429284180007,0.0278343445420988,2.66739445380284e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HYAL1,Hyaluronidase-1,39747,0.0100836158432144,0.00215124283050662,0.00586717989542141,0.0143000517910074,2.79071202447394e-06
NMR metabolomics,X23412.Phospholipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0300613436372967,0.00643039593163466,0.0174577676112928,0.0426649196633007,2.9705541006695e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00639186986929155,0.00136814675781174,0.00371030222398055,0.00907343751460255,3.01270228628072e-06
NMR metabolomics,X23412.Phospholipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0172450531407992,0.00369890691457841,0.00999519558822551,0.0244949106933729,3.15837223385287e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0160352966287387,0.0034414384936004,0.0092900771812819,0.0227805160761955,3.20044126100647e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CHGB,Secretogranin-1,39952,0.0173128942438371,0.00372266410224277,0.0100164726034413,0.0246093158842329,3.33484461774673e-06
NMR metabolomics,X23412.Phospholipids in VLDL,BRD3,Bromodomain-containing protein 3,37021,0.020417768994828,0.00439017154958351,0.0118130327576443,0.0290225052320117,3.33882710524457e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLGN,Calmegin,37039,0.0191908313723104,0.00412713037613697,0.011101655835082,0.0272800069095389,3.35286503289145e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CD7,T-cell antigen CD7,37037,0.018799970572512,0.00404861724078735,0.0108646807805688,0.0267352603644552,3.45776144202517e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0139794650680191,0.00301189059779587,-0.019882770639699,-0.00807615949633922,3.49329407695242e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KLK4,Kallikrein-4,40030,-0.0263222768022092,0.00567791024472013,-0.0374509808818607,-0.0151935727225578,3.58150166254514e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KLK8,Kallikrein-8,39315,0.0151374439996357,0.00328333076914478,0.00870211569211193,0.0215727723071595,4.05128106545131e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0129469572193548,0.00280836911567614,0.00744255375262959,0.01845136068608,4.0621306291926e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0232517174406022,0.00504541656275081,0.0133627009776106,0.0331407339035938,4.09329772959703e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PRL,Prolactin,40009,-0.0329508675904936,0.00715535780615265,-0.0469753688905528,-0.0189263662904344,4.15488775576256e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CR2,Complement receptor type 2,39931,0.0196394542516164,0.00427783242936989,0.0112549026900514,0.0280240058131814,4.44506952038704e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CDH17,Cadherin-17,39868,-0.0287718809010957,0.00626756500852996,-0.0410563083178145,-0.016487453484377,4.45335778503871e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2,Ataxin-2,36991,0.0482185734782182,0.0105204608929254,0.0275984701280844,0.068838676828352,4.61884310220024e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.022562425593472,0.00493258305775719,0.0128945628002679,0.0322302883866761,4.81682188729828e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.030719592567741,0.00672722426151367,0.0175342330151742,0.0439049521203077,5.00481191818222e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KLK11,Kallikrein-11,39779,0.0125343037189718,0.00274789192974447,0.00714843553667265,0.017920171901271,5.11866981429267e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0278388079376777,0.00610698925653921,0.0158691089948608,0.0398085068804945,5.19753051935301e-06
NMR metabolomics,X23412.Phospholipids in VLDL,BCAN,Brevican core protein,39749,0.0143148645655974,0.00314315423804975,0.00815428225901988,0.0204754468721749,5.29511366840979e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.0102199811249329,0.00224796746521647,0.00581396489310865,0.0146259973567572,5.49913777503614e-06
NMR metabolomics,X23412.Phospholipids in VLDL,INHBB,Inhibin beta B chain,37124,0.0210881751131544,0.00467978561454703,0.0119157953086422,0.0302605549176665,6.65548949384637e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00883856314261372,0.00196551304575781,0.00498615757292841,0.012690968712299,6.94635652616935e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0144894552995059,0.00322524392405204,-0.0208109333906479,-0.00816797720836391,7.09682659461314e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0252855858879188,0.00565346380435346,0.014204796831386,0.0363663749444516,7.79108988890873e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PGA4,Pepsin A-4,37445,0.0262372434521391,0.0058802690397421,0.0147119161342445,0.0377625707700336,8.18845091949005e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0109810626187605,0.00246210748999614,0.00615533193836802,0.0158067932991529,8.25054999475706e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0155218370278771,0.00348153629126188,0.00869802589700377,0.0223456481587503,8.32663440984763e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0166522479034658,0.00375711676099509,-0.0240161967550162,-0.00928829905191544,9.40166345862491e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00960972970560732,0.00216852141682225,0.0053594277286357,0.0138600316825789,9.42207148974334e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0458458564526057,0.0103701055143214,0.0255204496445359,0.0661712632606756,9.90467923153348e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SELENOP,Selenoprotein P,37453,0.00925453583056416,0.00210123487348034,0.00513611547854269,0.0133729561825856,1.06921395214367e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SNX18,Sorting nexin-18,37382,0.0188263403264416,0.00427704762265063,0.0104433269860464,0.0272093536668368,1.08222393245847e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM1,Neural cell adhesion molecule 1,39931,0.0124191669659088,0.0028269624234268,0.00687832061599224,0.0179600133158253,1.12453739981185e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0157194295393924,0.00357878184820827,0.00870501711690423,0.0227338419618806,1.12981496457207e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00950520699305494,0.00216644548742564,-0.0137514401484092,-0.00525897383770069,1.15569317935093e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAP,Cartilage-associated protein,37039,0.020486260613608,0.00467177724407839,0.0113295772152144,0.0296429440120017,1.16825565985372e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SATB1,DNA-binding protein SATB1,37411,0.012424164568071,0.00283601477938493,0.0068655756004765,0.0179827535356654,1.19103457687968e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB1A1,Uteroglobin,39903,0.0225848942637943,0.00516143967008809,0.0124684725104217,0.032701316017167,1.21809477311473e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.021272581858963,0.0048663813137623,0.0117344744839889,0.0308106892339372,1.24287198391185e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00952320304658124,0.00218371546452574,0.00524312073611079,0.0138032853570517,1.30278426299574e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0249001340741882,0.00571596847222505,0.0136968358686271,0.0361034322797493,1.33138469430667e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0147377164324744,0.00339770168564318,0.00807822112861382,0.0213972117363351,1.45146760713411e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0576921569658765,0.0133465013955546,0.0315330142305894,0.0838512997011636,1.55124951574916e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D17,TBC1 domain family member 17,39489,0.017903633332474,0.00414980641502833,0.00977001275901846,0.0260372539059295,1.61070832755658e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00759847094432685,0.00176148002478267,0.00414597009575281,0.0110509717929009,1.6168853378891e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0392320477987637,0.00912991126495919,0.0213374217194437,0.0571266738780837,1.7429633750755e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0205343041273172,0.0047855172124059,0.0111546903910017,0.0299139178636328,1.79200223758848e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0114609787337941,0.00267399452159521,0.00621994947146754,0.0167020079961208,1.82920551418946e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CFD,Complement factor D,37453,0.00739117326502016,0.00172656718525141,0.0040071015819274,0.0107752449481129,1.87458062380503e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MYL3,Myosin light chain 3,37043,-0.0293994974785633,0.00688215664816583,-0.0428885245089683,-0.0159104704481582,1.95222901867341e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0136703451492022,0.00320806615027063,0.00738253549467176,0.0199581548037326,2.04462496291624e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0137198610094556,0.0032367937296478,0.00737574529934595,0.0200639767195653,2.26080395641112e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CCL21,C-C motif chemokine 21,39931,0.0156303398460698,0.00369361040901523,0.00839086344439995,0.0228698162477397,2.33193082569281e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0260874296910001,0.00618937768552395,-0.038218609954627,-0.0139562494273731,2.51296444292869e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0110146836304904,0.002613398282923,-0.0161369442650195,-0.00589242299596134,2.51763221534159e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0106269118857781,0.00252190762496263,-0.0155698508307048,-0.00568397294085133,2.52443081385685e-05
NMR metabolomics,X23412.Phospholipids in VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0272606618934834,0.0064811882632803,0.014557532897454,0.0399637908895128,2.61508816154632e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR1,Cadherin-related family member 1,39489,0.0169431733730199,0.0040293114426343,0.00904572294545665,0.0248406238005831,2.62559060382199e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0136034813846523,0.00325099540684174,0.00723153038724254,0.0199754323820621,2.87430284089523e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SHISA5,Protein shisa-5,37437,0.0090437434156223,0.00216694469357487,0.00479653181621556,0.013290955015029,3.0182441794027e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0191233151857606,0.00458738158737,-0.0281145830970058,-0.0101320472745154,3.07985175974274e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA1,Annexin A1,37072,0.0172332288123723,0.00413614069040692,0.00912639305917478,0.0253400645655699,3.11279958758486e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN2,Alpha-actinin-2,37021,-0.0232723852319098,0.00559056266224155,-0.0342298880499032,-0.0123148824139164,3.1637170276751e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0235682410925145,0.00567288779913235,0.0124493810062151,0.0346871011788139,3.27646242889242e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0177083457315201,0.00426652088044522,-0.0260707266571927,-0.00934596480584744,3.33409763703909e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.0144251571022716,0.00347759328015836,0.00760907427316123,0.021241239931382,3.37432339816065e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.017274900169842,0.00417292787359604,0.00909596153759376,0.0254538388020902,3.4984297994174e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FOSB,Protein fosB,39489,0.0152495191604136,0.0036861603047308,0.00802464496314119,0.0224743933576859,3.53769790337043e-05
NMR metabolomics,X23412.Phospholipids in VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.00966065911234113,0.00233640848801661,-0.0142400197488537,-0.00508129847582857,3.57002917574281e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0164451591275924,0.00398132573717626,0.00864176068272697,0.0242485575724579,3.63729531301602e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PSPN,Persephin,39866,0.0366520847836862,0.0088904351434283,0.0192268319025668,0.0540773376648057,3.76439245068543e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.023869841427271,0.0057982272195265,0.012505316076999,0.0352343667775429,3.86259871116809e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA11,Integrin alpha-11,39866,-0.0131998391667262,0.00320838392145335,-0.0194882716527748,-0.00691140668067767,3.90517534062653e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0273084975539277,0.00664747001542095,0.0142794563237026,0.0403375387841527,4.01265214077117e-05
NMR metabolomics,X23412.Phospholipids in VLDL,OSM,Oncostatin-M,39785,0.0276187368484737,0.00674502595176641,0.0143984859830115,0.0408389877139359,4.24835514134136e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0139626690384907,0.0034116416029365,0.00727585149673514,0.0206494865802462,4.2900353922883e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD248,Endosialin,37437,-0.0153276538823768,0.00375021526894375,-0.0226780758095066,-0.00797723195524709,4.39236553162545e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL6,Interleukin-6,39788,0.0272905140967883,0.00668683540470329,0.0141843167035698,0.0403967114900067,4.50163839255156e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ERC2,ERC protein 2,37039,0.0288534452990056,0.00708956178000519,0.0149579042101954,0.0427489863878158,4.73180114058502e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0176589414584322,0.00433940710471154,-0.0261641793836668,-0.00915370353319762,4.73552206040364e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN10,Ataxin-10,39489,0.0280379922588798,0.00690382376776001,0.0145064976740701,0.0415694868436894,4.90536499465394e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0101003077754627,0.00248792888604479,-0.0149766483921105,-0.00522396715881492,4.94160064456561e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0715262948152172,0.0176239979446962,0.0369832588436126,0.106069330786822,4.96329206421962e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CTRC,Chymotrypsin-C,39856,0.0236380882686189,0.00582636698303884,0.0122184089818627,0.035057767555375,4.99240379697232e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.0122398613710383,0.00302229553441413,0.0063161621235866,0.01816356061849,5.15421669380364e-05
NMR metabolomics,X23412.Phospholipids in VLDL,OLFM4,Olfactomedin-4,36654,0.0471159901791933,0.0116394928173946,0.0243025842570999,0.0699293961012868,5.19741205153804e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PMS1,PMS1 protein homolog 1,37039,0.0190342397384194,0.00470404837748721,0.00981430491854448,0.0282541745582943,5.23185997601972e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB1,Lamin-B1,37348,0.0221692891598702,0.00548395992214252,0.0114207277124709,0.0329178506072695,5.31623033415244e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CAPS,Calcyphosin,37388,0.0332287801512845,0.00822834426729189,0.0171012253873924,0.0493563349151766,5.4129743482581e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RA,Interleukin-17 receptor A,39858,0.016791702780629,0.00415877263936244,0.00864050840747861,0.0249428971537794,5.42390100771756e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0182578479173827,0.00452625850816869,0.00938638124137207,0.0271293145933933,5.51502668931352e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LHB,Lutropin subunit beta,39477,0.03369330704506,0.00835297758093848,0.0173214709864206,0.0500651431036994,5.51693266495504e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0234647984536142,0.00583263388931794,0.0120328360305511,0.0348967608766774,5.77786680680259e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0207648990102804,0.00516205497300468,0.0106472712631912,0.0308825267573696,5.78293337069302e-05
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0158070992873359,0.00394248660507747,0.00807982554138401,0.0235343730332877,6.11932826599246e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0142314432144257,0.00355873898642618,0.0072563148010304,0.021206571627821,6.3892936216683e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.0102979294774716,0.00258506116705076,0.00523120959005214,0.0153646493648911,6.81671937639098e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0231696833849818,0.00582006240931033,0.0117623610627335,0.03457700570723,6.89954529484393e-05
NMR metabolomics,X23412.Phospholipids in VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0159983850769662,0.00402035494427811,-0.0238782807677513,-0.00811848938618112,6.94749366735974e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0184479788154314,0.00463932810637893,-0.0275410619039341,-0.00935489572692867,7.02633019986944e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0221582714591041,0.00558879691453064,0.0112042295066241,0.0331123134115842,7.38459767764817e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0133192669032954,0.00337282757951458,0.00670852484744681,0.0199300089591439,7.88782192832e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0141348227198892,0.00358260812133938,-0.0211567346377144,-0.00711291080206399,8.00813262911772e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0189323197127425,0.0048223778914657,0.00948045904546977,0.0283841803800153,8.68239965610597e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0113904051234619,0.00290505552056184,0.00569649630316073,0.0170843139437632,8.85917593846589e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0250066802087419,0.00638762586817488,0.0124869335071192,0.0375264269103647,9.08997764820701e-05
NMR metabolomics,X23412.Phospholipids in VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0232713675226471,0.00594684337020046,-0.03492718052824,-0.0116155545170542,9.14502876616479e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLSPN,Claspin,39453,0.0127040271320201,0.00325015192160869,0.00633372936566705,0.0190743248983731,9.31676818510037e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.014781648493707,0.00378745428237092,0.00735823810026004,0.022205058887154,9.54787989553957e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PROCR,Endothelial protein C receptor,37021,-0.0134909618902149,0.00345936076602115,-0.0202713089916163,-0.00671061478881345,9.67334979994229e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0115615795696684,0.00297333343953852,-0.0173893131111639,-0.00573384602817287,0.000101393187455773
NMR metabolomics,X23412.Phospholipids in VLDL,S100A14,Protein S100-A14,37411,0.0187544221550496,0.00483033620288906,0.00928696319738709,0.0282218811127122,0.00010382178853515
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN1,Nectin-1,37056,0.0117806756799328,0.0030365562745266,0.00582902538186063,0.0177323259780049,0.000105129292480578
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE1,Ribonuclease pancreatic,37445,0.00820788555341033,0.0021173287587268,0.0040579211863058,0.0123578499205149,0.000106455843428558
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL3,Follistatin-related protein 3,39803,0.0109422285097269,0.00282811477450606,0.00539912355169498,0.0164853334677587,0.00010967731134305
NMR metabolomics,X23412.Phospholipids in VLDL,LIF,Leukemia inhibitory factor,39489,0.0186555061002195,0.00484607999610936,0.00915718930784519,0.0281538228925939,0.000118778366789388
NMR metabolomics,X23412.Phospholipids in VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0167259338807532,0.00435590466122051,0.00818836074476101,0.0252635070167454,0.000123689878320088
NMR metabolomics,X23412.Phospholipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00818616166450173,0.00213667121680093,0.00399828607957191,0.0123740372494316,0.000127965410928001
NMR metabolomics,X23412.Phospholipids in VLDL,TNC,Tenascin,39931,-0.0169682540212305,0.00444162729315724,-0.0256738435158187,-0.0082626645266423,0.00013380251399441
NMR metabolomics,X23412.Phospholipids in VLDL,GZMH,Granzyme H,39585,0.027126838532396,0.0071133989295691,0.0131845766304405,0.0410691004343514,0.000137544334333283
NMR metabolomics,X23412.Phospholipids in VLDL,SBSN,Suprabasin,37420,-0.0122451042772124,0.00321162063038689,-0.0185398807127706,-0.00595032784165405,0.000138037919633993
NMR metabolomics,X23412.Phospholipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.021475879612332,0.00564784667046141,0.0104061001382277,0.0325456590864364,0.000143898889310489
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171B,Protein FAM171B,37368,0.00995046676398907,0.00262085547856317,0.00481359002600526,0.0150873435019729,0.000147307067543204
NMR metabolomics,X23412.Phospholipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0134503219774996,0.00354441795318401,-0.0203973811657402,-0.00650326278925893,0.000148429696716371
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN2,Calsyntenin-2,40058,-0.0140756953592145,0.00371698214072511,-0.0213609803550357,-0.00679041036339328,0.000153113220947762
NMR metabolomics,X23412.Phospholipids in VLDL,CHGA,Chromogranin-A,37437,-0.0280462494731333,0.00741015715051203,-0.0425701574881369,-0.0135223414581297,0.000154469802943378
NMR metabolomics,X23412.Phospholipids in VLDL,CST7,Cystatin-F,39882,0.0329684836550835,0.00871164053698917,0.0158936682025848,0.0500432991075823,0.000154630227937493
NMR metabolomics,X23412.Phospholipids in VLDL,MYO6,Unconventional myosin-VI,37411,0.0136474222257905,0.00360797629998791,0.00657578867781415,0.0207190557737668,0.000155884866814779
NMR metabolomics,X23412.Phospholipids in VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0250848047812851,0.00663408865236912,0.0120819910226416,0.0380876185399286,0.000156657403386967
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0320336328288027,0.00850661264809319,0.01536067203854,0.0487065936190653,0.000166782068457409
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.00927509527514351,0.00247268790927184,0.00442862697297071,0.0141215635773163,0.000176736987158688
NMR metabolomics,X23412.Phospholipids in VLDL,SDK2,Protein sidekick-2,37124,0.0131584937325654,0.00351479129149052,0.00626950280124395,0.0200474846638868,0.000182061285019165
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0119424648634344,0.00319214397943672,-0.0181990670631304,-0.00568586266373845,0.000183919714139446
NMR metabolomics,X23412.Phospholipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0207506092280627,0.00557120487381547,0.00983104767538437,0.031670170780741,0.000196419233436902
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0126534893108903,0.00340157329113102,-0.0193205729615071,-0.00598640566027347,0.000199993140032232
NMR metabolomics,X23412.Phospholipids in VLDL,EXTL1,Exostosin-like 1,37021,0.0167520765452468,0.00451953173767898,0.00789379433939595,0.0256103587510976,0.000210925480316804
NMR metabolomics,X23412.Phospholipids in VLDL,LY6D,Lymphocyte antigen 6D,39761,0.01263260295485,0.00341453998536603,0.0059401045835326,0.0193251013261674,0.000216624538150913
NMR metabolomics,X23412.Phospholipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0144051537250402,0.00389589096628294,0.00676920743112566,0.0220411000189548,0.00021859513155715
NMR metabolomics,X23412.Phospholipids in VLDL,CST6,Cystatin-M,39524,0.0163588441456123,0.00442470398948364,0.00768642432622434,0.0250312639650002,0.000218767830451814
NMR metabolomics,X23412.Phospholipids in VLDL,THBS2,Thrombospondin-2,39858,-0.0125290452558446,0.00340098647443775,-0.0191949787457426,-0.00586311176594662,0.000230409322201157
NMR metabolomics,X23412.Phospholipids in VLDL,VWF,von Willebrand factor,40052,-0.0254021182691705,0.00689743641908471,-0.0389210936505766,-0.0118831428877645,0.000231405071567204
NMR metabolomics,X23412.Phospholipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.0126187590881965,0.00342690401394837,0.00590202722085771,0.0193354909555353,0.000232096852968352
NMR metabolomics,X23412.Phospholipids in VLDL,GBP2,Guanylate-binding protein 2,39587,0.0205629737394882,0.00559598476159522,0.0095948436067616,0.0315311038722149,0.000239018882129663
NMR metabolomics,X23412.Phospholipids in VLDL,CASP1,Caspase-1,39489,0.0231399008015855,0.00631030756145225,0.0107716979811391,0.0355081036220319,0.000246226214968531
NMR metabolomics,X23412.Phospholipids in VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0269602503813086,0.00736108955805226,0.0125325148475262,0.041387985915091,0.000250556371807656
NMR metabolomics,X23412.Phospholipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.015354769270396,0.00420058462605525,0.00712162340332773,0.0235879151374643,0.00025776506685439
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0215510413707196,0.00589744181772157,0.00999205540798538,0.0331100273334539,0.000258883893861725
NMR metabolomics,X23412.Phospholipids in VLDL,CLASP1,CLIP-associating protein 1,36962,0.0253315602156185,0.0069409325176282,0.0117273324810672,0.0389357879501698,0.000263679748969275
NMR metabolomics,X23412.Phospholipids in VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.0135801011155291,0.00372270175990106,0.00628360566612303,0.0208765965649352,0.000265370095795578
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO4,Roundabout homolog 4,37043,-0.00614519091136889,0.0016858883607618,-0.00944953209846202,-0.00284084972427576,0.000268340770454202
NMR metabolomics,X23412.Phospholipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0139900751143838,0.00386423930411124,-0.0215639841504419,-0.0064161660783258,0.000295257261497121
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0111947955905211,0.00309552601052639,0.00512756460988934,0.0172620265711528,0.000299596305226473
NMR metabolomics,X23412.Phospholipids in VLDL,RLN1,Prorelaxin H1,37411,-0.0275000917890703,0.00762651607014854,-0.0424480632865614,-0.0125521202915792,0.000312247341399251
NMR metabolomics,X23412.Phospholipids in VLDL,CCL28,C-C motif chemokine 28,39815,0.0202591280575518,0.00562070482381146,0.00924254660288139,0.0312757095122223,0.000313857853676733
NMR metabolomics,X23412.Phospholipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0204016717529464,0.0056685214507459,0.00929136970948446,0.0315119737964084,0.000320469032218986
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0164167223247278,0.0045634587704239,0.00747234313469697,0.0253611015147587,0.000322521464768994
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD1,Leiomodin-1,37411,-0.0119811526541919,0.00333052624142699,-0.0185089840873888,-0.00545332122099504,0.000322588964093228
NMR metabolomics,X23412.Phospholipids in VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0122833778510812,0.00341891168911579,0.00558231094041427,0.0189844447617482,0.000328169697109263
NMR metabolomics,X23412.Phospholipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0129799835433912,0.00361641135759576,0.0058918172825035,0.0200681498042789,0.000332704384498763
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0128879421417929,0.00359471062023758,-0.0199335749574586,-0.00584230932612728,0.000337757608408539
NMR metabolomics,X23412.Phospholipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0237804336893422,0.00664197357486674,0.0107621654826034,0.036798701896081,0.000344387211771724
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0124274400239415,0.00347766090496361,-0.0192436553976702,-0.00561122465021283,0.000353457087943468
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0165383627982408,0.00463375567215656,-0.0256205239156677,-0.00745620168081398,0.000359247209636548
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0196660419097851,0.00551866457871236,0.00884945933550889,0.0304826244840613,0.000367151924284878
NMR metabolomics,X23412.Phospholipids in VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0177465393329379,0.00498191796860159,0.00798198011447883,0.0275110985513971,0.00036907145182301
NMR metabolomics,X23412.Phospholipids in VLDL,REN,Renin,39868,-0.0221227934794663,0.00622122149618714,-0.0343163876119931,-0.00992919934693946,0.000377600620338253
NMR metabolomics,X23412.Phospholipids in VLDL,EP300,Histone acetyltransferase p300,37056,0.00994175497509131,0.00280092449465809,0.00445194296556146,0.0154315669846212,0.000387371905139263
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.00797507486066555,0.00224775673419204,-0.0123806780596819,-0.00356947166164916,0.000389253436564159
NMR metabolomics,X23412.Phospholipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0292624429961358,0.00824823673462783,0.0130958989962653,0.0454289869960064,0.000389931752108031
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0176767647991679,0.00498650614345275,0.00790321275800051,0.0274503168403353,0.00039387267153372
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0145523242068178,0.00411096173405468,0.00649483920807066,0.022609809205565,0.000401467385846999
NMR metabolomics,X23412.Phospholipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0163356017074793,0.00462375954904309,0.0072730329913549,0.0253981704236038,0.00041210511445439
NMR metabolomics,X23412.Phospholipids in VLDL,IL17C,Interleukin-17C,39587,-0.022103092351009,0.00627023395063502,-0.0343927508942536,-0.00981343380776434,0.00042455429592347
NMR metabolomics,X23412.Phospholipids in VLDL,DRAXIN,Draxin,39749,0.0139891372984511,0.00397071560472563,0.00620653471318886,0.0217717398837133,0.000427764907120569
NMR metabolomics,X23412.Phospholipids in VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0250155039920099,0.00710150228934654,0.0110965595048907,0.0389344484791291,0.000428607058127301
NMR metabolomics,X23412.Phospholipids in VLDL,VASN,Vasorin,39642,0.00907580077462332,0.00258134570570489,0.00401636319144173,0.0141352383578049,0.000439465132433315
NMR metabolomics,X23412.Phospholipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0142734229332253,0.00406335559994877,-0.0222375999091249,-0.00630924595732567,0.000444765514595129
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0231097320939703,0.00658597517628062,0.0102012207484602,0.0360182434394803,0.000451132790523536
NMR metabolomics,X23412.Phospholipids in VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.013894049738184,0.00396242346297296,-0.021660399725611,-0.00612769975075696,0.000455594036767297
NMR metabolomics,X23412.Phospholipids in VLDL,DLL4,Delta-like protein 4,37043,0.0284879247686516,0.00813744766635557,0.0125385273425947,0.0444373221947085,0.000465322491538242
NMR metabolomics,X23412.Phospholipids in VLDL,CDH15,Cadherin-15,39973,0.0176914375114068,0.00506126751832492,0.00777135317549,0.0276115218473237,0.000474524944502769
NMR metabolomics,X23412.Phospholipids in VLDL,SAG,S-arrestin,36991,-0.0175550880389333,0.00502415170854187,-0.0274024253876753,-0.00770775069019123,0.000477159136005064
NMR metabolomics,X23412.Phospholipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0120362823647507,0.00344791707539805,0.00527836489697048,0.0187941998325308,0.000482998266267416
NMR metabolomics,X23412.Phospholipids in VLDL,OMD,Osteomodulin,39931,-0.0142814130698676,0.00410454277259445,-0.0223263169041527,-0.00623650923558244,0.000503838761433007
NMR metabolomics,X23412.Phospholipids in VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0109691218181487,0.00315453526489734,0.00478623269894992,0.0171520109373475,0.000508209609156487
NMR metabolomics,X23412.Phospholipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0123661261628855,0.00356273825603071,0.00538315918106526,0.0193490931447057,0.000520024312631416
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0128580273222485,0.00370694252847408,-0.0201236346780577,-0.00559241996643935,0.000524733386975148
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.019126597342687,0.00551453726502708,0.0083181043032339,0.02993509038214,0.000524976709107308
NMR metabolomics,X23412.Phospholipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0142352172475307,0.00410894921744092,0.00618167678134647,0.0222887577137149,0.000533019736642326
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.011600419842963,0.00335088785673332,-0.0181681600421603,-0.0050326796437657,0.000537774310141721
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.00920362358052795,0.00265987672226725,-0.0144169819561717,-0.00399026520488415,0.000541243504501054
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR1,Folate receptor alpha,39809,0.00890620324419108,0.00258559594216554,0.00383843519754663,0.0139739712908355,0.000573491017118585
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0128152573285866,0.00373720245420375,0.00549034051834728,0.020140174138826,0.000607139375553564
NMR metabolomics,X23412.Phospholipids in VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0106548175903044,0.00313007850631383,-0.0167897714626795,-0.00451986371792925,0.000666024426496529
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0104592287743004,0.00308599447022334,-0.0165077779359381,-0.00441067961266262,0.000702863273308911
NMR metabolomics,X23412.Phospholipids in VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0199868838592855,0.00592427694872213,-0.0315984666787809,-0.00837530103979012,0.000743727280567301
NMR metabolomics,X23412.Phospholipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0162358694027964,0.00482125363941739,0.00678621226953833,0.0256855265360545,0.000760191420027779
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0185845899728601,0.00552098281865669,0.00776346364829296,0.0294057162974272,0.000764371204463751
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0151070631949569,0.00450109786391224,0.00628491138168891,0.0239292150082249,0.000792081347220049
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0107452484021879,0.00320750129174443,0.00445854587036883,0.017031950934007,0.000809860577594048
NMR metabolomics,X23412.Phospholipids in VLDL,AZU1,Azurocidin,39344,0.0240629169423906,0.00723659928770112,0.00987918233849636,0.0382466515462847,0.000885702029529395
NMR metabolomics,X23412.Phospholipids in VLDL,MELTF,Melanotransferrin,37437,0.0091251642772746,0.00274647350636719,0.00374207620479492,0.0145082523497543,0.000894496807658645
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.015138239415077,0.00455676435957397,0.00620698127031198,0.024069497559842,0.000895326588427032
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN1,Tetraspanin-1,39585,0.012655251079954,0.00381321126263084,0.0051813570051976,0.0201291451547105,0.000906134449908018
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00946586871347557,0.00285244660412334,-0.0150566640575573,-0.00387507336939382,0.000907015200081269
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0133336858363963,0.00402619792026855,0.00544233791266993,0.0212250337601226,0.000929250027660423
NMR metabolomics,X23412.Phospholipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0125226328614096,0.00378326900334956,0.0051074256148445,0.0199378401079748,0.000935061760548026
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0133805631828088,0.00404590006431813,-0.0213105273088723,-0.00545059905674525,0.000944443996944768
NMR metabolomics,X23412.Phospholipids in VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00857019622269096,0.00259141434484726,0.00349102410679033,0.0136493683385916,0.000944956260191728
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.0124403277448465,0.00376304030924775,0.00506476873872096,0.0198158867509721,0.000948754696163796
NMR metabolomics,X23412.Phospholipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0221180279327037,0.00669638408781351,0.00899311512058923,0.0352429407448182,0.00095870826136452
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0201573630029632,0.00614489101179509,0.00811337661984477,0.0322013493860815,0.00103949016102559
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0110177671992213,0.00336719102964075,0.00441807278112545,0.0176174616173172,0.00107020422356748
NMR metabolomics,X23412.Phospholipids in VLDL,KLK15,Kallikrein-15,37351,0.015578529430484,0.0047646711605531,0.00623977395579997,0.0249172849051681,0.0010797265852489
NMR metabolomics,X23412.Phospholipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0109418640814765,0.00334945297958039,0.00437693624149896,0.0175067919214541,0.00109014698438178
NMR metabolomics,X23412.Phospholipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00916255892996166,0.00281393569154213,0.00364724497453908,0.0146778728853842,0.00113224331799158
NMR metabolomics,X23412.Phospholipids in VLDL,TMOD4,Tropomodulin-4,36962,-0.0125727487440798,0.00386626486186448,-0.0201506278733342,-0.00499486961482544,0.00114921833395212
NMR metabolomics,X23412.Phospholipids in VLDL,AMPD3,AMP deaminase 3,37388,0.0217493877678682,0.00669940012952969,0.00861856351399005,0.0348802120217464,0.00117131000926697
NMR metabolomics,X23412.Phospholipids in VLDL,CRNN,Cornulin,39397,0.0197804054769667,0.00610646711085466,0.00781172993969161,0.0317490810142419,0.00120094151319584
NMR metabolomics,X23412.Phospholipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0121606448420522,0.00375974851620847,-0.0195297519338208,-0.00479153775028366,0.00122186411609838
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0312018272970311,0.00965858824266179,0.012270994341414,0.0501326602526482,0.00123836179481174
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0077202337052423,0.0023957310969007,0.00302460075531693,0.0124158666551677,0.00127333427472214
NMR metabolomics,X23412.Phospholipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0134819001046378,0.00418473023850418,0.00527982883716958,0.021683971372106,0.00127693361747498
NMR metabolomics,X23412.Phospholipids in VLDL,SSB,Lupus La protein,39489,0.0183640717460266,0.00572919855277685,0.007134842582584,0.0295933009094692,0.00135170657005382
NMR metabolomics,X23412.Phospholipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0211902222532935,0.00661092370687281,0.0082328117878228,0.0341476327187642,0.00135176687008521
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH12,Protocadherin-12,37411,0.00767098502167901,0.00239313125202507,0.00298044776770987,0.0123615222756482,0.0013517931398285
NMR metabolomics,X23412.Phospholipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0125684641567358,0.00392119452926895,0.00488292287936871,0.020254005434103,0.00135203493910078
NMR metabolomics,X23412.Phospholipids in VLDL,STX3,Syntaxin-3,37388,0.0115179684322747,0.00359588870697398,0.0044700265666057,0.0185659102979437,0.00136274623632537
NMR metabolomics,X23412.Phospholipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0151281934275479,0.00473320395309566,0.00585111367948041,0.0244052731756154,0.00139534077894595
NMR metabolomics,X23412.Phospholipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00579079346343934,0.00181228222523447,-0.00934286662489891,-0.00223872030197977,0.00140002485164769
NMR metabolomics,X23412.Phospholipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0179309645642049,0.00561175154946691,0.00693193152724973,0.02892999760116,0.00140027927846137
NMR metabolomics,X23412.Phospholipids in VLDL,PI3,Elafin,39594,0.0159874875675018,0.00500397379075762,0.00617969893761685,0.0257952761973867,0.00140126906185867
NMR metabolomics,X23412.Phospholipids in VLDL,UNC5D,Netrin receptor UNC5D,37056,0.00804684559953483,0.0025187465594435,0.00311010234302557,0.0129835888560441,0.00140265692719737
NMR metabolomics,X23412.Phospholipids in VLDL,GSN,Gelsolin,37383,0.0056332993447476,0.00176345548760233,0.00217692658904703,0.00908967210044817,0.0014041093504056
NMR metabolomics,X23412.Phospholipids in VLDL,SNU13,NHP2-like protein 1,37021,0.0186498921881653,0.00586087510258224,0.00716257698710409,0.0301372073892265,0.00146550931654001
NMR metabolomics,X23412.Phospholipids in VLDL,RCC1,Regulator of chromosome condensation,37368,0.015077348201834,0.00479012766814264,0.0056886979722744,0.0244659984313935,0.00164981584303774
NMR metabolomics,X23412.Phospholipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0359461356171833,0.0114380000836655,0.013527655453199,0.0583646157811677,0.00167711552801043
NMR metabolomics,X23412.Phospholipids in VLDL,MBL2,Mannose-binding protein C,37257,-0.031937071494849,0.0101648987532179,-0.051860273051156,-0.0120138699385419,0.00168222337861688
NMR metabolomics,X23412.Phospholipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.00956949918125835,0.0030516093518981,-0.0155506535109786,-0.00358834485153807,0.00171653650339458
NMR metabolomics,X23412.Phospholipids in VLDL,PRKCQ,Protein kinase C theta type,39587,0.0128266157608263,0.00409402112595576,0.00480233435395298,0.0208508971676995,0.00173340288434109
NMR metabolomics,X23412.Phospholipids in VLDL,PLAU,Urokinase-type plasminogen activator,39858,0.0084578162818851,0.00270029803775781,0.00316523212787979,0.0137504004358904,0.00173827060202181
NMR metabolomics,X23412.Phospholipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.00832169489301825,0.00265775992164019,-0.013530904339433,-0.00311248544660349,0.00174472490808017
NMR metabolomics,X23412.Phospholipids in VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.00864628143066215,0.00276579570469985,-0.0140672410118738,-0.00322532184945045,0.00177498050732758
NMR metabolomics,X23412.Phospholipids in VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0123584989505681,0.00395592464194366,0.00460488665235851,0.0201121112487777,0.0017877035957499
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00941465045839611,0.003013902822414,0.00350740092646468,0.0153218999903275,0.00178892204397428
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0147099808105989,0.00476198463209692,0.00537649093168893,0.0240434706895089,0.00201208761372549
NMR metabolomics,X23412.Phospholipids in VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0376008871992479,0.0121807414117791,-0.061475140366335,-0.0137266340321608,0.00202589370957547
NMR metabolomics,X23412.Phospholipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0106971003404308,0.00347301316909575,-0.0175042061518585,-0.00388999452900314,0.00207382623273408
NMR metabolomics,X23412.Phospholipids in VLDL,TNN,Tenascin-N,37437,0.0124994944000425,0.00406416584306706,0.0045337293476311,0.020465259452454,0.00210541094584913
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.00852787738273805,0.00277341620165772,0.00309198162748892,0.0139637731379872,0.00210967575469175
NMR metabolomics,X23412.Phospholipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0127023216314963,0.00413894885931986,0.00458998186722934,0.0208146613957632,0.00215228189130347
NMR metabolomics,X23412.Phospholipids in VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.0134993493750691,0.00441129201961623,-0.0221454817335169,-0.00485321701662126,0.00221635318636535
NMR metabolomics,X23412.Phospholipids in VLDL,HMBS,Porphobilinogen deaminase,40030,0.0124149781817199,0.00405716167177767,0.00446294130503562,0.0203670150584041,0.00221687926094446
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00867360019232447,0.00284482508541796,0.00309774302490527,0.0142494573597437,0.00230059087858154
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.0125712190784919,0.00412545704510974,0.00448532327007676,0.020657114886907,0.00231336766205141
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0173283773113737,0.0056887693507511,0.00617838938390153,0.0284783652388459,0.00232235572967096
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00749161281291891,0.00245962167644294,0.00267075432709075,0.0123124712987471,0.00232410975345884
NMR metabolomics,X23412.Phospholipids in VLDL,TSC1,Hamartin,37056,0.0219718192198778,0.00723358340821824,0.00779399573977008,0.0361496426999856,0.00239036297389101
NMR metabolomics,X23412.Phospholipids in VLDL,RPS10,40S ribosomal protein S10,37021,-0.0123292061209886,0.00406415435313929,-0.0202949486531416,-0.00436346358883556,0.00242088754210676
NMR metabolomics,X23412.Phospholipids in VLDL,MATN3,Matrilin-3,39720,-0.00897441140142909,0.00295882175980139,-0.0147737020506398,-0.00317512075221836,0.00242444236045107
NMR metabolomics,X23412.Phospholipids in VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.00814541751458482,0.00269946057903949,0.00285447477966742,0.0134363602495022,0.00255332397985823
NMR metabolomics,X23412.Phospholipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0242178485809176,0.0080360516838912,-0.0399685098813444,-0.00846718728049085,0.0025854258444153
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3D,Protein FAM3D,37382,0.0237745406516314,0.00789705135776885,0.00829631999040448,0.0392527613128584,0.00261248322990192
NMR metabolomics,X23412.Phospholipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.0113796991426304,0.00379676613285587,0.00393803752223285,0.0188213607630279,0.00272879118189805
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00946836408678806,0.00316165902677449,0.00327151239431007,0.0156652157792661,0.00275183446318577
NMR metabolomics,X23412.Phospholipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00923061509442737,0.00309223519174674,0.00316983411860377,0.015291396070251,0.00283997428689528
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00773582444194732,0.00259457787777157,0.00265045180151505,0.0128211970823796,0.00287237672243263
NMR metabolomics,X23412.Phospholipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0225493256124918,0.00759943536961336,0.00765443228804966,0.037444218936934,0.00300931840653895
NMR metabolomics,X23412.Phospholipids in VLDL,TYMP,Thymidine phosphorylase,39764,0.0189556964796849,0.00639341904312473,0.00642459515516047,0.0314867978042094,0.00303253963419032
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.0156791531087529,0.00529456075410954,0.00530181403069825,0.0260564921868076,0.00306823099164488
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM1,Myomesin-1,36991,0.0132636039856478,0.00448115640118332,0.00448053743932845,0.0220466705319671,0.00308326744389949
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB5,Integrin beta-5,39913,0.0106000502680225,0.00358343547277531,0.00357651674138292,0.0176235837946621,0.0031002383959431
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA6C,Semaphorin-6C,37056,0.00732434950481688,0.00247791827827269,0.00246762967940242,0.0121810693302313,0.00312362302863968
NMR metabolomics,X23412.Phospholipids in VLDL,IFNG,Interferon gamma,39587,0.0318635734095464,0.0107958778027319,0.0107036529161919,0.0530234939029009,0.00316744954724852
NMR metabolomics,X23412.Phospholipids in VLDL,WNT9A,Protein Wnt-9a,39587,0.00783254295541076,0.00265506522137448,0.00262861512151678,0.0130364707893047,0.0031820309061571
NMR metabolomics,X23412.Phospholipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.011415484828502,0.00386988291987239,-0.0190004553514519,-0.00383051430555207,0.00318514167100942
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00846039444121137,0.0028769340514764,0.00282160370031762,0.0140991851821051,0.00327879917228701
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0162421836656586,0.00553045112189964,0.00540249946673535,0.0270818678645819,0.00332023091514534
NMR metabolomics,X23412.Phospholipids in VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0291385416345941,0.00997278685186415,0.00959187940494042,0.0486852038642479,0.00348497831316067
NMR metabolomics,X23412.Phospholipids in VLDL,VIM,Vimentin,39585,0.0323111565141605,0.011074613791536,0.01060491348275,0.054017399545571,0.00353249747376104
NMR metabolomics,X23412.Phospholipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0162702377626287,0.0055792587558825,0.00533489060109903,0.0272055849241584,0.00354820407303414
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00737674028391516,0.00253027569218892,0.00241739992722488,0.0123360806406054,0.00355732635437872
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0125008120042179,0.00430264494375949,0.00406762791444929,0.0209339960939865,0.00367320505758119
NMR metabolomics,X23412.Phospholipids in VLDL,SCGN,Secretagogin,39587,-0.0118163186226615,0.00406850663897968,-0.0197905916350617,-0.00384204561026138,0.00368542835341909
NMR metabolomics,X23412.Phospholipids in VLDL,APOF,Apolipoprotein F,37445,-0.00711136675656516,0.00244854663770465,-0.0119105181664663,-0.00231221534666404,0.00368643058938207
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00586202216721116,0.0020225637249456,0.00189779726631779,0.00982624706810454,0.00375779159253105
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN5,Contactin-5,39897,0.00981878819242503,0.00339884203252684,0.00315705780867242,0.0164805185761776,0.00387155409416922
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0116740357534804,0.00404910003240356,-0.0196102718169914,-0.00373779968996946,0.00394398369398667
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM25,Transmembrane protein 25,37411,-0.0121903540540595,0.00423223999888063,-0.0204855444518655,-0.00389516365625346,0.00397850218205193
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00704506925207889,0.00245458622895786,0.00223408024332148,0.0118560582608363,0.00410796666810417
NMR metabolomics,X23412.Phospholipids in VLDL,MSMB,Beta-microseminoprotein,39780,0.0181563857414696,0.00633595385856562,0.00573791617868094,0.0305748553042582,0.00416749055165726
NMR metabolomics,X23412.Phospholipids in VLDL,SOX9,Transcription factor SOX-9,37039,0.00730887961260078,0.00255565531301068,0.00229979519909985,0.0123179640261017,0.00424460706278939
NMR metabolomics,X23412.Phospholipids in VLDL,CDH6,Cadherin-6,39868,-0.010262075339493,0.00359033602916727,-0.0172991339566608,-0.00322501672232513,0.0042653531112673
NMR metabolomics,X23412.Phospholipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0158318696933554,0.00554080880236139,0.00497188444072712,0.0266918549459838,0.00427789216775983
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00724195571564017,0.00254099632900646,0.00226160291078751,0.0122223085204928,0.00437697740463368
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3G,Semaphorin-3G,37124,0.0117998959579583,0.00414543692265017,0.00367483958956396,0.0199249523263526,0.00442735801662712
NMR metabolomics,X23412.Phospholipids in VLDL,BMP10,Bone morphogenetic protein 10,37124,0.0075889435682612,0.00267516161221019,0.00234562680832922,0.0128322603281932,0.00456348004933945
NMR metabolomics,X23412.Phospholipids in VLDL,NPTN,Neuroplastin,39477,0.0223825802424829,0.00792761565678209,0.00684445355519001,0.0379207069297758,0.00475820453295284
NMR metabolomics,X23412.Phospholipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0182787017249794,0.0064743607168599,0.005588954719934,0.0309684487300248,0.0047611516266363
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.019547671703537,0.00693690415851427,0.00595133955284905,0.033144003854225,0.00484050443806285
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0105792005958549,0.00375459125069618,-0.0179381994472194,-0.00322020174449041,0.00484433327242555
NMR metabolomics,X23412.Phospholipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00790420482336064,0.00281166210626368,0.00239334709508381,0.0134150625516375,0.00494265679550461
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00783840448145339,0.00279049840702617,-0.0133077813592247,-0.0023690276036821,0.00497727869810945
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.0103194351181789,0.00368466536287694,0.00309749100694014,0.0175413792294178,0.00510751496211271
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00814680013554533,0.00291178463683661,-0.0138538980237451,-0.00243970224734557,0.00515152709356958
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.00759606024533246,0.00271566142169873,0.00227336385880295,0.012918756631862,0.00516314683724787
NMR metabolomics,X23412.Phospholipids in VLDL,AMBN,Ameloblastin,39587,-0.00750773257273724,0.00269382767900959,-0.012787634823596,-0.00222783032187844,0.00532601373679172
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.015197801535765,0.00545605469968449,-0.0258916687471466,-0.00450393432438344,0.00535228415783465
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0180879949585555,0.00649966605528924,0.00534864949018855,0.0308273404269224,0.00539494385944216
NMR metabolomics,X23412.Phospholipids in VLDL,STX1B,Syntaxin-1B,37039,0.0111606676824909,0.00401974095871747,0.00328197540340467,0.0190393599615771,0.00550312153955534
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0104139917952346,0.00375852923240292,0.00304727449972492,0.0177807090907444,0.00560036634937938
NMR metabolomics,X23412.Phospholipids in VLDL,BLVRB,Flavin reductase,39858,0.0168485039796008,0.00608716958174036,0.00491765159938966,0.0287793563598119,0.00564885482916758
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.0120550943904551,0.00436241384450374,0.00350476325522778,0.0206054255256825,0.00572812200984628
NMR metabolomics,X23412.Phospholipids in VLDL,STX5,Syntaxin-5,37056,0.0106447830602614,0.00385468573200092,0.00308959902553963,0.0181999670949833,0.0057612927413335
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.00733300705906546,0.00265669897077227,-0.0125401370417791,-0.00212587707635182,0.00578320210748214
NMR metabolomics,X23412.Phospholipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00697036866679585,0.00254258777522174,0.00198689662736123,0.0119538407062305,0.0061249359927471
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0191648933843745,0.00701572382961263,0.0054140746783337,0.0329157120904152,0.00630917498830235
NMR metabolomics,X23412.Phospholipids in VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0108546946269181,0.00397696607758449,0.00305984111485249,0.0186495481389837,0.00635347428763466
NMR metabolomics,X23412.Phospholipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0142254617790968,0.00523174637541993,0.00397123888327374,0.0244796846749199,0.00655501162770047
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.0146803141953825,0.00540231997608313,0.00409176704225961,0.0252688613485055,0.00658651287427767
NMR metabolomics,X23412.Phospholipids in VLDL,CTSV,Cathepsin L2,39967,0.0104274682898413,0.00386745973513201,0.00284724720898256,0.0180076893707001,0.00702071563343601
NMR metabolomics,X23412.Phospholipids in VLDL,NDRG1,Protein NDRG1,39489,0.0175474705714107,0.00653816088711644,0.00473267523266249,0.0303622659101589,0.00728555126905361
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00543616898532534,0.00202838583023397,-0.00941180521258393,-0.00146053275806675,0.007368855323874
NMR metabolomics,X23412.Phospholipids in VLDL,APOA4,Apolipoprotein A-IV,37453,0.00895844883059161,0.00334854392644457,0.00239530273476025,0.015521594926423,0.00747458824752726
NMR metabolomics,X23412.Phospholipids in VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0151070593347451,0.00566187836668718,-0.026204340933452,-0.00400977773603825,0.0076333469406059
NMR metabolomics,X23412.Phospholipids in VLDL,ABO,Histo-blood group ABO system transferase,37445,0.0359763481044251,0.0135670231927439,0.00938498264664715,0.0625677135622031,0.00801688765465564
NMR metabolomics,X23412.Phospholipids in VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0129859440794507,0.00490674439395214,0.00336872506730448,0.0226031630915969,0.00814131938071703
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0112757003938607,0.00428631154333895,0.00287452976891631,0.019676871018805,0.00853234415723646
NMR metabolomics,X23412.Phospholipids in VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0107596365668095,0.00409895472992426,-0.018793587837461,-0.0027256852961579,0.00867564123299982
NMR metabolomics,X23412.Phospholipids in VLDL,GKN1,Gastrokine-1,39123,0.00695493755398784,0.00265224450975218,0.00175653831487358,0.0121533367931021,0.00874294164270805
NMR metabolomics,X23412.Phospholipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.008773243874562,0.00335405060731512,-0.0153471830648996,-0.00219930468422437,0.00891232900045541
NMR metabolomics,X23412.Phospholipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0130237894279455,0.00498204776752785,-0.0227886030523001,-0.00325897580359091,0.00895534785858911
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00702611705118347,0.00268942147679072,0.00175485095667366,0.0122973831456933,0.0089981867502818
NMR metabolomics,X23412.Phospholipids in VLDL,ELAVL4,ELAV-like protein 4,36991,0.0208534726774332,0.00799002366367925,0.0051930262966219,0.0365139190582446,0.00906612047082748
NMR metabolomics,X23412.Phospholipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00850477885105707,0.00326634895419469,-0.0149068228012787,-0.00210273490083548,0.0092311887281441
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.00829177969489652,0.00318787134387996,-0.0145400075289012,-0.00204355186089181,0.0093042502175884
NMR metabolomics,X23412.Phospholipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.010221262297604,0.00393123702790459,-0.017926486872297,-0.00251603772291102,0.00933247168156461
NMR metabolomics,X23412.Phospholipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.0146274492362741,0.00566338320566645,0.00352721815316782,0.0257276803193803,0.00981029708034356
NMR metabolomics,X23412.Phospholipids in VLDL,CD27,CD27 antigen,39913,-0.00948878368512349,0.00367430348000097,-0.0166904185059254,-0.00228714886432159,0.00981831893797747
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA7A,Semaphorin-7A,40002,0.00655575850094047,0.00254362859670743,0.00157024645139391,0.011541270550487,0.00996560793672959
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00653677869920974,0.00253632597559804,0.00156557978703759,0.0115079776113819,0.00996910900990487
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.014208220584335,0.00554247218911108,0.00334497509367726,0.0250714660749927,0.0103727579614491
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00643717595550729,0.00251166654637854,-0.0113600423864092,-0.00151430952460536,0.0103908868348461
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0109768768477645,0.00428693125915897,0.0025744915798129,0.019379262115716,0.0104599022444323
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0117986048637923,0.00461342643733974,-0.0208409206809782,-0.00275628904660643,0.0105534130691139
NMR metabolomics,X23412.Phospholipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.0065541876451459,0.00256531882712231,0.00152616274398618,0.0115822125463056,0.0106320336926735
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0112945951748008,0.00442407147968446,-0.0199657752749823,-0.00262341507461927,0.0106894771267811
NMR metabolomics,X23412.Phospholipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0127940299006799,0.00502073143607813,0.00295339628596677,0.022634663515393,0.0108380332962966
NMR metabolomics,X23412.Phospholipids in VLDL,MYH7B,Myosin-7B,36962,-0.0106250287538013,0.00417047897106685,-0.0187991675370923,-0.00245088997051024,0.0108556374023929
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.012622184576946,0.00495809179223189,0.00290432466417148,0.0223400444897205,0.0109130778919108
NMR metabolomics,X23412.Phospholipids in VLDL,CENPJ,Centromere protein J,37169,0.0174775210986629,0.00686748592235818,0.00401724869084089,0.030937793506485,0.0109400136262333
NMR metabolomics,X23412.Phospholipids in VLDL,RAB44,Ras-related protein Rab-44,37368,0.0101299551531866,0.00399541035643245,0.00229895085457897,0.0179609594517942,0.0112431452318979
NMR metabolomics,X23412.Phospholipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0157463570550487,0.00622917943079569,-0.0279555487394083,-0.00353716537068917,0.0114880128553412
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00759280034449565,0.00300371050884939,-0.0134800729418405,-0.00170552774715084,0.0114893298602681
NMR metabolomics,X23412.Phospholipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0168377387105551,0.00666212009448899,-0.0298954940957535,-0.00377998332535666,0.0115028621789705
NMR metabolomics,X23412.Phospholipids in VLDL,PXDNL,Peroxidasin-like protein,37368,0.0142019211173168,0.00562936306865957,0.00316836950274406,0.0252354727318896,0.0116528805798267
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0101544411600883,0.00404327950672572,0.00222961332690586,0.0180792689932707,0.0120360109500929
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.00600130755368915,0.00239094442613871,-0.010687558628921,-0.00131505647845728,0.0120822601052005
NMR metabolomics,X23412.Phospholipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.00627205228932084,0.00250282525316889,0.00136651479310981,0.0111775897855319,0.0122208359374057
NMR metabolomics,X23412.Phospholipids in VLDL,RALB,Ras-related protein Ral-B,37056,0.00692239416099162,0.0027690013081865,0.00149515159694608,0.0123496367250372,0.0124327527376081
NMR metabolomics,X23412.Phospholipids in VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.00757886546141625,0.0030327359786679,-0.0135230279796053,-0.00163470294322716,0.0124658282817278
NMR metabolomics,X23412.Phospholipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.0109369833708931,0.00438917819695607,0.00233419410485917,0.019539772636927,0.0127194725844784
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.00963369463653276,0.0038666811888576,0.00205499950637186,0.0172123897666937,0.0127318532096739
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0101652984696103,0.00408922985896214,0.0021504079460445,0.0181801889931761,0.0129356516191081
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0149679622814537,0.00605487891203637,0.00310039961386242,0.026835524949045,0.0134446479797613
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.017818470240248,0.00721785730777473,-0.0319654705634865,-0.00367146991700953,0.0135740649587006
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00672469159965017,0.00272665796199638,-0.0120689412051631,-0.00138044199413726,0.0136652347657787
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0198192577942302,0.0080496094003795,-0.0355964922189741,-0.00404202336948644,0.013823810581457
NMR metabolomics,X23412.Phospholipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.0116225288073595,0.00474891827563589,0.0023146489871132,0.0209304086276059,0.0144018611213378
NMR metabolomics,X23412.Phospholipids in VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0109876824305263,0.004501726311,-0.0198110660000863,-0.00216429886096626,0.0146690425112807
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0676934370908877,0.0277516096378486,0.0133002822007044,0.122086591981071,0.0147280968658456
NMR metabolomics,X23412.Phospholipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0120185657552105,0.00493609084753972,0.00234382769403266,0.0216933038163884,0.0149097100308998
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00856507532823745,0.00352086529493588,-0.0154659713063118,-0.00166417935016313,0.0150015765176537
NMR metabolomics,X23412.Phospholipids in VLDL,ENO1,Alpha-enolase,39830,0.0181495340548912,0.00746278577477027,0.00352247393634146,0.0327765941734409,0.0150264051961011
NMR metabolomics,X23412.Phospholipids in VLDL,TEF,Thyrotroph embryonic factor,37021,0.00976691680886934,0.00401616424855102,0.00189523488170934,0.0176385987360293,0.0150330280757097
NMR metabolomics,X23412.Phospholipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0120863641115712,0.00498539066818975,0.00231499840191931,0.0218577298212231,0.0153487736489889
NMR metabolomics,X23412.Phospholipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0147732075688824,0.00609653324997037,-0.0267224127388243,-0.00282400239894043,0.0153971207533974
NMR metabolomics,X23412.Phospholipids in VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.00812220703318555,0.00336213460526209,0.00153242320687186,0.0147119908594992,0.0157125672033444
NMR metabolomics,X23412.Phospholipids in VLDL,CDH3,Cadherin-3,40009,0.00784255218131081,0.00327079980230564,0.00143178456879175,0.0142533197938299,0.016507513352584
NMR metabolomics,X23412.Phospholipids in VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0156890211032661,0.00655233726534725,-0.0285316021433467,-0.00284644006318551,0.0166586366233061
NMR metabolomics,X23412.Phospholipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00693272796118741,0.00290119398923243,0.00124638774229185,0.012619068180083,0.0168776805217844
NMR metabolomics,X23412.Phospholipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00887053164479945,0.00373170602982144,0.00155638782634943,0.0161846754632495,0.0174645102197735
NMR metabolomics,X23412.Phospholipids in VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0197769475864062,0.00840124093986805,0.00331051534426481,0.0362433798285476,0.0185846906385509
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00829928865796393,0.00355086186213934,0.00133959940817083,0.015258977907757,0.0194404469941218
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC1,Sialoadhesin,39931,0.00917484839934231,0.00394384716420877,0.00144490795749313,0.0169047888411915,0.0200111810115415
NMR metabolomics,X23412.Phospholipids in VLDL,IL20,Interleukin-20,39587,0.0107084651674765,0.00460958376617273,0.00167368098577792,0.019743249349175,0.020187155662506
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0176352868448236,0.00762252048419986,-0.0325754269938553,-0.00269514669579187,0.0207063453549506
NMR metabolomics,X23412.Phospholipids in VLDL,CD109,CD109 antigen,39858,-0.0073576200081843,0.00318513565885015,-0.0136004858995306,-0.001114754116838,0.020901572028627
NMR metabolomics,X23412.Phospholipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0122877376627295,0.00533637877003052,0.00182843527346971,0.0227470400519893,0.0213148581912161
NMR metabolomics,X23412.Phospholipids in VLDL,MYL4,Myosin light chain 4,37043,-0.0112918020144662,0.00490740062275334,-0.0209103072350627,-0.00167329679386962,0.021408619391244
NMR metabolomics,X23412.Phospholipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0140678697705232,0.00613196916888043,0.00204921019951753,0.0260865293415288,0.0217951146910445
NMR metabolomics,X23412.Phospholipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0149266469798948,0.00651094344170136,0.00216519783416012,0.0276880961256295,0.0218872934501868
NMR metabolomics,X23412.Phospholipids in VLDL,FGF9,Fibroblast growth factor 9,36931,0.0087918076420362,0.00384031205927457,0.00126479600585805,0.0163188192782144,0.0220750547343328
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00636712939245848,0.00278596964017165,0.00090662889772204,0.0118276298871949,0.0223036261844348
NMR metabolomics,X23412.Phospholipids in VLDL,NRTN,Neurturin,39587,0.0107018100204187,0.00468683850070572,0.00151560655903554,0.019888013481802,0.0224215618872358
NMR metabolomics,X23412.Phospholipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0109721766309251,0.00481140586245753,0.00154182114050833,0.0204025321213419,0.0225969245408498
NMR metabolomics,X23412.Phospholipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00807188283966896,0.0035482806051413,0.00111725285359201,0.0150265128257459,0.0229296034474921
NMR metabolomics,X23412.Phospholipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0154030321135681,0.00678487747883482,-0.0287013919720844,-0.00210467225505187,0.0232115174808526
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0142615838600786,0.0062860447892281,-0.0265822316469657,-0.00194093607319153,0.0232984728156634
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GL3,Endophilin-A3,37083,0.0176573373568763,0.00780561620504511,0.0023583295949879,0.0329563451187647,0.0237053851527954
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.0146410379484805,0.00647234827074248,0.00195523533782525,0.0273268405591358,0.0237080034046574
NMR metabolomics,X23412.Phospholipids in VLDL,PRR4,Proline-rich protein 4,37031,-0.0149484382275795,0.00661007895581871,-0.0279041929809842,-0.00199268347417487,0.0237469387357932
NMR metabolomics,X23412.Phospholipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00850811200636689,0.00376222692883525,0.00113414722584981,0.015882076786884,0.0237472613890456
NMR metabolomics,X23412.Phospholipids in VLDL,TCN1,Transcobalamin-1,37235,0.00731987299821172,0.00323778639096348,0.000973811671923307,0.0136659343245001,0.0237898360779636
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0116477469436113,0.00516399035528634,0.00152632584725007,0.0217691680399725,0.0241112802725802
NMR metabolomics,X23412.Phospholipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.00569361501948787,0.00252996368208966,0.000734886202592142,0.0106523438363836,0.0244325455472806
NMR metabolomics,X23412.Phospholipids in VLDL,COPE,Coatomer subunit epsilon,39489,0.0100417547181646,0.00446606985216138,0.00128825780792834,0.0187952516284009,0.0245610999533411
NMR metabolomics,X23412.Phospholipids in VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00515501608613424,0.0023023665639721,-0.00966765455151955,-0.00064237762074893,0.0251691092949791
NMR metabolomics,X23412.Phospholipids in VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00462432256281526,0.0020668814816307,-0.00867541026681143,-0.000573234858819092,0.0252805652440216
NMR metabolomics,X23412.Phospholipids in VLDL,CA14,Carbonic anhydrase 14,40030,-0.00739153611667812,0.0033145725117705,-0.0138880982397483,-0.000894973993607935,0.0257603255182275
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00533258514915299,0.00239837196699826,-0.0100333942044696,-0.000631776093836401,0.0262040317927107
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00706260615873533,0.00317980922192951,0.0008301800837535,0.0132950322337172,0.0263625694674294
NMR metabolomics,X23412.Phospholipids in VLDL,NGF,Beta-nerve growth factor,39749,0.00257207583135166,0.00116110253727083,0.000296314858300836,0.00484783680440248,0.0267603783473745
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA5,Annexin A5,39415,0.0063251525818721,0.0028559149420494,0.00072755929545528,0.0119227458682889,0.0267913054403516
NMR metabolomics,X23412.Phospholipids in VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0125899829140611,0.00571696203940798,0.00138473731682142,0.0237952285113007,0.0276645429468263
NMR metabolomics,X23412.Phospholipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00620842322352547,0.00284154854628477,-0.0117778583742436,-0.000638988072807318,0.0289158009789487
NMR metabolomics,X23412.Phospholipids in VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.00749510056651817,0.00343169852936268,0.000768971448967322,0.014221229684069,0.0289741146815075
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0112013487542198,0.00514398278886941,-0.0212835550204039,-0.00111914248803577,0.029453145669284
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00520065268354571,0.00239905406613551,0.000498506713920112,0.00990279865317132,0.0301924109017899
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0153641855577624,0.00708991672133023,-0.0292604223315696,-0.00146794878395512,0.0302491595373418
NMR metabolomics,X23412.Phospholipids in VLDL,BCAM,Basal cell adhesion molecule,39858,-0.00481325801463094,0.00222287532964444,-0.00917009366073404,-0.000456422368527846,0.0303771753999159
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.00857572460584995,0.00396535704813776,0.000803624791499931,0.0163478244202,0.0305819054462009
NMR metabolomics,X23412.Phospholipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00748031290536559,0.00346068054359709,-0.0142632467708159,-0.000697379039915292,0.0306735510000011
NMR metabolomics,X23412.Phospholipids in VLDL,SELL,L-selectin,37453,0.00462640428136235,0.00214095810528164,0.000430126395010345,0.00882268216771435,0.0307201896430789
NMR metabolomics,X23412.Phospholipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0115414274921855,0.00535996986732965,0.00103588655221941,0.0220469684321516,0.031312864383748
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0119005653529712,0.00552959110425195,-0.022738563917305,-0.0010625667886374,0.0313999173236485
NMR metabolomics,X23412.Phospholipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00946760190809551,0.00442227081417848,0.000799951112305691,0.0181352527038853,0.0323005349973473
NMR metabolomics,X23412.Phospholipids in VLDL,IL15,Interleukin-15,39866,0.00655768483759293,0.0030636316749551,0.000552966754680941,0.0125624029205049,0.0323299411348978
NMR metabolomics,X23412.Phospholipids in VLDL,IL1A,Interleukin-1 alpha,39587,0.0107584512671982,0.0050409739106574,0.000878142402309651,0.0206387601320867,0.0328417561115317
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00984155100212028,0.004620960446867,0.000784468526260962,0.0188986334779796,0.0332092024604467
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00405280362004224,0.00190717069219235,0.00031474906334524,0.00779085817673924,0.0336022586966402
NMR metabolomics,X23412.Phospholipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.00663710395185073,0.00312496377891335,0.000512174945180565,0.0127620329585209,0.0336939565534691
NMR metabolomics,X23412.Phospholipids in VLDL,JUN,Transcription factor AP-1,39587,0.0104047788715211,0.00490065059921755,0.000799503697054749,0.0200100540459875,0.033757497215487
NMR metabolomics,X23412.Phospholipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0117343047656546,0.00554083319035554,-0.0225943378187514,-0.000874271712557729,0.0342083035090875
NMR metabolomics,X23412.Phospholipids in VLDL,CDH23,Cadherin-23,37388,-0.00537635834170418,0.00254091950213803,-0.0103565605658947,-0.000396156117513636,0.034370636665026
NMR metabolomics,X23412.Phospholipids in VLDL,DCN,Decorin,39585,-0.00433935844480571,0.00205301458139574,-0.00836326702434136,-0.000315449865270054,0.0345607026660622
NMR metabolomics,X23412.Phospholipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00555879695996598,0.00262999807342818,0.000404000736046742,0.0107135931838852,0.0345670873289632
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0156563215186378,0.00740845518198024,0.00113574936195657,0.0301768936753191,0.0345904248658347
NMR metabolomics,X23412.Phospholipids in VLDL,GAL,Galanin peptides,39931,-0.0128374336678333,0.00607654111660825,-0.0247474542563854,-0.000927413079281087,0.0346485252712956
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0167277011778416,0.00792015773340437,-0.0322512103353141,-0.00120419202036903,0.0347012045488431
NMR metabolomics,X23412.Phospholipids in VLDL,TLR4,Toll-like receptor 4,37056,0.00549411222525123,0.0026101897772592,0.000378140261823201,0.0106100841886793,0.0353214131814055
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00432228914425688,0.00205785593966737,0.000288891502508835,0.00835568678600493,0.0357134105869956
NMR metabolomics,X23412.Phospholipids in VLDL,RYR1,Ryanodine receptor 1,37021,-0.00673099936346833,0.00320526279022459,-0.0130133144323085,-0.000448684294628127,0.0357492672436135
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM132A,Transmembrane protein 132A,37043,0.0124330780450436,0.00592853828936906,0.000813142997880207,0.0240530130922069,0.0359986416682861
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00556912761457978,0.00266401546929844,0.000347657294754828,0.0107905979344047,0.0365917866678507
NMR metabolomics,X23412.Phospholipids in VLDL,MAPT,Microtubule-associated protein tau,39489,0.0103901419929709,0.00497025949843256,0.000648433376043041,0.0201318506098987,0.0365923730609182
NMR metabolomics,X23412.Phospholipids in VLDL,GH2,Growth hormone variant,39477,0.0324357640767064,0.01552039301929,0.00201579375889797,0.0628557343945149,0.0366446868347186
NMR metabolomics,X23412.Phospholipids in VLDL,TFF3,Trefoil factor 3,39839,0.00956211265495113,0.00457801703958922,0.000589199257356249,0.018535026052546,0.036750356059358
NMR metabolomics,X23412.Phospholipids in VLDL,DCLRE1C,Protein artemis,36962,-0.00614312453496823,0.00294200500705333,-0.0119094543487928,-0.000376794721143707,0.0368104108446765
NMR metabolomics,X23412.Phospholipids in VLDL,MYH4,Myosin-4,37021,-0.00943629676301643,0.00452481340856312,-0.0183049310438001,-0.000567662482232723,0.0370471959559671
NMR metabolomics,X23412.Phospholipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.00917629468455386,0.00441610259747383,0.000520733593505152,0.0178318557756026,0.0377329035562105
NMR metabolomics,X23412.Phospholipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0050235562816251,0.0024194952929866,-0.00976576705587884,-0.000281345507371364,0.037886568152324
NMR metabolomics,X23412.Phospholipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00479197535781113,0.00230855588746579,-0.00931674489724408,-0.000267205818378176,0.0379362588960144
NMR metabolomics,X23412.Phospholipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00681539473900817,0.00329217559367453,0.000362730575406089,0.0132680589026103,0.038454380185259
NMR metabolomics,X23412.Phospholipids in VLDL,SPP1,Osteopontin,40012,-0.00879644569820114,0.0042504212405169,-0.0171272713296143,-0.000465620066788025,0.0385106668257764
NMR metabolomics,X23412.Phospholipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00753460071747176,0.00364344307356838,0.000393452293277738,0.0146757491416658,0.0386600076735997
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00736191506917451,0.00356496536025262,0.000374582963079381,0.0143492471752696,0.0389350935722138
NMR metabolomics,X23412.Phospholipids in VLDL,SHPK,Sedoheptulokinase,37169,-0.00817604776002787,0.00396063362497869,-0.0159388896649861,-0.000413205855069631,0.0390059391686808
NMR metabolomics,X23412.Phospholipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.00970148313579475,0.00470648137754105,0.000476779635814301,0.0189261866357752,0.0392932365919578
NMR metabolomics,X23412.Phospholipids in VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.0152776494859593,0.00741260479597915,0.000748944085840132,0.0298063548860784,0.0393156216207007
NMR metabolomics,X23412.Phospholipids in VLDL,EPO,Erythropoietin,39866,0.0150062940739287,0.00728526450686038,0.000727175640482322,0.029285412507375,0.0394324019012917
NMR metabolomics,X23412.Phospholipids in VLDL,FZD8,Frizzled-8,36991,0.00828789614339358,0.00402540539582571,0.000398101567575184,0.016177690719212,0.0395237600078014
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00633561729273223,0.00308251575635052,0.000293886410285213,0.0123773481751793,0.039862775768629
NMR metabolomics,X23412.Phospholipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00959100198414195,0.00467133863068577,0.000435178267997835,0.0187468257002861,0.0400737454663027
NMR metabolomics,X23412.Phospholipids in VLDL,TTN,Titin,37021,-0.013284586777825,0.00647704608452734,-0.0259795971034986,-0.000589576452151375,0.0402842168148597
NMR metabolomics,X23412.Phospholipids in VLDL,GSAP,Gamma-secretase-activating protein,39477,0.01703907097921,0.00830907491150399,0.000753284152662178,0.0333248578057578,0.0403169159637424
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00566067481874249,0.00276847357158557,0.000234466618434784,0.0110868830190502,0.0409014017600928
NMR metabolomics,X23412.Phospholipids in VLDL,MN1,Transcriptional activator MN1,37039,-0.0114346482873985,0.00559808768011866,-0.022406900140431,-0.000462396434365891,0.0411120063788543
NMR metabolomics,X23412.Phospholipids in VLDL,IL36G,Interleukin-36 gamma,37021,0.0130291009153237,0.00638552009229905,0.000513481534417614,0.0255447202962299,0.0413290822781107
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0109103159773838,0.00535447194746091,0.000415550960360432,0.0214050809944072,0.0416090364809756
NMR metabolomics,X23412.Phospholipids in VLDL,BEX3,Protein BEX3,36962,-0.00902885123311798,0.00443694336369874,-0.0177252602259675,-0.000332442240268439,0.0418784125759368
NMR metabolomics,X23412.Phospholipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00939580444131551,0.0046195112254942,0.000341562439346884,0.0184500464432841,0.0419782917147126
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.0109163057114822,0.00537927416225153,0.000372928353469216,0.0214596830694952,0.0424419175875794
NMR metabolomics,X23412.Phospholipids in VLDL,HSP90B1,Endoplasmin,39405,0.0128843993354071,0.00636526542228052,0.000408479107737289,0.0253603195630769,0.0429694074020911
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00993359448691453,0.00492481717612093,0.000280952821717513,0.0195862361521115,0.0437105046328049
NMR metabolomics,X23412.Phospholipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00987519598675415,0.00489744376560079,0.000276206206176599,0.0194741857673317,0.0437795984386434
NMR metabolomics,X23412.Phospholipids in VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00488309112244512,0.00242555664820093,-0.00963718215291895,-0.000129000091971299,0.0441149939129605
NMR metabolomics,X23412.Phospholipids in VLDL,IL31,Interleukin-31,37056,-0.0109437467108133,0.00543929598166197,-0.0216047668348707,-0.000282726586755827,0.0442424858211626
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00689882510951785,0.00343183160697315,0.000172435159850479,0.0136252150591852,0.0444254894123848
NMR metabolomics,X23412.Phospholipids in VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.011815805818829,0.00588709660843551,-0.0233545151713626,-0.000277096466295366,0.0447629096402762
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.00486343239470293,0.00242777706943015,0.000104989338619837,0.00962187545078603,0.0451708692094513
NMR metabolomics,X23412.Phospholipids in VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00875937139618884,0.00438554215558433,-0.0173550340211341,-0.000163708771243552,0.0458063970778206
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.00459405836240961,0.00230628528385623,-0.00911437751876783,-7.3739206051391e-05,0.0463907696306562
NMR metabolomics,X23412.Phospholipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,-0.022807570871946,0.0114514188329146,-0.0452523517844587,-0.000362789959433295,0.0464266695458283
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.00867716677936472,0.00438863948852518,7.54333818553648e-05,0.0172789001768741,0.0480379041409083
NMR metabolomics,X23412.Phospholipids in VLDL,RELB,Transcription factor RelB,37056,0.00916065693315076,0.0046566419568617,3.36386977018328e-05,0.0182876751685997,0.0491783301393455
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00826484701566912,0.00420435710502891,-0.0165053869415258,-2.43070898124642e-05,0.0493409739152078
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1B,Protein phosphatase 1B,37056,0.0118549857454383,0.00603569189124417,2.50296385996811e-05,0.0236849418522768,0.0495340119952816
NMR metabolomics,X23412.Phospholipids in VLDL,TCN2,Transcobalamin-2,40012,0.00542033253739831,0.00276243479257584,5.96034394966666e-06,0.010834704730847,0.0497612778892157
NMR metabolomics,X23412.Phospholipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0114417061752118,0.00586150913087633,-4.68517213058368e-05,0.0229302640717294,0.0509551109335563
NMR metabolomics,X23412.Phospholipids in VLDL,IL11,Interleukin-11,39587,0.0114671437940648,0.00587494305874898,-4.77446010832116e-05,0.0229820321892128,0.0509709860137573
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.00477177158228398,0.002446208443434,-0.00956634013141461,2.27969668466508e-05,0.0511155862706697
NMR metabolomics,X23412.Phospholipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00992732694913511,0.00509527879568338,-5.9419490404309e-05,0.0199140733886745,0.0513923678181491
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN3,Perilipin-3,39868,0.00786464363955865,0.00405412263723479,-8.1436729421543e-05,0.0158107240085388,0.0524078520334567
NMR metabolomics,X23412.Phospholipids in VLDL,PGM2,Phosphoglucomutase-2,37039,0.0111093553742093,0.00572750686522618,-0.000116558081634025,0.0223352688300526,0.0524436203645005
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00148156139252899,0.000765380006515178,-0.00298170620529874,1.85834202407601e-05,0.0529230314887019
NMR metabolomics,X23412.Phospholipids in VLDL,CD70,CD70 antigen,39866,0.00768920123840531,0.00398739617658098,-0.0001260952676934,0.015504497744504,0.0538259731937458
NMR metabolomics,X23412.Phospholipids in VLDL,LY96,Lymphocyte antigen 96,39749,-0.00642747883738227,0.00333666329477811,-0.0129673388951474,0.000112381220382833,0.0540823365144375
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB116,Beta-defensin 116,36991,-0.0140951540739725,0.00731885470034889,-0.0284401092866563,0.000249801138711328,0.0541423205937321
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF8,SLAM family member 8,39477,0.00945520257796133,0.00491353081031777,-0.000175317810261501,0.0190857229661842,0.0543327111791642
NMR metabolomics,X23412.Phospholipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,0.00742123667689464,0.00385779756430324,-0.000140046549139708,0.014982519902929,0.0544101365381219
NMR metabolomics,X23412.Phospholipids in VLDL,CPE,Carboxypeptidase E,39906,-0.00698292677841401,0.00364369780572373,-0.0141245744776325,0.000158720920804492,0.0553269083492394
NMR metabolomics,X23412.Phospholipids in VLDL,LTO1,Protein LTO1 homolog,39587,0.00729080568925376,0.00380956630007856,-0.000175944258900204,0.0147575556374077,0.0556619109693192
NMR metabolomics,X23412.Phospholipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0127663715648093,0.0066730891462716,-0.0258456262915016,0.00031288316188305,0.0557513190425937
NMR metabolomics,X23412.Phospholipids in VLDL,IL22,Interleukin-22,37368,-0.011799514480112,0.00619262437902141,-0.0239370582629939,0.000338029302769985,0.0567474601167412
NMR metabolomics,X23412.Phospholipids in VLDL,ARG1,Arginase-1,39754,0.00928485155888442,0.00488412531459922,-0.000288034057730058,0.0188577371754989,0.0573166143249926
NMR metabolomics,X23412.Phospholipids in VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.0115014826648128,0.00606057450825545,-0.00037724337136792,0.0233802087009934,0.0577503872204377
NMR metabolomics,X23412.Phospholipids in VLDL,ESPL1,Separin,36962,-0.00967630724636927,0.00510066736020347,-0.0196736152723681,0.000321000779629533,0.0578410768755528
NMR metabolomics,X23412.Phospholipids in VLDL,ACHE,Acetylcholinesterase,37124,0.00586340516586439,0.00309400115870325,-0.000200837105193978,0.0119276474369228,0.0581024378355666
NMR metabolomics,X23412.Phospholipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.00766071969453498,0.00404439405154195,-0.0155877320355572,0.000266292646487239,0.0582221945862597
NMR metabolomics,X23412.Phospholipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0111732953145793,0.0059352782539662,-0.0228064406923531,0.000459850063194453,0.0597871077660087
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00739710778145355,0.00394932491617673,-0.000343569054252842,0.0151377846171599,0.0610891881334282
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0211509461521159,0.0113649390117633,-0.00112433431094019,0.043426226615172,0.0627530802287445
NMR metabolomics,X23412.Phospholipids in VLDL,TFF2,Trefoil factor 2,39908,0.0100037246746978,0.00538553124456268,-0.000551916564645025,0.0205593659140407,0.0632557060659425
NMR metabolomics,X23412.Phospholipids in VLDL,CD160,CD160 antigen,40058,0.00782924170387854,0.00423266688859065,-0.000466785397759142,0.0161252688055162,0.0643723538569778
NMR metabolomics,X23412.Phospholipids in VLDL,TEX33,Testis-expressed protein 33,37169,-0.00691722090253302,0.00375550301114691,-0.014278006804381,0.000443564999314938,0.0655135755134993
NMR metabolomics,X23412.Phospholipids in VLDL,UNG,Uracil-DNA glycosylase,37368,0.00603905606174829,0.0032811427522912,-0.00039198373274247,0.012470095856239,0.0657117417270213
NMR metabolomics,X23412.Phospholipids in VLDL,FGF12,Fibroblast growth factor 12,37056,0.00810525999091114,0.00443649851156756,-0.000590277091761281,0.0168007970735836,0.0677298963779614
NMR metabolomics,X23412.Phospholipids in VLDL,RBP7,Retinoid-binding protein 7,37382,0.0104221845419109,0.00570481831350843,-0.000759259352565657,0.0216036284363874,0.067735468742974
NMR metabolomics,X23412.Phospholipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0109746425371834,0.00601291500868063,-0.0008106708798306,0.0227599559541975,0.0679967673980315
NMR metabolomics,X23412.Phospholipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00762323176776511,0.00418652888351208,-0.0158288283794488,0.000582364843918562,0.0686451806348308
NMR metabolomics,X23412.Phospholipids in VLDL,PTTG1,Securin,37169,0.00717517132290139,0.00394695372394786,-0.000560857976036414,0.0149112006218392,0.0691017294568003
NMR metabolomics,X23412.Phospholipids in VLDL,MMP8,Neutrophil collagenase,39985,0.0122742947741299,0.00676488455716835,-0.00098487895792005,0.0255334685061799,0.0696327338172065
NMR metabolomics,X23412.Phospholipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0110972202272195,0.00613270928837396,-0.000922889977993448,0.0231173304324325,0.0703901078217049
NMR metabolomics,X23412.Phospholipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00973642329350344,0.00538198424867862,-0.000812265833906646,0.0202851124209135,0.0704619705966948
NMR metabolomics,X23412.Phospholipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00449982326088693,0.00248790230915611,-0.000376465265059051,0.00937611178683291,0.0705233894615153
NMR metabolomics,X23412.Phospholipids in VLDL,TAP1,Antigen peptide transporter 1,37169,-0.01005903470349,0.00556360041885829,-0.0209636915244523,0.000845622117472225,0.07062780199206
NMR metabolomics,X23412.Phospholipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0254326242978506,0.0140898443931727,-0.00218347071276796,0.0530487193084692,0.0710884119101781
NMR metabolomics,X23412.Phospholipids in VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0096593478935561,0.00538104873239804,-0.000887507621944056,0.0202062034090563,0.0726620746209782
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_A,,37411,0.00544173539862458,0.00305402244089286,-0.000544148585525422,0.0114276193827746,0.0748000618352489
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0116955916504129,0.00657815777602452,-0.024588780891421,0.00119759759059516,0.0754321429664324
NMR metabolomics,X23412.Phospholipids in VLDL,HEBP1,Heme-binding protein 1,39585,-0.00899153010848883,0.00507569969237626,-0.0189399015055463,0.000956841288568643,0.0764993100225612
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN1,Contactin-1,40052,-0.00445647111554796,0.00251568377279368,-0.00938721131022357,0.000474269079127645,0.0765005383890096
NMR metabolomics,X23412.Phospholipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00963505445276355,0.00545615649118173,-0.00105901226995263,0.0203291211754797,0.0774350092515208
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00766333532944076,0.00434169613636754,-0.000846389097839614,0.0161730597567211,0.0775734783376095
NMR metabolomics,X23412.Phospholipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00783627775976055,0.00446539652034168,-0.0165884549396302,0.000915899420109136,0.0793014339079351
NMR metabolomics,X23412.Phospholipids in VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0124394243114726,0.00711156926185008,-0.00149925144175351,0.0263781000646988,0.0802828049890881
NMR metabolomics,X23412.Phospholipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.010184734994162,0.00582529665866085,-0.0216023164451373,0.00123284645681326,0.0804245037209062
NMR metabolomics,X23412.Phospholipids in VLDL,CDSN,Corneodesmosin,39992,0.00697453321820338,0.00399313418251961,-0.000852009779535052,0.0148010762159418,0.080720342546337
NMR metabolomics,X23412.Phospholipids in VLDL,CDAN1,Codanin-1,37388,0.00370912061575324,0.00213258238295322,-0.000470740854835066,0.00788898208634155,0.0820113421698151
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0112291783934081,0.00645720851256786,-0.0238853070780411,0.00142695029122489,0.0820549008263851
NMR metabolomics,X23412.Phospholipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00762230742642493,0.00438589698412078,-0.000974050662451794,0.0162186655153017,0.0822495326663253
NMR metabolomics,X23412.Phospholipids in VLDL,LEG1,Protein LEG1 homolog,36703,-0.0114910455978007,0.00662285208969513,-0.0244718356936032,0.00148974449800176,0.0827541712968847
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0046827805133413,0.00270126717966299,-0.000611703158798158,0.00997726418548076,0.083017073623179
NMR metabolomics,X23412.Phospholipids in VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.00814896215830302,0.00470400987284841,-0.0173688215090859,0.00107089719247986,0.083235802546648
NMR metabolomics,X23412.Phospholipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00671239429522881,0.00387823342664428,-0.000888943220993969,0.0143137318114516,0.0835088906367715
NMR metabolomics,X23412.Phospholipids in VLDL,S100A3,Protein S100-A3,37368,0.00738641377305528,0.00426968426226657,-0.000982167380987199,0.0157549949270978,0.0836589753858565
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5A,Cytochrome b5,36962,0.0117459039537868,0.00679414111323848,-0.00157061262816059,0.0250624205357343,0.083863372874338
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0104972693450641,0.00609705940689613,-0.0224475057825805,0.00145296709245233,0.0851484679902194
NMR metabolomics,X23412.Phospholipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.011613809286962,0.00675227378191154,-0.0248482658995086,0.00162064732558464,0.0854587398174863
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00797067808378758,0.00463767376115293,-0.00111916248807217,0.0170605186556473,0.0856961357705894
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00768694792123472,0.0044801494278584,-0.0164680407998372,0.00109414495736773,0.0862259683226395
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.00809716411095072,0.00472474898659877,-0.00116334390278288,0.0173576721246843,0.086593283472497
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00667450466386066,0.00389846579482858,-0.0143154976217247,0.000966488294003369,0.0869045699876854
NMR metabolomics,X23412.Phospholipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00852340611566772,0.00499499811584681,-0.0183136024227275,0.00126679019139203,0.0879595701651546
NMR metabolomics,X23412.Phospholipids in VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00634802150837321,0.00372029875601805,-0.00094376405342218,0.0136398070701686,0.0879719791096081
NMR metabolomics,X23412.Phospholipids in VLDL,EPN1,Epsin-1,37169,0.00692912945296572,0.00407336813163352,-0.00105467208503599,0.0149129309909674,0.0889511230500293
NMR metabolomics,X23412.Phospholipids in VLDL,LPO,Lactoperoxidase,39344,-0.00957854883708412,0.00564938110090552,-0.0206513357948589,0.00149423812069069,0.0899999371527802
NMR metabolomics,X23412.Phospholipids in VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00467142238687096,0.00275887575502223,-0.000735974092972615,0.0100788188667145,0.0904338648127358
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.00347741328721229,0.00206166762353892,-0.000563455254923991,0.00751828182934858,0.0916848283785724
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.0033938176334552,0.00201328803124783,-0.00733986217470095,0.000552226907790547,0.0918711928830713
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00641586571179482,0.00381467366583276,-0.013892626096827,0.00106089467323739,0.0926134177948399
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00744698894475418,0.00443226361662627,-0.0161342256333417,0.0012402477438333,0.0929465073818064
NMR metabolomics,X23412.Phospholipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0107088372335919,0.0063966312496068,-0.0232462344828212,0.00182856001563741,0.0941274331945613
NMR metabolomics,X23412.Phospholipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.0086427154349289,0.00516416122633774,-0.00147904056869308,0.0187644714385509,0.094230069273499
NMR metabolomics,X23412.Phospholipids in VLDL,WIF1,Wnt inhibitory factor 1,40030,0.00529494726066592,0.00316476736953086,-0.00090799678361456,0.0114978913049464,0.0943285116055756
NMR metabolomics,X23412.Phospholipids in VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00786647931739945,0.0047493873333517,-0.0171752784907688,0.00144231985596989,0.0976820823865833
NMR metabolomics,X23412.Phospholipids in VLDL,COL3A1,Collagen alpha-1(III) chain,37437,-0.00363540735676254,0.00219957432541391,-0.00794657303457382,0.00067575832104873,0.0983992391615813
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC8,Histone deacetylase 8,37056,0.00988456646984894,0.00598263143557973,-0.00184139114388733,0.0216105240835852,0.0985154381495853
NMR metabolomics,X23412.Phospholipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00751618678329913,0.00456760357901054,-0.0164686897981598,0.00143631623156152,0.0998817886261869
NMR metabolomics,X23412.Phospholipids in VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.00522748241407058,0.00318609284522114,-0.011472224390704,0.00101725956256285,0.100879665059074
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00508997608661794,0.00312579003859788,-0.0112165245622698,0.00103657238903391,0.103467394940179
NMR metabolomics,X23412.Phospholipids in VLDL,PROK1,Prokineticin-1,39866,0.00989162289668429,0.00611224927211723,-0.00208838567666549,0.0218716314700341,0.1056116767739
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB7,Integrin beta-7,40030,0.0069363279577525,0.00429595775460336,-0.00148374924127008,0.0153564051567751,0.106413095245208
NMR metabolomics,X23412.Phospholipids in VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00639241321211141,0.00396700519247452,-0.00138291696513864,0.0141677433893615,0.107117587361924
NMR metabolomics,X23412.Phospholipids in VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.012685496275651,0.00787647321850008,-0.00275239123260913,0.0281233837839112,0.107300682811677
NMR metabolomics,X23412.Phospholipids in VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.011402916325495,0.00710335744043083,-0.0025196642577494,0.0253254969087395,0.108455047634898
NMR metabolomics,X23412.Phospholipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00411803169004323,0.00257312617690842,-0.000925295616697268,0.00916135899678373,0.109529483092529
NMR metabolomics,X23412.Phospholipids in VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0144919466922537,0.00905721973859968,-0.00326020399540163,0.0322440973799091,0.109612845100859
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00421414452167615,0.00264861024211016,-0.00940542059621207,0.000977131552859769,0.111611773521872
NMR metabolomics,X23412.Phospholipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0130241218126173,0.00819676037624593,-0.00304152852482472,0.0290897721500593,0.112099131849283
NMR metabolomics,X23412.Phospholipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.00517148048827737,0.00326499164844175,-0.0115708641192232,0.00122790314266845,0.113231978284648
NMR metabolomics,X23412.Phospholipids in VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00462851674448395,0.00292382560516965,-0.0103592149306165,0.00110218144164856,0.113433188106962
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00484279412161735,0.00306550018432901,-0.0108511744829022,0.00116558623966751,0.114182969964187
NMR metabolomics,X23412.Phospholipids in VLDL,PAPPA,Pappalysin-1,39587,0.0070753763528865,0.00448050207605722,-0.00170640771618565,0.0158571604219587,0.114322201636058
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP1,Dipeptidase 1,39713,-0.00704819157623102,0.00447466824103469,-0.015818541328659,0.00172215817619698,0.115246013942182
NMR metabolomics,X23412.Phospholipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.0053096045719949,0.00338966413549704,-0.00133413713357929,0.0119533462775691,0.117276384440882
NMR metabolomics,X23412.Phospholipids in VLDL,CD48,CD48 antigen,39908,0.0042629618953909,0.00273241231804977,-0.00109256624798664,0.00961849003876845,0.118745123788154
NMR metabolomics,X23412.Phospholipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00641469027228301,0.00411310723436379,-0.00164699990707002,0.014476380451636,0.11888463926666
NMR metabolomics,X23412.Phospholipids in VLDL,EDNRB,Endothelin receptor type B,37056,0.00688501965640471,0.00441591738694164,-0.0017701784220009,0.0155402177348103,0.118987967065373
NMR metabolomics,X23412.Phospholipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00468714704410243,0.00301780417169049,-0.00122774913241092,0.0106020432206158,0.12040788161504
NMR metabolomics,X23412.Phospholipids in VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00873405708947374,0.00563214991149143,-0.0197730709159969,0.00230495673704945,0.120985358377704
NMR metabolomics,X23412.Phospholipids in VLDL,TAGLN3,Transgelin-3,36962,-0.00877702993400516,0.00566959928036688,-0.0198894445235243,0.00233538465551392,0.121625631847294
NMR metabolomics,X23412.Phospholipids in VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0143197530115698,0.00925179397380151,-0.00381376317708114,0.0324532692002208,0.121699114211529
NMR metabolomics,X23412.Phospholipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00751138912683503,0.00488368540954498,-0.0170834125295432,0.00206063427587313,0.124058555718244
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00859791669838305,0.00559879477783702,-0.0023757210661775,0.0195715544629436,0.12464242724054
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.00737760965917786,0.00480792740795398,-0.0168011473787677,0.00204592806041193,0.124938653333013
NMR metabolomics,X23412.Phospholipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00863255466108674,0.00569540673269829,-0.0197955518571754,0.0025304425350019,0.12961799505413
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.00475288831140992,0.00313937459893397,-0.0109060625253205,0.00140028590250066,0.130055646459995
NMR metabolomics,X23412.Phospholipids in VLDL,IL36A,Interleukin-36 alpha,37056,-0.00840894471801417,0.00557157213922901,-0.019329226110903,0.00251133667487468,0.131256580628043
NMR metabolomics,X23412.Phospholipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00756668952761091,0.00501522789631412,-0.00226315714916475,0.0173965362043866,0.131388607881321
NMR metabolomics,X23412.Phospholipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00488399805892302,0.00324103968013492,-0.00146843971414142,0.0112364358319875,0.131854064465315
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.00628011738755022,0.00417974488430938,-0.00191218258569616,0.0144724173607966,0.132984663914648
NMR metabolomics,X23412.Phospholipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.024341535105552,0.0162132666738085,-0.00743646757511263,0.0561195377862167,0.13328909966609
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00827523264907979,0.00555984858482212,-0.0191725358753312,0.00262207057717157,0.136671630654497
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN2,Neuroligin-2,36991,-0.00663032538562943,0.00445775855373742,-0.0153675321509548,0.00210688137969591,0.136941775893549
NMR metabolomics,X23412.Phospholipids in VLDL,ESR1,Estrogen receptor,37056,0.00835090067583484,0.00562824988183755,-0.00268046909256675,0.0193822704442364,0.137899850885056
NMR metabolomics,X23412.Phospholipids in VLDL,IGLON5,IgLON family member 5,36962,0.0129564704199462,0.00874317462390559,-0.00418015184290872,0.0300930926828012,0.138392173607239
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00446216471725145,0.00301486817894088,-0.00144697691347268,0.0103713063479756,0.138882348212638
NMR metabolomics,X23412.Phospholipids in VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00648760418748232,0.00439583514263509,-0.00212823269208245,0.0151034410670471,0.140007422718047
NMR metabolomics,X23412.Phospholipids in VLDL,ADA2,Adenosine deaminase 2,39782,-0.00573895724080975,0.00389560527835497,-0.0133743435863855,0.00189642910476599,0.140720236036592
NMR metabolomics,X23412.Phospholipids in VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.0118472342925593,0.00806506689364462,-0.0276547654041027,0.00396029681898416,0.141868481398063
NMR metabolomics,X23412.Phospholipids in VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.00838026420873972,0.00571644406007432,-0.0195844945664854,0.00282396614900594,0.142670318567473
NMR metabolomics,X23412.Phospholipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00415576927358145,0.00283955179421174,-0.00972129079023646,0.00140975224307356,0.143346343858811
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN4,Contactin-4,39858,-0.00329602858399193,0.00225316869957482,-0.00771223923515858,0.00112018206717471,0.143530410943764
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA10,Annexin A10,39489,0.0108043991172912,0.00739749122578011,-0.00369468368523785,0.0253034819198202,0.144159326355439
NMR metabolomics,X23412.Phospholipids in VLDL,NMI,N-myc-interactor,37311,0.00990573162477393,0.00682395773306537,-0.00346922553203419,0.0232806887815821,0.146633140232755
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00853177857480059,0.00591266431850611,-0.00305704348947139,0.0201206006390726,0.149053610399382
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00428756897870242,0.00298435687769725,-0.010136908458989,0.00156177050158418,0.150827962182687
NMR metabolomics,X23412.Phospholipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00892280138055217,0.00624157961154332,-0.0211562974191771,0.00331069465807274,0.152863045868601
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN15,Tetraspanin-15,37021,-0.00666734880256291,0.00467601056652956,-0.0158323295129609,0.00249763190783502,0.15393171079533
NMR metabolomics,X23412.Phospholipids in VLDL,IL33,Interleukin-33,39587,0.00526893970724401,0.00369572803536596,-0.00197468724207327,0.0125125666565613,0.153979472536801
NMR metabolomics,X23412.Phospholipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.00816213513236908,0.00579136977730095,-0.0195132198958789,0.00318894963114079,0.158751905355468
NMR metabolomics,X23412.Phospholipids in VLDL,CD5L,CD5 antigen-like,37380,0.00621353776422233,0.00442196806156744,-0.00245351963644985,0.0148805951648945,0.159999026751828
NMR metabolomics,X23412.Phospholipids in VLDL,S100A16,Protein S100-A16,39456,-0.00822314945249449,0.00586479857110615,-0.0197181546518625,0.00327185574687356,0.160899415981856
NMR metabolomics,X23412.Phospholipids in VLDL,NOP56,Nucleolar protein 56,37021,0.0146028101097749,0.0104508127228716,-0.00588078282705338,0.0350864030466032,0.162350109428267
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.00459184789942204,0.0032873802388042,-0.0110351131674783,0.00185141736863419,0.162489878743582
NMR metabolomics,X23412.Phospholipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0338404123014908,0.0244150357910086,-0.0816938824518676,0.0140130578488859,0.165755680706704
NMR metabolomics,X23412.Phospholipids in VLDL,CTNNA1,Catenin alpha-1,36991,-0.00460403415302544,0.00332183681629333,-0.0111148343129604,0.0019067660069095,0.165773350860468
NMR metabolomics,X23412.Phospholipids in VLDL,MET,Hepatocyte growth factor receptor,39879,0.00255419564880169,0.00184325330378581,-0.0010585808266185,0.00616697212422188,0.165857894545324
NMR metabolomics,X23412.Phospholipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0033870357046728,0.0024546067747951,-0.00142399357392559,0.0081980649832712,0.167650434834265
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.0043748426766864,0.00317661377670243,-0.00185132032565037,0.0106010056790232,0.168472852899498
NMR metabolomics,X23412.Phospholipids in VLDL,TPSG1,Tryptase gamma,37056,0.00350422946698765,0.00254698207795386,-0.00148785540580193,0.00849631433977722,0.168895783631266
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM2,Intercellular adhesion molecule 2,40052,-0.00406241810553097,0.00295691216803032,-0.00985796595487039,0.00173312974380845,0.169500518552565
NMR metabolomics,X23412.Phospholipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.0062680493472829,0.00457190849978573,-0.0152289900068629,0.00269289131229713,0.170400838517766
NMR metabolomics,X23412.Phospholipids in VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00421840030945305,0.00308224381577154,-0.00182279756945915,0.0102595981883653,0.171139812186979
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00482816341980575,0.00353388250111524,-0.00209824628238011,0.0117545731219916,0.171884166361653
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0107454463221785,0.00791447917934353,-0.0262578255136918,0.00476693286933484,0.174583966177292
NMR metabolomics,X23412.Phospholipids in VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00357236332131947,0.00263793278057969,-0.00874271157125565,0.00159798492861671,0.175686791675979
NMR metabolomics,X23412.Phospholipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00370189896727376,0.00273737643862329,-0.00166335885242789,0.00906715678697541,0.176282562225563
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO1,R-spondin-1,39749,0.00449752652219598,0.00333286170571365,-0.00203488242100278,0.0110299354653947,0.177212053979046
NMR metabolomics,X23412.Phospholipids in VLDL,F3,Tissue factor,39931,-0.00345661410744446,0.00256450226025909,-0.00848303853755227,0.00156981032266336,0.177719392243018
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0216990910077073,0.0161146352451272,-0.0532837760881566,0.00988559407274205,0.178149197750705
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,0.00405482750687971,0.00302692064109039,-0.00187793694965745,0.00998759196341687,0.1803985855426
NMR metabolomics,X23412.Phospholipids in VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00355029383081227,0.00266209608298436,-0.00876800215346161,0.00166741449183707,0.182343027612875
NMR metabolomics,X23412.Phospholipids in VLDL,MYOC,Myocilin,39858,0.00577890481436739,0.0043380612475065,-0.00272369523074534,0.0142815048594801,0.182833171733754
NMR metabolomics,X23412.Phospholipids in VLDL,MMP13,Collagenase 3,39489,-0.00401556198905875,0.00302926742717739,-0.00995292614632643,0.00192180216820894,0.184995421075119
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH17,Protocadherin-17,39868,-0.00436337028370135,0.00330134850841962,-0.0108340133602038,0.00210727279280111,0.186289180225469
NMR metabolomics,X23412.Phospholipids in VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00618045880908352,0.00468415934945594,-0.00300049351585012,0.0153614111340172,0.187044905329851
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00417169055534541,0.00316838914465724,-0.0103817332788736,0.00203835216818279,0.187975617712827
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00407784242452891,0.00310389897403205,-0.00200579956457391,0.0101614844136317,0.18894289145535
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN4,Alpha-actinin-4,39587,0.0038842205375737,0.00296457130771104,-0.00192633922553995,0.00969478030068734,0.190142847946087
NMR metabolomics,X23412.Phospholipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0104586019426488,0.00800955747701089,-0.00524013071229254,0.0261573345975902,0.19165518773065
NMR metabolomics,X23412.Phospholipids in VLDL,NRP2,Neuropilin-2,39858,-0.0035166145984174,0.00269319166432029,-0.00879527026048517,0.00176204106365037,0.191658943197434
NMR metabolomics,X23412.Phospholipids in VLDL,IL9,Interleukin-9,37169,-0.00706450003590855,0.00541646469971188,-0.0176807708473438,0.00355177077552674,0.192166132656088
NMR metabolomics,X23412.Phospholipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0120161545804594,0.00922365785236701,-0.0300945239710987,0.00606221481017997,0.192681649231565
NMR metabolomics,X23412.Phospholipids in VLDL,SKIV2L,Helicase SKI2W,37021,0.00494734765164873,0.00381275318192461,-0.0025256485849235,0.012420343888221,0.194454857734077
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR1B,Cornifin-B,37169,0.0107390659417354,0.00829097470543488,-0.00551124448091699,0.0269893763643877,0.195248941618996
NMR metabolomics,X23412.Phospholipids in VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.00828446118331908,0.00641454739681742,-0.0208569740810812,0.00428805171444307,0.196549049719858
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00734118440924229,0.00569182008685826,-0.00381478296099991,0.0184971517794845,0.197150346823591
NMR metabolomics,X23412.Phospholipids in VLDL,PKLR,Pyruvate kinase PKLR,39881,-0.00777728921501781,0.00603568197335942,-0.0196072258828023,0.00405264745276665,0.197572536888953
NMR metabolomics,X23412.Phospholipids in VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.00432666824052124,0.00337907015374401,-0.00229630926081702,0.0109496457418595,0.200415256702433
NMR metabolomics,X23412.Phospholipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.0030659777743055,0.00241415019053498,-0.00779771214775406,0.00166575659914305,0.204105357502947
NMR metabolomics,X23412.Phospholipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00620323947350641,0.00490081838687506,-0.0158088435117815,0.0034023645647687,0.205622917089242
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00608770923742353,0.00481127180655766,-0.0155178019782765,0.00334238350342948,0.205785684554932
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00378961365602186,0.00299927730593199,-0.00208896986360485,0.00966819717564856,0.206428720626845
NMR metabolomics,X23412.Phospholipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.00342919615361144,0.00271414706392725,-0.00874892439890886,0.00189053209168597,0.206444926524247
NMR metabolomics,X23412.Phospholipids in VLDL,NXPE4,NXPE family member 4,37021,-0.0041663325399928,0.00330956547049158,-0.0106530808621563,0.0023204157821707,0.20809745239161
NMR metabolomics,X23412.Phospholipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.00862512838936231,0.0068698978936722,-0.0220901282609598,0.0048398714822352,0.209317172231302
NMR metabolomics,X23412.Phospholipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00582206561750875,0.00464689759289583,-0.00328585366456707,0.0149299848995846,0.210266948486923
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0140039235788146,0.0112008377341043,-0.00794971838002984,0.0359575655376591,0.211224039835931
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_DRA,,39799,-0.00418150721947294,0.00334836349708847,-0.0107442996737663,0.00238128523482045,0.21174883017881
NMR metabolomics,X23412.Phospholipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00920849113640977,0.00739162317944063,-0.00527909029529386,0.0236960725681134,0.212859629327921
NMR metabolomics,X23412.Phospholipids in VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.00653008125845115,0.00527916012754224,-0.00381707259153165,0.0168772351084339,0.216125452021985
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00546815394298282,0.00442241664961655,-0.00319978269026562,0.0141360905762313,0.216308627360901
NMR metabolomics,X23412.Phospholipids in VLDL,NRXN3,Neurexin-3,37039,0.00410018020508347,0.00331914146004078,-0.00240533705659647,0.0106056974667634,0.216735877609512
NMR metabolomics,X23412.Phospholipids in VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00841865726665943,0.00686400557695359,-0.0050347936641696,0.0218721081974885,0.220035064647465
NMR metabolomics,X23412.Phospholipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0059489820813615,0.00487092173747339,-0.00359802452408635,0.0154959886868094,0.221984027776488
NMR metabolomics,X23412.Phospholipids in VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.00784909553979362,0.00643786339328867,-0.0204673077906394,0.00476911671105218,0.222786990609815
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,0.00556010872783353,0.00458091677977645,-0.00341848816052831,0.0145387056161954,0.224862610215227
NMR metabolomics,X23412.Phospholipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00364882111475296,0.00300662088353818,-0.00224415581698187,0.00954179804648778,0.22492051231963
NMR metabolomics,X23412.Phospholipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.0120683188731861,0.009945488062364,-0.00742483772904735,0.0315614754754195,0.224980937796581
NMR metabolomics,X23412.Phospholipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00756582828319053,0.00624706137274594,-0.0198100685737726,0.0046784120073915,0.225878173972099
NMR metabolomics,X23412.Phospholipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.00974307820312196,0.00805235855828904,-0.0255257009773685,0.00603954457112455,0.226313760473816
NMR metabolomics,X23412.Phospholipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00529936358447731,0.00438442362846534,-0.0138928338962694,0.00329410672731476,0.226807710064855
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0166495223594692,0.0137901320138753,-0.0103791363877265,0.0436781811066648,0.227318320081187
NMR metabolomics,X23412.Phospholipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00420641823870751,0.00348871393895652,-0.0110442975590623,0.00263146108164727,0.227946475970985
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00338948600393949,0.00281181070983651,-0.00890063499521905,0.00212166298734008,0.228048882378418
NMR metabolomics,X23412.Phospholipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00869418765269299,0.00727407732515708,-0.00556300390461489,0.0229513792100009,0.232019105692506
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00374877036775071,0.00314070773927947,-0.00990455753673847,0.00240701680123705,0.232649480532447
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00736728956273026,0.00619643282318179,-0.0195122978961666,0.00477771877070605,0.234477967230182
NMR metabolomics,X23412.Phospholipids in VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00303181739567505,0.0025502997292137,-0.0019667700735838,0.00803040486493391,0.234532605683557
NMR metabolomics,X23412.Phospholipids in VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.00683500021946217,0.00576132191113162,-0.0181271911652801,0.00445719072635579,0.23550102100707
NMR metabolomics,X23412.Phospholipids in VLDL,MTR,Methionine synthase,37021,0.00722705560106782,0.00609939800681058,-0.00472776449228092,0.0191818756944166,0.236086233637395
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP2,Dipeptidase 2,39788,0.00324792716903483,0.00274730783258286,-0.00213679618282757,0.00863265052089723,0.237135359093531
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.00375955452000621,0.00320586789389706,-0.0100430555920444,0.00252394655203202,0.24093312799518
NMR metabolomics,X23412.Phospholipids in VLDL,FBN2,Fibrillin-2,37039,0.00666151347796411,0.00568599112100488,-0.00448302911920545,0.0178060560751337,0.241392553165411
NMR metabolomics,X23412.Phospholipids in VLDL,REST,RE1-silencing transcription factor,36962,-0.00395968113039971,0.00338381311855882,-0.010591954842775,0.00267259258197557,0.241948552563788
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0100634801624784,0.00866445063795981,-0.0270458034128796,0.00691884308792281,0.245472881570088
NMR metabolomics,X23412.Phospholipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0101549147055983,0.0087890905376336,-0.00707170274816355,0.0273815321593601,0.247947755202025
NMR metabolomics,X23412.Phospholipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00270597851326062,0.00234570648076399,-0.0018916061890368,0.00730356321555804,0.248689473915754
NMR metabolomics,X23412.Phospholipids in VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00508474909352539,0.00441880048492559,-0.00357609985692878,0.0137455980439795,0.249873288163067
NMR metabolomics,X23412.Phospholipids in VLDL,SHH,Sonic hedgehog protein,37056,-0.00474050454200777,0.00413226083101348,-0.0128397357707942,0.00335872668677865,0.251322278501907
NMR metabolomics,X23412.Phospholipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00440899683073458,0.00385054070429373,-0.0119560566111503,0.00313806294968113,0.252216286339743
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00274658186830446,0.00241121369102542,-0.00747256070271429,0.00197939696610537,0.254687018228581
NMR metabolomics,X23412.Phospholipids in VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00857637289688646,0.00754543403705509,-0.0233654236095144,0.00621267781574151,0.255713437432253
NMR metabolomics,X23412.Phospholipids in VLDL,CPLX2,Complexin-2,36962,-0.00322814955194704,0.00284402654757551,-0.00880244158519504,0.00234614248130096,0.256369650621942
NMR metabolomics,X23412.Phospholipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00982839001672202,0.00867010077980752,-0.00716500751170072,0.0268217875451448,0.256984822369112
NMR metabolomics,X23412.Phospholipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00351090430828608,0.00310041325034942,-0.00256590566239879,0.00958771427897094,0.257487430776924
NMR metabolomics,X23412.Phospholipids in VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00464049886808603,0.00410970773739573,-0.0126955260333817,0.0034145282972096,0.258852892949346
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00492476338169302,0.00437889720012914,-0.0135074018939461,0.00365787513056011,0.260754432701676
NMR metabolomics,X23412.Phospholipids in VLDL,TBR1,T-box brain protein 1,37039,-0.00512640122915477,0.00456034396106524,-0.0140646753928426,0.00381187293453311,0.260980050047861
NMR metabolomics,X23412.Phospholipids in VLDL,TLR2,Toll-like receptor 2,37169,-0.00240564160662173,0.00214677589136532,-0.00661332235369775,0.0018020391404543,0.262485418593458
NMR metabolomics,X23412.Phospholipids in VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.00950476126237431,0.00849440507676165,-0.0261537952128272,0.00714427268807852,0.263184615637401
NMR metabolomics,X23412.Phospholipids in VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00428612268033732,0.00383104750662118,-0.0117949757933148,0.0032227304326402,0.263251824229157
NMR metabolomics,X23412.Phospholipids in VLDL,MMP9,Matrix metalloproteinase-9,39843,0.00639881621637188,0.00572014046730751,-0.00481265909955083,0.0176102915322946,0.263307707314593
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00573234239259739,0.00513557425199,-0.0157980679264978,0.00433338314130301,0.264355515708809
NMR metabolomics,X23412.Phospholipids in VLDL,AKAP12,A-kinase anchor protein 12,37124,0.00222703780669019,0.00199550526807331,-0.00168415251873349,0.00613822813211388,0.26443078448939
NMR metabolomics,X23412.Phospholipids in VLDL,CHIT1,Chitotriosidase-1,39906,0.0158797031957278,0.0142466882055562,-0.0120438056871623,0.043803212078618,0.265028197149899
NMR metabolomics,X23412.Phospholipids in VLDL,CD177,CD177 antigen,39844,-0.0131105853215044,0.0117841442135767,-0.0362075079801147,0.00998633733710596,0.265913529434939
NMR metabolomics,X23412.Phospholipids in VLDL,HCG22,Protein PBMUCL2,37021,-0.00568788471832374,0.00513165503033934,-0.0157459285777888,0.00437015914114137,0.267712868785686
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00509025219615668,0.00462450547792231,-0.0141542829328844,0.00397377854057104,0.271041867369031
NMR metabolomics,X23412.Phospholipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00234662772171418,0.00213314450197623,-0.00183433550215924,0.0065275909455876,0.271317718967223
NMR metabolomics,X23412.Phospholipids in VLDL,MUCL3,Mucin-like protein 3,36962,-0.00468597078188557,0.00426413678102116,-0.013043678872687,0.0036717373089159,0.27182053694242
NMR metabolomics,X23412.Phospholipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00266956604115587,0.00242984366013751,-0.00743205961502539,0.00209292753271365,0.271937660881765
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00404153557719963,0.00371010325598283,-0.011313337958926,0.00323026680452672,0.276023881361184
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00311711836545704,0.00287744056357018,-0.00875690187005459,0.00252266513914051,0.278694014271206
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00648239391349829,0.00603932752434824,-0.0183194758612208,0.00535468803422426,0.283127809006207
NMR metabolomics,X23412.Phospholipids in VLDL,KEL,Kell blood group glycoprotein,39489,0.00355171745014332,0.00334995714234912,-0.00301419854886095,0.0101176334491476,0.289057393426796
NMR metabolomics,X23412.Phospholipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00639218266952471,0.00602923446021693,-0.0182094822115499,0.00542511687250048,0.289073960013875
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL6,Fc receptor-like protein 6,39866,-0.0065702848635408,0.00622567705248207,-0.0187726118864057,0.00563204215932406,0.291279992582352
NMR metabolomics,X23412.Phospholipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0126188410232604,0.0119888368755247,-0.010879279252768,0.0361169612992888,0.292563921382519
NMR metabolomics,X23412.Phospholipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00496684991920257,0.00473779595276657,-0.0043192301482199,0.014252929986625,0.294497913384715
NMR metabolomics,X23412.Phospholipids in VLDL,PSCA,Prostate stem cell antigen,37382,0.025046571192284,0.0240161097557479,-0.022025003928982,0.0721181463135499,0.297009969214944
NMR metabolomics,X23412.Phospholipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.00325026657570963,0.00311835927961352,-0.00286171761233286,0.00936225076375212,0.297291740151672
NMR metabolomics,X23412.Phospholipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0114349591497515,0.0110185101429329,-0.0101613207303969,0.0330312390299,0.299384428224627
NMR metabolomics,X23412.Phospholipids in VLDL,GUK1,Guanylate kinase,37021,-0.0040086988482579,0.00392391506990885,-0.0116995723852792,0.00368217468876344,0.306985751897061
NMR metabolomics,X23412.Phospholipids in VLDL,GBP6,Guanylate-binding protein 6,37021,-0.0044654180411867,0.00437363859497051,-0.0130377496873289,0.00410691360495549,0.30728045948959
NMR metabolomics,X23412.Phospholipids in VLDL,MYL6B,Myosin light chain 6B,37039,-0.00885594795885836,0.00874713609597819,-0.0260003347069756,0.00828843878925888,0.3113464451854
NMR metabolomics,X23412.Phospholipids in VLDL,KLK12,Kallikrein-12,39477,-0.0131066266649275,0.0130084242663432,-0.0386031382269602,0.0123898848971051,0.313686566746514
NMR metabolomics,X23412.Phospholipids in VLDL,FGF6,Fibroblast growth factor 6,37056,0.00390679702869934,0.00388048265462453,-0.00369894897436473,0.0115125430317634,0.314058385622459
NMR metabolomics,X23412.Phospholipids in VLDL,IL13,Interleukin-13,39587,0.00460414807228505,0.0046025859020643,-0.00441692029576098,0.0136252164403311,0.317161671148197
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G1B,Phospholipase A2,40031,-0.0038509454059955,0.00385806949446847,-0.0114127616151537,0.00371087080316269,0.318219886629423
NMR metabolomics,X23412.Phospholipids in VLDL,TEX101,Testis-expressed protein 101,37039,0.00456572683719772,0.00460038805984014,-0.00445103376008895,0.0135824874344844,0.320988679550735
NMR metabolomics,X23412.Phospholipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00511616748111487,0.00517324593591967,-0.00502339455328768,0.0152557295155174,0.322697702559141
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00475934433797687,0.00483029203308424,-0.014226716722822,0.00470802804686824,0.324488965651005
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00436883055121922,0.00444442896734594,-0.00434225022477883,0.0130799113272173,0.325627670817936
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00692780305571044,0.00706800923807733,-0.00692549505092112,0.020781101162342,0.327023589368637
NMR metabolomics,X23412.Phospholipids in VLDL,ACTA2,"Actin, aortic smooth muscle",39585,0.00398893814740597,0.00408119021332903,-0.00401019467071894,0.0119880709655309,0.328388280434342
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00265312532344247,0.00272355271269239,-0.00799128864031955,0.00268503799343461,0.330004304155175
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD2,Leiomodin-2,36991,-0.00590168793963489,0.00606596274422104,-0.0177909749183081,0.00598759903903836,0.330611684803231
NMR metabolomics,X23412.Phospholipids in VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00315956554993826,0.0032572387079442,-0.00954375341750888,0.00322462231763237,0.3320575369321
NMR metabolomics,X23412.Phospholipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00422064312637515,0.00436814834323904,-0.0127822138791237,0.00434092762637336,0.33394295519316
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD9,COMM domain-containing protein 9,37368,0.00358444351810764,0.00371369657815259,-0.00369440177507145,0.0108632888112867,0.334464140046347
NMR metabolomics,X23412.Phospholipids in VLDL,NRN1,Neuritin,37411,-0.00320301254566075,0.00333029485034423,-0.00973039045233544,0.00332436536101394,0.336177051662535
NMR metabolomics,X23412.Phospholipids in VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00237435722985057,0.00246972959173263,-0.00246631276994539,0.00721502722964653,0.336377002734675
NMR metabolomics,X23412.Phospholipids in VLDL,PRND,Prion-like protein doppel,37388,-0.00461056965376673,0.0048063056705996,-0.014030928768142,0.00480978946060849,0.337437288200032
NMR metabolomics,X23412.Phospholipids in VLDL,OPTC,Opticin,39788,0.00399291308892472,0.00416746339928353,-0.004175315173671,0.0121611413515204,0.338018843759194
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171A2,Protein FAM171A2,37411,0.014213455248707,0.0148629327685844,-0.0149178929777184,0.0433448034751324,0.338936640339591
NMR metabolomics,X23412.Phospholipids in VLDL,BSND,Barttin,36962,-0.00302815915472795,0.00319694017994696,-0.00929416190742399,0.00323784359796809,0.343551568870851
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00698297509132266,0.00740930572390497,-0.0215052143101764,0.00753926412753109,0.345974231211157
NMR metabolomics,X23412.Phospholipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00501762454280066,0.00533505917937011,-0.0154743405343661,0.00543909144876476,0.346978317275857
NMR metabolomics,X23412.Phospholipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.0064311587514837,0.00684349522753662,-0.0198444093974555,0.00698209189448806,0.347364057472882
NMR metabolomics,X23412.Phospholipids in VLDL,PI16,Peptidase inhibitor 16,37445,0.00212216444913319,0.00225833773159488,-0.00230417750479277,0.00654850640305915,0.347387154234556
NMR metabolomics,X23412.Phospholipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00603032481435811,0.00644490385067805,-0.00660168673297086,0.0186623363616871,0.349458537173102
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB2,Beta-crystallin B2,37388,0.00500500484833811,0.00537303463657847,-0.00552614303935569,0.0155361527360319,0.351609386334934
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL1,Interferon lambda-1,39489,0.00394517738823472,0.00423825470702928,-0.00436180183754266,0.0122521566140121,0.351945784124162
NMR metabolomics,X23412.Phospholipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00442082637471942,0.00475248910598923,-0.0137357050224583,0.00489405227301947,0.352278034923348
NMR metabolomics,X23412.Phospholipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00383566013198186,0.00412562832851753,-0.0119218916558762,0.00425057139191249,0.352535594867766
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00539965706204439,0.0058341273675316,-0.00603523257831755,0.0168345467024063,0.354704740524112
NMR metabolomics,X23412.Phospholipids in VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.0052381037621645,0.00567378825621063,-0.00588252122000834,0.0163587287443373,0.355911419688681
NMR metabolomics,X23412.Phospholipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.00768610192973788,0.0083272722646956,-0.0086353517090655,0.0240075555685413,0.356022388150524
NMR metabolomics,X23412.Phospholipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00315194700568199,0.00341725114780287,-0.00354586524401163,0.00984975925537561,0.356355561677495
NMR metabolomics,X23412.Phospholipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00291106562207254,0.0031650632614367,-0.0032924583703434,0.00911458961448848,0.35771774253798
NMR metabolomics,X23412.Phospholipids in VLDL,PALLD,Palladin,37056,0.0035463601225625,0.0038567923899438,-0.00401295296172735,0.0111056732068524,0.357845555939642
NMR metabolomics,X23412.Phospholipids in VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00447964144513187,0.00488340081270384,-0.0140511070380314,0.00509182414776767,0.358991766538762
NMR metabolomics,X23412.Phospholipids in VLDL,LCN15,Lipocalin-15,37411,-0.00533342961192075,0.005864544139344,-0.016827936125035,0.00616107690119348,0.363136016531702
NMR metabolomics,X23412.Phospholipids in VLDL,CORO6,Coronin-6,36991,-0.00325953401961456,0.00358486957543263,-0.0102858783874625,0.0037668103482334,0.363236137180641
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00328669261492636,0.00363000937400811,-0.0104015109879822,0.00382812575812953,0.365258086134682
NMR metabolomics,X23412.Phospholipids in VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00338829290335312,0.00374748144920038,-0.00395677073707962,0.0107333565437859,0.365931349764184
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B4,Protein ATP1B4,36962,-0.00358728232515358,0.0039707421345673,-0.0113699369089055,0.00419537225859833,0.366315033775719
NMR metabolomics,X23412.Phospholipids in VLDL,MSLNL,Mesothelin-like protein,37039,-0.00309473151722242,0.00343261908888472,-0.00982266493143647,0.00363320189699163,0.367304111755976
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00387865515050338,0.00434541344679806,-0.0123956655062276,0.00463835520522082,0.372095202403717
NMR metabolomics,X23412.Phospholipids in VLDL,IL17F,Interleukin-17F,39587,-0.00651936385575308,0.00731752018054535,-0.020861703409622,0.0078229756981158,0.372982876055494
NMR metabolomics,X23412.Phospholipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00306117440215621,0.00343782120607537,-0.00367695516175151,0.00979930396606394,0.373245788201544
NMR metabolomics,X23412.Phospholipids in VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00218915122003534,0.00245885087259047,-0.00700849893031267,0.00263019649024199,0.373313246371762
NMR metabolomics,X23412.Phospholipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0121471930628471,0.0136510907328197,-0.0389033308991738,0.0146089447734796,0.373571821713647
NMR metabolomics,X23412.Phospholipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00342141503077404,0.00385739938115831,-0.0109819178178443,0.00413908775629625,0.375108790021233
NMR metabolomics,X23412.Phospholipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00714175957099442,0.00810010134630166,-0.0230179582097457,0.00873443906775683,0.377961647346914
NMR metabolomics,X23412.Phospholipids in VLDL,VCAN,Versican core protein,40009,-0.00245944230014456,0.00279198567621794,-0.00793173422553172,0.00301284962524261,0.378388523946066
NMR metabolomics,X23412.Phospholipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00481012109850023,0.00546057695849206,-0.00589260974014421,0.0155128519371447,0.378398131857349
NMR metabolomics,X23412.Phospholipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00458983214417665,0.00522045984928407,-0.0148219334487734,0.00564226916042013,0.379308454494467
NMR metabolomics,X23412.Phospholipids in VLDL,CASP4,Caspase-4,37169,-0.0137086602314873,0.0155928618231006,-0.0442706694047644,0.0168533489417899,0.379329016974469
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN4,Nectin-4,39913,0.00242896075730431,0.00277776212274493,-0.00301545300327576,0.00787337451788438,0.381896771383992
NMR metabolomics,X23412.Phospholipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00395900750294919,0.00453572501820359,-0.0128490285386282,0.00493101353272985,0.382760733901214
NMR metabolomics,X23412.Phospholipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.0047439953829382,0.0054376485876877,-0.00591379584892971,0.0154017866148061,0.382986553930569
NMR metabolomics,X23412.Phospholipids in VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00291318482752971,0.00335249162307157,-0.00365769875369057,0.00948406840874999,0.384881440878667
NMR metabolomics,X23412.Phospholipids in VLDL,S100G,Protein S100-G,37411,-0.00368886961704838,0.00425018691552324,-0.0120192359714739,0.00464149673737718,0.385447394738421
NMR metabolomics,X23412.Phospholipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00244209884216518,0.00281546137856517,-0.00796040314415292,0.00307620545982255,0.385744535893255
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00401200789719492,0.0046256045448627,-0.0130781928051258,0.00505417701073596,0.385767361715707
NMR metabolomics,X23412.Phospholipids in VLDL,FGF5,Fibroblast growth factor 5,39587,0.0027030918236937,0.00312683666170287,-0.00342550803324392,0.00883169168063131,0.387336733285754
NMR metabolomics,X23412.Phospholipids in VLDL,DCC,Netrin receptor DCC,37039,0.00184233984606405,0.00213954133916978,-0.00235116117870871,0.00603584087083681,0.389203577167209
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2B,Alpha-amylase 2B,38832,0.00391021523195069,0.00454683849763206,-0.00500158822340815,0.0128220186873095,0.38981079895908
NMR metabolomics,X23412.Phospholipids in VLDL,PALM3,Paralemmin-3,37021,0.00615233775919414,0.00716564041220035,-0.00789231744871853,0.0201969929671068,0.390583120802329
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00440133350809857,0.00513520181348616,-0.0144663290625314,0.00566366204633431,0.39141038903952
NMR metabolomics,X23412.Phospholipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00505647001993713,0.00590959030563353,-0.0166392670189789,0.00652632697910458,0.392213448469535
NMR metabolomics,X23412.Phospholipids in VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00285480738286674,0.00335015684242649,-0.00942111479402266,0.00371150002828919,0.39415122206183
NMR metabolomics,X23412.Phospholipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00586863305908318,0.00690842994529159,-0.00767188963368834,0.0194091557518547,0.395624704607085
NMR metabolomics,X23412.Phospholipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00284350238617649,0.0033534312140596,-0.00372922279338032,0.00941622756573331,0.396487775296583
NMR metabolomics,X23412.Phospholipids in VLDL,IL17A,Interleukin-17A,39558,-0.00337467909535538,0.00399807144987757,-0.0112108991371154,0.00446154094640466,0.398639389784285
NMR metabolomics,X23412.Phospholipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00516035211563964,0.00611900186148839,-0.0171535957641569,0.0068328915328776,0.399057931327438
NMR metabolomics,X23412.Phospholipids in VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00416527610878848,0.00495315947879444,-0.00554291646964861,0.0138734686872256,0.400398239306074
NMR metabolomics,X23412.Phospholipids in VLDL,PRTN3,Myeloblastin,39421,-0.00365541551292482,0.00436566955721446,-0.0122121278450652,0.00490129681921553,0.402431618931532
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00424580427971647,0.00509907358351914,-0.014239988503414,0.00574837994398105,0.405050583592742
NMR metabolomics,X23412.Phospholipids in VLDL,KLK14,Kallikrein-14,40030,0.0035424101033717,0.00426210542060629,-0.00481131652101663,0.01189613672776,0.40590631335072
NMR metabolomics,X23412.Phospholipids in VLDL,RRP15,RRP15-like protein,36991,0.00706978948568641,0.00855105282886655,-0.00969027405889203,0.0238298530302648,0.408380103915668
NMR metabolomics,X23412.Phospholipids in VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00509236129510499,0.00616053987722011,-0.00698229686424644,0.0171670194544564,0.40847092478736
NMR metabolomics,X23412.Phospholipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00293771179879384,0.00356187584746232,-0.00404356486223231,0.00991898845981998,0.409517328021482
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00649566575296815,0.00788335255921368,-0.00895570526309065,0.021947036769027,0.409967458527618
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF830,Zinc finger protein 830,37368,-0.00626715976869558,0.00762434810976097,-0.0212108820638271,0.00867656252643592,0.411095464433937
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00364820006195783,0.00444000119838328,-0.0050542022868734,0.0123506024107891,0.411279287532799
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00381075465651792,0.00464733832258424,-0.012919537768783,0.00529802845574719,0.412236005647148
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.0037594595254103,0.00459078039604548,-0.00523847005083884,0.0127573891016595,0.412849698636782
NMR metabolomics,X23412.Phospholipids in VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00738273310840562,0.00908290941914469,-0.010419769353118,0.0251852355699292,0.416338359713216
NMR metabolomics,X23412.Phospholipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00309620735944895,0.00381643761400221,-0.00438401036399538,0.0105764250828933,0.41721838276369
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00304913933648569,0.00376488740585293,-0.00433003997898605,0.0104283186519574,0.418018921150272
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00206064664488646,0.00254515586732198,-0.00292785885506462,0.00704915214483753,0.418162024807884
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00586729600037911,0.0072554186902465,-0.0200879166332622,0.00835332463250403,0.418714745021443
NMR metabolomics,X23412.Phospholipids in VLDL,HRAS,GTPase Hras,37161,0.00742358590827761,0.00924448816220988,-0.0106956108896538,0.025542782706209,0.42197270805058
NMR metabolomics,X23412.Phospholipids in VLDL,STC2,Stanniocalcin-2,39831,-0.00199790922713966,0.00249851574831776,-0.00689500009384246,0.00289918163956315,0.423932203740153
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.00253265970568231,0.00317602372375733,-0.00875766620424667,0.00369234679288205,0.425212608956601
NMR metabolomics,X23412.Phospholipids in VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00402689656681357,0.00505752766074226,-0.0139396507818684,0.00588585764824125,0.425919098799443
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00481514926356367,0.00609994878794647,-0.0071407503608114,0.0167710488879387,0.429904628265345
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00322595929477644,0.0041126245744599,-0.0112867034607178,0.00483478487116497,0.432817191562645
NMR metabolomics,X23412.Phospholipids in VLDL,NOS1,"Nitric oxide synthase, brain",39489,-0.00398183870131019,0.00509587734306363,-0.0139697582937149,0.00600608089109452,0.434588320834433
NMR metabolomics,X23412.Phospholipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00405133763120667,0.00518876671911144,-0.0142213204006651,0.00611864513825176,0.434940070255737
NMR metabolomics,X23412.Phospholipids in VLDL,TG,Thyroglobulin,37368,0.00797170420064752,0.0102805181556323,-0.0121781113843918,0.0281215197856868,0.438105967856147
NMR metabolomics,X23412.Phospholipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00300764450747503,0.00387980913537621,-0.00459678139786234,0.0106120704128124,0.438232570992974
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00236114771367843,0.00304685039042284,-0.0083329744789072,0.00361067905155033,0.4383849044308
NMR metabolomics,X23412.Phospholipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.00261468051836113,0.00337478387736661,-0.00922925691799969,0.00399989588127743,0.438487161891426
NMR metabolomics,X23412.Phospholipids in VLDL,CYTH3,Cytohesin-3,36962,0.00529720024055249,0.00685658317216166,-0.00814170277688437,0.0187361032579893,0.439789996276314
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX2,Peroxiredoxin-2,37249,0.00442765152826663,0.00575674553832872,-0.00685556972685765,0.0157108727833909,0.441833230626806
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00322151704810998,0.0042008662981078,-0.00501218089618131,0.0114552149924013,0.443172396820514
NMR metabolomics,X23412.Phospholipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00623646976555035,0.00818416429450332,-0.0222774317827769,0.00980449225167616,0.446063547924689
NMR metabolomics,X23412.Phospholipids in VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00376955160188091,0.00496284086339421,-0.0134967196941336,0.00595761649037174,0.447533717418375
NMR metabolomics,X23412.Phospholipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00453398719824509,0.00598072413471969,-0.00718823210580551,0.0162562065022957,0.448404519807217
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL2,Chordin-like protein 2,39868,0.00402190995637433,0.00531744572531092,-0.00640028366523507,0.0144441035779837,0.449443757944184
NMR metabolomics,X23412.Phospholipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00402506739149213,0.00533084479049507,-0.0144735231808625,0.00642338839787821,0.450231026514782
NMR metabolomics,X23412.Phospholipids in VLDL,AOC3,Membrane primary amine oxidase,39931,0.00212736664892358,0.00283662006952228,-0.00343240868734009,0.00768714198518724,0.453286576662191
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00540699790346039,0.00725951670170432,-0.0196356506388009,0.00882165483188008,0.456396814520483
NMR metabolomics,X23412.Phospholipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00413236952015978,0.00555456862010577,-0.00675458497524754,0.0150193240155671,0.456914787278812
NMR metabolomics,X23412.Phospholipids in VLDL,SOX2,Transcription factor SOX-2,37391,0.00166888447129561,0.0022474859923888,-0.00273618807378643,0.00607395701637766,0.457763355263515
NMR metabolomics,X23412.Phospholipids in VLDL,IL4,Interleukin-4,39587,0.00631212704408861,0.00852358232658531,-0.0103940943160186,0.0230183484041958,0.45897823273337
NMR metabolomics,X23412.Phospholipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00393857994634444,0.00532588062277556,-0.0143773059669845,0.00650014607429565,0.459606291722025
NMR metabolomics,X23412.Phospholipids in VLDL,NEB,Nebulin,37021,-0.00262428721087799,0.00355566608914682,-0.00959339274560576,0.00434481832384978,0.460492465314976
NMR metabolomics,X23412.Phospholipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00333393393586334,0.00452426285640369,-0.0122014891344146,0.00553362126268789,0.461195676335052
NMR metabolomics,X23412.Phospholipids in VLDL,CASQ2,Calsequestrin-2,37021,0.00339626444978349,0.00461832979376292,-0.00565566194599183,0.0124481908455588,0.462116313909476
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00300327971777426,0.00409073685607481,-0.0110211239556809,0.00501456452013236,0.462860646273959
NMR metabolomics,X23412.Phospholipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00471054331569828,0.00643013871886123,-0.0173136152046663,0.00789252857326974,0.463832060586247
NMR metabolomics,X23412.Phospholipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00274508142867299,0.00376563807149979,-0.0101257320488126,0.0046355691914666,0.466025827909782
NMR metabolomics,X23412.Phospholipids in VLDL,MB,Myoglobin,40052,-0.00354655570485235,0.00489608743966606,-0.0131428870865978,0.00604977567689313,0.468851981020201
NMR metabolomics,X23412.Phospholipids in VLDL,RTKN2,Rhotekin-2,37021,-0.0035564105553123,0.00492182386054194,-0.0132031853219745,0.0060903642113499,0.469950914754184
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN7,Tetraspanin-7,36991,0.00643618312777371,0.00891169389449883,-0.011030736905444,0.0239031031609914,0.470173499762963
NMR metabolomics,X23412.Phospholipids in VLDL,CNTF,Ciliary neurotrophic factor,36991,0.00231711536910822,0.00320947398936344,-0.00397345365004412,0.00860768438826056,0.470331250534763
NMR metabolomics,X23412.Phospholipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.002485982308478,0.00347358347441946,-0.00929420591834014,0.00432224130138414,0.474200221761548
NMR metabolomics,X23412.Phospholipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00660618901318248,0.00923310856433659,-0.0114907037729172,0.0247030817992822,0.474319208559917
NMR metabolomics,X23412.Phospholipids in VLDL,PGR,Progesterone receptor,37056,0.0070745277989213,0.00994534510442772,-0.012418348605757,0.0265674042035996,0.476885769048544
NMR metabolomics,X23412.Phospholipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00140728897803107,0.00198044325365715,-0.00528895775519909,0.00247437979913695,0.477349094857706
NMR metabolomics,X23412.Phospholipids in VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.0056470053212754,0.0079500726869581,-0.00993513714516248,0.0212291477877133,0.477523296462389
NMR metabolomics,X23412.Phospholipids in VLDL,CD99,CD99 antigen,39858,0.00128158328822182,0.00180761761743459,-0.00226134724194998,0.00482451381839362,0.478340851274852
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00356000876377941,0.00508062810444849,-0.00639802232093964,0.0135180398484985,0.483500758344252
NMR metabolomics,X23412.Phospholipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.00240430392324622,0.00343945026521252,-0.00433701859657032,0.00914562644306275,0.484539220247863
NMR metabolomics,X23412.Phospholipids in VLDL,FGF3,Fibroblast growth factor 3,37056,0.00202330272206064,0.00291450915322049,-0.00368913521825151,0.0077357406623728,0.487558155806096
NMR metabolomics,X23412.Phospholipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00200991773719529,0.002895457009361,-0.00366517800115226,0.00768501347554285,0.487590546935028
NMR metabolomics,X23412.Phospholipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00549860788917316,0.00794143647716364,-0.0100666076060676,0.0210638233844139,0.48870174291852
NMR metabolomics,X23412.Phospholipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00479861735708945,0.00693301834315061,-0.0183873333096646,0.00879009859548574,0.488861829916715
NMR metabolomics,X23412.Phospholipids in VLDL,TP73,Tumor protein p73,37039,-0.002263374862826,0.00327501205535261,-0.00868239849131713,0.00415564876566512,0.489512180686826
NMR metabolomics,X23412.Phospholipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00194119433045032,0.00282207298672141,-0.00747245738442427,0.00359006872352364,0.491551983460355
NMR metabolomics,X23412.Phospholipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00397718529012946,0.00579181808378571,-0.00737477815409052,0.0153291487343495,0.492289699171954
NMR metabolomics,X23412.Phospholipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00130404290894219,0.00190782410989512,-0.00243529234645224,0.00504337816433663,0.494285851161182
NMR metabolomics,X23412.Phospholipids in VLDL,IL25,Interleukin-25,36903,-0.00222357149132426,0.00325445780918676,-0.00860230879733032,0.0041551658146818,0.494468164202482
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00490067512276971,0.00718451313661875,-0.0189823208705425,0.00918097062500304,0.495177304815278
NMR metabolomics,X23412.Phospholipids in VLDL,GUCA2A,Guanylin,39796,-0.00207426596575909,0.00304533641186123,-0.0080431253330071,0.00389459340148892,0.495799969055226
NMR metabolomics,X23412.Phospholipids in VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.00492345010167628,0.00727536958058882,-0.0191831744796304,0.0093362742762778,0.498590078308496
NMR metabolomics,X23412.Phospholipids in VLDL,RETN,Resistin,39790,0.00260389106241545,0.00385183717931094,-0.00494570980903399,0.0101534919338649,0.499042360828476
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00441982792966555,0.00655722321221713,-0.0172719854256111,0.00843232956628002,0.500298020394294
NMR metabolomics,X23412.Phospholipids in VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00464008761788935,0.00690884921265526,-0.00890125683891495,0.0181814320746937,0.501840504638904
NMR metabolomics,X23412.Phospholipids in VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00624724978048525,0.00935346487072182,-0.0245800409271,0.0120855413661295,0.504204198156782
NMR metabolomics,X23412.Phospholipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00340855535913123,0.00510956560567365,-0.0134233039462516,0.00660619322798912,0.504724307531385
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN1,Neuroligin-1,37039,-0.0041815290672798,0.00636497219426701,-0.0166568745680432,0.00829381643348354,0.511218418130072
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2BP,LRP2-binding protein,37039,-0.00493359550721496,0.00754391860150734,-0.0197196759661693,0.00985248495173942,0.513134084641323
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL2,Interferon lambda-2,36991,-0.00381677223824519,0.00586034083175828,-0.0153030402684914,0.00766949579200103,0.514871706600015
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,0.00371000505332473,0.00569682468085384,-0.0074557713211488,0.0148757814277983,0.514902408863264
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB118,Beta-defensin 118,36991,0.00354937574557583,0.00549466342740304,-0.00722016457213413,0.0143189160632858,0.518311485655092
NMR metabolomics,X23412.Phospholipids in VLDL,IL19,Interleukin-19,39419,0.00417946187669631,0.00647319033054192,-0.00850799117116586,0.0168669149245585,0.518510912712888
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00413619801861971,0.0064264923708922,-0.008459727028329,0.0167321230655684,0.519835087391952
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00208726158353992,0.00324993139730617,-0.00428260395518017,0.00845712712226,0.520721670158907
NMR metabolomics,X23412.Phospholipids in VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.00502082839491233,0.0078229725184032,-0.0103121977411579,0.0203538545309826,0.521010547972577
NMR metabolomics,X23412.Phospholipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00337877122951895,0.00530392620939676,-0.00701692414089871,0.0137744665999366,0.5241150431365
NMR metabolomics,X23412.Phospholipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.0020831483014226,0.00327100349668047,-0.00849431515491633,0.00432801855207113,0.524231732769394
NMR metabolomics,X23412.Phospholipids in VLDL,ISM2,Isthmin-2,37437,-0.00266543270284116,0.00420887178811654,-0.0109148214075496,0.00558395600186726,0.526555525105978
NMR metabolomics,X23412.Phospholipids in VLDL,KLHL41,Kelch-like protein 41,37411,0.00303647270937847,0.00483491290936347,-0.00643995659297394,0.0125129020117309,0.529994551949479
NMR metabolomics,X23412.Phospholipids in VLDL,IL21R,Interleukin-21 receptor,37056,-0.00322584302244106,0.00514726356493299,-0.0133144796097097,0.0068627935648276,0.530860001436638
NMR metabolomics,X23412.Phospholipids in VLDL,DLL1,Delta-like protein 1,39913,0.00166489640807337,0.00268405041520855,-0.00359584240573538,0.00692563522188212,0.53507402085723
NMR metabolomics,X23412.Phospholipids in VLDL,TNPO1,Transportin-1,37169,-0.00204046068520338,0.00334950525726935,-0.00860549098945131,0.00452456961904455,0.542413738591524
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA11,Serpin A11,40052,-0.00232960861333747,0.00386291152154967,-0.00990091519557482,0.00524169796889988,0.546470128316093
NMR metabolomics,X23412.Phospholipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00277502556274821,0.00460307101549143,-0.0117970447531114,0.006246993627615,0.54660963609816
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00187033838961924,0.00311983007375428,-0.00424452855493914,0.00798520533417763,0.548848018225295
NMR metabolomics,X23412.Phospholipids in VLDL,OGN,Mimecan,39858,0.00220793249687458,0.00372827840220682,-0.00509949317145078,0.00951535816519994,0.553716772940926
NMR metabolomics,X23412.Phospholipids in VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00444960708494044,0.00756174744206972,-0.0103714179015162,0.0192706320713971,0.556249586424392
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1,DNA topoisomerase 1,37382,0.00631101531526187,0.0107725903327622,-0.014803261736952,0.0274252923674758,0.557992756178604
NMR metabolomics,X23412.Phospholipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00388973369742589,0.00671907303306667,-0.00927964944738478,0.0170591168422366,0.562660285228216
NMR metabolomics,X23412.Phospholipids in VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.0059152080471119,0.0103062674923484,-0.0261154923321148,0.014285076237891,0.566016019867585
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS2,Podocin,37056,-0.00552114530317665,0.00966209609802389,-0.0244588536553035,0.0134165630489502,0.567722578214453
NMR metabolomics,X23412.Phospholipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00301873355948071,0.00530939043156495,-0.013425138805348,0.00738767168638658,0.569661107300794
NMR metabolomics,X23412.Phospholipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00208898301885509,0.00369366251848419,-0.00515059551737391,0.0093285615550841,0.57170344258183
NMR metabolomics,X23412.Phospholipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00256311878206135,0.00454224790847102,-0.00633968711854185,0.0114659246826646,0.572570093243763
NMR metabolomics,X23412.Phospholipids in VLDL,CDC25A,M-phase inducer phosphatase 1,36962,0.00221791713095005,0.00395116982990265,-0.00552637573565914,0.00996220999755925,0.574580991975504
NMR metabolomics,X23412.Phospholipids in VLDL,NENF,Neudesin,37368,0.00582724162524569,0.0103877921678314,-0.0145328310237038,0.0261873142741952,0.57482717195772
NMR metabolomics,X23412.Phospholipids in VLDL,RUVBL1,RuvB-like 1,39477,0.00526193108387389,0.00959197793871078,-0.0135383456759992,0.024062207843747,0.583304144841498
NMR metabolomics,X23412.Phospholipids in VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.0047954907918973,0.00881626208665909,-0.0220753644817491,0.0124843828979545,0.586494044130848
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00688752402564495,0.0127226438118099,-0.0318239058967923,0.0180488578455024,0.588268702853325
NMR metabolomics,X23412.Phospholipids in VLDL,CLINT1,Clathrin interactor 1,36962,-0.00249694300926271,0.00463830056569282,-0.0115880121180206,0.00659412609949522,0.590357396425461
NMR metabolomics,X23412.Phospholipids in VLDL,PRG3,Proteoglycan 3,37437,-0.00252864005742632,0.00472605120871933,-0.0117917004265162,0.00673442031166357,0.592628967852269
NMR metabolomics,X23412.Phospholipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00165824441510224,0.00311673242948103,-0.00776703997688506,0.00445055114668058,0.594701625912349
NMR metabolomics,X23412.Phospholipids in VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00267727141966972,0.00503574634498689,-0.012547334255844,0.00719279141650458,0.594975120080137
NMR metabolomics,X23412.Phospholipids in VLDL,POF1B,Protein POF1B,37056,-0.00227670734621682,0.0042838600728434,-0.0106730730889899,0.00611965839655625,0.595107854909224
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.00349772202070086,0.00659423611283679,-0.016422424801861,0.00942698076045924,0.595828701098926
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00275270518905547,0.00524122600007745,-0.0130255081492073,0.00752009777109634,0.599451237119123
NMR metabolomics,X23412.Phospholipids in VLDL,CD200,OX-2 membrane glycoprotein,39866,0.00126397080763762,0.0024283210440621,-0.00349553843872409,0.00602348005399934,0.602713804035237
NMR metabolomics,X23412.Phospholipids in VLDL,REG1B,Lithostathine-1-beta,40052,-0.00264760729769129,0.0051305625981771,-0.0127035099901184,0.00740829539473583,0.605829193385619
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.00240155074538007,0.0046720368104457,-0.00675564140309351,0.0115587428938536,0.607240609407851
NMR metabolomics,X23412.Phospholipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.000975359520584594,0.00191019014834287,-0.00471933221133661,0.00276861317016743,0.609633715567688
NMR metabolomics,X23412.Phospholipids in VLDL,GAGE2A,G antigen 2A,36962,-0.00294484659400222,0.00578345857953056,-0.0142804254098821,0.00839073222187768,0.610631587118147
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC9,Histone deacetylase 9,36991,-0.00309193634926723,0.00607488193278093,-0.0149987049375179,0.0088148322389834,0.610781378370858
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00234725401511238,0.00463429693603828,-0.00673596797952265,0.0114304760097474,0.612515423395505
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00345744350561521,0.0068274554204878,-0.00992436911854088,0.0168392561297713,0.612582312448923
NMR metabolomics,X23412.Phospholipids in VLDL,FZD10,Frizzled-10,37039,0.00283205786297489,0.005666185151358,-0.00827366503368678,0.0139377807596366,0.617212010498696
NMR metabolomics,X23412.Phospholipids in VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.00497300808512542,0.00997597160031039,-0.0245259124217338,0.014579896251483,0.618140716364116
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF174,Zinc finger protein 174,37056,0.00179912547516127,0.00361564329205031,-0.00528753537725733,0.00888578632757987,0.618777926837892
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00244731452528744,0.00495645292619354,-0.0121619622606268,0.0072673332100519,0.621481520332603
NMR metabolomics,X23412.Phospholipids in VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00169204463794333,0.00343209271243706,-0.00841894635431997,0.00503485707843332,0.622016128805733
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN6,Prefoldin subunit 6,37039,0.00307710024626765,0.00624365949064832,-0.00916047235540307,0.0153146728479384,0.622136673497386
NMR metabolomics,X23412.Phospholipids in VLDL,YY1,Transcriptional repressor protein YY1,37056,0.00129054929157628,0.00262895967731313,-0.00386221167595745,0.00644331025911002,0.623507227352119
NMR metabolomics,X23412.Phospholipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00170198948569678,0.00348378751894135,-0.00512623405142826,0.00853021302282182,0.625171477755457
NMR metabolomics,X23412.Phospholipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.00354286319017942,0.00725665378182488,-0.0106801782221973,0.0177659046025562,0.625400142166573
NMR metabolomics,X23412.Phospholipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00258834364810124,0.00534645866238707,-0.00789071533017742,0.0130674026263799,0.628306665549335
NMR metabolomics,X23412.Phospholipids in VLDL,EVI2B,Protein EVI2B,36962,0.00187545249887559,0.00390967792467443,-0.00578751623348628,0.00953842123123747,0.631452373341558
NMR metabolomics,X23412.Phospholipids in VLDL,SHC1,SHC-transforming protein 1,36962,-0.00525121818209542,0.010958809004121,-0.0267304838301725,0.0162280474659817,0.631820130801405
NMR metabolomics,X23412.Phospholipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00228279397994827,0.00476769980643311,-0.00706189764066062,0.0116274856005572,0.632085967939158
NMR metabolomics,X23412.Phospholipids in VLDL,EXOSC10,Exosome component 10,37021,-0.00275421936235811,0.00577366394795376,-0.0140706007003475,0.00856216197563126,0.633347637799968
NMR metabolomics,X23412.Phospholipids in VLDL,ERVV_1,,37021,-0.00214592802512494,0.00455631812077248,-0.011076311541839,0.00678445549158913,0.637663870738489
NMR metabolomics,X23412.Phospholipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00122973145234106,0.00264790548012341,-0.00396016328870082,0.00641962619338294,0.642356720895182
NMR metabolomics,X23412.Phospholipids in VLDL,TLR1,Toll-like receptor 1,37056,0.00114655279940205,0.00247086113449776,-0.00369633502421357,0.00598944062301766,0.642634165448271
NMR metabolomics,X23412.Phospholipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00152685270207509,0.00329460353744256,-0.00493057023131233,0.0079842756354625,0.643055114774478
NMR metabolomics,X23412.Phospholipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00271279054230521,0.00585921110208593,-0.0141968443023936,0.00877126321778322,0.643374982696747
NMR metabolomics,X23412.Phospholipids in VLDL,EVPL,Envoplakin,37169,0.00142135826170421,0.00311347683854442,-0.00468105634184284,0.00752377286525127,0.648024970152499
NMR metabolomics,X23412.Phospholipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00432210304618842,0.00948503956713967,-0.0142685745054053,0.0229127805977822,0.648630640375544
NMR metabolomics,X23412.Phospholipids in VLDL,EFNB2,Ephrin-B2,37039,-0.00259459304317478,0.00569894382821256,-0.0137645229464714,0.00857533686012185,0.648918102784203
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB5,Serpin B5,39585,0.00207165270920602,0.00459641953403053,-0.00693732957749382,0.0110806349959059,0.65220471603977
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR3,Folate receptor gamma,39858,-0.00801226028653878,0.0178637217940445,-0.043025155002866,0.0270006344297884,0.653783069195857
NMR metabolomics,X23412.Phospholipids in VLDL,PRR5,Proline-rich protein 5,37056,0.00201602952388724,0.00450781692788546,-0.00681929165476826,0.0108513507025427,0.65471657384565
NMR metabolomics,X23412.Phospholipids in VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.00367706002160873,0.00822431864599557,-0.0124426045245426,0.01979672456776,0.654813132936154
NMR metabolomics,X23412.Phospholipids in VLDL,IFNW1,Interferon omega-1,37021,0.00148739711186279,0.00335389304131829,-0.00508623324912106,0.00806102747284664,0.657423150036225
NMR metabolomics,X23412.Phospholipids in VLDL,IL2,Interleukin-2,39587,0.00129649622129341,0.00294225030144599,-0.00447031436954074,0.00706330681212756,0.659474024457495
NMR metabolomics,X23412.Phospholipids in VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.0034771955971899,0.00792359635264601,-0.0120530532539963,0.0190074444483761,0.660784179922573
NMR metabolomics,X23412.Phospholipids in VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00211326272872296,0.00485655160229359,-0.0116321038692184,0.00740557841177248,0.663470497032977
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00233701556800605,0.00540257476076306,-0.00825203096308955,0.0129260620991017,0.665329810409111
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN1,Cerebellin-1,36991,-0.00387789599828477,0.00909411027050019,-0.0217023521284651,0.0139465601318956,0.669809982477829
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.0031050718033517,0.00731010972949162,-0.0174328868731553,0.0112227432664519,0.67101543210626
NMR metabolomics,X23412.Phospholipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00132649045979364,0.00312620098316414,-0.00745384438679536,0.00480086346720808,0.671342650714675
NMR metabolomics,X23412.Phospholipids in VLDL,GPA33,Cell surface A33 antigen,39788,0.00525481693954141,0.0124049464717242,-0.019058878145038,0.0295685120241208,0.671858476286653
NMR metabolomics,X23412.Phospholipids in VLDL,OSTN,Osteocrin,37039,-0.00162648480011458,0.00395672208671115,-0.00938166009006844,0.00612869048983928,0.681028807790098
NMR metabolomics,X23412.Phospholipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,0.00278618414164074,0.0067830879860063,-0.0105086683109316,0.0160810365942131,0.681259222237829
NMR metabolomics,X23412.Phospholipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00132991331195636,0.00327312679263684,-0.00774524182552456,0.00508541520161184,0.684519387890971
NMR metabolomics,X23412.Phospholipids in VLDL,RBM25,RNA-binding protein 25,36962,-0.00175931861730429,0.00433028724332886,-0.0102466816142289,0.00672804437962028,0.684541899873931
NMR metabolomics,X23412.Phospholipids in VLDL,CRX,Cone-rod homeobox protein,39585,0.0041388006300046,0.0102218240229555,-0.0158959744549883,0.0241735757149975,0.685557670638808
NMR metabolomics,X23412.Phospholipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00174558324390461,0.0044248892794412,-0.00692719974380014,0.0104183662316094,0.693223244846413
NMR metabolomics,X23412.Phospholipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.000889085307848412,0.00225939513278674,-0.00531749976811043,0.00353932915241361,0.693952060502731
NMR metabolomics,X23412.Phospholipids in VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.00064411655549704,0.00164376040876994,-0.00386588695668611,0.00257765384569203,0.695170212242185
NMR metabolomics,X23412.Phospholipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00098970326697753,0.00252802569582889,-0.00396522709684709,0.00594463363080215,0.695438420152448
NMR metabolomics,X23412.Phospholipids in VLDL,LPA,Apolipoprotein(a),37186,-0.00650884500776373,0.0166473602248922,-0.0391376710485524,0.0261199810330249,0.695815600951968
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6,Seizure protein 6 homolog,37039,0.00113198165470648,0.00294151114611389,-0.00463338019167675,0.0068973435010897,0.700369600772407
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3B,Sodium channel subunit beta-3,36991,0.00161405658321443,0.00420697495356913,-0.00663161432578107,0.00985972749220992,0.701235164314051
NMR metabolomics,X23412.Phospholipids in VLDL,PMCH,Pro-MCH,37021,0.0030075123051945,0.00784933058686005,-0.0123771756450512,0.0183922002554402,0.701610836633737
NMR metabolomics,X23412.Phospholipids in VLDL,COL5A1,Collagen alpha-1(V) chain,37124,-0.00142177166100276,0.00374417988215782,-0.00876036423003209,0.00591682090802658,0.704153071144199
NMR metabolomics,X23412.Phospholipids in VLDL,TFF1,Trefoil factor 1,39789,0.00269064329292299,0.00710425458487998,-0.0112336956934418,0.0166149822792878,0.7048883033923
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS5,Transmembrane protease serine 5,39667,0.00136124025533825,0.0035945282428337,-0.00568403510061579,0.0084065156112923,0.7049173076478
NMR metabolomics,X23412.Phospholipids in VLDL,IL24,Interleukin-24,39587,-0.00168306661349384,0.00445834227158666,-0.0104214174658037,0.00705528423881601,0.705800091339384
NMR metabolomics,X23412.Phospholipids in VLDL,ANK2,Ankyrin-2,37021,0.00253093371072847,0.00672744097259433,-0.0106548505955564,0.0157167180170134,0.706766498632154
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.00219966555046061,0.00585997969353526,-0.0136852257497897,0.0092858946488685,0.707389655943961
NMR metabolomics,X23412.Phospholipids in VLDL,OTOA,Otoancorin,36991,-0.00188030233913431,0.00501099210771372,-0.0117018468702532,0.00794124219198459,0.707491360081127
NMR metabolomics,X23412.Phospholipids in VLDL,EPGN,Epigen,37368,-0.00176873404808206,0.00472159934700596,-0.0110230687682137,0.00748560067204961,0.707960240837146
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00364839436478893,0.00978453721197887,-0.0155292985706897,0.0228260873002675,0.709248613092435
NMR metabolomics,X23412.Phospholipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00173391314466224,0.00467625103970548,-0.010899365182485,0.00743153889316049,0.710798020154971
NMR metabolomics,X23412.Phospholipids in VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00160811115289974,0.00436541907474091,-0.0101643325393919,0.00694811023359244,0.712599569539118
NMR metabolomics,X23412.Phospholipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00403580388646601,0.0109715831911939,-0.0255401069412061,0.017468499168274,0.71299731975674
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA3,GDNF family receptor alpha-3,39709,0.000952656685513934,0.00261182246472328,-0.0041665153453437,0.00607182871637156,0.715304486865961
NMR metabolomics,X23412.Phospholipids in VLDL,SLC51B,Organic solute transporter subunit beta,37021,-0.00256072629799379,0.00717915639381736,-0.0166318728298758,0.0115104202338882,0.721330340448851
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3A,Uroplakin-3a,36991,0.00157390580460179,0.00451449514169701,-0.00727450467312436,0.0104223162823279,0.727369804062627
NMR metabolomics,X23412.Phospholipids in VLDL,CDH22,Cadherin-22,37169,-0.000952470750782427,0.00274156007996591,-0.00632592850751561,0.00442098700595075,0.728281866129318
NMR metabolomics,X23412.Phospholipids in VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00148522416371975,0.00436598733473304,-0.0100425593397965,0.00707211101235702,0.733725821192298
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.00206726204669681,0.00607708171472881,-0.00984381811417165,0.0139783422075653,0.733730340406452
NMR metabolomics,X23412.Phospholipids in VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00130187026637424,0.00383536633112621,-0.00621544774263314,0.00881918827538162,0.734284971197346
NMR metabolomics,X23412.Phospholipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00247087056700748,0.00737258239238827,-0.0119793909220735,0.0169211320560885,0.73752243005015
NMR metabolomics,X23412.Phospholipids in VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00232918946802513,0.00701833417892693,-0.0160851244587219,0.0114267455226716,0.739991046611479
NMR metabolomics,X23412.Phospholipids in VLDL,TP53BP1,TP53-binding protein 1,37056,0.00276187846030506,0.00832901201791603,-0.0135629850948103,0.0190867420154205,0.740198573443573
NMR metabolomics,X23412.Phospholipids in VLDL,SPRING1,SREBP regulating gene protein,36962,0.00186012830290466,0.00567743362620617,-0.00926764160445944,0.0129878982102688,0.743192578747262
NMR metabolomics,X23412.Phospholipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.00251536048760405,0.00771993027033713,-0.0176464238174648,0.0126157028422567,0.744560573721269
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB2,Integrin beta-2,39731,0.000878673680024861,0.00271442016167003,-0.0044415898368484,0.00619893719689812,0.746165008332462
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00180556796433884,0.00575815378393054,-0.00948041345216501,0.0130915493808427,0.75385476277364
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN7,Septin-7,37169,0.00150778260850036,0.00485397668916669,-0.00800601170226636,0.0110215769192671,0.756088062076688
NMR metabolomics,X23412.Phospholipids in VLDL,IKZF2,Zinc finger protein Helios,39477,0.0027187916987399,0.00888130017898534,-0.0146885566520714,0.0201261400495512,0.75951323890456
NMR metabolomics,X23412.Phospholipids in VLDL,NCLN,Nicalin,39587,0.00150087257902177,0.0049771848748566,-0.00825440977569717,0.0112561549337407,0.762998735782531
NMR metabolomics,X23412.Phospholipids in VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00126499354109525,0.00423651453499488,-0.00703857494749471,0.00956856202968521,0.765255276600475
NMR metabolomics,X23412.Phospholipids in VLDL,CA11,Carbonic anhydrase-related protein 11,39477,0.000879378252917099,0.00296282267044216,-0.00492775418114953,0.00668651068698373,0.766619935492412
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00141881681481485,0.0048140561539818,-0.0108543668766192,0.00801673324698948,0.768209494559817
NMR metabolomics,X23412.Phospholipids in VLDL,BOC,Brother of CDO,39585,0.000642974406044088,0.00221355619056039,-0.00369559572745428,0.00498154453954246,0.771459582213841
NMR metabolomics,X23412.Phospholipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.000965500566242787,0.00332939941222294,-0.00556012228171417,0.00749112341419974,0.771826604934122
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.0011449246626089,0.00395918425531802,-0.00661507647781442,0.00890492580303223,0.772446684949442
NMR metabolomics,X23412.Phospholipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000901071539752444,0.00316739321174852,-0.00530701915527465,0.00710916223477954,0.77604411921572
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00105790867781977,0.00372072911484081,-0.00835053774290776,0.00623472038726822,0.776163204534246
NMR metabolomics,X23412.Phospholipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.000817981742627254,0.00294184316759107,-0.00658399435110575,0.00494803086585124,0.7809769737557
NMR metabolomics,X23412.Phospholipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00236923037752159,0.00861431260853452,-0.0145148223352061,0.0192532830902493,0.783294286992868
NMR metabolomics,X23412.Phospholipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00116933767821117,0.00432606724385457,-0.00730975411974378,0.00964842947616612,0.786933389745345
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00158627077333586,0.00587346053156205,-0.00992571186852577,0.0130982534151975,0.787106544266414
NMR metabolomics,X23412.Phospholipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.000751255320922786,0.00280095757488373,-0.0062411321676949,0.00473862152584932,0.788538870221883
NMR metabolomics,X23412.Phospholipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00162017416797597,0.00620627647386038,-0.0137844760567423,0.0105441277207904,0.794054795763667
NMR metabolomics,X23412.Phospholipids in VLDL,GDF15,Growth/differentiation factor 15,40052,0.00102395463036399,0.00400461175340082,-0.00682508440630161,0.00887299366702959,0.798190485809389
NMR metabolomics,X23412.Phospholipids in VLDL,SPARCL1,SPARC-like protein 1,39871,-0.000644714613757522,0.00257148961611921,-0.00568483426135117,0.00439540503383613,0.80203659896296
NMR metabolomics,X23412.Phospholipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00101381691681018,0.00409870952885768,-0.00701965375975088,0.00904728759337124,0.804640903086517
NMR metabolomics,X23412.Phospholipids in VLDL,GAD2,Glutamate decarboxylase 2,37056,0.00107613967132336,0.00441094853674485,-0.00756931946069654,0.00972159880334326,0.807257749487435
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00148279802008272,0.00610112590553908,-0.0134410047949393,0.0104754087547739,0.807980689426723
NMR metabolomics,X23412.Phospholipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00135405373235383,0.00560818485763455,-0.0123460960533175,0.0096379885886099,0.809216007412814
NMR metabolomics,X23412.Phospholipids in VLDL,UBQLN3,Ubiquilin-3,37021,-0.00107161761860256,0.00445062469952625,-0.00979484202967402,0.0076516067924689,0.809730043043969
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00127747113931288,0.00542266409375583,-0.00935095048444854,0.0119058927630743,0.813762175432637
NMR metabolomics,X23412.Phospholipids in VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.000738527649136965,0.00320190463965182,-0.00701426074285454,0.00553720544458061,0.817588288989367
NMR metabolomics,X23412.Phospholipids in VLDL,IL5,Interleukin-5,39587,0.00312409487732242,0.01362371513572,-0.0235783867886888,0.0298265765433336,0.818628638425711
NMR metabolomics,X23412.Phospholipids in VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.000891536331718223,0.00390502569607052,-0.00854538669601645,0.00676231403258001,0.819412790193977
NMR metabolomics,X23412.Phospholipids in VLDL,CD82,CD82 antigen,37169,-0.000901009850879927,0.00398607956808664,-0.00871372580432973,0.00691170610256988,0.821174478358741
NMR metabolomics,X23412.Phospholipids in VLDL,OMP,Olfactory marker protein,36991,0.00102615784097359,0.00459797826096134,-0.00798587955051064,0.0100381952324578,0.823402095645953
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.000914588494855649,0.00410699123806342,-0.00713511433174865,0.00896429132145995,0.8237797526369
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.000749526426735574,0.00338746441434936,-0.00588990382538917,0.00738895667886032,0.824889732318432
NMR metabolomics,X23412.Phospholipids in VLDL,ENG,Endoglin,40052,-0.000342964305085069,0.00159987139722739,-0.00347871224365075,0.00279278363348061,0.830261295417965
NMR metabolomics,X23412.Phospholipids in VLDL,FBLN2,Fibulin-2,37437,-0.000572292000997546,0.00286340038508865,-0.00618455675577131,0.00503997275377621,0.841589571676662
NMR metabolomics,X23412.Phospholipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000927635929245886,0.00465071074158592,-0.00818775712426251,0.0100430289827543,0.841905142808275
NMR metabolomics,X23412.Phospholipids in VLDL,ARG2,"Arginase-2, mitochondrial",37368,0.00080227489493831,0.00414964041074014,-0.00733102031011237,0.00893557009998899,0.846698737941555
NMR metabolomics,X23412.Phospholipids in VLDL,TNXB,Tenascin-X,39858,-0.000468331678237728,0.00242833291008838,-0.00522786418201096,0.0042912008255355,0.84706996602472
NMR metabolomics,X23412.Phospholipids in VLDL,CGN,Cingulin,37039,0.000684545487373743,0.00367716481899653,-0.00652269755785946,0.00789178853260694,0.852321199770401
NMR metabolomics,X23412.Phospholipids in VLDL,C9orf40,Uncharacterized protein C9orf40,37382,-0.00139366924109237,0.00750677468991342,-0.0161069476333227,0.0133196091511379,0.852718210102111
NMR metabolomics,X23412.Phospholipids in VLDL,SCIN,Adseverin,36991,0.00122488681278005,0.00699205621136407,-0.0124795433614935,0.0149293169870536,0.860938831715249
NMR metabolomics,X23412.Phospholipids in VLDL,KLK3,Prostate-specific antigen,37437,0.00130349720332133,0.00744496712099659,-0.013288638353832,0.0158956327604746,0.86101596875714
NMR metabolomics,X23412.Phospholipids in VLDL,KLK1,Kallikrein-1,39720,0.00204744432604036,0.0118689743067663,-0.0212157453152216,0.0253106339673023,0.863043598739861
NMR metabolomics,X23412.Phospholipids in VLDL,MLLT1,Protein ENL,36962,-0.00116542739082526,0.00676736724087873,-0.0144294671829476,0.012098612401297,0.86327288005899
NMR metabolomics,X23412.Phospholipids in VLDL,DUOX2,Dual oxidase 2,39585,0.00114991217651776,0.00673606622714396,-0.0120527776286844,0.0143526019817199,0.864454192872202
NMR metabolomics,X23412.Phospholipids in VLDL,TPSD1,Tryptase delta,37411,0.000583653257072898,0.00346027176085604,-0.00619847939420494,0.00736578590835074,0.86605663881933
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,0.000556161679987429,0.00342771189166025,-0.00616215362766667,0.00727447698764153,0.871107527825937
NMR metabolomics,X23412.Phospholipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00093429034982338,0.00591921148193689,-0.0125359448544197,0.0106673641547729,0.874585037770218
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG4,Proteasome assembly chaperone 4,37056,-0.000828114065944155,0.00524950322273281,-0.0111171403825005,0.00946091225061216,0.874655472644468
NMR metabolomics,X23412.Phospholipids in VLDL,GJA8,Gap junction alpha-8 protein,36962,-0.00088686829863285,0.0056637879979147,-0.0119878927745457,0.01021415617728,0.875573773291825
NMR metabolomics,X23412.Phospholipids in VLDL,CA3,Carbonic anhydrase 3,40017,0.000886734843451904,0.00568918271561898,-0.0102640632791613,0.0120375329660651,0.876142714171212
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,0.000684825791561584,0.00446861016501548,-0.00807365013186875,0.00944330171499192,0.878201075010031
NMR metabolomics,X23412.Phospholipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000588725171024598,0.00386584075289615,-0.00816577304670106,0.00698832270465186,0.878961301357532
NMR metabolomics,X23412.Phospholipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,0.000457235616226074,0.00305215479603828,-0.00552498778400896,0.00643945901646111,0.880918814260858
NMR metabolomics,X23412.Phospholipids in VLDL,CD209,CD209 antigen,39885,-0.000546107177456083,0.00367085632928107,-0.00774098558284697,0.00664877122793481,0.881738310920625
NMR metabolomics,X23412.Phospholipids in VLDL,IL3,Interleukin-3,36962,0.000825940137146098,0.00565327329420164,-0.0102544755194891,0.0119063557937813,0.883845125686303
NMR metabolomics,X23412.Phospholipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.000709166184728796,0.00490898380751136,-0.0103307744474511,0.00891244207799348,0.885137138814323
NMR metabolomics,X23412.Phospholipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.000586320424529165,0.00409276893447188,-0.00743550668703572,0.00860814753609405,0.886088842548412
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS4,Galectin-4,39862,-0.000707410416659782,0.00497893954452288,-0.0104661319239246,0.00905131109060506,0.887018178129732
NMR metabolomics,X23412.Phospholipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.000555011233499968,0.00392346252497924,-0.00713497531545933,0.00824499778245927,0.887509074392645
NMR metabolomics,X23412.Phospholipids in VLDL,HK2,Hexokinase-2,39585,-0.000363081928982294,0.00258311980465446,-0.00542599674610504,0.00469983288814045,0.888219775497932
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.000617357098859624,0.0045576069139659,-0.00955026665023278,0.00831555245251353,0.892253097748721
NMR metabolomics,X23412.Phospholipids in VLDL,RBP1,Retinol-binding protein 1,37039,0.000899025125097984,0.00664512037066574,-0.0121254108014069,0.0139234610516028,0.892383849526524
NMR metabolomics,X23412.Phospholipids in VLDL,CD2,T-cell surface antigen CD2,37021,-0.000479397243486422,0.00363512119905038,-0.00760423479362516,0.00664544030665232,0.895081776798632
NMR metabolomics,X23412.Phospholipids in VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.000590200251765953,0.00450303748552601,-0.00941615372339693,0.00823575321986503,0.895724209496247
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.000476559038274192,0.00368172769102697,-0.00673962723613867,0.00769274531268705,0.897012276491169
NMR metabolomics,X23412.Phospholipids in VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.000761329006391735,0.00603258979690709,-0.0110625469955462,0.0125852050083296,0.89957342559025
NMR metabolomics,X23412.Phospholipids in VLDL,HMCN2,Hemicentin-2,37100,-0.000675928737252608,0.00537505749083693,-0.011211041419293,0.00985918394478777,0.899929483989242
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00048530459078239,0.00404781298387036,-0.0084190180391683,0.00744840885760352,0.904569708094835
NMR metabolomics,X23412.Phospholipids in VLDL,PSMA1,Proteasome subunit alpha type-1,39477,-0.000519265580978871,0.0043892551974082,-0.00912220576789894,0.00808367460594119,0.90582846593271
NMR metabolomics,X23412.Phospholipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.000657978857870276,0.00557530875874383,-0.0115855840250082,0.0102696263092676,0.906056323775424
NMR metabolomics,X23412.Phospholipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.000563649043318191,0.00479277086828661,-0.00995747994515995,0.00883018185852357,0.906383211609495
NMR metabolomics,X23412.Phospholipids in VLDL,CAPN3,Calpain-3,37368,0.000411676177660229,0.0035617702810059,-0.00656939357311134,0.0073927459284318,0.90798562624433
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00037207420268606,0.00341022352777881,-0.0063119639117604,0.00705611231713253,0.913120414205476
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.000443563734139613,0.00410633227492136,-0.00849197499298548,0.00760484752470626,0.913981909675542
NMR metabolomics,X23412.Phospholipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.000356834764850702,0.00358738046540531,-0.00738810047704511,0.0066744309473437,0.920767057250857
NMR metabolomics,X23412.Phospholipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.000306812182179885,0.00318505988528343,-0.00593590519297563,0.0065495295573354,0.923261114737298
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,0.000495580909259888,0.00515396092694639,-0.00960618250755504,0.0105973443260748,0.923398663757976
NMR metabolomics,X23412.Phospholipids in VLDL,LAYN,Layilin,39713,0.000290836464773229,0.003047198137881,-0.00568167188547354,0.00626334481501999,0.923963456899229
NMR metabolomics,X23412.Phospholipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.000534081921319335,0.00616279782584275,-0.0126131656599711,0.0115450018173325,0.930941305583331
NMR metabolomics,X23412.Phospholipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.000519574166456244,0.0060178875292106,-0.012314633723709,0.0112754853907965,0.931198814088152
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAX,Integrin alpha-X,37169,-0.000417412520715934,0.00500088102440232,-0.0102191393285445,0.00938431428711262,0.933480837829993
NMR metabolomics,X23412.Phospholipids in VLDL,FGF20,Fibroblast growth factor 20,37056,0.000331299082488066,0.00406901248003509,-0.00764396537838072,0.00830656354335685,0.935109162130188
NMR metabolomics,X23412.Phospholipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.000475804862952774,0.00617085894664793,-0.0116190786724772,0.0125706883983827,0.938540879555478
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.000283679374704502,0.00392555192898475,-0.00741040240610561,0.00797776115551461,0.942392232509089
NMR metabolomics,X23412.Phospholipids in VLDL,DKKL1,Dickkopf-like protein 1,39788,-0.000540116420591313,0.00795119780102226,-0.016124464110595,0.0150442312694123,0.945843055587912
NMR metabolomics,X23412.Phospholipids in VLDL,KHDC3L,KH domain-containing protein 3,36962,0.000424605451433909,0.00630351478177326,-0.0119302835208417,0.0127794944237095,0.94629605217286
NMR metabolomics,X23412.Phospholipids in VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.000424048624558291,0.00710776464719025,-0.0143552673330512,0.0135071700839346,0.952427407053386
NMR metabolomics,X23412.Phospholipids in VLDL,CDH4,Cadherin-4,36991,0.000262350034636482,0.00442677998533497,-0.00841413873662007,0.00893883880589303,0.952742494272556
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.000151240461557537,0.00256367403967549,-0.0051760415793215,0.00487356065620643,0.952957908708782
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.000600402796123903,0.0109411079125215,-0.022044974304666,0.0208441687124182,0.956238166244038
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,0.000281426797367816,0.00529372272698174,-0.0100942697475164,0.010657123342252,0.957603201672155
NMR metabolomics,X23412.Phospholipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.000251958459335465,0.00481152903217698,-0.00968255536240236,0.00917863844373142,0.958238202529737
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.000200340645802475,0.00394434629887414,-0.00793125939159579,0.00753057809999084,0.959492153957436
NMR metabolomics,X23412.Phospholipids in VLDL,DAND5,DAN domain family member 5,37056,-0.000255582500766493,0.00508431422012221,-0.010220838372206,0.00970967337067304,0.959908927369535
NMR metabolomics,X23412.Phospholipids in VLDL,RLN2,Prorelaxin H2,37095,0.000572901754342861,0.0134334591071904,-0.0257566780957504,0.0269024816044361,0.965983274184827
NMR metabolomics,X23412.Phospholipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.00013200916206062,0.0039508178452297,-0.00787561213871082,0.00761159381458958,0.973345556671387
NMR metabolomics,X23412.Phospholipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,0.000142645120336051,0.0044036399118641,-0.00848848910691758,0.00877377934758968,0.974159482729379
NMR metabolomics,X23412.Phospholipids in VLDL,SCG3,Secretogranin-3,39885,-8.93411755122775e-05,0.00305974351577439,-0.00608643846643008,0.00590775611540553,0.976706314170958
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-8.23148766418861e-05,0.00282000766805231,-0.0056095299060244,0.00544490015274063,0.976713822539113
NMR metabolomics,X23412.Phospholipids in VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.000190431239214522,0.00749795351943852,-0.014886420137314,0.014505557658885,0.979738083879129
NMR metabolomics,X23412.Phospholipids in VLDL,TFRC,Transferrin receptor protein 1,39918,9.22066147973356e-05,0.00368837596980763,-0.00713701028602562,0.00732142351562029,0.98005587639758
NMR metabolomics,X23412.Phospholipids in VLDL,IL10,Interleukin-10,39587,0.000181745712171562,0.00747442213941595,-0.0144681216810837,0.0148316131054268,0.980601108595391
NMR metabolomics,X23412.Phospholipids in VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.000133022575043312,0.0060760508898974,-0.0117760371691556,0.0120420823192422,0.982533693511065
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.000135781580586232,0.00750566266107827,-0.0145753172351272,0.0148468803962996,0.985566846063342
NMR metabolomics,X23412.Phospholipids in VLDL,TNR,Tenascin-R,39749,6.61354386007388e-05,0.00396369104783541,-0.00770269901515666,0.00783496989235814,0.986687870972524
NMR metabolomics,X23412.Phospholipids in VLDL,RGS8,Regulator of G-protein signaling 8,39587,-7.70695469616022e-05,0.00621119479367187,-0.0122510113425585,0.0120968722486353,0.990100125947947
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-2.67405736467246e-05,0.00226884192327757,-0.00447367074327077,0.00442018959597732,0.99059649692231
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-5.0861236168381e-05,0.00464426120567685,-0.00915361319929501,0.00905189072695825,0.991262374054282
NMR metabolomics,X23412.Phospholipids in VLDL,BTNL10,Butyrophilin-like protein 10,36962,3.46072753461287e-05,0.00374306108128429,-0.00730179244397107,0.00737100699466333,0.992623232750494
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,3.46015626956171e-05,0.00704892151265372,-0.0137812846021057,0.0138504877274969,0.996083443435398
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN4,Prefoldin subunit 4,36962,2.75940537053509e-06,0.00515890597909336,-0.0101086963136525,0.0101142151243935,0.999573234163218
